ID   CENPA_HUMAN             Reviewed;         140 AA.
AC   P49450; D6W544; Q53T74; Q9BVW2;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   26-FEB-2020, entry version 195.
DE   RecName: Full=Histone H3-like centromeric protein A;
DE   AltName: Full=Centromere autoantigen A;
DE   AltName: Full=Centromere protein A;
DE            Short=CENP-A;
GN   Name=CENPA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   REGION.
RX   PubMed=7962047; DOI=10.1083/jcb.127.3.581;
RA   Sullivan K.F., Hechenberger M., Masri K.;
RT   "Human CENP-A contains a histone H3 related histone fold domain that is
RT   required for targeting to the centromere.";
RL   J. Cell Biol. 127:581-592(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-33, FUNCTION, SUBCELLULAR LOCATION,
RP   AND SUBUNIT.
RX   PubMed=9024683; DOI=10.1083/jcb.136.3.501;
RA   Shelby R.D., Vafa O., Sullivan K.F.;
RT   "Assembly of CENP-A into centromeric chromatin requires a cooperative array
RT   of nucleosomal DNA contact sites.";
RL   J. Cell Biol. 136:501-513(1997).
RN   [7]
RP   IDENTIFICATION OF AUTOANTIGENIC EPITOPES.
RX   PubMed=10759786; DOI=10.1046/j.1365-2249.2000.01189.x;
RA   Muro Y., Azuma N., Onouchi H., Kunimatsu M., Tomita Y., Sasaki M.,
RA   Sugimoto K.;
RT   "Autoepitopes on autoantigen centromere protein-A (CENP-A) are restricted
RT   to the N-terminal region, which has no homology with histone H3.";
RL   Clin. Exp. Immunol. 120:218-223(2000).
RN   [8]
RP   UBIQUITINATION, AND INTERACTION WITH HHV-1 ICP0 (MICROBIAL INFECTION).
RX   PubMed=11053442; DOI=10.1074/jbc.m008547200;
RA   Lomonte P., Sullivan K.F., Everett R.D.;
RT   "Degradation of nucleosome-associated centromeric histone H3-like protein
RT   CENP-A induced by herpes simplex virus type 1 protein ICP0.";
RL   J. Biol. Chem. 276:5829-5835(2001).
RN   [9]
RP   PHOSPHORYLATION AT SER-7, MUTAGENESIS OF SER-7, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11756469; DOI=10.1083/jcb.200108125;
RA   Zeitlin S.G., Shelby R.D., Sullivan K.F.;
RT   "CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role
RT   in completion of cytokinesis.";
RL   J. Cell Biol. 155:1147-1157(2001).
RN   [10]
RP   PHOSPHORYLATION AT SER-7, MUTAGENESIS OF SER-7, FUNCTION, INTERACTION WITH
RP   AURKA, AND SUBCELLULAR LOCATION.
RX   PubMed=14667408; DOI=10.1016/s1534-5807(03)00364-2;
RA   Kunitoku N., Sasayama T., Marumoto T., Zhang D., Honda S., Kobayashi O.,
RA   Hatakeyama K., Ushio Y., Saya H., Hirota T.;
RT   "CENP-A phosphorylation by Aurora-A in prophase is required for enrichment
RT   of Aurora-B at inner centromeres and for kinetochore function.";
RL   Dev. Cell 5:853-864(2003).
RN   [11]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15702419; DOI=10.1007/s10577-005-5377-4;
RA   Irvine D.V., Amor D.J., Perry J., Sirvent N., Pedeutour F., Choo K.H.,
RA   Saffery R.;
RT   "Chromosome size and origin as determinants of the level of CENP-A
RT   incorporation into human centromeres.";
RL   Chromosome Res. 12:805-815(2004).
RN   [12]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15475964; DOI=10.1038/nsmb845;
RA   Sullivan B.A., Karpen G.H.;
RT   "Centromeric chromatin exhibits a histone modification pattern that is
RT   distinct from both euchromatin and heterochromatin.";
RL   Nat. Struct. Mol. Biol. 11:1076-1083(2004).
RN   [13]
RP   SUBUNIT, DOMAIN CATD, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15282608; DOI=10.1038/nature02766;
RA   Black B.E., Foltz D.R., Chakravarthy S., Luger K., Woods V.L. Jr.,
RA   Cleveland D.W.;
RT   "Structural determinants for generating centromeric chromatin.";
RL   Nature 430:578-582(2004).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE CENPA-NAC
RP   COMPLEX WITH CENPC; CENPH; CENPM; CENPN; CENPT AND CENPU.
RX   PubMed=16622419; DOI=10.1038/ncb1397;
RA   Foltz D.R., Jansen L.E.T., Black B.E., Bailey A.O., Yates J.R. III,
RA   Cleveland D.W.;
RT   "The human CENP-A centromeric nucleosome-associated complex.";
RL   Nat. Cell Biol. 8:458-469(2006).
RN   [16]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17651496; DOI=10.1186/gb-2007-8-7-r148;
RA   Alonso A., Fritz B., Hasson D., Abrusan G., Cheung F., Yoda K.,
RA   Radlwimmer B., Ladurner A.G., Warburton P.E.;
RT   "Co-localization of CENP-C and CENP-H to discontinuous domains of CENP-A
RT   chromatin at human neocentromeres.";
RL   Genome Biol. 8:R148.1-R148.19(2007).
RN   [17]
RP   PHOSPHORYLATION AT SER-7.
RX   PubMed=18239465; DOI=10.4161/cc.7.6.5563;
RA   Slattery S.D., Moore R.V., Brinkley B.R., Hall R.M.;
RT   "Aurora-C and Aurora-B share phosphorylation and regulation of CENP-A and
RT   Borealin during mitosis.";
RL   Cell Cycle 7:787-795(2008).
RN   [18]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=18072184; DOI=10.1002/cbic.200700358;
RA   Orthaus S., Biskup C., Hoffmann B., Hoischen C., Ohndorf S., Benndorf K.,
RA   Diekmann S.;
RT   "Assembly of the inner kinetochore proteins CENP-A and CENP-B in living
RT   human cells.";
RL   ChemBioChem 9:77-92(2008).
RN   [19]
RP   INTERACTION WITH CENPT.
RX   PubMed=19412974; DOI=10.1002/jbio.200810014;
RA   Hellwig D., Muench S., Orthaus S., Hoischen C., Hemmerich P., Diekmann S.;
RT   "Live-cell imaging reveals sustained centromere binding of CENP-T via CENP-
RT   A and CENP-B.";
RL   J. Biophotonics 1:245-254(2008).
RN   [20]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=19114591; DOI=10.1083/jcb.200804078;
RA   Marshall O.J., Marshall A.T., Choo K.H.A.;
RT   "Three-dimensional localization of CENP-A suggests a complex higher order
RT   structure of centromeric chromatin.";
RL   J. Cell Biol. 183:1193-1202(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-19 AND SER-27, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   INTERACTION WITH HJURP.
RX   PubMed=19410544; DOI=10.1016/j.cell.2009.02.039;
RA   Foltz D.R., Jansen L.E.T., Bailey A.O., Yates J.R. III, Bassett E.A.,
RA   Wood S., Black B.E., Cleveland D.W.;
RT   "Centromere-specific assembly of CENP-A nucleosomes is mediated by HJURP.";
RL   Cell 137:472-484(2009).
RN   [23]
RP   INTERACTION WITH HJURP.
RX   PubMed=19410545; DOI=10.1016/j.cell.2009.02.040;
RA   Dunleavy E.M., Roche D., Tagami H., Lacoste N., Ray-Gallet D., Nakamura Y.,
RA   Daigo Y., Nakatani Y., Almouzni-Pettinotti G.;
RT   "HJURP is a cell-cycle-dependent maintenance and deposition factor of CENP-
RT   A at centromeres.";
RL   Cell 137:485-497(2009).
RN   [24]
RP   IDENTIFICATION IN COMPLEX WITH CENPT AND CENPW.
RX   PubMed=19533040; DOI=10.1007/s10059-009-0083-2;
RA   Kim H., Lee M., Lee S., Park B., Koh W., Lee D.J., Lim D.S., Lee S.;
RT   "Cancer-upregulated gene 2 (CUG2), a new component of centromere complex,
RT   is required for kinetochore function.";
RL   Mol. Cells 27:697-701(2009).
RN   [25]
RP   INTERACTION WITH CENPN.
RX   PubMed=19543270; DOI=10.1038/ncb1899;
RA   Carroll C.W., Silva M.C.C., Godek K.M., Jansen L.E.T., Straight A.F.;
RT   "Centromere assembly requires the direct recognition of CENP-A nucleosomes
RT   by CENP-N.";
RL   Nat. Cell Biol. 11:896-902(2009).
RN   [26]
RP   INTERACTION WITH CENPC.
RX   PubMed=19503796; DOI=10.1371/journal.pone.0005832;
RA   Trazzi S., Perini G., Bernardoni R., Zoli M., Reese J.C., Musacchio A.,
RA   Della Valle G.;
RT   "The C-terminal domain of CENP-C displays multiple and critical functions
RT   for mammalian centromere formation.";
RL   PLoS ONE 4:E5832-E5832(2009).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-19 AND SER-27, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND SER-19, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY,
RP   PHOSPHORYLATION AT SER-17 AND SER-19, MUTAGENESIS OF SER-17 AND SER-19,
RP   METHYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, SUBUNIT, AND
RP   INTERACTION WITH HJURP.
RX   PubMed=23818633; DOI=10.1073/pnas.1300325110;
RA   Bailey A.O., Panchenko T., Sathyan K.M., Petkowski J.J., Pai P.J.,
RA   Bai D.L., Russell D.H., Macara I.G., Shabanowitz J., Hunt D.F., Black B.E.,
RA   Foltz D.R.;
RT   "Posttranslational modification of CENP-A influences the conformation of
RT   centromeric chromatin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:11827-11832(2013).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND SER-19, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=24522885; DOI=10.1098/rsob.130229;
RA   Dornblut C., Quinn N., Monajambashi S., Prendergast L., van Vuuren C.,
RA   Muench S., Deng W., Leonhardt H., Cardoso M.C., Hoischen C., Diekmann S.,
RA   Sullivan K.F.;
RT   "A CENP-S/X complex assembles at the centromere in S and G2 phases of the
RT   human cell cycle.";
RL   Open Biol. 4:130229-130229(2014).
RN   [32]
RP   FUNCTION, PHOSPHORYLATION AT SER-68, MUTAGENESIS OF SER-68, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH HJURP; CDK1; PPP1CA AND RBBP7.
RX   PubMed=25556658; DOI=10.1016/j.devcel.2014.11.030;
RA   Yu Z., Zhou X., Wang W., Deng W., Fang J., Hu H., Wang Z., Li S., Cui L.,
RA   Shen J., Zhai L., Peng S., Wong J., Dong S., Yuan Z., Ou G., Zhang X.,
RA   Xu P., Lou J., Yang N., Chen P., Xu R.M., Li G.;
RT   "Dynamic phosphorylation of CENP-A at Ser68 orchestrates its cell-cycle-
RT   dependent deposition at centromeres.";
RL   Dev. Cell 32:68-81(2015).
RN   [33]
RP   FUNCTION, ELECTRON MICROSCOPY OF NUCLEOSOME, SUBUNIT, DOMAIN, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=27499292; DOI=10.1016/j.molcel.2016.06.023;
RA   Roulland Y., Ouararhni K., Naidenov M., Ramos L., Shuaib M., Syed S.H.,
RA   Lone I.N., Boopathi R., Fontaine E., Papai G., Tachiwana H., Gautier T.,
RA   Skoufias D., Padmanabhan K., Bednar J., Kurumizaka H., Schultz P.,
RA   Angelov D., Hamiche A., Dimitrov S.;
RT   "The flexible ends of CENP-A nucleosome are required for mitotic
RT   fidelity.";
RL   Mol. Cell 63:674-685(2016).
RN   [34]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=26878239; DOI=10.1038/nsmb.3175;
RA   Falk S.J., Lee J., Sekulic N., Sennett M.A., Lee T.H., Black B.E.;
RT   "CENP-C directs a structural transition of CENP-A nucleosomes mainly
RT   through sliding of DNA gyres.";
RL   Nat. Struct. Mol. Biol. 23:204-208(2016).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), FUNCTION, SUBCELLULAR LOCATION,
RP   SUBUNIT, AND MUTAGENESIS OF HIS-104 AND LEU-112.
RX   PubMed=20739937; DOI=10.1038/nature09323;
RA   Sekulic N., Bassett E.A., Rogers D.J., Black B.E.;
RT   "The structure of (CENP-A-H4)(2) reveals physical features that mark
RT   centromeres.";
RL   Nature 467:347-351(2010).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH HJURP AND HISTONE H4,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=21478274; DOI=10.1101/gad.2045111;
RA   Hu H., Liu Y., Wang M., Fang J., Huang H., Yang N., Li Y., Wang J., Yao X.,
RA   Shi Y., Li G., Xu R.M.;
RT   "Structure of a CENP-A-histone H4 heterodimer in complex with chaperone
RT   HJURP.";
RL   Genes Dev. 25:901-906(2011).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (3.60 ANGSTROMS) OF NUCLEOSOME, SUBUNIT, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF 80-ARG-GLY-81.
RX   PubMed=21743476; DOI=10.1038/nature10258;
RA   Tachiwana H., Kagawa W., Shiga T., Osakabe A., Miya Y., Saito K.,
RA   Hayashi-Takanaka Y., Oda T., Sato M., Park S.Y., Kimura H., Kurumizaka H.;
RT   "Crystal structure of the human centromeric nucleosome containing CENP-A.";
RL   Nature 476:232-235(2011).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.67 ANGSTROMS) OF NUCLEOSOME CONTAINING BOTH CENPA
RP   AND HISTONE H3, AND SUBUNIT.
RX   PubMed=25408271; DOI=10.1038/srep07115;
RA   Arimura Y., Shirayama K., Horikoshi N., Fujita R., Taguchi H., Kagawa W.,
RA   Fukagawa T., Almouzni G., Kurumizaka H.;
RT   "Crystal structure and stable property of the cancer-associated heterotypic
RT   nucleosome containing CENP-A and H3.3.";
RL   Sci. Rep. 4:7115-7115(2014).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.30 ANGSTROMS) OF 3-10 IN COMPLEX WITH NTMT1, AND
RP   METHYLATION AT GLY-2.
RX   PubMed=26543159; DOI=10.1101/gad.270926.115;
RA   Wu R., Yue Y., Zheng X., Li H.;
RT   "Molecular basis for histone N-terminal methylation by NRMT1.";
RL   Genes Dev. 29:2337-2342(2015).
CC   -!- FUNCTION: Histone H3-like nucleosomal protein that is specifically
CC       found in centromeric nucleosomes (PubMed:7962047, PubMed:9024683,
CC       PubMed:11756469, PubMed:14667408, PubMed:15702419, PubMed:15475964,
CC       PubMed:15282608, PubMed:17651496, PubMed:19114591, PubMed:27499292,
CC       PubMed:20739937). Replaces conventional H3 in the nucleosome core of
CC       centromeric chromatin at the inner plate of the kinetochore
CC       (PubMed:18072184). The presence of CENPA subtly modifies the nucleosome
CC       structure and the way DNA is wrapped around the nucleosome and gives
CC       rise to protruding DNA ends that are less well-ordered and rigid
CC       compared to nucleosomes containing histone H3 (PubMed:27499292,
CC       PubMed:26878239). May serve as an epigenetic mark that propagates
CC       centromere identity through replication and cell division
CC       (PubMed:15475964, PubMed:15282608, PubMed:26878239, PubMed:20739937,
CC       PubMed:21478274). Required for recruitment and assembly of kinetochore
CC       proteins, and as a consequence required for progress through mitosis,
CC       chromosome segregation and cytokinesis (PubMed:11756469,
CC       PubMed:14667408, PubMed:18072184, PubMed:23818633, PubMed:25556658,
CC       PubMed:27499292). {ECO:0000269|PubMed:11756469,
CC       ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:15282608,
CC       ECO:0000269|PubMed:15475964, ECO:0000269|PubMed:15702419,
CC       ECO:0000269|PubMed:17651496, ECO:0000269|PubMed:18072184,
CC       ECO:0000269|PubMed:19114591, ECO:0000269|PubMed:21478274,
CC       ECO:0000269|PubMed:23818633, ECO:0000269|PubMed:25556658,
CC       ECO:0000269|PubMed:26878239, ECO:0000269|PubMed:27499292,
CC       ECO:0000269|PubMed:7962047, ECO:0000269|PubMed:9024683,
CC       ECO:0000305|PubMed:20739937}.
CC   -!- SUBUNIT: Component of centromeric nucleosomes, where DNA is wrapped
CC       around a histone octamer core (PubMed:23818633, PubMed:26878239,
CC       PubMed:20739937, PubMed:21743476). The octamer contains two molecules
CC       each of H2A, H2B, CENPA and H4 assembled in one CENPA-H4 heterotetramer
CC       and two H2A-H2B heterodimers (PubMed:23818633, PubMed:26878239,
CC       PubMed:20739937, PubMed:21743476). CENPA modulates the DNA-binding
CC       characteristics of nucleosomes so that protruding DNA ends have higher
CC       flexibility than in nucleosomes containing conventional histone H3
CC       (PubMed:27499292, PubMed:21743476). Inhibits binding of histone H1 to
CC       nucleosomes, since histone H1 binds preferentially to rigid DNA linkers
CC       that protrude from nucleosomes (PubMed:27499292). Nucleosomes
CC       containing CENPA also contain histone H2A variants such as MACROH2A and
CC       H2A.Z/H2AZ1 (Probable). The CENPA-H4 heterotetramer is more compact and
CC       structurally more rigid than corresponding H3-H4 heterotetramers
CC       (PubMed:15282608, PubMed:20739937). Can assemble into nucleosomes that
CC       contain both CENPA and histone H3.3; these nucleosomes interact with a
CC       single CENPC chain (PubMed:25408271). Heterotrimer composed of HJURP,
CC       CENPA and histone H4, where HJURP interacts with the dimer formed by
CC       CENPA and histone H4 and prevents tetramerization of CENPA and H4
CC       (PubMed:21478274). Component of the CENPA-NAC complex, at least
CC       composed of CENPA, CENPC, CENPH, CENPM, CENPN, CENPT and CENPU
CC       (PubMed:16622419). Interacts (via CATD domain) with HJURP; the
CC       interaction is direct and is required for its localization to
CC       centromeres (PubMed:15282608, PubMed:19410544, PubMed:19410545,
CC       PubMed:23818633, PubMed:25556658). Interacts with CENPC, CENPN and
CC       CENPT; interaction is direct. Part of a centromere complex consisting
CC       of CENPA, CENPT and CENPW (PubMed:19533040). Identified in centromere
CC       complexes containing histones H2A, H2B and H4, and at least CENPA,
CC       CENPB, CENPC, CENPT, CENPN, HJURP, SUPT16H, SSRP1 and RSF1
CC       (PubMed:27499292). Can self-associate (PubMed:9024683). The CENPA-H4
CC       heterotetramer can bind DNA by itself (in vitro) (PubMed:20739937).
CC       Interacts with CDK1, PPP1CA and RBBP7 (PubMed:25556658).
CC       {ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:16622419,
CC       ECO:0000269|PubMed:19410544, ECO:0000269|PubMed:19410545,
CC       ECO:0000269|PubMed:19412974, ECO:0000269|PubMed:19503796,
CC       ECO:0000269|PubMed:19533040, ECO:0000269|PubMed:19543270,
CC       ECO:0000269|PubMed:20739937, ECO:0000269|PubMed:21478274,
CC       ECO:0000269|PubMed:21743476, ECO:0000269|PubMed:23818633,
CC       ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26878239,
CC       ECO:0000269|PubMed:27499292, ECO:0000269|PubMed:9024683, ECO:0000305}.
CC   -!- SUBUNIT: (Microbial infection) Interacts directly with herpes virus
CC       HHV-1 protein ICP0. {ECO:0000269|PubMed:11053442}.
CC   -!- INTERACTION:
CC       Q03188:CENPC; NbExp=4; IntAct=EBI-1751979, EBI-295799;
CC       P62805:HIST1H4K; NbExp=6; IntAct=EBI-1751979, EBI-302023;
CC       Q8NCD3:HJURP; NbExp=15; IntAct=EBI-1751979, EBI-719429;
CC       Q8NCD3-1:HJURP; NbExp=2; IntAct=EBI-1751979, EBI-15825976;
CC       P49736:MCM2; NbExp=3; IntAct=EBI-1751979, EBI-374819;
CC       P06748-1:NPM1; NbExp=3; IntAct=EBI-15826012, EBI-354150;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14667408,
CC       ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:9024683}. Chromosome,
CC       centromere, kinetochore {ECO:0000269|PubMed:18072184,
CC       ECO:0000269|PubMed:19114591, ECO:0000269|PubMed:23818633}. Chromosome,
CC       centromere {ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:15282608,
CC       ECO:0000269|PubMed:15475964, ECO:0000269|PubMed:15702419,
CC       ECO:0000269|PubMed:17651496, ECO:0000269|PubMed:18072184,
CC       ECO:0000269|PubMed:20739937, ECO:0000269|PubMed:21743476,
CC       ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:27499292,
CC       ECO:0000269|PubMed:7962047, ECO:0000269|PubMed:9024683}. Note=Localizes
CC       exclusively in the kinetochore domain of centromeres. Occupies a
CC       compact domain at the inner kinetochore plate stretching across 2
CC       thirds of the length of the constriction but encompassing only one
CC       third of the constriction width and height (PubMed:19114591).
CC       Phosphorylation at Ser-68 during early mitosis abolishes association
CC       with chromatin and centromeres and results in dispersed nuclear
CC       location (PubMed:25556658). {ECO:0000269|PubMed:19114591,
CC       ECO:0000269|PubMed:25556658}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49450-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49450-2; Sequence=VSP_020430;
CC   -!- DEVELOPMENTAL STAGE: Expression varies across the cell cycle, with high
CC       levels in G2 phase (at the mRNA level). {ECO:0000269|PubMed:24522885}.
CC   -!- DOMAIN: The CATD (CENPA targeting domain) region is responsible for the
CC       more compact structure of nucleosomes containing CENPA
CC       (PubMed:15282608). It is necessary and sufficient to mediate the
CC       localization into centromeres (PubMed:7962047, PubMed:15282608).
CC       {ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:7962047}.
CC   -!- PTM: Ubiquitinated (Probable). Interaction with herpes virus HSV-1 ICP0
CC       protein, leads to its degradation by the proteasome pathway.
CC       {ECO:0000269|PubMed:11053442, ECO:0000305}.
CC   -!- PTM: Trimethylated by NTMT1 at the N-terminal glycine after cleavage of
CC       Met-1. Methylation is low before incorporation into nucleosomes and
CC       increases with cell cycle progression, with the highest levels in
CC       mitotic nucleosomes. {ECO:0000269|PubMed:23818633}.
CC   -!- PTM: Phosphorylated by CDK1 at Ser-68 during early mitosis; this
CC       abolishes association with chromatin and centromeres, prevents
CC       interaction with HJURP and thereby prevents premature assembly of CENPA
CC       into centromeres (PubMed:25556658). Dephosphorylated at Ser-68 by
CC       PPP1CA during late mitosis (PubMed:25556658). Phosphorylation of Ser-7
CC       by AURKA and AURKB during prophase is required for localization of
CC       AURKA and AURKB at inner centromere and is essential for normal
CC       cytokinesis (PubMed:11756469, PubMed:14667408, PubMed:18239465).
CC       Initial phosphorylation during prophase is mediated by AURKA and is
CC       maintained by AURKB. {ECO:0000269|PubMed:11756469,
CC       ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:18239465,
CC       ECO:0000269|PubMed:25556658}.
CC   -!- PTM: Poly-ADP-ribosylated by PARP1. {ECO:0000250|UniProtKB:O35216}.
CC   -!- MISCELLANEOUS: Antibodies against CENPA are present in sera from
CC       patients with autoimmune diseases that developed autoantibodies against
CC       centrosomal proteins.
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U14518; AAA57416.1; -; mRNA.
DR   EMBL; BT007246; AAP35910.1; -; mRNA.
DR   EMBL; AC011740; AAX93267.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00669.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00670.1; -; Genomic_DNA.
DR   EMBL; BC000881; AAH00881.1; -; mRNA.
DR   EMBL; BC002703; AAH02703.1; -; mRNA.
DR   EMBL; U82609; AAB47505.1; -; Genomic_DNA.
DR   CCDS; CCDS1729.1; -. [P49450-1]
DR   CCDS; CCDS42662.1; -. [P49450-2]
DR   PIR; I38855; I38855.
DR   RefSeq; NP_001035891.1; NM_001042426.1. [P49450-2]
DR   RefSeq; NP_001800.1; NM_001809.3. [P49450-1]
DR   PDB; 3AN2; X-ray; 3.60 A; A/E=1-140.
DR   PDB; 3NQJ; X-ray; 2.10 A; A=60-140.
DR   PDB; 3NQU; X-ray; 2.50 A; A=1-140.
DR   PDB; 3R45; X-ray; 2.60 A; A=1-140.
DR   PDB; 3WTP; X-ray; 2.67 A; A=1-140.
DR   PDB; 5CVD; X-ray; 1.30 A; D/E=3-10.
DR   PDB; 5Z23; X-ray; 2.73 A; A/E=75-116.
DR   PDB; 6BUZ; EM; 3.92 A; A/E=1-140.
DR   PDB; 6C0W; EM; 4.00 A; A/E=1-140.
DR   PDB; 6E0C; EM; 2.63 A; A/E=1-140.
DR   PDB; 6E0P; EM; 2.60 A; A/E=1-140.
DR   PDB; 6MUO; EM; 3.60 A; A/E=38-139.
DR   PDB; 6MUP; EM; 3.50 A; A/E=38-139.
DR   PDB; 6O1D; EM; 3.40 A; A/E=1-140.
DR   PDB; 6SE0; EM; 3.80 A; A/E=1-140.
DR   PDB; 6SE6; EM; 3.50 A; A/E=1-140.
DR   PDB; 6SEE; EM; 4.20 A; A/E=1-140.
DR   PDB; 6SEF; EM; 3.70 A; A/E=1-140.
DR   PDB; 6SEG; EM; 3.10 A; A/E=1-140.
DR   PDBsum; 3AN2; -.
DR   PDBsum; 3NQJ; -.
DR   PDBsum; 3NQU; -.
DR   PDBsum; 3R45; -.
DR   PDBsum; 3WTP; -.
DR   PDBsum; 5CVD; -.
DR   PDBsum; 5Z23; -.
DR   PDBsum; 6BUZ; -.
DR   PDBsum; 6C0W; -.
DR   PDBsum; 6E0C; -.
DR   PDBsum; 6E0P; -.
DR   PDBsum; 6MUO; -.
DR   PDBsum; 6MUP; -.
DR   PDBsum; 6O1D; -.
DR   PDBsum; 6SE0; -.
DR   PDBsum; 6SE6; -.
DR   PDBsum; 6SEE; -.
DR   PDBsum; 6SEF; -.
DR   PDBsum; 6SEG; -.
DR   SMR; P49450; -.
DR   BioGrid; 107487; 98.
DR   CORUM; P49450; -.
DR   DIP; DIP-52297N; -.
DR   IntAct; P49450; 47.
DR   STRING; 9606.ENSP00000336868; -.
DR   iPTMnet; P49450; -.
DR   PhosphoSitePlus; P49450; -.
DR   BioMuta; CENPA; -.
DR   DMDM; 1345726; -.
DR   EPD; P49450; -.
DR   jPOST; P49450; -.
DR   MassIVE; P49450; -.
DR   PaxDb; P49450; -.
DR   PeptideAtlas; P49450; -.
DR   PRIDE; P49450; -.
DR   ProteomicsDB; 56013; -. [P49450-1]
DR   ProteomicsDB; 56014; -. [P49450-2]
DR   DNASU; 1058; -.
DR   Ensembl; ENST00000233505; ENSP00000233505; ENSG00000115163. [P49450-2]
DR   Ensembl; ENST00000335756; ENSP00000336868; ENSG00000115163. [P49450-1]
DR   GeneID; 1058; -.
DR   KEGG; hsa:1058; -.
DR   UCSC; uc002rhr.4; human. [P49450-1]
DR   CTD; 1058; -.
DR   DisGeNET; 1058; -.
DR   GeneCards; CENPA; -.
DR   HGNC; HGNC:1851; CENPA.
DR   HPA; CAB008371; -.
DR   HPA; HPA073086; -.
DR   MIM; 117139; gene.
DR   neXtProt; NX_P49450; -.
DR   OpenTargets; ENSG00000115163; -.
DR   PharmGKB; PA26396; -.
DR   eggNOG; KOG1745; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00960000186578; -.
DR   HOGENOM; CLU_078295_3_2_1; -.
DR   InParanoid; P49450; -.
DR   KO; K11495; -.
DR   OMA; VREICVK; -.
DR   OrthoDB; 1564596at2759; -.
DR   PhylomeDB; P49450; -.
DR   TreeFam; TF354293; -.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   SIGNOR; P49450; -.
DR   ChiTaRS; CENPA; human.
DR   EvolutionaryTrace; P49450; -.
DR   GeneWiki; CENPA; -.
DR   GenomeRNAi; 1058; -.
DR   Pharos; P49450; Tbio.
DR   PRO; PR:P49450; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P49450; protein.
DR   Bgee; ENSG00000115163; Expressed in oocyte and 132 other tissues.
DR   ExpressionAtlas; P49450; baseline and differential.
DR   Genevisible; P49450; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB.
DR   GO; GO:0000939; C:condensed chromosome inner kinetochore; IEA:Ensembl.
DR   GO; GO:0000778; C:condensed nuclear chromosome kinetochore; IDA:BHF-UCL.
DR   GO; GO:0000780; C:condensed nuclear chromosome, centromeric region; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0031618; C:nuclear pericentric heterochromatin; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0034080; P:CENP-A containing nucleosome assembly; TAS:Reactome.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB.
DR   GO; GO:0051382; P:kinetochore assembly; IDA:BHF-UCL.
DR   GO; GO:0000281; P:mitotic cytokinesis; IMP:UniProtKB.
DR   GO; GO:0071459; P:protein localization to chromosome, centromeric region; IDA:BHF-UCL.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00959; HISTONE_H3_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Alternative splicing; Cell cycle;
KW   Cell division; Centromere; Chromosome; DNA-binding; Host-virus interaction;
KW   Kinetochore; Methylation; Mitosis; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:23818633"
FT   CHAIN           2..140
FT                   /note="Histone H3-like centromeric protein A"
FT                   /id="PRO_0000221373"
FT   REGION          39..54
FT                   /note="Important for flexibility of DNA ends that protrude
FT                   from nucleosomes"
FT                   /evidence="ECO:0000269|PubMed:27499292"
FT   REGION          75..116
FT                   /note="CATD"
FT                   /evidence="ECO:0000269|PubMed:15282608,
FT                   ECO:0000269|PubMed:7962047"
FT   MOD_RES         2
FT                   /note="N,N,N-trimethylglycine"
FT                   /evidence="ECO:0000269|PubMed:23818633,
FT                   ECO:0000269|PubMed:26543159"
FT   MOD_RES         7
FT                   /note="Phosphoserine; by AURKA and AURKB"
FT                   /evidence="ECO:0000269|PubMed:11756469,
FT                   ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:18239465"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:23818633"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:23818633"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         68
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25556658"
FT   VAR_SEQ         71..96
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020430"
FT   MUTAGEN         7
FT                   /note="S->A: Induces a delay at the terminal stage of
FT                   cytokinesis and chromosome misalignment during mitosis due
FT                   to a defect in kinetochore attachment to microtubules."
FT                   /evidence="ECO:0000269|PubMed:11756469,
FT                   ECO:0000269|PubMed:14667408"
FT   MUTAGEN         17
FT                   /note="S->A: Impaired mitotic chromosome congression and
FT                   chromosome segregation; when associated with A-19."
FT                   /evidence="ECO:0000269|PubMed:23818633"
FT   MUTAGEN         19
FT                   /note="S->A: Impaired mitotic chromosome congression and
FT                   chromosome segregation; when associated with A-17."
FT                   /evidence="ECO:0000269|PubMed:23818633"
FT   MUTAGEN         68
FT                   /note="S->A: No effect on interaction with HJURP. Impairs
FT                   localization at centromeres."
FT                   /evidence="ECO:0000269|PubMed:25556658"
FT   MUTAGEN         68
FT                   /note="S->E,Q: Impairs interaction with HJURP, association
FT                   with chromatin and localization at centromeres."
FT                   /evidence="ECO:0000269|PubMed:25556658"
FT   MUTAGEN         80..81
FT                   /note="RG->AA: Impairs retention at centromeres, but not
FT                   targeting to centromeres."
FT                   /evidence="ECO:0000269|PubMed:21743476"
FT   MUTAGEN         104
FT                   /note="H->G: Reduces location at centromeres. Abolishes
FT                   location at centromeres; when associated with C-112."
FT                   /evidence="ECO:0000269|PubMed:20739937"
FT   MUTAGEN         112
FT                   /note="L->C: No effect on location at centromeres.
FT                   Abolishes location at centromeres; when associated with G-
FT                   104."
FT                   /evidence="ECO:0000269|PubMed:20739937"
FT   HELIX           47..54
FT                   /evidence="ECO:0000244|PDB:6E0P"
FT   HELIX           64..79
FT                   /evidence="ECO:0000244|PDB:3NQJ"
FT   STRAND          85..87
FT                   /evidence="ECO:0000244|PDB:3R45"
FT   HELIX           88..115
FT                   /evidence="ECO:0000244|PDB:3NQJ"
FT   STRAND          119..121
FT                   /evidence="ECO:0000244|PDB:3NQJ"
FT   HELIX           123..133
FT                   /evidence="ECO:0000244|PDB:3NQJ"
FT   TURN            134..138
FT                   /evidence="ECO:0000244|PDB:6E0P"
SQ   SEQUENCE   140 AA;  15991 MW;  11A28FEB54486489 CRC64;
     MGPRRRSRKP EAPRRRSPSP TPTPGPSRRG PSLGASSHQH SRRRQGWLKE IRKLQKSTHL
     LIRKLPFSRL AREICVKFTR GVDFNWQAQA LLALQEAAEA FLVHLFEDAY LLTLHAGRVT
     LFPKDVQLAR RIRGLEEGLG
//
ID   H10_HUMAN               Reviewed;         194 AA.
AC   P07305; B2R6I0; B4DRD6; Q6FG88; Q8N6R3;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 194.
DE   RecName: Full=Histone H1.0;
DE   AltName: Full=Histone H1';
DE   AltName: Full=Histone H1(0);
DE   Contains:
DE     RecName: Full=Histone H1.0, N-terminally processed;
GN   Name=H1-0 {ECO:0000312|HGNC:HGNC:4714};
GN   Synonyms=H1F0 {ECO:0000312|HGNC:HGNC:4714}, H1FV;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=3084796; DOI=10.1016/0022-2836(86)90446-8;
RA   Doenecke D., Tonjes R.;
RT   "Differential distribution of lysine and arginine residues in the closely
RT   related histones H1 and H5. Analysis of a human H1 gene.";
RL   J. Mol. Biol. 187:461-464(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PARTIAL PROTEIN SEQUENCE (RNA EDITED VERSION), IDENTIFICATION BY MASS
RP   SPECTROMETRY, RNA EDITING, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=18993075; DOI=10.1016/j.cub.2008.09.059;
RA   Zougman A., Ziolkowski P., Mann M., Wisniewski J.R.;
RT   "Evidence for insertional RNA editing in humans.";
RL   Curr. Biol. 18:1760-1765(2008).
RN   [9]
RP   ACETYLATION AT THR-2, CLEAVAGE OF INITIATOR METHIONINE, AND DEAMIDATION AT
RP   ASN-4.
RX   PubMed=9582379; DOI=10.1074/jbc.273.21.13324;
RA   Lindner H., Sarg B., Hoertnagl B., Helliger W.;
RT   "The microheterogeneity of the mammalian H1(0) histone. Evidence for an
RT   age-dependent deamidation.";
RL   J. Biol. Chem. 273:13324-13330(1998).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   ADP-RIBOSYLATION AT SER-104.
RX   PubMed=27723750; DOI=10.1038/nchembio.2180;
RA   Leidecker O., Bonfiglio J.J., Colby T., Zhang Q., Atanassov I., Zaja R.,
RA   Palazzo L., Stockum A., Ahel I., Matic I.;
RT   "Serine is a new target residue for endogenous ADP-ribosylation on
RT   histones.";
RL   Nat. Chem. Biol. 12:998-1000(2016).
CC   -!- FUNCTION: Histones H1 are necessary for the condensation of nucleosome
CC       chains into higher-order structures. The histones H1.0 are found in
CC       cells that are in terminal stages of differentiation or that have low
CC       rates of cell division.
CC   -!- INTERACTION:
CC       P04014:E1 (xeno); NbExp=2; IntAct=EBI-725224, EBI-7014446;
CC       Q8IYW5:RNF168; NbExp=2; IntAct=EBI-725224, EBI-914207;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00837,
CC       ECO:0000269|PubMed:18993075}. Chromosome {ECO:0000255|PROSITE-
CC       ProRule:PRU00837, ECO:0000269|PubMed:18993075}. Note=The RNA edited
CC       version has been localized to nuclear speckles. During mitosis, it
CC       appears in the vicinity of condensed chromosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P07305-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P07305-2; Sequence=VSP_042163;
CC   -!- INDUCTION: Both the unedited and the RNA edited versions are induced by
CC       butyrate (at protein level). Only RNA edited version is induced by DTT,
CC       vinblastine or TNF (at protein level). {ECO:0000269|PubMed:18993075}.
CC   -!- PTM: Phosphorylated on Ser-17 in RNA edited version.
CC       {ECO:0000269|PubMed:18993075}.
CC   -!- PTM: ADP-ribosylated on Ser-104 in response to DNA damage.
CC       {ECO:0000269|PubMed:27723750}.
CC   -!- RNA EDITING: Modified_positions=Not_applicable; Note=Partially edited.
CC       In approximately 3.6% of the mRNA molecules, a new initiator methionine
CC       is created by a single uridine insertion in the 5'-UTR, causing an N-
CC       terminal extension of 99 amino acids. The existence of the RNA edited
CC       version is supported by direct protein sequencing by MS/MS of the
CC       following peptides specific to that version: 12-21; 22-33; 37-47; 48-
CC       67; 68-83; 84-94 and 97-113. The RNA edited version is called ET-H1.0.
CC       {ECO:0000269|PubMed:18993075};
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Histone H1 entry;
CC       URL="https://en.wikipedia.org/wiki/Histone_H1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03473; CAA27190.1; -; Genomic_DNA.
DR   EMBL; CR456502; CAG30388.1; -; mRNA.
DR   EMBL; CR542220; CAG47016.1; -; mRNA.
DR   EMBL; AK299209; BAG61248.1; -; mRNA.
DR   EMBL; AK312583; BAG35477.1; -; mRNA.
DR   EMBL; Z97630; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60188.1; -; Genomic_DNA.
DR   EMBL; BC000145; AAH00145.1; -; mRNA.
DR   EMBL; BC029046; AAH29046.1; -; mRNA.
DR   CCDS; CCDS13956.1; -. [P07305-1]
DR   PIR; A24850; HSHU10.
DR   RefSeq; NP_005309.1; NM_005318.3. [P07305-1]
DR   PDB; 6HQ1; NMR; -; A=24-97.
DR   PDB; 6N88; EM; 6.20 A; C=1-194.
DR   PDB; 6N89; EM; 7.50 A; B=1-194.
DR   PDBsum; 6HQ1; -.
DR   PDBsum; 6N88; -.
DR   PDBsum; 6N89; -.
DR   SMR; P07305; -.
DR   BioGrid; 109260; 60.
DR   DIP; DIP-41775N; -.
DR   ELM; P07305; -.
DR   IntAct; P07305; 63.
DR   MINT; P07305; -.
DR   STRING; 9606.ENSP00000344504; -.
DR   BindingDB; P07305; -.
DR   ChEMBL; CHEMBL3707465; -.
DR   iPTMnet; P07305; -.
DR   PhosphoSitePlus; P07305; -.
DR   BioMuta; H1F0; -.
DR   DMDM; 121897; -.
DR   EPD; P07305; -.
DR   jPOST; P07305; -.
DR   MassIVE; P07305; -.
DR   MaxQB; P07305; -.
DR   PaxDb; P07305; -.
DR   PeptideAtlas; P07305; -.
DR   PRIDE; P07305; -.
DR   ProteomicsDB; 51978; -. [P07305-1]
DR   ProteomicsDB; 51979; -. [P07305-2]
DR   TopDownProteomics; P07305-1; -. [P07305-1]
DR   DNASU; 3005; -.
DR   Ensembl; ENST00000340857; ENSP00000344504; ENSG00000189060. [P07305-1]
DR   GeneID; 3005; -.
DR   KEGG; hsa:3005; -.
DR   UCSC; uc003aty.4; human. [P07305-1]
DR   CTD; 3005; -.
DR   DisGeNET; 3005; -.
DR   GeneCards; H1-0; -.
DR   HGNC; HGNC:4714; H1-0.
DR   HPA; HPA000843; -.
DR   MIM; 142708; gene.
DR   neXtProt; NX_P07305; -.
DR   OpenTargets; ENSG00000189060; -.
DR   PharmGKB; PA29092; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00810000125570; -.
DR   HOGENOM; CLU_052897_1_1_1; -.
DR   InParanoid; P07305; -.
DR   KO; K11275; -.
DR   OMA; HASYQDM; -.
DR   OrthoDB; 1565299at2759; -.
DR   PhylomeDB; P07305; -.
DR   TreeFam; TF313664; -.
DR   Reactome; R-HSA-140342; Apoptosis induced DNA fragmentation.
DR   Reactome; R-HSA-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).
DR   ChiTaRS; H1F0; human.
DR   GenomeRNAi; 3005; -.
DR   Pharos; P07305; Tchem.
DR   PRO; PR:P07305; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P07305; protein.
DR   Bgee; ENSG00000189060; Expressed in ectocervix and 233 other tissues.
DR   Genevisible; P07305; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0005719; C:nuclear euchromatin; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0017053; C:transcriptional repressor complex; IDA:UniProtKB.
DR   GO; GO:0003680; F:AT DNA binding; IEA:Ensembl.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome.
DR   GO; GO:0006342; P:chromatin silencing; IGI:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IGI:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   DisProt; DP01156; -.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR005819; Histone_H5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Alternative splicing;
KW   Chromosome; Citrullination; Direct protein sequencing; DNA-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; RNA editing.
FT   CHAIN           1..194
FT                   /note="Histone H1.0"
FT                   /id="PRO_0000423207"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000269|PubMed:9582379"
FT   CHAIN           2..194
FT                   /note="Histone H1.0, N-terminally processed"
FT                   /id="PRO_0000195904"
FT   DOMAIN          24..97
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine; partial; in Histone H1.0, N-
FT                   terminally processed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000269|PubMed:9582379"
FT   MOD_RES         4
FT                   /note="Deamidated asparagine; partial"
FT                   /evidence="ECO:0000269|PubMed:9582379"
FT   MOD_RES         42
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   MOD_RES         104
FT                   /note="ADP-ribosylserine"
FT                   /evidence="ECO:0000269|PubMed:27723750"
FT   VAR_SEQ         3..19
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042163"
FT   VARIANT         1
FT                   /note="M -> MLGKGRQRRRRQRQRQSPVPRPSDRPAGLGLAKPARRALPTPEPGRK
FT                   SSDSSLASPGAALQTGPVVRGSGADPEAGFAQPPTRAGPLEGAFNSRTRQATM (in
FT                   RNA edited version)"
FT                   /id="VAR_054789"
FT   CONFLICT        65
FT                   /note="D -> H (in Ref. 7; AAH29046)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   194 AA;  20863 MW;  03ED6F01919F8BE1 CRC64;
     MTENSTSAPA AKPKRAKASK KSTDHPKYSD MIVAAIQAEK NRAGSSRQSI QKYIKSHYKV
     GENADSQIKL SIKRLVTTGV LKQTKGVGAS GSFRLAKSDE PKKSVAFKKT KKEIKKVATP
     KKASKPKKAA SKAPTKKPKA TPVKKAKKKL AATPKKAKKP KTVKAKPVKA SKPKKAKPVK
     PKAKSSAKRA GKKK
//
ID   H11_HUMAN               Reviewed;         215 AA.
AC   Q02539; Q3MJ34;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 163.
DE   RecName: Full=Histone H1.1;
DE   AltName: Full=Histone H1a;
GN   Name=H1-1 {ECO:0000312|HGNC:HGNC:4715}; Synonyms=H1F1, HIST1H1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=2759094;
RA   Eick S., Nicolai M., Mumberg D., Doenecke D.;
RT   "Human H1 histones: conserved and varied sequence elements in two H1
RT   subtype genes.";
RL   Eur. J. Cell Biol. 49:110-115(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NOMENCLATURE.
RX   PubMed=8003976; DOI=10.1002/pro.5560030406;
RA   Parseghian M.H., Henschen A.H., Krieglstein K.G., Hamkalo B.A.;
RT   "A proposal for a coherent mammalian histone H1 nomenclature correlated
RT   with amino acid sequences.";
RL   Protein Sci. 3:575-587(1994).
RN   [6]
RP   DOMAIN, AND MUTAGENESIS OF THR-152 AND SER-183.
RX   PubMed=14985337; DOI=10.1074/jbc.m400070200;
RA   Hendzel M.J., Lever M.A., Crawford E., Th'ng J.P.;
RT   "The C-terminal domain is the primary determinant of histone H1 binding to
RT   chromatin in vivo.";
RL   J. Biol. Chem. 279:20028-20034(2004).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15911621; DOI=10.1074/jbc.m501627200;
RA   Th'ng J.P., Sung R., Ye M., Hendzel M.J.;
RT   "H1 family histones in the nucleus. Control of binding and localization by
RT   the C-terminal domain.";
RL   J. Biol. Chem. 280:27809-27814(2005).
RN   [8]
RP   INTERACTION WITH DFFB.
RX   PubMed=19882353; DOI=10.1007/s10495-009-0418-7;
RA   Ninios Y.P., Sekeri-Pataryas K.E., Sourlingas T.G.;
RT   "Histone H1 subtype preferences of DFF40 and possible nuclear localization
RT   of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells.";
RL   Apoptosis 15:128-138(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes
CC       forming the macromolecular structure known as the chromatin fiber.
CC       Histones H1 are necessary for the condensation of nucleosome chains
CC       into higher-order structured fibers. Acts also as a regulator of
CC       individual gene transcription through chromatin remodeling, nucleosome
CC       spacing and DNA methylation (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with DFFB. {ECO:0000269|PubMed:19882353}.
CC   -!- INTERACTION:
CC       Q8IUE6:HIST2H2AB; NbExp=2; IntAct=EBI-932603, EBI-1642157;
CC       Q57V41:SIR2rp1 (xeno); NbExp=2; IntAct=EBI-932603, EBI-7579996;
CC       O94811:TPPP; NbExp=2; IntAct=EBI-932603, EBI-3927802;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00837,
CC       ECO:0000269|PubMed:15911621}. Chromosome {ECO:0000255|PROSITE-
CC       ProRule:PRU00837, ECO:0000269|PubMed:15911621}. Note=Mainly localizes
CC       in euchromatin.
CC   -!- DOMAIN: The C-terminal domain is required for high-affinity binding to
CC       chromatin. {ECO:0000269|PubMed:14985337}.
CC   -!- PTM: H1 histones are progressively phosphorylated during the cell
CC       cycle, becoming maximally phosphorylated during late G2 phase and M
CC       phase, and being dephosphorylated sharply thereafter.
CC       {ECO:0000250|UniProtKB:P43275}.
CC   -!- PTM: Citrullination at Arg-57 (H1R54ci) by PADI4 takes place within the
CC       DNA-binding site of H1 and results in its displacement from chromatin
CC       and global chromatin decondensation, thereby promoting pluripotency and
CC       stem cell maintenance. {ECO:0000250|UniProtKB:P43275}.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57130; CAA40409.1; -; Genomic_DNA.
DR   EMBL; AF531299; AAN06699.1; -; Genomic_DNA.
DR   EMBL; U91328; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069492; AAH69492.1; -; mRNA.
DR   EMBL; BC101593; AAI01594.1; -; mRNA.
DR   EMBL; BC112140; AAI12141.1; -; mRNA.
DR   CCDS; CCDS4569.1; -.
DR   PIR; S26363; S26363.
DR   RefSeq; NP_005316.1; NM_005325.3.
DR   SMR; Q02539; -.
DR   BioGrid; 109275; 202.
DR   CORUM; Q02539; -.
DR   IntAct; Q02539; 209.
DR   MINT; Q02539; -.
DR   STRING; 9606.ENSP00000244573; -.
DR   CarbonylDB; Q02539; -.
DR   iPTMnet; Q02539; -.
DR   PhosphoSitePlus; Q02539; -.
DR   SwissPalm; Q02539; -.
DR   BioMuta; HIST1H1A; -.
DR   DMDM; 18202479; -.
DR   EPD; Q02539; -.
DR   jPOST; Q02539; -.
DR   MassIVE; Q02539; -.
DR   MaxQB; Q02539; -.
DR   PaxDb; Q02539; -.
DR   PeptideAtlas; Q02539; -.
DR   PRIDE; Q02539; -.
DR   ProteomicsDB; 58107; -.
DR   DNASU; 3024; -.
DR   Ensembl; ENST00000244573; ENSP00000244573; ENSG00000124610.
DR   GeneID; 3024; -.
DR   KEGG; hsa:3024; -.
DR   UCSC; uc003nfo.4; human.
DR   CTD; 3024; -.
DR   DisGeNET; 3024; -.
DR   GeneCards; H1-1; -.
DR   HGNC; HGNC:4715; H1-1.
DR   HPA; HPA043753; -.
DR   HPA; HPA056830; -.
DR   MIM; 142709; gene.
DR   neXtProt; NX_Q02539; -.
DR   OpenTargets; ENSG00000124610; -.
DR   PharmGKB; PA29093; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00940000163269; -.
DR   HOGENOM; CLU_052897_7_0_1; -.
DR   InParanoid; Q02539; -.
DR   KO; K11275; -.
DR   OMA; PKYEDMI; -.
DR   OrthoDB; 1565299at2759; -.
DR   PhylomeDB; Q02539; -.
DR   TreeFam; TF313664; -.
DR   Reactome; R-HSA-140342; Apoptosis induced DNA fragmentation.
DR   Reactome; R-HSA-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).
DR   SIGNOR; Q02539; -.
DR   GeneWiki; HIST1H1A; -.
DR   GenomeRNAi; 3024; -.
DR   Pharos; Q02539; Tbio.
DR   PRO; PR:Q02539; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q02539; protein.
DR   Bgee; ENSG00000124610; Expressed in lung and 33 other tissues.
DR   Genevisible; Q02539; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0005719; C:nuclear euchromatin; IDA:UniProtKB.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0031982; C:vesicle; IEA:Ensembl.
DR   GO; GO:0031490; F:chromatin DNA binding; IMP:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0008201; F:heparin binding; IEA:Ensembl.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0048260; P:positive regulation of receptor-mediated endocytosis; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR005819; Histone_H5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Citrullination; DNA-binding; Hydroxylation;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   CHAIN           2..215
FT                   /note="Histone H1.1"
FT                   /id="PRO_0000195905"
FT   DOMAIN          39..112
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:D4A3K5"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:D4A3K5"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:D4A3K5"
FT   MOD_RES         55
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         57
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   MOD_RES         67
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         78
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   MOD_RES         88
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         93
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         93
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   MOD_RES         107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G3N131"
FT   MOD_RES         109
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         125
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   MOD_RES         204
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   VARIANT         99
FT                   /note="T -> I (in dbSNP:rs417751)"
FT                   /id="VAR_049301"
FT   VARIANT         115
FT                   /note="S -> F (in dbSNP:rs34541321)"
FT                   /id="VAR_049302"
FT   VARIANT         140
FT                   /note="K -> R (in dbSNP:rs16891235)"
FT                   /id="VAR_049303"
FT   MUTAGEN         152
FT                   /note="T->E: Significant destabilization of binding to
FT                   chromatin."
FT                   /evidence="ECO:0000269|PubMed:14985337"
FT   MUTAGEN         183
FT                   /note="S->E: Significant destabilization of binding to
FT                   chromatin."
FT                   /evidence="ECO:0000269|PubMed:14985337"
SQ   SEQUENCE   215 AA;  21842 MW;  854B03622D78774A CRC64;
     MSETVPPAPA ASAAPEKPLA GKKAKKPAKA AAASKKKPAG PSVSELIVQA ASSSKERGGV
     SLAALKKALA AAGYDVEKNN SRIKLGIKSL VSKGTLVQTK GTGASGSFKL NKKASSVETK
     PGASKVATKT KATGASKKLK KATGASKKSV KTPKKAKKPA ATRKSSKNPK KPKTVKPKKV
     AKSPAKAKAV KPKAAKARVT KPKTAKPKKA APKKK
//
ID   H12_HUMAN               Reviewed;         213 AA.
AC   P16403; A8K4I2;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 202.
DE   RecName: Full=Histone H1.2;
DE   AltName: Full=Histone H1c;
DE   AltName: Full=Histone H1d;
DE   AltName: Full=Histone H1s-1;
GN   Name=H1-2 {ECO:0000312|HGNC:HGNC:4716};
GN   Synonyms=H1F2 {ECO:0000312|HGNC:HGNC:4716},
GN   HIST1H1C {ECO:0000312|HGNC:HGNC:4716};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2759094;
RA   Eick S., Nicolai M., Mumberg D., Doenecke D.;
RT   "Human H1 histones: conserved and varied sequence elements in two H1
RT   subtype genes.";
RL   Eur. J. Cell Biol. 49:110-115(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA   Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA   Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA   Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA   Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA   Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA   Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in vitro-
RT   expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-213.
RC   TISSUE=Spleen;
RX   PubMed=2613692; DOI=10.1093/oxfordjournals.jbchem.a122941;
RA   Ohe Y., Hayashi H., Iwai K.;
RT   "Human spleen histone H1. Isolation and amino acid sequences of three minor
RT   variants, H1a, H1c, and H1d.";
RL   J. Biochem. 106:844-857(1989).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-17; 34-46; 55-75 AND 86-97, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT SER-2, METHYLATION AT LYS-34, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 2-17; 34-46; 55-63 AND 65-75, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [11]
RP   NOMENCLATURE.
RX   PubMed=8003976; DOI=10.1002/pro.5560030406;
RA   Parseghian M.H., Henschen A.H., Krieglstein K.G., Hamkalo B.A.;
RT   "A proposal for a coherent mammalian histone H1 nomenclature correlated
RT   with amino acid sequences.";
RL   Protein Sci. 3:575-587(1994).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10997781; DOI=10.1023/a:1009262819961;
RA   Parseghian M.H., Newcomb R.L., Winokur S.T., Hamkalo B.A.;
RT   "The distribution of somatic H1 subtypes is non-random on active vs.
RT   inactive chromatin: distribution in human fetal fibroblasts.";
RL   Chromosome Res. 8:405-424(2000).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15911621; DOI=10.1074/jbc.m501627200;
RA   Th'ng J.P., Sung R., Ye M., Hendzel M.J.;
RT   "H1 family histones in the nucleus. Control of binding and localization by
RT   the C-terminal domain.";
RL   J. Biol. Chem. 280:27809-27814(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   METHYLATION AT LYS-187 BY EHMT1 AND EHMT2, MUTAGENESIS OF LYS-187, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20334638; DOI=10.1186/1756-8935-3-7;
RA   Weiss T., Hergeth S., Zeissler U., Izzo A., Tropberger P., Zee B.M.,
RA   Dundr M., Garcia B.A., Daujat S., Schneider R.;
RT   "Histone H1 variant-specific lysine methylation by G9a/KMT1C and
RT   Glp1/KMT1D.";
RL   Epigenetics Chromatin 3:7-7(2010).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2 AND THR-146, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   CROTONYLATION AT LYS-34; LYS-64; LYS-85; LYS-90; LYS-97; LYS-159 AND
RP   LYS-168.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   HYDROXYBUTYRYLATION AT LYS-23; LYS-26; LYS-27; LYS-46; LYS-52; LYS-63;
RP   LYS-64; LYS-75; LYS-81; LYS-85; LYS-90; LYS-97; LYS-110; LYS-117; LYS-121;
RP   LYS-129; LYS-136; LYS-148; LYS-159; LYS-168 AND LYS-213.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   ADP-RIBOSYLATION AT SER-188.
RX   PubMed=27723750; DOI=10.1038/nchembio.2180;
RA   Leidecker O., Bonfiglio J.J., Colby T., Zhang Q., Atanassov I., Zaja R.,
RA   Palazzo L., Stockum A., Ahel I., Matic I.;
RT   "Serine is a new target residue for endogenous ADP-ribosylation on
RT   histones.";
RL   Nat. Chem. Biol. 12:998-1000(2016).
CC   -!- FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes
CC       forming the macromolecular structure known as the chromatin fiber.
CC       Histones H1 are necessary for the condensation of nucleosome chains
CC       into higher-order structured fibers. Acts also as a regulator of
CC       individual gene transcription through chromatin remodeling, nucleosome
CC       spacing and DNA methylation (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in
CC       euchromatin. Distribution goes in parallel with DNA concentration.
CC   -!- DOMAIN: The C-terminal domain is required for high-affinity binding to
CC       chromatin. {ECO:0000250}.
CC   -!- PTM: H1 histones are progressively phosphorylated during the cell
CC       cycle, becoming maximally phosphorylated during late G2 phase and M
CC       phase, and being dephosphorylated sharply thereafter.
CC       {ECO:0000250|UniProtKB:P15864}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Citrullination at Arg-54 (H1R54ci) by PADI4 takes place within the
CC       DNA-binding site of H1 and results in its displacement from chromatin
CC       and global chromatin decondensation, thereby promoting pluripotency and
CC       stem cell maintenance. {ECO:0000250|UniProtKB:P15864}.
CC   -!- PTM: ADP-ribosylated on Ser-188 in response to DNA damage.
CC       {ECO:0000269|PubMed:27723750}.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57129; CAA40408.1; -; Genomic_DNA.
DR   EMBL; AF531300; AAN06700.1; -; Genomic_DNA.
DR   EMBL; AK290947; BAF83636.1; -; mRNA.
DR   EMBL; AB451259; BAG70073.1; -; mRNA.
DR   EMBL; AB451385; BAG70199.1; -; mRNA.
DR   EMBL; U91328; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471087; EAW55515.1; -; Genomic_DNA.
DR   EMBL; BC002649; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS4577.1; -.
DR   PIR; S26364; HSHU11.
DR   RefSeq; NP_005310.1; NM_005319.3.
DR   SMR; P16403; -.
DR   BioGrid; 109261; 148.
DR   DIP; DIP-36359N; -.
DR   IntAct; P16403; 198.
DR   MINT; P16403; -.
DR   STRING; 9606.ENSP00000339566; -.
DR   iPTMnet; P16403; -.
DR   PhosphoSitePlus; P16403; -.
DR   SwissPalm; P16403; -.
DR   BioMuta; HIST1H1C; -.
DR   DMDM; 417101; -.
DR   EPD; P16403; -.
DR   jPOST; P16403; -.
DR   MassIVE; P16403; -.
DR   MaxQB; P16403; -.
DR   PaxDb; P16403; -.
DR   PeptideAtlas; P16403; -.
DR   PRIDE; P16403; -.
DR   ProteomicsDB; 53353; -.
DR   TopDownProteomics; P16403; -.
DR   DNASU; 3006; -.
DR   Ensembl; ENST00000343677; ENSP00000339566; ENSG00000187837.
DR   GeneID; 3006; -.
DR   KEGG; hsa:3006; -.
DR   UCSC; uc003nfw.4; human.
DR   CTD; 3006; -.
DR   DisGeNET; 3006; -.
DR   GeneCards; H1-2; -.
DR   HGNC; HGNC:4716; H1-2.
DR   HPA; CAB011507; -.
DR   MIM; 142710; gene.
DR   neXtProt; NX_P16403; -.
DR   OpenTargets; ENSG00000187837; -.
DR   PharmGKB; PA29094; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00940000163082; -.
DR   HOGENOM; CLU_052897_7_0_1; -.
DR   InParanoid; P16403; -.
DR   KO; K11275; -.
DR   OMA; NPTHPPY; -.
DR   OrthoDB; 1565299at2759; -.
DR   PhylomeDB; P16403; -.
DR   TreeFam; TF313664; -.
DR   Reactome; R-HSA-140342; Apoptosis induced DNA fragmentation.
DR   Reactome; R-HSA-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).
DR   ChiTaRS; HIST1H1C; human.
DR   GeneWiki; HIST1H1C; -.
DR   GenomeRNAi; 3006; -.
DR   Pharos; P16403; Tbio.
DR   PRO; PR:P16403; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P16403; protein.
DR   Bgee; ENSG00000187837; Expressed in stomach and 204 other tissues.
DR   Genevisible; P16403; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005719; C:nuclear euchromatin; IDA:UniProtKB.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0035327; C:transcriptionally active chromatin; IEA:Ensembl.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0098532; P:histone H3-K27 trimethylation; IEA:Ensembl.
DR   GO; GO:0080182; P:histone H3-K4 trimethylation; IEA:Ensembl.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR005819; Histone_H5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ADP-ribosylation; Chromosome; Citrullination;
KW   Direct protein sequencing; DNA-binding; Hydroxylation; Methylation;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:2613692,
FT                   ECO:0000269|Ref.10, ECO:0000269|Ref.9"
FT   CHAIN           2..213
FT                   /note="Histone H1.2"
FT                   /id="PRO_0000195906"
FT   DOMAIN          36..109
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOD_RES         2
FT                   /note="N-acetylserine; partial"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000244|PubMed:25944712, ECO:0000269|Ref.10,
FT                   ECO:0000269|Ref.9"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P15864"
FT   MOD_RES         23
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         26
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         27
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         34
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         34
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         34
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|Ref.9"
FT   MOD_RES         46
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         52
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         52
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         54
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P15864"
FT   MOD_RES         63
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         64
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         64
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         64
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         81
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         85
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         85
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         85
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         90
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         90
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         90
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         97
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         97
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         97
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P15864"
FT   MOD_RES         104
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P02253"
FT   MOD_RES         106
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         110
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         129
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         136
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         146
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         148
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         159
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         159
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         168
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         168
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         187
FT                   /note="N6-methyllysine; by EHMT1 and EHMT2"
FT                   /evidence="ECO:0000269|PubMed:20334638"
FT   MOD_RES         188
FT                   /note="ADP-ribosylserine"
FT                   /evidence="ECO:0000269|PubMed:27723750"
FT   MOD_RES         213
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   VARIANT         18
FT                   /note="A -> V (in dbSNP:rs2230653)"
FT                   /id="VAR_003618"
FT   VARIANT         113
FT                   /note="S -> A (in dbSNP:rs34810376)"
FT                   /id="VAR_049304"
FT   VARIANT         124
FT                   /note="G -> A (in dbSNP:rs12111009)"
FT                   /id="VAR_049305"
FT   MUTAGEN         187
FT                   /note="K->R: Abolishes methylation."
FT                   /evidence="ECO:0000269|PubMed:20334638"
SQ   SEQUENCE   213 AA;  21365 MW;  AA66EA1901D8D56B CRC64;
     MSETAPAAPA AAPPAEKAPV KKKAAKKAGG TPRKASGPPV SELITKAVAA SKERSGVSLA
     ALKKALAAAG YDVEKNNSRI KLGLKSLVSK GTLVQTKGTG ASGSFKLNKK AASGEAKPKV
     KKAGGTKPKK PVGAAKKPKK AAGGATPKKS AKKTPKKAKK PAAATVTKKV AKSPKKAKVA
     KPKKAAKSAA KAVKPKAAKP KVVKPKKAAP KKK
//
ID   H13_HUMAN               Reviewed;         221 AA.
AC   P16402; B2R751; Q2M2I2;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 181.
DE   RecName: Full=Histone H1.3;
DE   AltName: Full=Histone H1c;
DE   AltName: Full=Histone H1s-2;
GN   Name=H1-3 {ECO:0000312|HGNC:HGNC:4717};
GN   Synonyms=H1F3 {ECO:0000312|HGNC:HGNC:4717},
GN   HIST1H1D {ECO:0000312|HGNC:HGNC:4717};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-f;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-221.
RC   TISSUE=Spleen;
RX   PubMed=2613692; DOI=10.1093/oxfordjournals.jbchem.a122941;
RA   Ohe Y., Hayashi H., Iwai K.;
RT   "Human spleen histone H1. Isolation and amino acid sequences of three minor
RT   variants, H1a, H1c, and H1d.";
RL   J. Biochem. 106:844-857(1989).
RN   [8]
RP   NOMENCLATURE.
RX   PubMed=8003976; DOI=10.1002/pro.5560030406;
RA   Parseghian M.H., Henschen A.H., Krieglstein K.G., Hamkalo B.A.;
RT   "A proposal for a coherent mammalian histone H1 nomenclature correlated
RT   with amino acid sequences.";
RL   Protein Sci. 3:575-587(1994).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10997781; DOI=10.1023/a:1009262819961;
RA   Parseghian M.H., Newcomb R.L., Winokur S.T., Hamkalo B.A.;
RT   "The distribution of somatic H1 subtypes is non-random on active vs.
RT   inactive chromatin: distribution in human fetal fibroblasts.";
RL   Chromosome Res. 8:405-424(2000).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11746507; DOI=10.1002/jcb.1224;
RA   Parseghian M.H., Newcomb R.L., Hamkalo B.A.;
RT   "Distribution of somatic H1 subtypes is non-random on active vs. inactive
RT   chromatin II: distribution in human adult fibroblasts.";
RL   J. Cell. Biochem. 83:643-659(2001).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15911621; DOI=10.1074/jbc.m501627200;
RA   Th'ng J.P., Sung R., Ye M., Hendzel M.J.;
RT   "H1 family histones in the nucleus. Control of binding and localization by
RT   the C-terminal domain.";
RL   J. Biol. Chem. 280:27809-27814(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2 AND THR-18, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   HYDROXYBUTYRYLATION AT LYS-35; LYS-47; LYS-53; LYS-65; LYS-76; LYS-86;
RP   LYS-91; LYS-107 AND LYS-170.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
CC   -!- FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes
CC       forming the macromolecular structure known as the chromatin fiber.
CC       Histones H1 are necessary for the condensation of nucleosome chains
CC       into higher-order structured fibers. Acts also as a regulator of
CC       individual gene transcription through chromatin remodeling, nucleosome
CC       spacing and DNA methylation (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=According to
CC       PubMed:15911621 more commonly found in euchromatin. According to
CC       PubMed:10997781 is associated with inactive chromatin.
CC   -!- DOMAIN: The C-terminal domain is required for high-affinity binding to
CC       chromatin. {ECO:0000250}.
CC   -!- PTM: H1 histones are progressively phosphorylated during the cell
CC       cycle, becoming maximally phosphorylated during late G2 phase and M
CC       phase, and being dephosphorylated sharply thereafter.
CC       {ECO:0000250|UniProtKB:P43275}.
CC   -!- PTM: Citrullination at Arg-55 (H1R54ci) by PADI4 takes place within the
CC       DNA-binding site of H1 and results in its displacement from chromatin
CC       and global chromatin decondensation, thereby promoting pluripotency and
CC       stem cell maintenance. {ECO:0000250|UniProtKB:P43277}.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M60747; AAA63186.1; -; Genomic_DNA.
DR   EMBL; AF531303; AAN06703.1; -; Genomic_DNA.
DR   EMBL; AK312845; BAG35698.1; -; mRNA.
DR   EMBL; AL031777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471087; EAW55548.1; -; Genomic_DNA.
DR   EMBL; BC104874; AAI04875.1; -; mRNA.
DR   EMBL; BC111971; AAI11972.1; -; mRNA.
DR   CCDS; CCDS4597.1; -.
DR   PIR; B40335; B40335.
DR   RefSeq; NP_005311.1; NM_005320.2.
DR   SMR; P16402; -.
DR   BioGrid; 109262; 68.
DR   CORUM; P16402; -.
DR   IntAct; P16402; 30.
DR   MINT; P16402; -.
DR   STRING; 9606.ENSP00000244534; -.
DR   iPTMnet; P16402; -.
DR   PhosphoSitePlus; P16402; -.
DR   SwissPalm; P16402; -.
DR   BioMuta; HIST1H1D; -.
DR   DMDM; 121925; -.
DR   EPD; P16402; -.
DR   jPOST; P16402; -.
DR   MassIVE; P16402; -.
DR   MaxQB; P16402; -.
DR   PaxDb; P16402; -.
DR   PeptideAtlas; P16402; -.
DR   PRIDE; P16402; -.
DR   ProteomicsDB; 53352; -.
DR   DNASU; 3007; -.
DR   Ensembl; ENST00000244534; ENSP00000244534; ENSG00000124575.
DR   GeneID; 3007; -.
DR   KEGG; hsa:3007; -.
DR   UCSC; uc003nhd.4; human.
DR   CTD; 3007; -.
DR   DisGeNET; 3007; -.
DR   GeneCards; H1-3; -.
DR   HGNC; HGNC:4717; H1-3.
DR   HPA; HPA055907; -.
DR   MIM; 142210; gene.
DR   neXtProt; NX_P16402; -.
DR   OpenTargets; ENSG00000124575; -.
DR   PharmGKB; PA29095; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00940000155501; -.
DR   HOGENOM; CLU_052897_7_0_1; -.
DR   InParanoid; P16402; -.
DR   KO; K11275; -.
DR   OMA; TAAHPPY; -.
DR   OrthoDB; 1565299at2759; -.
DR   PhylomeDB; P16402; -.
DR   TreeFam; TF313664; -.
DR   Reactome; R-HSA-140342; Apoptosis induced DNA fragmentation.
DR   Reactome; R-HSA-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).
DR   ChiTaRS; HIST1H1D; human.
DR   GeneWiki; HIST1H1D; -.
DR   GenomeRNAi; 3007; -.
DR   Pharos; P16402; Tbio.
DR   PRO; PR:P16402; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P16402; protein.
DR   Bgee; ENSG00000124575; Expressed in stomach and 88 other tissues.
DR   Genevisible; P16402; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0005719; C:nuclear euchromatin; IDA:UniProtKB.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0098532; P:histone H3-K27 trimethylation; IEA:Ensembl.
DR   GO; GO:0080182; P:histone H3-K4 trimethylation; IEA:Ensembl.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR005819; Histone_H5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Citrullination; Direct protein sequencing;
KW   DNA-binding; Hydroxylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:2613692"
FT   CHAIN           2..221
FT                   /note="Histone H1.3"
FT                   /id="PRO_0000195907"
FT   DOMAIN          37..110
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:25944712"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         18
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         47
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         53
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         55
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         65
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         76
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         91
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         105
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:A7MAZ5"
FT   MOD_RES         107
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         170
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   VARIANT         75
FT                   /note="E -> K (in dbSNP:rs2050949)"
FT                   /id="VAR_049306"
SQ   SEQUENCE   221 AA;  22350 MW;  DB987FE8DE034D12 CRC64;
     MSETAPLAPT IPAPAEKTPV KKKAKKAGAT AGKRKASGPP VSELITKAVA ASKERSGVSL
     AALKKALAAA GYDVEKNNSR IKLGLKSLVS KGTLVQTKGT GASGSFKLNK KAASGEGKPK
     AKKAGAAKPR KPAGAAKKPK KVAGAATPKK SIKKTPKKVK KPATAAGTKK VAKSAKKVKT
     PQPKKAAKSP AKAKAPKPKA AKPKSGKPKV TKAKKAAPKK K
//
ID   H14_HUMAN               Reviewed;         219 AA.
AC   P10412; Q4VB25;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 196.
DE   RecName: Full=Histone H1.4;
DE   AltName: Full=Histone H1b;
DE   AltName: Full=Histone H1s-4;
GN   Name=H1-4 {ECO:0000312|HGNC:HGNC:4718};
GN   Synonyms=H1F4 {ECO:0000312|HGNC:HGNC:4718},
GN   HIST1H1E {ECO:0000312|HGNC:HGNC:4718};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-f;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-219, AND METHYLATION AT LYS-26.
RC   TISSUE=Spleen;
RX   PubMed=3782055; DOI=10.1093/oxfordjournals.jbchem.a121722;
RA   Ohe Y., Hayashi H., Iwai K.;
RT   "Human spleen histone H1. Isolation and amino acid sequence of a main
RT   variant, H1b.";
RL   J. Biochem. 100:359-368(1986).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10997781; DOI=10.1023/a:1009262819961;
RA   Parseghian M.H., Newcomb R.L., Winokur S.T., Hamkalo B.A.;
RT   "The distribution of somatic H1 subtypes is non-random on active vs.
RT   inactive chromatin: distribution in human fetal fibroblasts.";
RL   Chromosome Res. 8:405-424(2000).
RN   [7]
RP   ACETYLATION AT LYS-26.
RX   PubMed=15469825; DOI=10.1016/j.molcel.2004.08.031;
RA   Vaquero A., Scher M., Lee D., Erdjument-Bromage H., Tempst P., Reinberg D.;
RT   "Human SirT1 interacts with histone H1 and promotes formation of
RT   facultative heterochromatin.";
RL   Mol. Cell 16:93-105(2004).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15911621; DOI=10.1074/jbc.m501627200;
RA   Th'ng J.P., Sung R., Ye M., Hendzel M.J.;
RT   "H1 family histones in the nucleus. Control of binding and localization by
RT   the C-terminal domain.";
RL   J. Biol. Chem. 280:27809-27814(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-187, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT THR-18; THR-146 AND SER-187, CLEAVAGE OF INITIATOR METHIONINE
RP   [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT THR-18 AND SER-187, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   ADP-RIBOSYLATION AT SER-150.
RX   PubMed=27723750; DOI=10.1038/nchembio.2180;
RA   Leidecker O., Bonfiglio J.J., Colby T., Zhang Q., Atanassov I., Zaja R.,
RA   Palazzo L., Stockum A., Ahel I., Matic I.;
RT   "Serine is a new target residue for endogenous ADP-ribosylation on
RT   histones.";
RL   Nat. Chem. Biol. 12:998-1000(2016).
RN   [22]
RP   INVOLVEMENT IN RMNS.
RX   PubMed=28475857; DOI=10.1016/j.ajhg.2017.03.010;
RG   Childhood Overgrowth Collaboration;
RA   Tatton-Brown K., Loveday C., Yost S., Clarke M., Ramsay E., Zachariou A.,
RA   Elliott A., Wylie H., Ardissone A., Rittinger O., Stewart F., Temple I.K.,
RA   Cole T., Mahamdallie S., Seal S., Ruark E., Rahman N.;
RT   "Mutations in epigenetic regulation genes are a major cause of overgrowth
RT   with intellectual disability.";
RL   Am. J. Hum. Genet. 100:725-736(2017).
RN   [23]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-128.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes
CC       forming the macromolecular structure known as the chromatin fiber.
CC       Histones H1 are necessary for the condensation of nucleosome chains
CC       into higher-order structured fibers. Acts also as a regulator of
CC       individual gene transcription through chromatin remodeling, nucleosome
CC       spacing and DNA methylation (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8IY81:FTSJ3; NbExp=2; IntAct=EBI-358163, EBI-744088;
CC       Q9Y468:L3MBTL1; NbExp=7; IntAct=EBI-358163, EBI-1265089;
CC       P16333:NCK1; NbExp=2; IntAct=EBI-358163, EBI-389883;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in
CC       heterochromatin. Dysplays a punctuate staining pattern in the nucleus.
CC   -!- DOMAIN: The C-terminal domain is required for high-affinity binding to
CC       chromatin. {ECO:0000250}.
CC   -!- PTM: H1 histones are progressively phosphorylated during the cell
CC       cycle, becoming maximally phosphorylated during late G2 phase and M
CC       phase, and being dephosphorylated sharply thereafter.
CC       {ECO:0000250|UniProtKB:P43275}.
CC   -!- PTM: Acetylated at Lys-26. Deacetylated at Lys-26 by SIRT1.
CC       {ECO:0000269|PubMed:15469825}.
CC   -!- PTM: Citrullination at Arg-54 (H1R54ci) by PADI4 takes place within the
CC       DNA-binding site of H1 and results in its displacement from chromatin
CC       and global chromatin decondensation, thereby promoting pluripotency and
CC       stem cell maintenance. {ECO:0000250|UniProtKB:P43274}.
CC   -!- PTM: ADP-ribosylated on Ser-150 in response to DNA damage.
CC       {ECO:0000269|PubMed:27723750}.
CC   -!- DISEASE: Rahman syndrome (RMNS) [MIM:617537]: An autosomal dominant
CC       syndrome characterized by intellectual disability and overgrowth
CC       manifesting as increased birth length, height, weight, and/or head
CC       circumference. {ECO:0000269|PubMed:28475857}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: This variant accounts for 60% of histone H1.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M60748; AAA63187.1; -; Genomic_DNA.
DR   EMBL; AF531302; AAN06702.1; -; Genomic_DNA.
DR   EMBL; AL353759; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC096168; AAH96168.1; -; mRNA.
DR   EMBL; BC096169; AAH96169.1; -; mRNA.
DR   EMBL; BC099632; AAH99632.1; -; mRNA.
DR   CCDS; CCDS4586.1; -.
DR   PIR; C40335; HSHU1B.
DR   RefSeq; NP_005312.1; NM_005321.2.
DR   PDB; 3TZD; X-ray; 1.81 A; T=19-36.
DR   PDB; 5JJZ; X-ray; 2.00 A; B=21-32.
DR   PDB; 6H8P; X-ray; 1.98 A; C/D=18-32.
DR   PDBsum; 3TZD; -.
DR   PDBsum; 5JJZ; -.
DR   PDBsum; 6H8P; -.
DR   SMR; P10412; -.
DR   BioGrid; 109263; 151.
DR   IntAct; P10412; 185.
DR   MINT; P10412; -.
DR   STRING; 9606.ENSP00000307705; -.
DR   DrugBank; DB09130; Copper.
DR   iPTMnet; P10412; -.
DR   PhosphoSitePlus; P10412; -.
DR   SwissPalm; P10412; -.
DR   BioMuta; HIST1H1E; -.
DR   DMDM; 121919; -.
DR   EPD; P10412; -.
DR   jPOST; P10412; -.
DR   MassIVE; P10412; -.
DR   MaxQB; P10412; -.
DR   PaxDb; P10412; -.
DR   PeptideAtlas; P10412; -.
DR   PRIDE; P10412; -.
DR   ProteomicsDB; 52602; -.
DR   TopDownProteomics; P10412; -.
DR   Ensembl; ENST00000304218; ENSP00000307705; ENSG00000168298.
DR   GeneID; 3008; -.
DR   KEGG; hsa:3008; -.
DR   UCSC; uc003ngq.4; human.
DR   CTD; 3008; -.
DR   DisGeNET; 3008; -.
DR   GeneCards; H1-4; -.
DR   HGNC; HGNC:4718; H1-4.
DR   HPA; CAB011506; -.
DR   HPA; HPA055907; -.
DR   MalaCards; H1-4; -.
DR   MIM; 142220; gene.
DR   MIM; 617537; phenotype.
DR   neXtProt; NX_P10412; -.
DR   OpenTargets; ENSG00000168298; -.
DR   PharmGKB; PA29096; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00940000155501; -.
DR   HOGENOM; CLU_052897_7_0_1; -.
DR   InParanoid; P10412; -.
DR   KO; K11275; -.
DR   OMA; WIDMIKE; -.
DR   OrthoDB; 1565299at2759; -.
DR   PhylomeDB; P10412; -.
DR   TreeFam; TF313664; -.
DR   Reactome; R-HSA-140342; Apoptosis induced DNA fragmentation.
DR   Reactome; R-HSA-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).
DR   ChiTaRS; HIST1H1E; human.
DR   GeneWiki; HIST1H1E; -.
DR   GenomeRNAi; 3008; -.
DR   Pharos; P10412; Tbio.
DR   PRO; PR:P10412; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P10412; protein.
DR   Bgee; ENSG00000168298; Expressed in stomach and 88 other tissues.
DR   ExpressionAtlas; P10412; baseline and differential.
DR   Genevisible; P10412; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005719; C:nuclear euchromatin; IBA:GO_Central.
DR   GO; GO:0005720; C:nuclear heterochromatin; IDA:UniProtKB.
DR   GO; GO:0000788; C:nuclear nucleosome; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; IEA:Ensembl.
DR   GO; GO:0016208; F:AMP binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0031490; F:chromatin DNA binding; IMP:UniProtKB.
DR   GO; GO:0032564; F:dATP binding; IEA:Ensembl.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0098532; P:histone H3-K27 trimethylation; IEA:Ensembl.
DR   GO; GO:0080182; P:histone H3-K4 trimethylation; IEA:Ensembl.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR005819; Histone_H5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Chromosome; Citrullination;
KW   Direct protein sequencing; DNA-binding; Hydroxylation; Mental retardation;
KW   Methylation; Nucleus; Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:3782055"
FT   CHAIN           2..219
FT                   /note="Histone H1.4"
FT                   /id="PRO_0000195908"
FT   DOMAIN          36..109
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000244|PubMed:25944712"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15865"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43274"
FT   MOD_RES         18
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         26
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15469825"
FT   MOD_RES         26
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:3782055"
FT   MOD_RES         34
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         34
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43274"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43274"
FT   MOD_RES         52
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         54
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P43274"
FT   MOD_RES         64
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         85
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         90
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         106
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         146
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         150
FT                   /note="ADP-ribosylserine"
FT                   /evidence="ECO:0000269|PubMed:27723750"
FT   MOD_RES         187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692"
FT   VARIANT         128
FT                   /note="A -> V (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs768731472)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036203"
FT   VARIANT         152
FT                   /note="K -> R (in dbSNP:rs2298090)"
FT                   /id="VAR_049307"
FT   STRAND          20..25
FT                   /evidence="ECO:0000244|PDB:3TZD"
SQ   SEQUENCE   219 AA;  21865 MW;  1720FECCCBEBCC7F CRC64;
     MSETAPAAPA APAPAEKTPV KKKARKSAGA AKRKASGPPV SELITKAVAA SKERSGVSLA
     ALKKALAAAG YDVEKNNSRI KLGLKSLVSK GTLVQTKGTG ASGSFKLNKK AASGEAKPKA
     KKAGAAKAKK PAGAAKKPKK ATGAATPKKS AKKTPKKAKK PAAAAGAKKA KSPKKAKAAK
     PKKAPKSPAK AKAVKPKAAK PKTAKPKAAK PKKAAAKKK
//
ID   H15_HUMAN               Reviewed;         226 AA.
AC   P16401; Q14529; Q3MJ42;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 184.
DE   RecName: Full=Histone H1.5;
DE   AltName: Full=Histone H1a;
DE   AltName: Full=Histone H1b;
DE   AltName: Full=Histone H1s-3;
GN   Name=H1-5 {ECO:0000312|HGNC:HGNC:4719};
GN   Synonyms=H1F5, HIST1H1B {ECO:0000312|HGNC:HGNC:4719};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=9031620; DOI=10.1016/s0378-1119(96)00582-3;
RA   Albig W., Meergans T., Doenecke D.;
RT   "Characterization of the H1.5 gene completes the set of human H1 subtype
RT   genes.";
RL   Gene 184:141-148(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-226.
RC   TISSUE=Spleen;
RX   PubMed=2613692; DOI=10.1093/oxfordjournals.jbchem.a122941;
RA   Ohe Y., Hayashi H., Iwai K.;
RT   "Human spleen histone H1. Isolation and amino acid sequences of three minor
RT   variants, H1a, H1c, and H1d.";
RL   J. Biochem. 106:844-857(1989).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-17; 37-49; 58-78 AND 89-100, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10997781; DOI=10.1023/a:1009262819961;
RA   Parseghian M.H., Newcomb R.L., Winokur S.T., Hamkalo B.A.;
RT   "The distribution of somatic H1 subtypes is non-random on active vs.
RT   inactive chromatin: distribution in human fetal fibroblasts.";
RL   Chromosome Res. 8:405-424(2000).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11746507; DOI=10.1002/jcb.1224;
RA   Parseghian M.H., Newcomb R.L., Hamkalo B.A.;
RT   "Distribution of somatic H1 subtypes is non-random on active vs. inactive
RT   chromatin II: distribution in human adult fibroblasts.";
RL   J. Cell. Biochem. 83:643-659(2001).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15911621; DOI=10.1074/jbc.m501627200;
RA   Th'ng J.P., Sung R., Ye M., Hendzel M.J.;
RT   "H1 family histones in the nucleus. Control of binding and localization by
RT   the C-terminal domain.";
RL   J. Biol. Chem. 280:27809-27814(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION AT THR-11; SER-18; THR-138; THR-155; SER-173 AND SER-189.
RX   PubMed=16377619; DOI=10.1074/jbc.m508957200;
RA   Sarg B., Helliger W., Talasz H., Forg B., Lindner H.H.;
RT   "Histone H1 phosphorylation occurs site-specifically during interphase and
RT   mitosis: identification of a novel phosphorylation site on histone H1.";
RL   J. Biol. Chem. 281:6573-6580(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-11; SER-18 AND THR-39, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION AT THR-11 BY GSK3B.
RX   PubMed=19136008; DOI=10.1016/j.jmb.2008.12.047;
RA   Happel N., Stoldt S., Schmidt B., Doenecke D.;
RT   "M phase-specific phosphorylation of histone H1.5 at threonine 10 by GSK-
RT   3.";
RL   J. Mol. Biol. 386:339-350(2009).
RN   [15]
RP   METHYLATION AT LYS-27.
RX   PubMed=19552482; DOI=10.1021/pr9000652;
RA   Lu A., Zougman A., Pudelko M., Bebenek M., Ziolkowski P., Mann M.,
RA   Wisniewski J.R.;
RT   "Mapping of lysine monomethylation of linker histones in human breast and
RT   its cancer.";
RL   J. Proteome Res. 8:4207-4215(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-168, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-18 AND THR-138, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2; SER-18 AND THR-138, CLEAVAGE OF INITIATOR METHIONINE
RP   [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-11 AND SER-18, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [26]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-86.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes
CC       forming the macromolecular structure known as the chromatin fiber.
CC       Histones H1 are necessary for the condensation of nucleosome chains
CC       into higher-order structured fibers. Acts also as a regulator of
CC       individual gene transcription through chromatin remodeling, nucleosome
CC       spacing and DNA methylation (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9HC52:CBX8; NbExp=2; IntAct=EBI-5327611, EBI-712912;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=According to
CC       PubMed:15911621 more commonly found in heterochromatin. According to
CC       PubMed:10997781 associates with actively transcribed chromatin and not
CC       heterochromatin.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Expressed in the majority of the cell
CC       lines tested and in testis. {ECO:0000269|PubMed:9031620}.
CC   -!- DOMAIN: The C-terminal domain is required for high-affinity binding to
CC       chromatin. {ECO:0000250}.
CC   -!- PTM: H1 histones are progressively phosphorylated during the cell
CC       cycle, becoming maximally phosphorylated during late G2 phase and M
CC       phase, and being dephosphorylated sharply thereafter (By similarity).
CC       Phosphorylated at Thr-11 by GSK3B during mitosis in prometaphase and
CC       dephosphorylated in telophase. {ECO:0000250,
CC       ECO:0000269|PubMed:16377619, ECO:0000269|PubMed:19136008}.
CC   -!- PTM: Citrullination at Arg-57 (H1R54ci) by PADI4 takes place within the
CC       DNA-binding site of H1 and results in its displacement from chromatin
CC       and global chromatin decondensation, thereby promoting pluripotency and
CC       stem cell maintenance. {ECO:0000250|UniProtKB:P43276}.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X83509; CAA58498.1; -; Genomic_DNA.
DR   EMBL; AF531304; AAN06704.1; -; Genomic_DNA.
DR   EMBL; Z98744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069101; AAH69101.1; -; mRNA.
DR   EMBL; BC101581; AAI01582.1; -; mRNA.
DR   EMBL; BC101583; AAI01584.1; -; mRNA.
DR   CCDS; CCDS4635.1; -.
DR   PIR; S51660; S51660.
DR   RefSeq; NP_005313.1; NM_005322.2.
DR   PDB; 2FE2; Model; -; A=2-226.
DR   PDB; 2RHI; X-ray; 1.66 A; B=23-27.
DR   PDBsum; 2FE2; -.
DR   PDBsum; 2RHI; -.
DR   SMR; P16401; -.
DR   BioGrid; 109264; 78.
DR   IntAct; P16401; 207.
DR   MINT; P16401; -.
DR   STRING; 9606.ENSP00000330074; -.
DR   iPTMnet; P16401; -.
DR   PhosphoSitePlus; P16401; -.
DR   SwissPalm; P16401; -.
DR   BioMuta; HIST1H1B; -.
DR   DMDM; 19856407; -.
DR   EPD; P16401; -.
DR   jPOST; P16401; -.
DR   MassIVE; P16401; -.
DR   MaxQB; P16401; -.
DR   PaxDb; P16401; -.
DR   PeptideAtlas; P16401; -.
DR   PRIDE; P16401; -.
DR   ProteomicsDB; 53351; -.
DR   TopDownProteomics; P16401; -.
DR   DNASU; 3009; -.
DR   Ensembl; ENST00000331442; ENSP00000330074; ENSG00000184357.
DR   GeneID; 3009; -.
DR   KEGG; hsa:3009; -.
DR   UCSC; uc003njx.4; human.
DR   CTD; 3009; -.
DR   DisGeNET; 3009; -.
DR   GeneCards; H1-5; -.
DR   HGNC; HGNC:4719; H1-5.
DR   HPA; CAB012241; -.
DR   HPA; HPA055907; -.
DR   MIM; 142711; gene.
DR   neXtProt; NX_P16401; -.
DR   OpenTargets; ENSG00000184357; -.
DR   PharmGKB; PA29097; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00940000162950; -.
DR   HOGENOM; CLU_052897_7_0_1; -.
DR   InParanoid; P16401; -.
DR   KO; K11275; -.
DR   OMA; FVESKYH; -.
DR   OrthoDB; 1565299at2759; -.
DR   PhylomeDB; P16401; -.
DR   TreeFam; TF313664; -.
DR   Reactome; R-HSA-140342; Apoptosis induced DNA fragmentation.
DR   Reactome; R-HSA-2559584; Formation of Senescence-Associated Heterochromatin Foci (SAHF).
DR   SIGNOR; P16401; -.
DR   EvolutionaryTrace; P16401; -.
DR   GeneWiki; HIST1H1B; -.
DR   GenomeRNAi; 3009; -.
DR   Pharos; P16401; Tbio.
DR   PRO; PR:P16401; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P16401; protein.
DR   Bgee; ENSG00000184357; Expressed in lung and 47 other tissues.
DR   Genevisible; P16401; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0005719; C:nuclear euchromatin; IBA:GO_Central.
DR   GO; GO:0005720; C:nuclear heterochromatin; IDA:UniProtKB.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; IMP:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:UniProtKB.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IMP:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProtKB.
DR   GO; GO:0007517; P:muscle organ development; IEA:Ensembl.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB.
DR   GO; GO:0051574; P:positive regulation of histone H3-K9 methylation; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR005819; Histone_H5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Citrullination;
KW   Direct protein sequencing; DNA-binding; Hydroxylation; Methylation;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:2613692,
FT                   ECO:0000269|Ref.6"
FT   CHAIN           2..226
FT                   /note="Histone H1.5"
FT                   /id="PRO_0000195909"
FT   DOMAIN          39..112
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOD_RES         2
FT                   /note="N-acetylserine; partial"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000244|PubMed:25944712, ECO:0000269|Ref.6"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         11
FT                   /note="Phosphothreonine; by GSK3"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:16377619,
FT                   ECO:0000269|PubMed:19136008"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43276"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:16377619"
FT   MOD_RES         27
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000269|PubMed:19552482"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         37
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P43276"
FT   MOD_RES         39
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         49
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43276"
FT   MOD_RES         55
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         57
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P43276"
FT   MOD_RES         67
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         78
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43276"
FT   MOD_RES         88
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         93
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         109
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P43277"
FT   MOD_RES         138
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:16377619"
FT   MOD_RES         155
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:16377619"
FT   MOD_RES         168
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         173
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16377619"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16377619"
FT   VARIANT         86
FT                   /note="G -> D (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036204"
FT   VARIANT         144
FT                   /note="K -> R (in dbSNP:rs11970638)"
FT                   /id="VAR_049308"
FT   VARIANT         211
FT                   /note="A -> T (in dbSNP:rs34144478)"
FT                   /id="VAR_049309"
FT   CONFLICT        216..218
FT                   /note="Missing (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   226 AA;  22580 MW;  0BA1402101766FDF CRC64;
     MSETAPAETA TPAPVEKSPA KKKATKKAAG AGAAKRKATG PPVSELITKA VAASKERNGL
     SLAALKKALA AGGYDVEKNN SRIKLGLKSL VSKGTLVQTK GTGASGSFKL NKKAASGEAK
     PKAKKAGAAK AKKPAGATPK KAKKAAGAKK AVKKTPKKAK KPAAAGVKKV AKSPKKAKAA
     AKPKKATKSP AKPKAVKPKA AKPKAAKPKA AKPKAAKAKK AAAKKK
//
ID   H1FNT_HUMAN             Reviewed;         255 AA.
AC   Q75WM6; Q147U8; Q5GKZ5; Q7Z694;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   26-FEB-2020, entry version 108.
DE   RecName: Full=Testis-specific H1 histone;
DE   AltName: Full=Haploid germ cell-specific nuclear protein 1;
DE   AltName: Full=Histone H1t2;
GN   Name=H1FNT; Synonyms=HANP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Huang C.Q., Shan Y.X., Wu S.L., Cheng Z.;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-174.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 17-255, FUNCTION, TISSUE SPECIFICITY, AND
RP   VARIANTS GLY-84; PRO-108; SER-136; GLN-174 AND PHE-237.
RC   TISSUE=Testis;
RX   PubMed=16533358; DOI=10.1111/j.1365-2605.2005.00600.x;
RA   Tanaka H., Matsuoka Y., Onishi M., Kitamura K., Miyagawa Y., Nishimura H.,
RA   Tsujimura A., Okuyama A., Nishimune Y.;
RT   "Expression profiles and single-nucleotide polymorphism analysis of human
RT   HANP1/H1T2 encoding a histone H1-like protein.";
RL   Int. J. Androl. 29:353-359(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 22-255.
RX   PubMed=15710904; DOI=10.1073/pnas.0406060102;
RA   Martianov I., Brancorsini S., Catena R., Gansmuller A., Kotaja N.,
RA   Parvinen M., Sassone-Corsi P., Davidson I.;
RT   "Polar nuclear localization of H1T2, a histone H1 variant, required for
RT   spermatid elongation and DNA condensation during spermiogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:2808-2813(2005).
CC   -!- FUNCTION: Essential for normal spermatogenesis and male fertility
CC       (PubMed:16533358). Required for proper cell restructuring and DNA
CC       condensation during the elongation phase of spermiogenesis. Involved in
CC       the histone-protamine transition of sperm chromatin and the subsequent
CC       production of functional sperm. Binds both double-stranded and single-
CC       stranded DNA, ATP and protamine-1. {ECO:0000250|UniProtKB:Q8CJI4,
CC       ECO:0000269|PubMed:16533358}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8CJI4}.
CC       Chromosome {ECO:0000250|UniProtKB:Q8CJI4}. Note=In round and elongating
CC       spermatids, specifically localizes to a chromatin domain at the apical
CC       pole. {ECO:0000250|UniProtKB:Q8CJI4}.
CC   -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:16533358}.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-22 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD13382.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY302593; AAP60022.1; -; mRNA.
DR   EMBL; AC024257; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC118635; AAI18636.1; -; mRNA.
DR   EMBL; BC119787; AAI19788.1; -; mRNA.
DR   EMBL; AB121028; BAD13382.2; ALT_INIT; mRNA.
DR   EMBL; AY496854; AAS49492.1; -; Genomic_DNA.
DR   CCDS; CCDS8762.1; -.
DR   RefSeq; NP_861453.1; NM_181788.1.
DR   SMR; Q75WM6; -.
DR   BioGrid; 131143; 95.
DR   IntAct; Q75WM6; 4.
DR   STRING; 9606.ENSP00000334805; -.
DR   iPTMnet; Q75WM6; -.
DR   PhosphoSitePlus; Q75WM6; -.
DR   BioMuta; H1FNT; -.
DR   DMDM; 215274115; -.
DR   MassIVE; Q75WM6; -.
DR   PaxDb; Q75WM6; -.
DR   PeptideAtlas; Q75WM6; -.
DR   PRIDE; Q75WM6; -.
DR   ProteomicsDB; 68656; -.
DR   Ensembl; ENST00000335017; ENSP00000334805; ENSG00000187166.
DR   GeneID; 341567; -.
DR   KEGG; hsa:341567; -.
DR   UCSC; uc001rrm.3; human.
DR   CTD; 341567; -.
DR   DisGeNET; 341567; -.
DR   GeneCards; H1-7; -.
DR   HGNC; HGNC:24893; H1FNT.
DR   HPA; HPA046204; -.
DR   MIM; 618565; gene.
DR   neXtProt; NX_Q75WM6; -.
DR   OpenTargets; ENSG00000187166; -.
DR   PharmGKB; PA143485486; -.
DR   eggNOG; ENOG410IX90; Eukaryota.
DR   eggNOG; ENOG4111BIG; LUCA.
DR   GeneTree; ENSGT00730000111596; -.
DR   HOGENOM; CLU_094439_0_0_1; -.
DR   InParanoid; Q75WM6; -.
DR   OMA; KEPPCAR; -.
DR   OrthoDB; 1487385at2759; -.
DR   PhylomeDB; Q75WM6; -.
DR   TreeFam; TF338403; -.
DR   GenomeRNAi; 341567; -.
DR   Pharos; Q75WM6; Tdark.
DR   PRO; PR:Q75WM6; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q75WM6; protein.
DR   Bgee; ENSG00000187166; Expressed in right testis and 75 other tissues.
DR   ExpressionAtlas; Q75WM6; baseline and differential.
DR   Genevisible; Q75WM6; HS.
DR   GO; GO:0000790; C:nuclear chromatin; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0035092; P:sperm chromatin condensation; ISS:UniProtKB.
DR   GO; GO:0007290; P:spermatid nucleus elongation; ISS:UniProtKB.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
PE   2: Evidence at transcript level;
KW   ATP-binding; Chromosome; Developmental protein; Differentiation;
KW   DNA condensation; DNA-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Spermatogenesis.
FT   CHAIN           1..255
FT                   /note="Testis-specific H1 histone"
FT                   /id="PRO_0000343414"
FT   COMPBIAS        129..195
FT                   /note="Arg-rich"
FT   MOD_RES         56
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RKG3"
FT   VARIANT         84
FT                   /note="R -> G (in dbSNP:rs2732441)"
FT                   /evidence="ECO:0000269|PubMed:16533358"
FT                   /id="VAR_044371"
FT   VARIANT         108
FT                   /note="L -> P (in dbSNP:rs766280749)"
FT                   /evidence="ECO:0000269|PubMed:16533358"
FT                   /id="VAR_044372"
FT   VARIANT         136
FT                   /note="R -> S (in dbSNP:rs752698412)"
FT                   /evidence="ECO:0000269|PubMed:16533358"
FT                   /id="VAR_044373"
FT   VARIANT         174
FT                   /note="R -> Q (in dbSNP:rs1471997)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:16533358"
FT                   /id="VAR_044374"
FT   VARIANT         195
FT                   /note="R -> Q (in dbSNP:rs1471997)"
FT                   /id="VAR_047359"
FT   VARIANT         237
FT                   /note="S -> F (in dbSNP:rs2291483)"
FT                   /evidence="ECO:0000269|PubMed:16533358"
FT                   /id="VAR_044375"
FT   CONFLICT        231
FT                   /note="K -> N (in Ref. 3; AAI18636)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   255 AA;  28116 MW;  F5BA8AB6A4D4E912 CRC64;
     MEQALTGEAQ SRWPRRGGSG AMAEAPGPSG ESRGHSATQL PAEKTVGGPS RGCSSSVLRV
     SQLVLQAIST HKGLTLAALK KELRNAGYEV RRKSGRHEAP RGQAKATLLR VSGSDAAGYF
     RVWKVPKPRR KPGRARQEEG TRAPWRTPAA PRSSRRRRQP LRKAARKARE VWRRNARAKA
     KANARARRTR RARPRAKEPP CARAKEEAGA TAADEGRGQA VKEDTTPRSG KDKRRSSKPR
     EEKQEPKKPA QRTIQ
//
ID   H1FOO_HUMAN             Reviewed;         346 AA.
AC   Q8IZA3; Q86WT7;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   26-FEB-2020, entry version 136.
DE   RecName: Full=Histone H1oo;
DE   AltName: Full=Oocyte-specific histone H1;
DE   AltName: Full=Oocyte-specific linker histone H1;
DE            Short=osH1;
GN   Name=H1FOO; Synonyms=H1OO, OSH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=12711322; DOI=10.1016/s0006-291x(03)00610-7;
RA   Tanaka Y., Kato S., Tanaka M., Kuji N., Yoshimura Y.;
RT   "Structure and expression of the human oocyte-specific histone H1 gene
RT   elucidated by direct RT-nested PCR of a single oocyte.";
RL   Biochem. Biophys. Res. Commun. 304:351-357(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May play a key role in the control of gene expression during
CC       oogenesis and early embryogenesis, presumably through the perturbation
CC       of chromatin structure. Essential for meiotic maturation of germinal
CC       vesicle-stage oocytes. The somatic type linker histone H1c is rapidly
CC       replaced by H1oo in a donor nucleus transplanted into an oocyte. The
CC       greater mobility of H1oo as compared to H1c may contribute to this
CC       rapid replacement and increased instability of the embryonic chromatin
CC       structure. The rapid replacement of H1c with H1oo may play an important
CC       role in nuclear remodeling (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00837}. Chromosome
CC       {ECO:0000255|PROSITE-ProRule:PRU00837}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IZA3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IZA3-2; Sequence=VSP_034592;
CC   -!- TISSUE SPECIFICITY: Oocyte-specific. {ECO:0000269|PubMed:12711322}.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY158091; AAN46899.1; -; mRNA.
DR   EMBL; CH471052; EAW79242.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79243.1; -; Genomic_DNA.
DR   EMBL; BC047943; AAH47943.1; -; mRNA.
DR   CCDS; CCDS3064.1; -. [Q8IZA3-1]
DR   CCDS; CCDS77815.1; -. [Q8IZA3-2]
DR   RefSeq; NP_001295191.1; NM_001308262.1. [Q8IZA3-2]
DR   RefSeq; NP_722575.1; NM_153833.2. [Q8IZA3-1]
DR   RefSeq; XP_016861222.1; XM_017005733.1. [Q8IZA3-2]
DR   SMR; Q8IZA3; -.
DR   BioGrid; 126315; 50.
DR   IntAct; Q8IZA3; 1.
DR   STRING; 9606.ENSP00000319799; -.
DR   iPTMnet; Q8IZA3; -.
DR   PhosphoSitePlus; Q8IZA3; -.
DR   BioMuta; H1FOO; -.
DR   DMDM; 74762503; -.
DR   EPD; Q8IZA3; -.
DR   jPOST; Q8IZA3; -.
DR   PaxDb; Q8IZA3; -.
DR   PeptideAtlas; Q8IZA3; -.
DR   PRIDE; Q8IZA3; -.
DR   ProteomicsDB; 71310; -. [Q8IZA3-1]
DR   ProteomicsDB; 71311; -. [Q8IZA3-2]
DR   Ensembl; ENST00000324382; ENSP00000319799; ENSG00000178804. [Q8IZA3-1]
DR   Ensembl; ENST00000503977; ENSP00000422964; ENSG00000178804. [Q8IZA3-2]
DR   GeneID; 132243; -.
DR   KEGG; hsa:132243; -.
DR   UCSC; uc003emu.3; human. [Q8IZA3-1]
DR   CTD; 132243; -.
DR   GeneCards; H1-8; -.
DR   HGNC; HGNC:18463; H1FOO.
DR   HPA; HPA037992; -.
DR   neXtProt; NX_Q8IZA3; -.
DR   PharmGKB; PA134958422; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00940000160900; -.
DR   HOGENOM; CLU_070976_0_0_1; -.
DR   InParanoid; Q8IZA3; -.
DR   OMA; FPVGRRH; -.
DR   OrthoDB; 1342218at2759; -.
DR   PhylomeDB; Q8IZA3; -.
DR   TreeFam; TF333386; -.
DR   GeneWiki; H1FOO; -.
DR   GenomeRNAi; 132243; -.
DR   Pharos; Q8IZA3; Tbio.
DR   PRO; PR:Q8IZA3; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8IZA3; protein.
DR   Bgee; ENSG00000178804; Expressed in oocyte and 30 other tissues.
DR   Genevisible; Q8IZA3; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; ISS:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:2000737; P:negative regulation of stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; ISS:UniProtKB.
DR   GO; GO:0044030; P:regulation of DNA methylation; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Chromosome; Cytoplasm; DNA-binding; Meiosis; Nucleus;
KW   Polymorphism; Reference proteome.
FT   CHAIN           1..346
FT                   /note="Histone H1oo"
FT                   /id="PRO_0000343412"
FT   DOMAIN          51..129
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOTIF           164..179
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..139
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034592"
FT   VARIANT         296
FT                   /note="N -> S (in dbSNP:rs59415528)"
FT                   /id="VAR_061208"
SQ   SEQUENCE   346 AA;  35813 MW;  666964009BE6F4AC CRC64;
     MAPGSVTSDI SPSSTSTAGS SRSPESEKPG PSHGGVPPGG PSHSSLPVGR RHPPVLRMVL
     EALQAGEQRR GTSVAAIKLY ILHKYPTVDV LRFKYLLKQA LATGMRRGLL ARPLNSKARG
     ATGSFKLVPK HKKKIQPRKM APATAPRRAG EAKGKGPKKP SEAKEDPPNV GKVKKAAKRP
     AKVQKPPPKP GAATEKARKQ GGAAKDTRAQ SGEARKVPPK PDKAMRAPSS AGGLSRKAKA
     KGSRSSQGDA EAYRKTKAES KSSKPTASKV KNGAASPTKK KVVAKAKAPK AGQGPNTKAA
     APAKGSGSKV VPAHLSRKTE APKGPRKAGL PIKASSSKVS SQRAEA
//
ID   H1T_HUMAN               Reviewed;         207 AA.
AC   P22492; Q6ISI1; Q8IUE8;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   26-FEB-2020, entry version 166.
DE   RecName: Full=Histone H1t;
DE   AltName: Full=Testicular H1 histone;
GN   Name=HIST1H1T; Synonyms=H1FT, H1T;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND VARIANT LEU-14.
RX   PubMed=1889752; DOI=10.1016/0378-1119(91)90284-i;
RA   Drabent B., Kardalinou E., Doenecke D.;
RT   "Structure and expression of the human gene encoding testicular H1 histone
RT   (H1t).";
RL   Gene 103:263-268(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   AND VARIANT LYS-178.
RX   PubMed=8175896; DOI=10.1002/jcb.240540210;
RA   Koppel D.A., Wolfe S.A., Fogelfeld L., Grimes S.R.;
RT   "Primate testicular histone H1t genes are highly conserved and the human
RT   H1t gene is located on chromosome 6.";
RL   J. Cell. Biochem. 54:219-230(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=26757249; DOI=10.1021/acs.biochem.5b01126;
RA   Machida S., Hayashida R., Takaku M., Fukuto A., Sun J., Kinomura A.,
RA   Tashiro S., Kurumizaka H.;
RT   "Relaxed chromatin formation and weak suppression of homologous pairing by
RT   the testis-specific linker histone H1T.";
RL   Biochemistry 55:637-646(2016).
CC   -!- FUNCTION: Testis-specific histone H1 that forms less compacted
CC       chromatin compared to other H1 histone subtypes (PubMed:26757249).
CC       Formation of more relaxed chromatin may be required to promote
CC       chromatin architecture required for proper chromosome regulation during
CC       meiosis, such as homologous recombination (PubMed:26757249). Histones
CC       H1 act as linkers that bind to nucleosomes and compact polynucleosomes
CC       into a higher-order chromatin configuration (Probable).
CC       {ECO:0000269|PubMed:26757249, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Chromosome {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:1889752,
CC       ECO:0000269|PubMed:8175896}.
CC   -!- DEVELOPMENTAL STAGE: This histone is a testis-specific H1 variant that
CC       appears during meiosis in spermatogenesis.
CC       {ECO:0000269|PubMed:8175896}.
CC   -!- PTM: Phosphorylated in early spermatids.
CC       {ECO:0000250|UniProtKB:P06349}.
CC   -!- PTM: Citrullination at Arg-58 (H1R54ci) by PADI4 takes place within the
CC       DNA-binding site of H1 and results in its displacement from chromatin
CC       and global chromatin decondensation, thereby promoting pluripotency and
CC       stem cell maintenance. {ECO:0000250|UniProtKB:P43275}.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M60094; AAA35944.1; -; Genomic_DNA.
DR   EMBL; M97755; AAA19936.1; -; Genomic_DNA.
DR   EMBL; AF531301; AAN06701.1; -; Genomic_DNA.
DR   EMBL; BC069517; AAH69517.2; -; mRNA.
DR   CCDS; CCDS34349.1; -.
DR   PIR; JH0550; JH0550.
DR   RefSeq; NP_005314.2; NM_005323.3.
DR   SMR; P22492; -.
DR   BioGrid; 109265; 118.
DR   IntAct; P22492; 101.
DR   MINT; P22492; -.
DR   STRING; 9606.ENSP00000341214; -.
DR   iPTMnet; P22492; -.
DR   PhosphoSitePlus; P22492; -.
DR   SwissPalm; P22492; -.
DR   BioMuta; HIST1H1T; -.
DR   DMDM; 34395930; -.
DR   EPD; P22492; -.
DR   jPOST; P22492; -.
DR   MassIVE; P22492; -.
DR   MaxQB; P22492; -.
DR   PaxDb; P22492; -.
DR   PeptideAtlas; P22492; -.
DR   PRIDE; P22492; -.
DR   ProteomicsDB; 53996; -.
DR   DNASU; 3010; -.
DR   Ensembl; ENST00000338379; ENSP00000341214; ENSG00000187475.
DR   GeneID; 3010; -.
DR   KEGG; hsa:3010; -.
DR   UCSC; uc003ngj.4; human.
DR   CTD; 3010; -.
DR   DisGeNET; 3010; -.
DR   GeneCards; H1-6; -.
DR   HGNC; HGNC:4720; HIST1H1T.
DR   HPA; HPA065718; -.
DR   HPA; HPA068266; -.
DR   MIM; 142712; gene.
DR   neXtProt; NX_P22492; -.
DR   OpenTargets; ENSG00000187475; -.
DR   PharmGKB; PA29098; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00940000163525; -.
DR   HOGENOM; CLU_052897_7_0_1; -.
DR   InParanoid; P22492; -.
DR   KO; K11275; -.
DR   OMA; KPKLTQH; -.
DR   OrthoDB; 1565299at2759; -.
DR   PhylomeDB; P22492; -.
DR   TreeFam; TF313664; -.
DR   GeneWiki; HIST1H1T; -.
DR   GenomeRNAi; 3010; -.
DR   Pharos; P22492; Tdark.
DR   PRO; PR:P22492; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P22492; protein.
DR   Bgee; ENSG00000187475; Expressed in corpus callosum and 37 other tissues.
DR   Genevisible; P22492; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005719; C:nuclear euchromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR005819; Histone_H5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   2: Evidence at transcript level;
KW   Chromosome; Citrullination; Developmental protein; Differentiation;
KW   DNA-binding; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Spermatogenesis.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..207
FT                   /note="Histone H1t"
FT                   /id="PRO_0000195910"
FT   DOMAIN          40..113
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   SITE            56
FT                   /note="Important for nucleosome binding properties"
FT                   /evidence="ECO:0000250|UniProtKB:P06349"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07133"
FT   MOD_RES         58
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07133"
FT   MOD_RES         159
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07133"
FT   MOD_RES         166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07133"
FT   MOD_RES         181
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07133"
FT   MOD_RES         190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06349"
FT   VARIANT         14
FT                   /note="V -> L (in dbSNP:rs198844)"
FT                   /evidence="ECO:0000269|PubMed:1889752"
FT                   /id="VAR_049310"
FT   VARIANT         52
FT                   /note="L -> F (in dbSNP:rs2051542)"
FT                   /id="VAR_049311"
FT   VARIANT         178
FT                   /note="Q -> K (in dbSNP:rs198845)"
FT                   /evidence="ECO:0000269|PubMed:8175896"
FT                   /id="VAR_049312"
SQ   SEQUENCE   207 AA;  22019 MW;  9CF27B275DA29B48 CRC64;
     MSETVPAASA SAGVAAMEKL PTKKRGRKPA GLISASRKVP NLSVSKLITE ALSVSQERVG
     MSLVALKKAL AAAGYDVEKN NSRIKLSLKS LVNKGILVQT RGTGASGSFK LSKKVIPKST
     RSKAKKSVSA KTKKLVLSRD SKSPKTAKTN KRAKKPRATT PKTVRSGRKA KGAKGKQQQK
     SPVKARASKS KLTQHHEVNV RKATSKK
//
ID   H1X_HUMAN               Reviewed;         213 AA.
AC   Q92522;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   26-FEB-2020, entry version 180.
DE   RecName: Full=Histone H1x;
GN   Name=H1FX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8964515; DOI=10.1016/0378-1119(96)00020-0;
RA   Yamamoto T., Horikoshi M.;
RT   "Cloning of the cDNA encoding a novel subtype of histone H1.";
RL   Gene 173:281-285(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-19; 48-57; 76-86; 95-118 AND 128-143, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Calvo F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   INTERACTION WITH RRP1B.
RX   PubMed=19710015; DOI=10.1074/jbc.m109.023457;
RA   Crawford N.P., Yang H., Mattaini K.R., Hunter K.W.;
RT   "The metastasis efficiency modifier ribosomal RNA processing 1 homolog B
RT   (RRP1B) is a chromatin-associated factor.";
RL   J. Biol. Chem. 284:28660-28673(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-47, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2; SER-31 AND SER-33, CLEAVAGE OF INITIATOR METHIONINE
RP   [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-31, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Histones H1 are necessary for the condensation of nucleosome
CC       chains into higher-order structures.
CC   -!- SUBUNIT: Interacts with RRP1B. {ECO:0000269|PubMed:19710015}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously.
CC   -!- PTM: Citrullination at Arg-62 (H1R54ci) by PADI4 takes place within the
CC       DNA-binding site of H1 and results in its displacement from chromatin
CC       and global chromatin decondensation, thereby promoting pluripotency and
CC       stem cell maintenance. {ECO:0000250|UniProtKB:P43275}.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D64142; BAA11018.1; -; mRNA.
DR   EMBL; BC000426; AAH00426.1; -; mRNA.
DR   EMBL; BC010435; AAH10435.1; -; mRNA.
DR   CCDS; CCDS3057.1; -.
DR   PIR; JC4928; JC4928.
DR   RefSeq; NP_006017.1; NM_006026.3.
DR   PDB; 2LSO; NMR; -; A=44-123.
DR   PDBsum; 2LSO; -.
DR   SMR; Q92522; -.
DR   BioGrid; 114461; 95.
DR   CORUM; Q92522; -.
DR   DIP; DIP-36358N; -.
DR   IntAct; Q92522; 68.
DR   MINT; Q92522; -.
DR   STRING; 9606.ENSP00000329662; -.
DR   iPTMnet; Q92522; -.
DR   PhosphoSitePlus; Q92522; -.
DR   SwissPalm; Q92522; -.
DR   BioMuta; H1FX; -.
DR   DMDM; 6016184; -.
DR   EPD; Q92522; -.
DR   jPOST; Q92522; -.
DR   MassIVE; Q92522; -.
DR   MaxQB; Q92522; -.
DR   PaxDb; Q92522; -.
DR   PeptideAtlas; Q92522; -.
DR   PRIDE; Q92522; -.
DR   ProteomicsDB; 75281; -.
DR   TopDownProteomics; Q92522; -.
DR   Ensembl; ENST00000333762; ENSP00000329662; ENSG00000184897.
DR   GeneID; 8971; -.
DR   KEGG; hsa:8971; -.
DR   UCSC; uc003elx.3; human.
DR   CTD; 8971; -.
DR   DisGeNET; 8971; -.
DR   GeneCards; H1-10; -.
DR   HGNC; HGNC:4722; H1FX.
DR   HPA; CAB012235; -.
DR   HPA; HPA040099; -.
DR   MIM; 602785; gene.
DR   neXtProt; NX_Q92522; -.
DR   OpenTargets; ENSG00000184897; -.
DR   PharmGKB; PA29099; -.
DR   eggNOG; KOG4012; Eukaryota.
DR   eggNOG; ENOG4112541; LUCA.
DR   GeneTree; ENSGT00730000111536; -.
DR   HOGENOM; CLU_102232_0_0_1; -.
DR   InParanoid; Q92522; -.
DR   KO; K11275; -.
DR   OMA; AKKVSWF; -.
DR   OrthoDB; 1565299at2759; -.
DR   PhylomeDB; Q92522; -.
DR   TreeFam; TF313664; -.
DR   ChiTaRS; H1FX; human.
DR   GeneWiki; H1FX; -.
DR   GenomeRNAi; 8971; -.
DR   Pharos; Q92522; Tbio.
DR   PRO; PR:Q92522; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q92522; protein.
DR   Bgee; ENSG00000184897; Expressed in bone marrow and 216 other tissues.
DR   Genevisible; Q92522; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; IBA:GO_Central.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   CDD; cd00073; H15; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR005819; Histone_H5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   PRINTS; PR00624; HISTONEH5.
DR   SMART; SM00526; H15; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Citrullination;
KW   Direct protein sequencing; DNA-binding; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895,
FT                   ECO:0000269|Ref.3"
FT   CHAIN           2..213
FT                   /note="Histone H1x"
FT                   /id="PRO_0000195912"
FT   DOMAIN          44..118
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895,
FT                   ECO:0000269|Ref.3"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         33
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         47
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         62
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P43275"
FT   HELIX           47..59
FT                   /evidence="ECO:0000244|PDB:2LSO"
FT   HELIX           67..74
FT                   /evidence="ECO:0000244|PDB:2LSO"
FT   TURN            82..84
FT                   /evidence="ECO:0000244|PDB:2LSO"
FT   HELIX           85..98
FT                   /evidence="ECO:0000244|PDB:2LSO"
FT   STRAND          101..105
FT                   /evidence="ECO:0000244|PDB:2LSO"
FT   STRAND          107..109
FT                   /evidence="ECO:0000244|PDB:2LSO"
FT   STRAND          111..116
FT                   /evidence="ECO:0000244|PDB:2LSO"
FT   TURN            120..122
FT                   /evidence="ECO:0000244|PDB:2LSO"
SQ   SEQUENCE   213 AA;  22487 MW;  11548D85C5448FF2 CRC64;
     MSVELEEALP VTTAEGMAKK VTKAGGSAAL SPSKKRKNSK KKNQPGKYSQ LVVETIRRLG
     ERNGSSLAKI YTEAKKVPWF DQQNGRTYLK YSIKALVQND TLLQVKGTGA NGSFKLNRKK
     LEGGGERRGA PAAATAPAPT AHKAKKAAPG AAGSRRADKK PARGQKPEQR SHKKGAGAKK
     DKGGKAKKTA AAGGKKVKKA AKPSVPKVPK GRK
//
ID   H2A1A_HUMAN             Reviewed;         131 AA.
AC   Q96QV6;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 156.
DE   RecName: Full=Histone H2A type 1-A;
DE   AltName: Full=Histone H2A/r;
GN   Name=HIST1H2AA; Synonyms=H2AFR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=15078818; DOI=10.1101/gad.1184604;
RA   Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K.,
RA   Kaneko M., Takeshima Y., Muramatsu M., Ito T.;
RT   "Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in
RT   the early Drosophila embryo.";
RL   Genes Dev. 18:877-888(2004).
RN   [5]
RP   PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [6]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S.,
RA   Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [7]
RP   ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15823041; DOI=10.1021/bi047505c;
RA   Hagiwara T., Hidaka Y., Yamada M.;
RT   "Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.";
RL   Biochemistry 44:5827-5834(2005).
RN   [8]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [9]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16702407; DOI=10.1101/gad.373706;
RA   Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M., de Waard H.,
RA   Wu J., Yuan L., Citterio E., Houtsmuller A.B., Neefjes J.,
RA   Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
RT   "DNA damage triggers nucleotide excision repair-dependent
RT   monoubiquitylation of histone H2A.";
RL   Genes Dev. 20:1343-1352(2006).
RN   [10]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [11]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [12]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [13]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [14]
RP   CROTONYLATION AT LYS-37; LYS-119; LYS-120 AND LYS-127.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [15]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [16]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22713238; DOI=10.4161/cc.20919;
RA   Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L.;
RT   "A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by
RT   RNF168 ubiquitin ligase.";
RL   Cell Cycle 11:2538-2544(2012).
RN   [17]
RP   SUCCINYLATION AT LYS-10 AND LYS-96.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [18]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=24140421; DOI=10.1016/j.molcel.2013.09.017;
RA   Kim K., Kim J.M., Kim J.S., Choi J., Lee Y.S., Neamati N., Song J.S.,
RA   Heo K., An W.;
RT   "VprBP has intrinsic kinase activity targeting histone H2A and represses
RT   gene transcription.";
RL   Mol. Cell 52:459-467(2013).
RN   [19]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-10; LYS-37; LYS-75; LYS-76; LYS-96 AND
RP   LYS-119.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [20]
RP   METHYLATION AT GLN-105.
RX   PubMed=24352239; DOI=10.1038/nature12819;
RA   Tessarz P., Santos-Rosa H., Robson S.C., Sylvestersen K.B., Nelson C.J.,
RA   Nielsen M.L., Kouzarides T.;
RT   "Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated
RT   modification.";
RL   Nature 505:564-568(2014).
RN   [21]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=25470042; DOI=10.1038/nature13955;
RA   Bhatnagar S., Gazin C., Chamberlain L., Ou J., Zhu X., Tushir J.S.,
RA   Virbasius C.M., Lin L., Zhu L.J., Wajapeyee N., Green M.R.;
RT   "TRIM37 is a new histone H2A ubiquitin ligase and breast cancer
RT   oncoprotein.";
RL   Nature 516:116-120(2014).
RN   [22]
RP   DEUBIQUITINATION AT LYS-14 AND LYS-16 BY USP51.
RX   PubMed=27083998; DOI=10.1101/gad.271841.115;
RA   Wang Z., Zhang H., Liu J., Cheruiyot A., Lee J.H., Ordog T., Lou Z.,
RA   You Z., Zhang Z.;
RT   "USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.";
RL   Genes Dev. 30:946-959(2016).
RN   [23]
RP   HYDROXYBUTYRYLATION AT LYS-10; LYS-14; LYS-37; LYS-96 AND LYS-119.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [24]
RP   GLUTARYLATION AT LYS-96; LYS-119 AND LYS-120.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Deiminated on Arg-4 in granulocytes upon calcium entry.
CC       {ECO:0000269|PubMed:15823041}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AK119Ub) by RING1, TRIM37 and
CC       RNF2/RING2 complex gives a specific tag for epigenetic transcriptional
CC       repression and participates in X chromosome inactivation of female
CC       mammals. It is involved in the initiation of both imprinted and random
CC       X inactivation. Ubiquitinated H2A is enriched in inactive X chromosome
CC       chromatin. Ubiquitination of H2A functions downstream of methylation of
CC       'Lys-27' of histone H3 (H3K27me). H2AK119Ub by RNF2/RING2 can also be
CC       induced by ultraviolet and may be involved in DNA repair.
CC       Monoubiquitination of Lys-120 (H2AK119Ub) by TRIM37 may promote
CC       transformation of cells in a number of breast cancers
CC       (PubMed:25470042). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. Deubiquitinated by USP51 at Lys-14 and Lys-16 (H2AK13Ub and
CC       H2AK15Ub, respectively) after damaged DNA is repaired
CC       (PubMed:27083998). H2AK119Ub and ionizing radiation-induced 'Lys-63'-
CC       linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901,
CC       ECO:0000269|PubMed:16702407, ECO:0000269|PubMed:18001824,
CC       ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:22713238,
CC       ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:24352239,
CC       ECO:0000269|PubMed:25470042, ECO:0000269|PubMed:27083998}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription. {ECO:0000269|PubMed:15010469,
CC       ECO:0000269|PubMed:15078818, ECO:0000269|PubMed:15823041,
CC       ECO:0000269|PubMed:24140421}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (PubMed:24352239).
CC       {ECO:0000269|PubMed:24352239}.
CC   -!- PTM: Symmetric dimethylation on Arg-4 by the PRDM1/PRMT5 complex may
CC       play a crucial role in the germ-cell lineage.
CC       {ECO:0000250|UniProtKB:P22752}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY131982; AAN59963.1; -; Genomic_DNA.
DR   EMBL; AL512384; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC062211; AAH62211.1; -; mRNA.
DR   CCDS; CCDS4562.1; -.
DR   RefSeq; NP_734466.1; NM_170745.3.
DR   PDB; 5GSU; X-ray; 3.10 A; C/G=2-131.
DR   PDB; 5GT0; X-ray; 2.82 A; C/G=2-131.
DR   PDBsum; 5GSU; -.
DR   PDBsum; 5GT0; -.
DR   SMR; Q96QV6; -.
DR   BioGrid; 128742; 31.
DR   CORUM; Q96QV6; -.
DR   DIP; DIP-43896N; -.
DR   IntAct; Q96QV6; 12.
DR   MINT; Q96QV6; -.
DR   STRING; 9606.ENSP00000297012; -.
DR   iPTMnet; Q96QV6; -.
DR   PhosphoSitePlus; Q96QV6; -.
DR   SwissPalm; Q96QV6; -.
DR   BioMuta; HIST1H2AA; -.
DR   DMDM; 74752099; -.
DR   jPOST; Q96QV6; -.
DR   MassIVE; Q96QV6; -.
DR   MaxQB; Q96QV6; -.
DR   PaxDb; Q96QV6; -.
DR   PeptideAtlas; Q96QV6; -.
DR   PRIDE; Q96QV6; -.
DR   ProteomicsDB; 77911; -.
DR   TopDownProteomics; Q96QV6; -.
DR   DNASU; 221613; -.
DR   Ensembl; ENST00000297012; ENSP00000297012; ENSG00000164508.
DR   GeneID; 221613; -.
DR   KEGG; hsa:221613; -.
DR   UCSC; uc003nfc.4; human.
DR   CTD; 221613; -.
DR   DisGeNET; 221613; -.
DR   GeneCards; H2AC1; -.
DR   HGNC; HGNC:18729; HIST1H2AA.
DR   HPA; HPA041189; -.
DR   MIM; 613499; gene.
DR   neXtProt; NX_Q96QV6; -.
DR   OpenTargets; ENSG00000164508; -.
DR   PharmGKB; PA134988774; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000161385; -.
DR   HOGENOM; CLU_062828_3_1_1; -.
DR   InParanoid; Q96QV6; -.
DR   KO; K11251; -.
DR   OMA; TRINPKH; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; Q96QV6; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   GeneWiki; HIST1H2AA; -.
DR   GenomeRNAi; 221613; -.
DR   Pharos; Q96QV6; Tbio.
DR   PRO; PR:Q96QV6; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q96QV6; protein.
DR   Bgee; ENSG00000164508; Expressed in testis and 15 other tissues.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Citrullination; DNA-binding;
KW   Hydroxylation; Isopeptide bond; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   CHAIN           2..131
FT                   /note="Histone H2A type 1-A"
FT                   /id="PRO_0000230199"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         2
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:15010469"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22752"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         14
FT                   /note="N6-(beta-hydroxybutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         76
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         96
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         96
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:24352239"
FT   MOD_RES         119
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         119
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         119
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         119
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         120
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         120
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000269|PubMed:15078818,
FT                   ECO:0000269|PubMed:24140421"
FT   MOD_RES         127
FT                   /note="N6-crotonyllysine"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:15386022,
FT                   ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16702407,
FT                   ECO:0000269|PubMed:25470042"
FT   MUTAGEN         2
FT                   /note="S->A: Blocks the inhibition of transcription by
FT                   RPS6KA5/MSK1."
FT                   /evidence="ECO:0000269|PubMed:15010469"
FT   HELIX           20..22
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   HELIX           28..36
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   TURN            37..39
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   STRAND          42..44
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   HELIX           47..73
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   STRAND          77..79
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   HELIX           81..90
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   HELIX           92..97
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   TURN            98..100
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   STRAND          101..103
FT                   /evidence="ECO:0000244|PDB:5GT0"
FT   HELIX           114..116
FT                   /evidence="ECO:0000244|PDB:5GT0"
SQ   SEQUENCE   131 AA;  14234 MW;  D7E5D3D43BD84D32 CRC64;
     MSGRGKQGGK ARAKSKSRSS RAGLQFPVGR IHRLLRKGNY AERIGAGAPV YLAAVLEYLT
     AEILELAGNA SRDNKKTRII PRHLQLAIRN DEELNKLLGG VTIAQGGVLP NIQAVLLPKK
     TESHHHKAQS K
//
ID   H2A1B_HUMAN             Reviewed;         130 AA.
AC   P04908; P28001; Q76P63;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 208.
DE   RecName: Full=Histone H2A type 1-B/E;
DE   AltName: Full=Histone H2A.2;
DE   AltName: Full=Histone H2A/a;
DE   AltName: Full=Histone H2A/m;
GN   Name=H2AC4 {ECO:0000312|HGNC:HGNC:4734};
GN   Synonyms=H2AFM {ECO:0000312|HGNC:HGNC:4734},
GN   HIST1H2AB {ECO:0000312|HGNC:HGNC:4734};
GN   and
GN   Name=H2AC8 {ECO:0000312|HGNC:HGNC:4724};
GN   Synonyms=H2AFA {ECO:0000312|HGNC:HGNC:4724},
GN   HIST1H2AE {ECO:0000312|HGNC:HGNC:4724};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H2AC4).
RX   PubMed=6647026; DOI=10.1093/nar/11.21.7409;
RA   Zhong R., Roeder R.G., Heintz N.;
RT   "The primary structure and expression of four cloned human histone genes.";
RL   Nucleic Acids Res. 11:7409-7425(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H2AC8).
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-f;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H2AC8).
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H2AC4 AND H2AC8).
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (H2AC8).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=15078818; DOI=10.1101/gad.1184604;
RA   Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K.,
RA   Kaneko M., Takeshima Y., Muramatsu M., Ito T.;
RT   "Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in
RT   the early Drosophila embryo.";
RL   Genes Dev. 18:877-888(2004).
RN   [8]
RP   PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [9]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S.,
RA   Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, PHOSPHORYLATION AT SER-2, AND
RP   ACETYLATION AT SER-2.
RX   PubMed=11709551; DOI=10.1074/jbc.m107894200;
RA   Galasinski S.C., Louie D.F., Gloor K.K., Resing K.A., Ahn N.G.;
RT   "Global regulation of post-translational modifications on core histones.";
RL   J. Biol. Chem. 277:2579-2588(2002).
RN   [11]
RP   ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15823041; DOI=10.1021/bi047505c;
RA   Hagiwara T., Hidaka Y., Yamada M.;
RT   "Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.";
RL   Biochemistry 44:5827-5834(2005).
RN   [12]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [13]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16702407; DOI=10.1101/gad.373706;
RA   Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M., de Waard H.,
RA   Wu J., Yuan L., Citterio E., Houtsmuller A.B., Neefjes J.,
RA   Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
RT   "DNA damage triggers nucleotide excision repair-dependent
RT   monoubiquitylation of histone H2A.";
RL   Genes Dev. 20:1343-1352(2006).
RN   [14]
RP   MASS SPECTROMETRY, AND ACETYLATION AT SER-2.
RX   PubMed=16457589; DOI=10.1021/pr050269n;
RA   Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.;
RT   "Precise characterization of human histones in the H2A gene family by top
RT   down mass spectrometry.";
RL   J. Proteome Res. 5:248-253(2006).
RN   [15]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [16]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [17]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [18]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [19]
RP   CROTONYLATION AT LYS-37; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [20]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [21]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22713238; DOI=10.4161/cc.20919;
RA   Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L.;
RT   "A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by
RT   RNF168 ubiquitin ligase.";
RL   Cell Cycle 11:2538-2544(2012).
RN   [22]
RP   SUCCINYLATION AT LYS-10 AND LYS-96.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [23]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=24140421; DOI=10.1016/j.molcel.2013.09.017;
RA   Kim K., Kim J.M., Kim J.S., Choi J., Lee Y.S., Neamati N., Song J.S.,
RA   Heo K., An W.;
RT   "VprBP has intrinsic kinase activity targeting histone H2A and represses
RT   gene transcription.";
RL   Mol. Cell 52:459-467(2013).
RN   [24]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-10; LYS-37; LYS-75; LYS-76; LYS-96 AND
RP   LYS-119.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [25]
RP   METHYLATION AT GLN-105.
RX   PubMed=24352239; DOI=10.1038/nature12819;
RA   Tessarz P., Santos-Rosa H., Robson S.C., Sylvestersen K.B., Nelson C.J.,
RA   Nielsen M.L., Kouzarides T.;
RT   "Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated
RT   modification.";
RL   Nature 505:564-568(2014).
RN   [26]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=25470042; DOI=10.1038/nature13955;
RA   Bhatnagar S., Gazin C., Chamberlain L., Ou J., Zhu X., Tushir J.S.,
RA   Virbasius C.M., Lin L., Zhu L.J., Wajapeyee N., Green M.R.;
RT   "TRIM37 is a new histone H2A ubiquitin ligase and breast cancer
RT   oncoprotein.";
RL   Nature 516:116-120(2014).
RN   [27]
RP   DEUBIQUITINATION AT LYS-14 AND LYS-16 BY USP51.
RX   PubMed=27083998; DOI=10.1101/gad.271841.115;
RA   Wang Z., Zhang H., Liu J., Cheruiyot A., Lee J.H., Ordog T., Lou Z.,
RA   You Z., Zhang Z.;
RT   "USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.";
RL   Genes Dev. 30:946-959(2016).
RN   [28]
RP   HYDROXYBUTYRYLATION AT LYS-10; LYS-14; LYS-37; LYS-96 AND LYS-119.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [29]
RP   GLUTARYLATION AT LYS-96; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
RN   [30] {ECO:0000244|PDB:5AY8}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH H2B; H3.Y AND H4.
RX   PubMed=27016736; DOI=10.1093/nar/gkw202;
RA   Kujirai T., Horikoshi N., Sato K., Maehara K., Machida S., Osakabe A.,
RA   Kimura H., Ohkawa Y., Kurumizaka H.;
RT   "Structure and function of human histone H3.Y nucleosome.";
RL   Nucleic Acids Res. 44:6127-6141(2016).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- INTERACTION:
CC       P06899:HIST1H2BJ; NbExp=11; IntAct=EBI-358971, EBI-6150252;
CC       P62805:HIST1H4K; NbExp=11; IntAct=EBI-358971, EBI-302023;
CC       Q16695:HIST3H3; NbExp=2; IntAct=EBI-358971, EBI-358900;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Deiminated on Arg-4 in granulocytes upon calcium entry.
CC       {ECO:0000269|PubMed:15823041}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AK119Ub) by RING1, TRIM37 and
CC       RNF2/RING2 complex gives a specific tag for epigenetic transcriptional
CC       repression and participates in X chromosome inactivation of female
CC       mammals. It is involved in the initiation of both imprinted and random
CC       X inactivation. Ubiquitinated H2A is enriched in inactive X chromosome
CC       chromatin. Ubiquitination of H2A functions downstream of methylation of
CC       'Lys-27' of histone H3 (H3K27me). H2AK119Ub by RNF2/RING2 can also be
CC       induced by ultraviolet and may be involved in DNA repair.
CC       Monoubiquitination of Lys-120 (H2AK119Ub) by TRIM37 may promote
CC       transformation of cells in a number of breast cancers
CC       (PubMed:25470042). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. Deubiquitinated by USP51 at Lys-14 and Lys-16 (H2AK13Ub and
CC       H2AK15Ub, respectively) after damaged DNA is repaired
CC       (PubMed:27083998). H2AK119Ub and ionizing radiation-induced 'Lys-63'-
CC       linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901,
CC       ECO:0000269|PubMed:16702407, ECO:0000269|PubMed:18001824,
CC       ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:22713238,
CC       ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:24352239,
CC       ECO:0000269|PubMed:25470042, ECO:0000269|PubMed:27083998}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription. {ECO:0000269|PubMed:11709551,
CC       ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:15078818,
CC       ECO:0000269|PubMed:15823041, ECO:0000269|PubMed:16457589,
CC       ECO:0000269|PubMed:24140421}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (PubMed:24352239).
CC       {ECO:0000269|PubMed:24352239}.
CC   -!- PTM: Symmetric dimethylation on Arg-4 by the PRDM1/PRMT5 complex may
CC       play a crucial role in the germ-cell lineage.
CC       {ECO:0000250|UniProtKB:P22752}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- MASS SPECTROMETRY: Mass=14037.9; Method=Electrospray; Note=Monoisotopic
CC       with N-acetylserine.; Evidence={ECO:0000269|PubMed:16457589};
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00089; CAA24951.1; -; Genomic_DNA.
DR   EMBL; M60752; AAA63191.1; -; Genomic_DNA.
DR   EMBL; Z83741; CAB06036.1; -; Genomic_DNA.
DR   EMBL; AY131983; AAN59964.1; -; Genomic_DNA.
DR   EMBL; AY131986; AAN59967.1; -; Genomic_DNA.
DR   EMBL; AL031777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC093836; AAH93836.1; -; mRNA.
DR   EMBL; BC093862; AAH93862.1; -; mRNA.
DR   CCDS; CCDS4574.1; -.
DR   CCDS; CCDS4595.1; -.
DR   PIR; B26318; HSHUA5.
DR   PIR; G40335; G40335.
DR   RefSeq; NP_003504.2; NM_003513.2.
DR   RefSeq; NP_066390.1; NM_021052.2.
DR   PDB; 2CV5; X-ray; 2.50 A; C/G=1-130.
DR   PDB; 2RVQ; NMR; -; C=1-130.
DR   PDB; 3A6N; X-ray; 2.70 A; C/G=1-130.
DR   PDB; 3AFA; X-ray; 2.50 A; C/G=1-130.
DR   PDB; 3AN2; X-ray; 3.60 A; C/G=1-130.
DR   PDB; 3AV1; X-ray; 2.50 A; C/G=1-130.
DR   PDB; 3AV2; X-ray; 2.80 A; C/G=1-130.
DR   PDB; 3AYW; X-ray; 2.90 A; C/G=1-130.
DR   PDB; 3AZE; X-ray; 3.00 A; C/G=1-130.
DR   PDB; 3AZF; X-ray; 2.70 A; C/G=1-130.
DR   PDB; 3AZG; X-ray; 2.40 A; C/G=1-130.
DR   PDB; 3AZH; X-ray; 3.49 A; C/G=1-130.
DR   PDB; 3AZI; X-ray; 2.70 A; C/G=1-130.
DR   PDB; 3AZJ; X-ray; 2.89 A; C/G=1-130.
DR   PDB; 3AZK; X-ray; 3.20 A; C/G=1-130.
DR   PDB; 3AZL; X-ray; 2.70 A; C/G=1-130.
DR   PDB; 3AZM; X-ray; 2.89 A; C/G=1-130.
DR   PDB; 3AZN; X-ray; 3.00 A; C/G=1-130.
DR   PDB; 3W96; X-ray; 3.00 A; C/G=11-130.
DR   PDB; 3W97; X-ray; 3.20 A; C/G=1-130.
DR   PDB; 3W98; X-ray; 3.42 A; C/G=1-130.
DR   PDB; 3W99; X-ray; 3.00 A; C/G=1-130.
DR   PDB; 3WKJ; X-ray; 2.80 A; C/G=1-130.
DR   PDB; 3WTP; X-ray; 2.67 A; C/G=1-130.
DR   PDB; 3X1S; X-ray; 2.81 A; C/G=2-130.
DR   PDB; 3X1V; X-ray; 2.92 A; C/G=2-130.
DR   PDB; 4YM5; X-ray; 4.00 A; C/G=1-130.
DR   PDB; 4YM6; X-ray; 3.51 A; C/G=1-130.
DR   PDB; 4Z5T; X-ray; 2.80 A; C/G=1-130.
DR   PDB; 5AV5; X-ray; 2.40 A; C/G=1-130.
DR   PDB; 5AV6; X-ray; 2.20 A; C/G=1-130.
DR   PDB; 5AV8; X-ray; 2.20 A; C/G=1-130.
DR   PDB; 5AV9; X-ray; 2.20 A; C/G=1-130.
DR   PDB; 5AVB; X-ray; 2.40 A; C/G=1-130.
DR   PDB; 5AVC; X-ray; 2.40 A; C/G=1-130.
DR   PDB; 5AY8; X-ray; 2.80 A; C/G=1-130.
DR   PDB; 5B0Y; X-ray; 2.56 A; C/G=1-130.
DR   PDB; 5B0Z; X-ray; 1.99 A; C/G=1-130.
DR   PDB; 5B24; X-ray; 3.60 A; C/G=1-130.
DR   PDB; 5B2I; X-ray; 3.00 A; C/G=1-130.
DR   PDB; 5B2J; X-ray; 2.60 A; C/G=1-130.
DR   PDB; 5B31; X-ray; 2.20 A; C=1-130.
DR   PDB; 5B32; X-ray; 2.35 A; C=1-130.
DR   PDB; 5B40; X-ray; 3.33 A; C/G=1-130.
DR   PDB; 5CPI; X-ray; 2.90 A; C/G=1-130.
DR   PDB; 5CPJ; X-ray; 3.15 A; C/G=1-130.
DR   PDB; 5CPK; X-ray; 2.63 A; C/G=1-130.
DR   PDB; 5GSE; X-ray; 3.14 A; C/G/M=1-130.
DR   PDB; 5GTC; X-ray; 2.70 A; C/G=1-130.
DR   PDB; 5GXQ; X-ray; 2.85 A; C/G=1-130.
DR   PDB; 5JRG; X-ray; 2.50 A; C/G=1-130.
DR   PDB; 5X7X; X-ray; 2.18 A; C/G=1-130.
DR   PDB; 5XF3; X-ray; 2.60 A; C/G=1-130.
DR   PDB; 5XF4; X-ray; 2.87 A; C/G=1-130.
DR   PDB; 5XF5; X-ray; 2.82 A; C/G=1-130.
DR   PDB; 5Y0C; X-ray; 2.09 A; C/G=1-130.
DR   PDB; 5Y0D; X-ray; 1.99 A; C/G=1-130.
DR   PDB; 5Z23; X-ray; 2.73 A; C/G=1-130.
DR   PDB; 5ZBX; X-ray; 2.58 A; C/G=1-130.
DR   PDB; 6A5L; EM; 5.60 A; c/g=1-130.
DR   PDB; 6A5O; EM; 9.90 A; c/g=1-130.
DR   PDB; 6A5P; EM; 7.00 A; c/g=1-130.
DR   PDB; 6A5R; EM; 8.70 A; c/g=1-130.
DR   PDB; 6A5T; EM; 6.70 A; c/g=1-130.
DR   PDB; 6A5U; EM; 7.60 A; c/g=1-130.
DR   PDB; 6ACL; X-ray; 1.92 A; B=93-102.
DR   PDB; 6AEE; X-ray; 3.30 A; C/F=78-86.
DR   PDB; 6BUZ; EM; 3.92 A; C/G=1-130.
DR   PDB; 6E0C; EM; 2.63 A; C/G=1-130.
DR   PDB; 6E0P; EM; 2.60 A; C/G=1-130.
DR   PDB; 6HKT; X-ray; 9.70 A; 0/2/C/G/M/Q/W/c/g/m/q/w=1-130.
DR   PDB; 6HTS; EM; 4.80 A; K/O=1-130.
DR   PDB; 6INQ; EM; 6.90 A; c/g=1-130.
DR   PDB; 6IQ4; X-ray; 2.25 A; C/G=15-120.
DR   PDB; 6IR9; EM; 3.80 A; c/g=1-130.
DR   PDB; 6J4W; EM; 7.90 A; c/g=1-130.
DR   PDB; 6J4X; EM; 4.30 A; c/g=1-130.
DR   PDB; 6J4Y; EM; 4.30 A; c/g=1-130.
DR   PDB; 6J4Z; EM; 4.10 A; c/g=1-130.
DR   PDB; 6J50; EM; 4.70 A; c/g=1-130.
DR   PDB; 6J51; EM; 4.20 A; c/g=1-130.
DR   PDB; 6JR0; X-ray; 2.50 A; C/G=1-130.
DR   PDB; 6JR1; X-ray; 2.40 A; C/G=1-130.
DR   PDB; 6O1D; EM; 3.40 A; C/G=1-130.
DR   PDB; 6R8Y; EM; 4.30 A; C/G=1-130.
DR   PDB; 6R8Z; EM; 3.90 A; C/G=1-130.
DR   PDB; 6R90; EM; 4.50 A; C/G=1-130.
DR   PDB; 6R91; EM; 4.10 A; C/G=1-130.
DR   PDB; 6R92; EM; 4.80 A; C/G=1-130.
DR   PDB; 6R93; EM; 4.00 A; C/G=1-130.
DR   PDB; 6R94; EM; 3.50 A; C/G=1-130.
DR   PDBsum; 2CV5; -.
DR   PDBsum; 2RVQ; -.
DR   PDBsum; 3A6N; -.
DR   PDBsum; 3AFA; -.
DR   PDBsum; 3AN2; -.
DR   PDBsum; 3AV1; -.
DR   PDBsum; 3AV2; -.
DR   PDBsum; 3AYW; -.
DR   PDBsum; 3AZE; -.
DR   PDBsum; 3AZF; -.
DR   PDBsum; 3AZG; -.
DR   PDBsum; 3AZH; -.
DR   PDBsum; 3AZI; -.
DR   PDBsum; 3AZJ; -.
DR   PDBsum; 3AZK; -.
DR   PDBsum; 3AZL; -.
DR   PDBsum; 3AZM; -.
DR   PDBsum; 3AZN; -.
DR   PDBsum; 3W96; -.
DR   PDBsum; 3W97; -.
DR   PDBsum; 3W98; -.
DR   PDBsum; 3W99; -.
DR   PDBsum; 3WKJ; -.
DR   PDBsum; 3WTP; -.
DR   PDBsum; 3X1S; -.
DR   PDBsum; 3X1V; -.
DR   PDBsum; 4YM5; -.
DR   PDBsum; 4YM6; -.
DR   PDBsum; 4Z5T; -.
DR   PDBsum; 5AV5; -.
DR   PDBsum; 5AV6; -.
DR   PDBsum; 5AV8; -.
DR   PDBsum; 5AV9; -.
DR   PDBsum; 5AVB; -.
DR   PDBsum; 5AVC; -.
DR   PDBsum; 5AY8; -.
DR   PDBsum; 5B0Y; -.
DR   PDBsum; 5B0Z; -.
DR   PDBsum; 5B24; -.
DR   PDBsum; 5B2I; -.
DR   PDBsum; 5B2J; -.
DR   PDBsum; 5B31; -.
DR   PDBsum; 5B32; -.
DR   PDBsum; 5B40; -.
DR   PDBsum; 5CPI; -.
DR   PDBsum; 5CPJ; -.
DR   PDBsum; 5CPK; -.
DR   PDBsum; 5GSE; -.
DR   PDBsum; 5GTC; -.
DR   PDBsum; 5GXQ; -.
DR   PDBsum; 5JRG; -.
DR   PDBsum; 5X7X; -.
DR   PDBsum; 5XF3; -.
DR   PDBsum; 5XF4; -.
DR   PDBsum; 5XF5; -.
DR   PDBsum; 5Y0C; -.
DR   PDBsum; 5Y0D; -.
DR   PDBsum; 5Z23; -.
DR   PDBsum; 5ZBX; -.
DR   PDBsum; 6A5L; -.
DR   PDBsum; 6A5O; -.
DR   PDBsum; 6A5P; -.
DR   PDBsum; 6A5R; -.
DR   PDBsum; 6A5T; -.
DR   PDBsum; 6A5U; -.
DR   PDBsum; 6ACL; -.
DR   PDBsum; 6AEE; -.
DR   PDBsum; 6BUZ; -.
DR   PDBsum; 6E0C; -.
DR   PDBsum; 6E0P; -.
DR   PDBsum; 6HKT; -.
DR   PDBsum; 6HTS; -.
DR   PDBsum; 6INQ; -.
DR   PDBsum; 6IQ4; -.
DR   PDBsum; 6IR9; -.
DR   PDBsum; 6J4W; -.
DR   PDBsum; 6J4X; -.
DR   PDBsum; 6J4Y; -.
DR   PDBsum; 6J4Z; -.
DR   PDBsum; 6J50; -.
DR   PDBsum; 6J51; -.
DR   PDBsum; 6JR0; -.
DR   PDBsum; 6JR1; -.
DR   PDBsum; 6O1D; -.
DR   PDBsum; 6R8Y; -.
DR   PDBsum; 6R8Z; -.
DR   PDBsum; 6R90; -.
DR   PDBsum; 6R91; -.
DR   PDBsum; 6R92; -.
DR   PDBsum; 6R93; -.
DR   PDBsum; 6R94; -.
DR   SMR; P04908; -.
DR   BioGrid; 109266; 34.
DR   BioGrid; 113931; 345.
DR   DIP; DIP-44197N; -.
DR   IntAct; P04908; 111.
DR   MINT; P04908; -.
DR   STRING; 9606.ENSP00000483842; -.
DR   iPTMnet; P04908; -.
DR   PhosphoSitePlus; P04908; -.
DR   SwissPalm; P04908; -.
DR   BioMuta; HIST1H2AE; -.
DR   DMDM; 124028530; -.
DR   EPD; P04908; -.
DR   jPOST; P04908; -.
DR   MassIVE; P04908; -.
DR   PaxDb; P04908; -.
DR   PeptideAtlas; P04908; -.
DR   PRIDE; P04908; -.
DR   ProteomicsDB; 51756; -.
DR   TopDownProteomics; P04908; -.
DR   ABCD; P04908; -.
DR   DNASU; 3012; -.
DR   DNASU; 8335; -.
DR   Ensembl; ENST00000303910; ENSP00000303373; ENSG00000277075.
DR   Ensembl; ENST00000615868; ENSP00000483842; ENSG00000278463.
DR   GeneID; 3012; -.
DR   GeneID; 8335; -.
DR   KEGG; hsa:3012; -.
DR   KEGG; hsa:8335; -.
DR   CTD; 3012; -.
DR   CTD; 8335; -.
DR   DisGeNET; 3012; -.
DR   DisGeNET; 8335; -.
DR   GeneCards; H2AC4; -.
DR   GeneCards; H2AC8; -.
DR   HGNC; HGNC:4734; H2AC4.
DR   HGNC; HGNC:4724; H2AC8.
DR   HPA; CAB012242; -.
DR   HPA; HPA041189; -.
DR   MIM; 602786; gene.
DR   MIM; 602795; gene.
DR   neXtProt; NX_P04908; -.
DR   OpenTargets; ENSG00000277075; -.
DR   OpenTargets; ENSG00000278463; -.
DR   PharmGKB; PA29111; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000153092; -.
DR   HOGENOM; CLU_062828_3_1_1; -.
DR   InParanoid; P04908; -.
DR   KO; K11251; -.
DR   OMA; CSTVERF; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; P04908; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   EvolutionaryTrace; P04908; -.
DR   GeneWiki; HIST1H2AB; -.
DR   GeneWiki; HIST1H2AE; -.
DR   Pharos; P04908; Tbio.
DR   PRO; PR:P04908; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P04908; protein.
DR   Bgee; ENSG00000277075; Expressed in stomach and 128 other tissues.
DR   ExpressionAtlas; P04908; baseline and differential.
DR   Genevisible; P04908; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:UniProtKB.
DR   CDD; cd00074; H2A; 1.
DR   DisProt; DP01157; -.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Citrullination; DNA-binding;
KW   Hydroxylation; Isopeptide bond; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:11709551,
FT                   ECO:0000269|PubMed:15823041, ECO:0000269|PubMed:16457589"
FT   CHAIN           2..130
FT                   /note="Histone H2A type 1-B/E"
FT                   /id="PRO_0000055237"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:11709551,
FT                   ECO:0000269|PubMed:15823041, ECO:0000269|PubMed:16457589"
FT   MOD_RES         2
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:11709551,
FT                   ECO:0000269|PubMed:15010469"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:C0HKE1"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:C0HKE1"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         14
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         76
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         96
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         96
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:24352239"
FT   MOD_RES         119
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         119
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         119
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         119
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         120
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         120
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000269|PubMed:15078818,
FT                   ECO:0000269|PubMed:24140421"
FT   MOD_RES         126
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         126
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:15386022,
FT                   ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16702407,
FT                   ECO:0000269|PubMed:25470042"
FT   MUTAGEN         2
FT                   /note="S->A: Blocks the inhibition of transcription by
FT                   RPS6KA5/MSK1."
FT                   /evidence="ECO:0000269|PubMed:15010469"
FT   CONFLICT        38..39
FT                   /note="GN -> AH (in Ref. 1; CAA24951)"
FT                   /evidence="ECO:0000305"
FT   HELIX           18..22
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   HELIX           28..37
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   STRAND          42..44
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   HELIX           47..73
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   STRAND          77..79
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   HELIX           81..89
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   HELIX           92..97
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   TURN            98..100
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   STRAND          101..103
FT                   /evidence="ECO:0000244|PDB:5B0Z"
FT   HELIX           114..116
FT                   /evidence="ECO:0000244|PDB:5B0Z"
SQ   SEQUENCE   130 AA;  14135 MW;  9CFE6184B2CC89F5 CRC64;
     MSGRGKQGGK ARAKAKTRSS RAGLQFPVGR VHRLLRKGNY SERVGAGAPV YLAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGR VTIAQGGVLP NIQAVLLPKK
     TESHHKAKGK
//
ID   H2A1H_HUMAN             Reviewed;         128 AA.
AC   Q96KK5;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 152.
DE   RecName: Full=Histone H2A type 1-H;
DE   AltName: Full=Histone H2A/s;
GN   Name=HIST1H2AH; Synonyms=HIST1H2AI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=15078818; DOI=10.1101/gad.1184604;
RA   Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K.,
RA   Kaneko M., Takeshima Y., Muramatsu M., Ito T.;
RT   "Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in
RT   the early Drosophila embryo.";
RL   Genes Dev. 18:877-888(2004).
RN   [5]
RP   PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [6]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S.,
RA   Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [7]
RP   ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15823041; DOI=10.1021/bi047505c;
RA   Hagiwara T., Hidaka Y., Yamada M.;
RT   "Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.";
RL   Biochemistry 44:5827-5834(2005).
RN   [8]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [9]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16702407; DOI=10.1101/gad.373706;
RA   Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M., de Waard H.,
RA   Wu J., Yuan L., Citterio E., Houtsmuller A.B., Neefjes J.,
RA   Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
RT   "DNA damage triggers nucleotide excision repair-dependent
RT   monoubiquitylation of histone H2A.";
RL   Genes Dev. 20:1343-1352(2006).
RN   [10]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [11]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [12]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [13]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [14]
RP   CROTONYLATION AT LYS-37; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [15]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [16]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22713238; DOI=10.4161/cc.20919;
RA   Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L.;
RT   "A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by
RT   RNF168 ubiquitin ligase.";
RL   Cell Cycle 11:2538-2544(2012).
RN   [17]
RP   SUCCINYLATION AT LYS-10 AND LYS-96.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [18]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=24140421; DOI=10.1016/j.molcel.2013.09.017;
RA   Kim K., Kim J.M., Kim J.S., Choi J., Lee Y.S., Neamati N., Song J.S.,
RA   Heo K., An W.;
RT   "VprBP has intrinsic kinase activity targeting histone H2A and represses
RT   gene transcription.";
RL   Mol. Cell 52:459-467(2013).
RN   [19]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-10; LYS-37; LYS-75; LYS-76; LYS-96 AND
RP   LYS-119.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [20]
RP   METHYLATION AT GLN-105.
RX   PubMed=24352239; DOI=10.1038/nature12819;
RA   Tessarz P., Santos-Rosa H., Robson S.C., Sylvestersen K.B., Nelson C.J.,
RA   Nielsen M.L., Kouzarides T.;
RT   "Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated
RT   modification.";
RL   Nature 505:564-568(2014).
RN   [21]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=25470042; DOI=10.1038/nature13955;
RA   Bhatnagar S., Gazin C., Chamberlain L., Ou J., Zhu X., Tushir J.S.,
RA   Virbasius C.M., Lin L., Zhu L.J., Wajapeyee N., Green M.R.;
RT   "TRIM37 is a new histone H2A ubiquitin ligase and breast cancer
RT   oncoprotein.";
RL   Nature 516:116-120(2014).
RN   [22]
RP   DEUBIQUITINATION AT LYS-14 AND LYS-16 BY USP51.
RX   PubMed=27083998; DOI=10.1101/gad.271841.115;
RA   Wang Z., Zhang H., Liu J., Cheruiyot A., Lee J.H., Ordog T., Lou Z.,
RA   You Z., Zhang Z.;
RT   "USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.";
RL   Genes Dev. 30:946-959(2016).
RN   [23]
RP   HYDROXYBUTYRYLATION AT LYS-10; LYS-14; LYS-37; LYS-96 AND LYS-119.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [24]
RP   GLUTARYLATION AT LYS-96; LYS-100; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Deiminated on Arg-4 in granulocytes upon calcium entry.
CC       {ECO:0000269|PubMed:15823041}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AK119Ub) by RING1, TRIM37 and
CC       RNF2/RING2 complex gives a specific tag for epigenetic transcriptional
CC       repression and participates in X chromosome inactivation of female
CC       mammals. It is involved in the initiation of both imprinted and random
CC       X inactivation. Ubiquitinated H2A is enriched in inactive X chromosome
CC       chromatin. Ubiquitination of H2A functions downstream of methylation of
CC       'Lys-27' of histone H3 (H3K27me). H2AK119Ub by RNF2/RING2 can also be
CC       induced by ultraviolet and may be involved in DNA repair.
CC       Monoubiquitination of Lys-120 (H2AK119Ub) by TRIM37 may promote
CC       transformation of cells in a number of breast cancers
CC       (PubMed:25470042). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. Deubiquitinated by USP51 at Lys-14 and Lys-16 (H2AK13Ub and
CC       H2AK15Ub, respectively) after damaged DNA is repaired
CC       (PubMed:27083998). H2AK119Ub and ionizing radiation-induced 'Lys-63'-
CC       linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901,
CC       ECO:0000269|PubMed:16702407, ECO:0000269|PubMed:18001824,
CC       ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:22713238,
CC       ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:24352239,
CC       ECO:0000269|PubMed:25470042, ECO:0000269|PubMed:27083998}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription. {ECO:0000269|PubMed:15010469,
CC       ECO:0000269|PubMed:15078818, ECO:0000269|PubMed:15823041,
CC       ECO:0000269|PubMed:24140421}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (PubMed:24352239).
CC       {ECO:0000269|PubMed:24352239}.
CC   -!- PTM: Symmetric dimethylation on Arg-4 by the PRDM1/PRMT5 complex may
CC       play a crucial role in the germ-cell lineage.
CC       {ECO:0000250|UniProtKB:P22752}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY131988; AAN59969.1; -; Genomic_DNA.
DR   EMBL; AL021807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC093851; AAH93851.1; -; mRNA.
DR   EMBL; BC093849; AAH93849.1; -; mRNA.
DR   CCDS; CCDS4622.1; -.
DR   RefSeq; NP_542163.1; NM_080596.2.
DR   SMR; Q96KK5; -.
DR   BioGrid; 124438; 23.
DR   DIP; DIP-61699N; -.
DR   IntAct; Q96KK5; 49.
DR   MINT; Q96KK5; -.
DR   STRING; 9606.ENSP00000366679; -.
DR   iPTMnet; Q96KK5; -.
DR   PhosphoSitePlus; Q96KK5; -.
DR   SwissPalm; Q96KK5; -.
DR   BioMuta; HIST1H2AH; -.
DR   DMDM; 74751984; -.
DR   jPOST; Q96KK5; -.
DR   MassIVE; Q96KK5; -.
DR   MaxQB; Q96KK5; -.
DR   PaxDb; Q96KK5; -.
DR   PeptideAtlas; Q96KK5; -.
DR   PRIDE; Q96KK5; -.
DR   ProteomicsDB; 77082; -.
DR   TopDownProteomics; Q96KK5; -.
DR   DNASU; 85235; -.
DR   Ensembl; ENST00000377459; ENSP00000366679; ENSG00000274997.
DR   GeneID; 85235; -.
DR   KEGG; hsa:85235; -.
DR   UCSC; uc003niz.5; human.
DR   CTD; 85235; -.
DR   DisGeNET; 85235; -.
DR   GeneCards; H2AC12; -.
DR   HGNC; HGNC:13671; HIST1H2AH.
DR   HPA; CAB004030; -.
DR   HPA; HPA041189; -.
DR   MIM; 615013; gene.
DR   neXtProt; NX_Q96KK5; -.
DR   OpenTargets; ENSG00000274997; -.
DR   PharmGKB; PA134913416; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000153125; -.
DR   HOGENOM; CLU_062828_3_3_1; -.
DR   InParanoid; Q96KK5; -.
DR   KO; K11251; -.
DR   OMA; LEPWSSK; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; Q96KK5; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   ChiTaRS; HIST1H2AH; human.
DR   GeneWiki; HIST1H2AH; -.
DR   GenomeRNAi; 85235; -.
DR   Pharos; Q96KK5; Tbio.
DR   PRO; PR:Q96KK5; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q96KK5; protein.
DR   Bgee; ENSG00000274997; Expressed in stomach and 64 other tissues.
DR   ExpressionAtlas; Q96KK5; baseline and differential.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Citrullination; DNA-binding; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   CHAIN           2..128
FT                   /note="Histone H2A type 1-H"
FT                   /id="PRO_0000230200"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         2
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:15010469"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGP6"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         14
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         76
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         96
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         96
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         100
FT                   /note="N6-glutaryllysine"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:24352239"
FT   MOD_RES         119
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         119
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         119
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         119
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         120
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         120
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000269|PubMed:15078818,
FT                   ECO:0000269|PubMed:24140421"
FT   MOD_RES         126
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         126
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:15386022,
FT                   ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16702407,
FT                   ECO:0000269|PubMed:25470042"
FT   MUTAGEN         2
FT                   /note="S->A: Blocks the inhibition of transcription by
FT                   RPS6KA5/MSK1."
FT                   /evidence="ECO:0000269|PubMed:15010469"
SQ   SEQUENCE   128 AA;  13906 MW;  639793FE8256343E CRC64;
     MSGRGKQGGK ARAKAKTRSS RAGLQFPVGR VHRLLRKGNY AERVGAGAPV YLAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGK VTIAQGGVLP NIQAVLLPKK
     TESHHKAK
//
ID   H2A1_HUMAN              Reviewed;         130 AA.
AC   P0C0S8; P02261; Q2M1R2; Q76PA6;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 149.
DE   RecName: Full=Histone H2A type 1;
DE            Short=H2A.1;
DE   AltName: Full=Histone H2A/ptl;
GN   Name=H2AC11 {ECO:0000312|HGNC:HGNC:4737}; Synonyms=H2AFP, HIST1H2AG;
GN   and
GN   Name=H2AC13 {ECO:0000312|HGNC:HGNC:4725}; Synonyms=H2AFC, HIST1H2AI;
GN   and
GN   Name=H2AC15 {ECO:0000312|HGNC:HGNC:4726}; Synonyms=H2AFD, HIST1H2AK;
GN   and
GN   Name=H2AC16 {ECO:0000312|HGNC:HGNC:4730}; Synonyms=H2AFI, HIST1H2AL;
GN   and
GN   Name=H2AC17 {ECO:0000312|HGNC:HGNC:4735}; Synonyms=H2AFN, HIST1H2AM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H2AC13; H2AC15 AND H2AC16).
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H2AC13; H2AC15 AND H2AC16).
RX   PubMed=10064132; DOI=10.1515/bc.1999.002;
RA   Albig W., Trappe R., Kardalinou E., Eick S., Doenecke D.;
RT   "The human H2A and H2B histone gene complement.";
RL   Biol. Chem. 380:7-18(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (H2AC17).
RX   PubMed=1768865; DOI=10.3109/10425179109020799;
RA   Dobner T., Wolf I., Mai B., Lipp M.;
RT   "A novel divergently transcribed human histone H2A/H2B gene pair.";
RL   DNA Seq. 1:409-413(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (H2AC11).
RX   PubMed=8179821; DOI=10.1089/dna.1994.13.161;
RA   Mannironi C., Orr A., Hatch C., Pilch D., Ivanova V., Bonner W.;
RT   "The relative expression of human histone H2A genes is similar in different
RT   types of proliferating cells.";
RL   DNA Cell Biol. 13:161-170(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H2AC11; H2AC13; H2AC15; H2AC16 AND
RP   H2AC17).
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (H2AC13; H2AC15; H2AC16 AND
RP   H2AC17).
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   AMINO-ACID COMPOSITION OF TRYPTIC PEPTIDES.
RC   TISSUE=Spleen;
RX   PubMed=7410338;
RA   Hayashi T., Ohe Y., Hayashi H., Iwai K.;
RT   "Human spleen histone H2A. Isolation and four variant sequences.";
RL   J. Biochem. 88:27-34(1980).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, PHOSPHORYLATION AT SER-2, AND
RP   ACETYLATION AT SER-2.
RX   PubMed=11709551; DOI=10.1074/jbc.m107894200;
RA   Galasinski S.C., Louie D.F., Gloor K.K., Resing K.A., Ahn N.G.;
RT   "Global regulation of post-translational modifications on core histones.";
RL   J. Biol. Chem. 277:2579-2588(2002).
RN   [10]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=15078818; DOI=10.1101/gad.1184604;
RA   Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K.,
RA   Kaneko M., Takeshima Y., Muramatsu M., Ito T.;
RT   "Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in
RT   the early Drosophila embryo.";
RL   Genes Dev. 18:877-888(2004).
RN   [11]
RP   PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [12]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S.,
RA   Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [13]
RP   ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15823041; DOI=10.1021/bi047505c;
RA   Hagiwara T., Hidaka Y., Yamada M.;
RT   "Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.";
RL   Biochemistry 44:5827-5834(2005).
RN   [14]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [15]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16702407; DOI=10.1101/gad.373706;
RA   Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M., de Waard H.,
RA   Wu J., Yuan L., Citterio E., Houtsmuller A.B., Neefjes J.,
RA   Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
RT   "DNA damage triggers nucleotide excision repair-dependent
RT   monoubiquitylation of histone H2A.";
RL   Genes Dev. 20:1343-1352(2006).
RN   [16]
RP   MASS SPECTROMETRY, AND ACETYLATION AT SER-2.
RX   PubMed=16457589; DOI=10.1021/pr050269n;
RA   Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.;
RT   "Precise characterization of human histones in the H2A gene family by top
RT   down mass spectrometry.";
RL   J. Proteome Res. 5:248-253(2006).
RN   [17]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [18]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [19]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [20]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [21]
RP   CROTONYLATION AT LYS-37; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [22]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [23]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22713238; DOI=10.4161/cc.20919;
RA   Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L.;
RT   "A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by
RT   RNF168 ubiquitin ligase.";
RL   Cell Cycle 11:2538-2544(2012).
RN   [24]
RP   SUCCINYLATION AT LYS-10 AND LYS-96.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [25]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=24140421; DOI=10.1016/j.molcel.2013.09.017;
RA   Kim K., Kim J.M., Kim J.S., Choi J., Lee Y.S., Neamati N., Song J.S.,
RA   Heo K., An W.;
RT   "VprBP has intrinsic kinase activity targeting histone H2A and represses
RT   gene transcription.";
RL   Mol. Cell 52:459-467(2013).
RN   [26]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-10; LYS-37; LYS-75; LYS-76; LYS-96 AND
RP   LYS-119.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [27]
RP   METHYLATION AT GLN-105.
RX   PubMed=24352239; DOI=10.1038/nature12819;
RA   Tessarz P., Santos-Rosa H., Robson S.C., Sylvestersen K.B., Nelson C.J.,
RA   Nielsen M.L., Kouzarides T.;
RT   "Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated
RT   modification.";
RL   Nature 505:564-568(2014).
RN   [28]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=25470042; DOI=10.1038/nature13955;
RA   Bhatnagar S., Gazin C., Chamberlain L., Ou J., Zhu X., Tushir J.S.,
RA   Virbasius C.M., Lin L., Zhu L.J., Wajapeyee N., Green M.R.;
RT   "TRIM37 is a new histone H2A ubiquitin ligase and breast cancer
RT   oncoprotein.";
RL   Nature 516:116-120(2014).
RN   [29]
RP   DEUBIQUITINATION AT LYS-14 AND LYS-16 BY USP51.
RX   PubMed=27083998; DOI=10.1101/gad.271841.115;
RA   Wang Z., Zhang H., Liu J., Cheruiyot A., Lee J.H., Ordog T., Lou Z.,
RA   You Z., Zhang Z.;
RT   "USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.";
RL   Genes Dev. 30:946-959(2016).
RN   [30]
RP   HYDROXYBUTYRYLATION AT LYS-10; LYS-14; LYS-37; LYS-96 AND LYS-119.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [31]
RP   GLUTARYLATION AT LYS-96; LYS-100; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- INTERACTION:
CC       Q9DUM3:- (xeno); NbExp=3; IntAct=EBI-1390628, EBI-7971837;
CC       P55201:BRPF1; NbExp=8; IntAct=EBI-1390628, EBI-2837428;
CC       Q99543:DNAJC2; NbExp=2; IntAct=EBI-1390628, EBI-11017224;
CC       O95760:IL33; NbExp=3; IntAct=EBI-1390628, EBI-724057;
CC       Q99496:RNF2; NbExp=5; IntAct=EBI-1390628, EBI-722416;
CC       P63104:YWHAZ; NbExp=2; IntAct=EBI-1390628, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Deiminated on Arg-4 in granulocytes upon calcium entry.
CC       {ECO:0000269|PubMed:15823041}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AK119Ub) by RING1, TRIM37 and
CC       RNF2/RING2 complex gives a specific tag for epigenetic transcriptional
CC       repression and participates in X chromosome inactivation of female
CC       mammals. It is involved in the initiation of both imprinted and random
CC       X inactivation. Ubiquitinated H2A is enriched in inactive X chromosome
CC       chromatin. Ubiquitination of H2A functions downstream of methylation of
CC       'Lys-27' of histone H3 (H3K27me). H2AK119Ub by RNF2/RING2 can also be
CC       induced by ultraviolet and may be involved in DNA repair.
CC       Monoubiquitination of Lys-120 (H2AK119Ub) by TRIM37 may promote
CC       transformation of cells in a number of breast cancers
CC       (PubMed:25470042). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. Deubiquitinated by USP51 at Lys-14 and Lys-16 (H2AK13Ub and
CC       H2AK15Ub, respectively) after damaged DNA is repaired
CC       (PubMed:27083998). H2AK119Ub and ionizing radiation-induced 'Lys-63'-
CC       linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901,
CC       ECO:0000269|PubMed:16702407, ECO:0000269|PubMed:18001824,
CC       ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:22713238,
CC       ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:24352239,
CC       ECO:0000269|PubMed:25470042, ECO:0000269|PubMed:27083998}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription. {ECO:0000269|PubMed:11709551,
CC       ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:15078818,
CC       ECO:0000269|PubMed:15823041, ECO:0000269|PubMed:16457589,
CC       ECO:0000269|PubMed:24140421}.
CC   -!- PTM: Symmetric dimethylation on Arg-4 by the PRDM1/PRMT5 complex may
CC       play a crucial role in the germ-cell lineage.
CC       {ECO:0000250|UniProtKB:P22752}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (PubMed:24352239).
CC       {ECO:0000269|PubMed:24352239}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- MASS SPECTROMETRY: Mass=13993.9; Method=Electrospray; Note=Monoisotopic
CC       with N-acetylserine.; Evidence={ECO:0000269|PubMed:16457589};
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z83742; CAB06037.1; -; Genomic_DNA.
DR   EMBL; Z83739; CAB06034.1; -; Genomic_DNA.
DR   EMBL; X83549; CAA58539.1; -; Genomic_DNA.
DR   EMBL; X57138; CAA40417.1; -; Genomic_DNA.
DR   EMBL; L19778; AAC24466.1; -; mRNA.
DR   EMBL; AY131987; AAN59968.1; -; Genomic_DNA.
DR   EMBL; AY131989; AAN59970.1; -; Genomic_DNA.
DR   EMBL; AY131991; AAN59972.1; -; Genomic_DNA.
DR   EMBL; AY131992; AAN59973.1; -; Genomic_DNA.
DR   EMBL; AY131993; AAN59974.1; -; Genomic_DNA.
DR   EMBL; Z98744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL009179; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL021807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016677; AAH16677.1; -; mRNA.
DR   EMBL; BC069306; AAH69306.1; -; mRNA.
DR   EMBL; BC104199; AAI04200.1; -; mRNA.
DR   EMBL; BC104198; AAI04199.1; -; mRNA.
DR   EMBL; BC105129; AAI05130.1; -; mRNA.
DR   EMBL; BC112072; AAI12073.1; -; mRNA.
DR   EMBL; BC112254; AAI12255.1; -; mRNA.
DR   EMBL; BC112256; AAI12257.1; -; mRNA.
DR   CCDS; CCDS4619.1; -.
DR   CCDS; CCDS4626.1; -.
DR   CCDS; CCDS4632.1; -.
DR   CCDS; CCDS4634.1; -.
DR   CCDS; CCDS4639.1; -.
DR   PIR; B56624; HSHUA1.
DR   RefSeq; NP_003500.1; NM_003509.2.
DR   RefSeq; NP_003501.1; NM_003510.2.
DR   RefSeq; NP_003502.1; NM_003511.2.
DR   RefSeq; NP_003505.1; NM_003514.2.
DR   RefSeq; NP_066408.1; NM_021064.4.
DR   PDB; 4QYL; X-ray; 1.80 A; E/F/G/H=2-13.
DR   PDB; 5KGF; EM; 4.54 A; C/G=1-130.
DR   PDB; 6R0C; EM; 4.20 A; C/G=1-130.
DR   PDB; 6RNY; EM; 3.90 A; C/G=1-130.
DR   PDBsum; 4QYL; -.
DR   PDBsum; 5KGF; -.
DR   PDBsum; 6R0C; -.
DR   PDBsum; 6RNY; -.
DR   SMR; P0C0S8; -.
DR   BioGrid; 113925; 13.
DR   BioGrid; 113926; 13.
DR   BioGrid; 113928; 10.
DR   BioGrid; 113932; 13.
DR   BioGrid; 114459; 60.
DR   DIP; DIP-39638N; -.
DR   IntAct; P0C0S8; 64.
DR   MINT; P0C0S8; -.
DR   STRING; 9606.ENSP00000482538; -.
DR   iPTMnet; P0C0S8; -.
DR   PhosphoSitePlus; P0C0S8; -.
DR   SwissPalm; P0C0S8; -.
DR   BioMuta; HIST1H2AI; -.
DR   DMDM; 83288406; -.
DR   EPD; P0C0S8; -.
DR   jPOST; P0C0S8; -.
DR   MassIVE; P0C0S8; -.
DR   MaxQB; P0C0S8; -.
DR   PaxDb; P0C0S8; -.
DR   PeptideAtlas; P0C0S8; -.
DR   PRIDE; P0C0S8; -.
DR   ProteomicsDB; 52296; -.
DR   TopDownProteomics; P0C0S8; -.
DR   DNASU; 8329; -.
DR   DNASU; 8330; -.
DR   DNASU; 8332; -.
DR   DNASU; 8969; -.
DR   Ensembl; ENST00000358739; ENSP00000351589; ENSG00000196747.
DR   Ensembl; ENST00000359193; ENSP00000352119; ENSG00000196787.
DR   Ensembl; ENST00000359611; ENSP00000352627; ENSG00000278677.
DR   Ensembl; ENST00000613174; ENSP00000482538; ENSG00000276903.
DR   Ensembl; ENST00000618958; ENSP00000482431; ENSG00000275221.
DR   GeneID; 8329; -.
DR   GeneID; 8330; -.
DR   GeneID; 8332; -.
DR   GeneID; 8336; -.
DR   GeneID; 8969; -.
DR   KEGG; hsa:8329; -.
DR   KEGG; hsa:8330; -.
DR   KEGG; hsa:8332; -.
DR   KEGG; hsa:8336; -.
DR   KEGG; hsa:8969; -.
DR   UCSC; uc003niw.4; human.
DR   CTD; 8329; -.
DR   CTD; 8330; -.
DR   CTD; 8332; -.
DR   CTD; 8336; -.
DR   CTD; 8969; -.
DR   DisGeNET; 8330; -.
DR   DisGeNET; 8332; -.
DR   DisGeNET; 8336; -.
DR   GeneCards; H2AC11; -.
DR   GeneCards; H2AC13; -.
DR   GeneCards; H2AC15; -.
DR   GeneCards; H2AC16; -.
DR   GeneCards; H2AC17; -.
DR   HGNC; HGNC:4737; H2AC11.
DR   HGNC; HGNC:4725; H2AC13.
DR   HGNC; HGNC:4726; H2AC15.
DR   HGNC; HGNC:4730; H2AC16.
DR   HGNC; HGNC:4735; H2AC17.
DR   HPA; HPA041189; -.
DR   MIM; 602787; gene.
DR   MIM; 602788; gene.
DR   MIM; 602793; gene.
DR   MIM; 602796; gene.
DR   MIM; 615012; gene.
DR   neXtProt; NX_P0C0S8; -.
DR   OpenTargets; ENSG00000196747; -.
DR   OpenTargets; ENSG00000196787; -.
DR   OpenTargets; ENSG00000275221; -.
DR   OpenTargets; ENSG00000276903; -.
DR   OpenTargets; ENSG00000278677; -.
DR   PharmGKB; PA29114; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000153125; -.
DR   HOGENOM; CLU_062828_3_1_1; -.
DR   InParanoid; P0C0S8; -.
DR   KO; K11251; -.
DR   OMA; MPNIHQT; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; P0C0S8; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   SIGNOR; P0C0S8; -.
DR   ChiTaRS; HIST1H2AI; human.
DR   ChiTaRS; HIST1H2AM; human.
DR   GeneWiki; HIST1H2AG; -.
DR   GeneWiki; HIST1H2AI; -.
DR   GeneWiki; HIST1H2AK; -.
DR   GeneWiki; HIST1H2AL; -.
DR   GeneWiki; HIST1H2AM; -.
DR   Pharos; P0C0S8; Tbio.
DR   PRO; PR:P0C0S8; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P0C0S8; protein.
DR   Bgee; ENSG00000196747; Expressed in stomach and 70 other tissues.
DR   ExpressionAtlas; P0C0S8; baseline and differential.
DR   Genevisible; P0C0S8; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Citrullination; DNA-binding;
KW   Hydroxylation; Isopeptide bond; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P0C0S9"
FT   CHAIN           2..130
FT                   /note="Histone H2A type 1"
FT                   /id="PRO_0000055235"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:11709551,
FT                   ECO:0000269|PubMed:15823041, ECO:0000269|PubMed:16457589"
FT   MOD_RES         2
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:11709551,
FT                   ECO:0000269|PubMed:15010469"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22752"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         14
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         76
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         96
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         96
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         100
FT                   /note="N6-glutaryllysine"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:24352239"
FT   MOD_RES         119
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         119
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         119
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         119
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         120
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         120
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000269|PubMed:15078818,
FT                   ECO:0000269|PubMed:24140421"
FT   MOD_RES         126
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         126
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:15386022,
FT                   ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16702407,
FT                   ECO:0000269|PubMed:25470042"
FT   MUTAGEN         2
FT                   /note="S->A: Blocks the inhibition of transcription by
FT                   RPS6KA5/MSK1."
FT                   /evidence="ECO:0000269|PubMed:15010469"
SQ   SEQUENCE   130 AA;  14091 MW;  48DD539793FE8256 CRC64;
     MSGRGKQGGK ARAKAKTRSS RAGLQFPVGR VHRLLRKGNY AERVGAGAPV YLAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGK VTIAQGGVLP NIQAVLLPKK
     TESHHKAKGK
//
ID   H2A1J_HUMAN             Reviewed;         128 AA.
AC   Q99878; A2RUU6; Q5JXQ5;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 190.
DE   RecName: Full=Histone H2A type 1-J;
DE   AltName: Full=Histone H2A/e;
GN   Name=H2AC14 {ECO:0000312|HGNC:HGNC:4727};
GN   Synonyms=H2AFE, HIST1H2AJ {ECO:0000312|HGNC:HGNC:4727};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=15078818; DOI=10.1101/gad.1184604;
RA   Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K.,
RA   Kaneko M., Takeshima Y., Muramatsu M., Ito T.;
RT   "Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in
RT   the early Drosophila embryo.";
RL   Genes Dev. 18:877-888(2004).
RN   [7]
RP   PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [8]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S.,
RA   Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [9]
RP   ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15823041; DOI=10.1021/bi047505c;
RA   Hagiwara T., Hidaka Y., Yamada M.;
RT   "Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.";
RL   Biochemistry 44:5827-5834(2005).
RN   [10]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [11]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16702407; DOI=10.1101/gad.373706;
RA   Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M., de Waard H.,
RA   Wu J., Yuan L., Citterio E., Houtsmuller A.B., Neefjes J.,
RA   Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
RT   "DNA damage triggers nucleotide excision repair-dependent
RT   monoubiquitylation of histone H2A.";
RL   Genes Dev. 20:1343-1352(2006).
RN   [12]
RP   MASS SPECTROMETRY, AND ACETYLATION AT SER-2.
RX   PubMed=16457589; DOI=10.1021/pr050269n;
RA   Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.;
RT   "Precise characterization of human histones in the H2A gene family by top
RT   down mass spectrometry.";
RL   J. Proteome Res. 5:248-253(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16319397; DOI=10.1074/mcp.m500288-mcp200;
RA   Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
RT   "Characterization of histones H2A and H2B variants and their post-
RT   translational modifications by mass spectrometry.";
RL   Mol. Cell. Proteomics 5:541-552(2006).
RN   [14]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [15]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [16]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [17]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [18]
RP   CROTONYLATION AT LYS-37; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [19]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [20]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22713238; DOI=10.4161/cc.20919;
RA   Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L.;
RT   "A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by
RT   RNF168 ubiquitin ligase.";
RL   Cell Cycle 11:2538-2544(2012).
RN   [21]
RP   SUCCINYLATION AT LYS-10 AND LYS-96.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [22]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=24140421; DOI=10.1016/j.molcel.2013.09.017;
RA   Kim K., Kim J.M., Kim J.S., Choi J., Lee Y.S., Neamati N., Song J.S.,
RA   Heo K., An W.;
RT   "VprBP has intrinsic kinase activity targeting histone H2A and represses
RT   gene transcription.";
RL   Mol. Cell 52:459-467(2013).
RN   [23]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-10; LYS-37; LYS-75; LYS-76; LYS-96 AND
RP   LYS-119.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [24]
RP   METHYLATION AT GLN-105.
RX   PubMed=24352239; DOI=10.1038/nature12819;
RA   Tessarz P., Santos-Rosa H., Robson S.C., Sylvestersen K.B., Nelson C.J.,
RA   Nielsen M.L., Kouzarides T.;
RT   "Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated
RT   modification.";
RL   Nature 505:564-568(2014).
RN   [25]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=25470042; DOI=10.1038/nature13955;
RA   Bhatnagar S., Gazin C., Chamberlain L., Ou J., Zhu X., Tushir J.S.,
RA   Virbasius C.M., Lin L., Zhu L.J., Wajapeyee N., Green M.R.;
RT   "TRIM37 is a new histone H2A ubiquitin ligase and breast cancer
RT   oncoprotein.";
RL   Nature 516:116-120(2014).
RN   [26]
RP   DEUBIQUITINATION AT LYS-14 AND LYS-16 BY USP51.
RX   PubMed=27083998; DOI=10.1101/gad.271841.115;
RA   Wang Z., Zhang H., Liu J., Cheruiyot A., Lee J.H., Ordog T., Lou Z.,
RA   You Z., Zhang Z.;
RT   "USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.";
RL   Genes Dev. 30:946-959(2016).
RN   [27]
RP   HYDROXYBUTYRYLATION AT LYS-10; LYS-14; LYS-37; LYS-96 AND LYS-119.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [28]
RP   GLUTARYLATION AT LYS-96; LYS-100; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Deiminated on Arg-4 in granulocytes upon calcium entry.
CC       {ECO:0000269|PubMed:15823041}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AK119Ub) by RING1, TRIM37 and
CC       RNF2/RING2 complex gives a specific tag for epigenetic transcriptional
CC       repression and participates in X chromosome inactivation of female
CC       mammals. It is involved in the initiation of both imprinted and random
CC       X inactivation. Ubiquitinated H2A is enriched in inactive X chromosome
CC       chromatin. Ubiquitination of H2A functions downstream of methylation of
CC       'Lys-27' of histone H3 (H3K27me). H2AK119Ub by RNF2/RING2 can also be
CC       induced by ultraviolet and may be involved in DNA repair.
CC       Monoubiquitination of Lys-120 (H2AK119Ub) by TRIM37 may promote
CC       transformation of cells in a number of breast cancers
CC       (PubMed:25470042). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. Deubiquitinated by USP51 at Lys-14 and Lys-16 (H2AK13Ub and
CC       H2AK15Ub, respectively) after damaged DNA is repaired
CC       (PubMed:27083998). H2AK119Ub and ionizing radiation-induced 'Lys-63'-
CC       linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901,
CC       ECO:0000269|PubMed:16702407, ECO:0000269|PubMed:18001824,
CC       ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:22713238,
CC       ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:24352239,
CC       ECO:0000269|PubMed:25470042, ECO:0000269|PubMed:27083998}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription. {ECO:0000269|PubMed:15010469,
CC       ECO:0000269|PubMed:15078818, ECO:0000269|PubMed:15823041,
CC       ECO:0000269|PubMed:16457589, ECO:0000269|PubMed:24140421}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (PubMed:24352239).
CC       {ECO:0000269|PubMed:24352239}.
CC   -!- PTM: Symmetric dimethylation on Arg-4 by the PRDM1/PRMT5 complex may
CC       play a crucial role in the germ-cell lineage.
CC       {ECO:0000250|UniProtKB:P22752}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- MASS SPECTROMETRY: Mass=13838.7; Method=Electrospray; Note=Monoisotopic
CC       with N-acetylserine.; Evidence={ECO:0000269|PubMed:16457589};
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z83736; CAB06031.1; -; Genomic_DNA.
DR   EMBL; AY131990; AAN59971.1; -; Genomic_DNA.
DR   EMBL; AL049822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03109.1; -; Genomic_DNA.
DR   EMBL; BC066232; AAH66232.1; -; mRNA.
DR   EMBL; BC066233; AAH66233.1; -; mRNA.
DR   EMBL; BC066234; AAH66234.1; -; mRNA.
DR   EMBL; BC066235; AAH66235.1; -; mRNA.
DR   EMBL; BC066236; AAH66236.1; -; mRNA.
DR   EMBL; BC066237; AAH66237.1; -; mRNA.
DR   EMBL; BC133048; AAI33049.1; -; mRNA.
DR   EMBL; BC133050; AAI33051.1; -; mRNA.
DR   RefSeq; NP_066544.1; NM_021066.2.
DR   SMR; Q99878; -.
DR   BioGrid; 113927; 19.
DR   IntAct; Q99878; 35.
DR   MINT; Q99878; -.
DR   STRING; 9606.ENSP00000328484; -.
DR   iPTMnet; Q99878; -.
DR   PhosphoSitePlus; Q99878; -.
DR   SwissPalm; Q99878; -.
DR   BioMuta; HIST1H2AJ; -.
DR   DMDM; 12585257; -.
DR   SWISS-2DPAGE; P99059; -.
DR   EPD; Q99878; -.
DR   jPOST; Q99878; -.
DR   MassIVE; Q99878; -.
DR   MaxQB; Q99878; -.
DR   PaxDb; Q99878; -.
DR   PeptideAtlas; Q99878; -.
DR   PRIDE; Q99878; -.
DR   ProteomicsDB; 78515; -.
DR   TopDownProteomics; Q99878; -.
DR   DNASU; 8331; -.
DR   Ensembl; ENST00000333151; ENSP00000328484; ENSG00000276368.
DR   GeneID; 8331; -.
DR   KEGG; hsa:8331; -.
DR   UCSC; uc003njn.2; human.
DR   CTD; 8331; -.
DR   GeneCards; H2AC14; -.
DR   HGNC; HGNC:4727; H2AC14.
DR   HPA; HPA041189; -.
DR   MIM; 602791; gene.
DR   neXtProt; NX_Q99878; -.
DR   OpenTargets; ENSG00000276368; -.
DR   PharmGKB; PA29104; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000153125; -.
DR   HOGENOM; CLU_062828_3_3_1; -.
DR   InParanoid; Q99878; -.
DR   KO; K11251; -.
DR   OMA; GCAFAQE; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; Q99878; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; HIST1H2AJ; human.
DR   GeneWiki; HIST1H2AJ; -.
DR   GenomeRNAi; 8331; -.
DR   Pharos; Q99878; Tdark.
DR   PRO; PR:Q99878; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q99878; protein.
DR   Bgee; ENSG00000276368; Expressed in lung and 54 other tissues.
DR   Genevisible; Q99878; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Citrullination; DNA-binding; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:15823041,
FT                   ECO:0000269|PubMed:16457589"
FT   CHAIN           2..128
FT                   /note="Histone H2A type 1-J"
FT                   /id="PRO_0000055239"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:15823041,
FT                   ECO:0000269|PubMed:16457589"
FT   MOD_RES         2
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:15010469"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22752"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         14
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         76
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         96
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         96
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         100
FT                   /note="N6-glutaryllysine"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:24352239"
FT   MOD_RES         119
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         119
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         119
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         119
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         120
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         120
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000269|PubMed:15078818,
FT                   ECO:0000269|PubMed:24140421"
FT   MOD_RES         126
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         126
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:15386022,
FT                   ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16702407,
FT                   ECO:0000269|PubMed:25470042"
FT   MUTAGEN         2
FT                   /note="S->A: Blocks the inhibition of transcription by
FT                   RPS6KA5/MSK1."
FT                   /evidence="ECO:0000269|PubMed:15010469"
SQ   SEQUENCE   128 AA;  13936 MW;  638BE3FE8256343E CRC64;
     MSGRGKQGGK ARAKAKTRSS RAGLQFPVGR VHRLLRKGNY AERVGAGAPV YLAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGK VTIAQGGVLP NIQAVLLPKK
     TESHHKTK
//
ID   H2A2A_HUMAN             Reviewed;         130 AA.
AC   Q6FI13; B2R5F0; P20670;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 166.
DE   RecName: Full=Histone H2A type 2-A;
DE   AltName: Full=Histone H2A.2;
DE   AltName: Full=Histone H2A/o;
GN   Name=HIST2H2AA3; Synonyms=H2AFO, HIST2H2AA;
GN   and
GN   Name=HIST2H2AA4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8179821; DOI=10.1089/dna.1994.13.161;
RA   Mannironi C., Orr A., Hatch C., Pilch D., Ivanova V., Bonner W.;
RT   "The relative expression of human histone H2A genes is similar in different
RT   types of proliferating cells.";
RL   DNA Cell Biol. 13:161-170(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=15078818; DOI=10.1101/gad.1184604;
RA   Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K.,
RA   Kaneko M., Takeshima Y., Muramatsu M., Ito T.;
RT   "Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in
RT   the early Drosophila embryo.";
RL   Genes Dev. 18:877-888(2004).
RN   [9]
RP   PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [10]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S.,
RA   Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [11]
RP   ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15823041; DOI=10.1021/bi047505c;
RA   Hagiwara T., Hidaka Y., Yamada M.;
RT   "Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.";
RL   Biochemistry 44:5827-5834(2005).
RN   [12]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [13]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16702407; DOI=10.1101/gad.373706;
RA   Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M., de Waard H.,
RA   Wu J., Yuan L., Citterio E., Houtsmuller A.B., Neefjes J.,
RA   Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
RT   "DNA damage triggers nucleotide excision repair-dependent
RT   monoubiquitylation of histone H2A.";
RL   Genes Dev. 20:1343-1352(2006).
RN   [14]
RP   MASS SPECTROMETRY, ACETYLATION AT SER-2 AND LYS-6, AND UBIQUITINATION AT
RP   LYS-120.
RX   PubMed=16457589; DOI=10.1021/pr050269n;
RA   Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.;
RT   "Precise characterization of human histones in the H2A gene family by top
RT   down mass spectrometry.";
RL   J. Proteome Res. 5:248-253(2006).
RN   [15]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [16]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [17]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [18]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [19]
RP   CROTONYLATION AT LYS-37; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [20]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [21]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22713238; DOI=10.4161/cc.20919;
RA   Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L.;
RT   "A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by
RT   RNF168 ubiquitin ligase.";
RL   Cell Cycle 11:2538-2544(2012).
RN   [22]
RP   SUCCINYLATION AT LYS-10 AND LYS-96.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [23]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=24140421; DOI=10.1016/j.molcel.2013.09.017;
RA   Kim K., Kim J.M., Kim J.S., Choi J., Lee Y.S., Neamati N., Song J.S.,
RA   Heo K., An W.;
RT   "VprBP has intrinsic kinase activity targeting histone H2A and represses
RT   gene transcription.";
RL   Mol. Cell 52:459-467(2013).
RN   [24]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-10; LYS-37; LYS-75; LYS-76; LYS-96 AND
RP   LYS-119.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [25]
RP   METHYLATION AT GLN-105.
RX   PubMed=24352239; DOI=10.1038/nature12819;
RA   Tessarz P., Santos-Rosa H., Robson S.C., Sylvestersen K.B., Nelson C.J.,
RA   Nielsen M.L., Kouzarides T.;
RT   "Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated
RT   modification.";
RL   Nature 505:564-568(2014).
RN   [26]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=25470042; DOI=10.1038/nature13955;
RA   Bhatnagar S., Gazin C., Chamberlain L., Ou J., Zhu X., Tushir J.S.,
RA   Virbasius C.M., Lin L., Zhu L.J., Wajapeyee N., Green M.R.;
RT   "TRIM37 is a new histone H2A ubiquitin ligase and breast cancer
RT   oncoprotein.";
RL   Nature 516:116-120(2014).
RN   [27]
RP   DEUBIQUITINATION AT LYS-14 AND LYS-16 BY USP51.
RX   PubMed=27083998; DOI=10.1101/gad.271841.115;
RA   Wang Z., Zhang H., Liu J., Cheruiyot A., Lee J.H., Ordog T., Lou Z.,
RA   You Z., Zhang Z.;
RT   "USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.";
RL   Genes Dev. 30:946-959(2016).
RN   [28]
RP   HYDROXYBUTYRYLATION AT LYS-10; LYS-14; LYS-37; LYS-96 AND LYS-119.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [29]
RP   GLUTARYLATION AT LYS-96; LYS-100; LYS-119; LYS-120 AND LYS-126.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Deiminated on Arg-4 in granulocytes upon calcium entry.
CC       {ECO:0000269|PubMed:15823041}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AK119Ub) by RING1, TRIM37 and
CC       RNF2/RING2 complex gives a specific tag for epigenetic transcriptional
CC       repression and participates in X chromosome inactivation of female
CC       mammals. It is involved in the initiation of both imprinted and random
CC       X inactivation. Ubiquitinated H2A is enriched in inactive X chromosome
CC       chromatin. Ubiquitination of H2A functions downstream of methylation of
CC       'Lys-27' of histone H3 (H3K27me). H2AK119Ub by RNF2/RING2 can also be
CC       induced by ultraviolet and may be involved in DNA repair.
CC       Monoubiquitination of Lys-120 (H2AK119Ub) by TRIM37 may promote
CC       transformation of cells in a number of breast cancers
CC       (PubMed:25470042). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. Deubiquitinated by USP51 at Lys-14 and Lys-16 (H2AK13Ub and
CC       H2AK15Ub, respectively) after damaged DNA is repaired
CC       (PubMed:27083998). H2AK119Ub and ionizing radiation-induced 'Lys-63'-
CC       linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901,
CC       ECO:0000269|PubMed:16457589, ECO:0000269|PubMed:16702407,
CC       ECO:0000269|PubMed:18001824, ECO:0000269|PubMed:18001825,
CC       ECO:0000269|PubMed:19203578, ECO:0000269|PubMed:19203579,
CC       ECO:0000269|PubMed:22713238, ECO:0000269|PubMed:22980979,
CC       ECO:0000269|PubMed:24352239, ECO:0000269|PubMed:25470042,
CC       ECO:0000269|PubMed:27083998}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription. {ECO:0000269|PubMed:15010469,
CC       ECO:0000269|PubMed:15078818, ECO:0000269|PubMed:15823041,
CC       ECO:0000269|PubMed:16457589, ECO:0000269|PubMed:24140421}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (PubMed:24352239).
CC       {ECO:0000269|PubMed:24352239}.
CC   -!- PTM: Symmetric dimethylation on Arg-4 by the PRDM1/PRMT5 complex may
CC       play a crucial role in the germ-cell lineage.
CC       {ECO:0000250|UniProtKB:P22752}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- MASS SPECTROMETRY: Mass=13997.9; Method=Electrospray; Note=Monoisotopic
CC       with N-acetylserine.; Evidence={ECO:0000269|PubMed:16457589};
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L19779; AAC24465.1; -; mRNA.
DR   EMBL; AY131971; AAN59957.1; -; Genomic_DNA.
DR   EMBL; AK312163; BAG35097.1; -; mRNA.
DR   EMBL; CR536525; CAG38762.1; -; mRNA.
DR   EMBL; CR541872; CAG46670.1; -; mRNA.
DR   EMBL; AL591493; CAI12562.1; -; Genomic_DNA.
DR   EMBL; AL591493; CAI12565.1; -; Genomic_DNA.
DR   EMBL; CH878687; EAW50859.1; -; Genomic_DNA.
DR   EMBL; BC096705; AAH96705.1; -; mRNA.
DR   EMBL; BC096739; AAH96739.1; -; mRNA.
DR   EMBL; BC098171; AAH98171.1; -; mRNA.
DR   CCDS; CCDS30849.1; -.
DR   CCDS; CCDS934.1; -.
DR   PIR; S06742; S06742.
DR   RefSeq; NP_001035807.1; NM_001040874.1.
DR   RefSeq; NP_003507.1; NM_003516.2.
DR   PDB; 6SE6; EM; 3.50 A; C/G=1-130.
DR   PDB; 6SEE; EM; 4.20 A; C/G=1-130.
DR   PDB; 6SEF; EM; 3.70 A; C/G=1-130.
DR   PDB; 6SEG; EM; 3.10 A; C/G=1-130.
DR   PDBsum; 6SE6; -.
DR   PDBsum; 6SEE; -.
DR   PDBsum; 6SEF; -.
DR   PDBsum; 6SEG; -.
DR   SMR; Q6FI13; -.
DR   BioGrid; 113933; 42.
DR   BioGrid; 593221; 18.
DR   CORUM; Q6FI13; -.
DR   DIP; DIP-33167N; -.
DR   IntAct; Q6FI13; 24.
DR   MINT; Q6FI13; -.
DR   STRING; 9606.ENSP00000475814; -.
DR   iPTMnet; Q6FI13; -.
DR   PhosphoSitePlus; Q6FI13; -.
DR   SwissPalm; Q6FI13; -.
DR   BioMuta; HIST2H2AA4; -.
DR   DMDM; 74757558; -.
DR   EPD; Q6FI13; -.
DR   jPOST; Q6FI13; -.
DR   MassIVE; Q6FI13; -.
DR   MaxQB; Q6FI13; -.
DR   PaxDb; Q6FI13; -.
DR   PeptideAtlas; Q6FI13; -.
DR   PRIDE; Q6FI13; -.
DR   ProteomicsDB; 66294; -.
DR   TopDownProteomics; Q6FI13; -.
DR   DNASU; 723790; -.
DR   DNASU; 8337; -.
DR   Ensembl; ENST00000369159; ENSP00000358155; ENSG00000203812.
DR   Ensembl; ENST00000607355; ENSP00000475814; ENSG00000272196.
DR   GeneID; 723790; -.
DR   GeneID; 8337; -.
DR   KEGG; hsa:723790; -.
DR   KEGG; hsa:8337; -.
DR   UCSC; uc001esw.4; human.
DR   CTD; 723790; -.
DR   CTD; 8337; -.
DR   DisGeNET; 723790; -.
DR   DisGeNET; 8337; -.
DR   GeneCards; H2AC18; -.
DR   GeneCards; H2AC19; -.
DR   HGNC; HGNC:4736; HIST2H2AA3.
DR   HGNC; HGNC:29668; HIST2H2AA4.
DR   HPA; HPA041189; -.
DR   MIM; 142720; gene.
DR   neXtProt; NX_Q6FI13; -.
DR   OpenTargets; ENSG00000272196; -.
DR   PharmGKB; PA29113; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000156302; -.
DR   HOGENOM; CLU_062828_3_1_1; -.
DR   InParanoid; Q6FI13; -.
DR   KO; K11251; -.
DR   OMA; HINWSIN; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; Q6FI13; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; HIST2H2AA3; human.
DR   ChiTaRS; HIST2H2AA4; human.
DR   GeneWiki; HIST2H2AA3; -.
DR   Pharos; Q6FI13; Tbio.
DR   PRO; PR:Q6FI13; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q6FI13; protein.
DR   Bgee; ENSG00000203812; Expressed in blood and 86 other tissues.
DR   Genevisible; Q6FI13; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Citrullination; DNA-binding;
KW   Hydroxylation; Isopeptide bond; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:15823041,
FT                   ECO:0000269|PubMed:16457589"
FT   CHAIN           2..130
FT                   /note="Histone H2A type 2-A"
FT                   /id="PRO_0000055232"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:15823041,
FT                   ECO:0000269|PubMed:16457589"
FT   MOD_RES         2
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:15010469"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GSS7"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16457589"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         14
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         76
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         96
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         96
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         100
FT                   /note="N6-glutaryllysine"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:24352239"
FT   MOD_RES         119
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         119
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         119
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         119
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         120
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         120
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000269|PubMed:15078818,
FT                   ECO:0000269|PubMed:24140421"
FT   MOD_RES         126
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         126
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:15386022,
FT                   ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16457589,
FT                   ECO:0000269|PubMed:16702407, ECO:0000269|PubMed:25470042"
FT   MUTAGEN         2
FT                   /note="S->A: Blocks the inhibition of transcription by
FT                   RPS6KA5/MSK1."
FT                   /evidence="ECO:0000269|PubMed:15010469"
FT   HELIX           18..21
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   HELIX           29..36
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   TURN            37..39
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   STRAND          42..44
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   HELIX           47..73
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   STRAND          77..79
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   HELIX           81..90
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   HELIX           94..97
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   TURN            98..100
FT                   /evidence="ECO:0000244|PDB:6SEG"
FT   STRAND          101..103
FT                   /evidence="ECO:0000244|PDB:6SEG"
SQ   SEQUENCE   130 AA;  14095 MW;  53AEDC6CE3FE8317 CRC64;
     MSGRGKQGGK ARAKAKSRSS RAGLQFPVGR VHRLLRKGNY AERVGAGAPV YMAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGK VTIAQGGVLP NIQAVLLPKK
     TESHHKAKGK
//
ID   H2A2B_HUMAN             Reviewed;         130 AA.
AC   Q8IUE6;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 148.
DE   RecName: Full=Histone H2A type 2-B;
GN   Name=HIST2H2AB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=15078818; DOI=10.1101/gad.1184604;
RA   Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K.,
RA   Kaneko M., Takeshima Y., Muramatsu M., Ito T.;
RT   "Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in
RT   the early Drosophila embryo.";
RL   Genes Dev. 18:877-888(2004).
RN   [4]
RP   PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [5]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S.,
RA   Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [6]
RP   ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15823041; DOI=10.1021/bi047505c;
RA   Hagiwara T., Hidaka Y., Yamada M.;
RT   "Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.";
RL   Biochemistry 44:5827-5834(2005).
RN   [7]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [8]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16702407; DOI=10.1101/gad.373706;
RA   Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M., de Waard H.,
RA   Wu J., Yuan L., Citterio E., Houtsmuller A.B., Neefjes J.,
RA   Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
RT   "DNA damage triggers nucleotide excision repair-dependent
RT   monoubiquitylation of histone H2A.";
RL   Genes Dev. 20:1343-1352(2006).
RN   [9]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [10]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [11]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [12]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   CROTONYLATION AT LYS-37; LYS-119 AND LYS-120.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [15]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [16]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22713238; DOI=10.4161/cc.20919;
RA   Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L.;
RT   "A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by
RT   RNF168 ubiquitin ligase.";
RL   Cell Cycle 11:2538-2544(2012).
RN   [17]
RP   SUCCINYLATION AT LYS-10 AND LYS-96.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [18]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=24140421; DOI=10.1016/j.molcel.2013.09.017;
RA   Kim K., Kim J.M., Kim J.S., Choi J., Lee Y.S., Neamati N., Song J.S.,
RA   Heo K., An W.;
RT   "VprBP has intrinsic kinase activity targeting histone H2A and represses
RT   gene transcription.";
RL   Mol. Cell 52:459-467(2013).
RN   [19]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-10; LYS-37; LYS-75; LYS-76; LYS-96 AND
RP   LYS-119.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [20]
RP   METHYLATION AT GLN-105.
RX   PubMed=24352239; DOI=10.1038/nature12819;
RA   Tessarz P., Santos-Rosa H., Robson S.C., Sylvestersen K.B., Nelson C.J.,
RA   Nielsen M.L., Kouzarides T.;
RT   "Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated
RT   modification.";
RL   Nature 505:564-568(2014).
RN   [21]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=25470042; DOI=10.1038/nature13955;
RA   Bhatnagar S., Gazin C., Chamberlain L., Ou J., Zhu X., Tushir J.S.,
RA   Virbasius C.M., Lin L., Zhu L.J., Wajapeyee N., Green M.R.;
RT   "TRIM37 is a new histone H2A ubiquitin ligase and breast cancer
RT   oncoprotein.";
RL   Nature 516:116-120(2014).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [23]
RP   DEUBIQUITINATION AT LYS-14 AND LYS-16 BY USP51.
RX   PubMed=27083998; DOI=10.1101/gad.271841.115;
RA   Wang Z., Zhang H., Liu J., Cheruiyot A., Lee J.H., Ordog T., Lou Z.,
RA   You Z., Zhang Z.;
RT   "USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.";
RL   Genes Dev. 30:946-959(2016).
RN   [24]
RP   HYDROXYBUTYRYLATION AT LYS-10; LYS-14; LYS-37; LYS-96 AND LYS-119.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [25]
RP   GLUTARYLATION AT LYS-96; LYS-119 AND LYS-120.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
RN   [26]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-53.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- INTERACTION:
CC       Q02539:HIST1H1A; NbExp=2; IntAct=EBI-1642157, EBI-932603;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Deiminated on Arg-4 in granulocytes upon calcium entry.
CC       {ECO:0000269|PubMed:15823041}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AK119Ub) by RING1, TRIM37 and
CC       RNF2/RING2 complex gives a specific tag for epigenetic transcriptional
CC       repression and participates in X chromosome inactivation of female
CC       mammals. It is involved in the initiation of both imprinted and random
CC       X inactivation. Ubiquitinated H2A is enriched in inactive X chromosome
CC       chromatin. Ubiquitination of H2A functions downstream of methylation of
CC       'Lys-27' of histone H3 (H3K27me). H2AK119Ub by RNF2/RING2 can also be
CC       induced by ultraviolet and may be involved in DNA repair.
CC       Monoubiquitination of Lys-120 (H2AK119Ub) by TRIM37 may promote
CC       transformation of cells in a number of breast cancers
CC       (PubMed:25470042). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. Deubiquitinated by USP51 at Lys-14 and Lys-16 (H2AK13Ub and
CC       H2AK15Ub, respectively) after damaged DNA is repaired
CC       (PubMed:27083998). H2AK119Ub and ionizing radiation-induced 'Lys-63'-
CC       linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901,
CC       ECO:0000269|PubMed:16702407, ECO:0000269|PubMed:18001824,
CC       ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:22713238,
CC       ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:24352239,
CC       ECO:0000269|PubMed:25470042}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription. {ECO:0000269|PubMed:15010469,
CC       ECO:0000269|PubMed:15078818, ECO:0000269|PubMed:15823041,
CC       ECO:0000269|PubMed:24140421}.
CC   -!- PTM: Symmetric dimethylation on Arg-4 by the PRDM1/PRMT5 complex may
CC       play a crucial role in the germ-cell lineage.
CC       {ECO:0000250|UniProtKB:P22752}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (PubMed:24352239).
CC       {ECO:0000269|PubMed:24352239}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY131972; AAN59958.1; -; Genomic_DNA.
DR   EMBL; AL591493; CAI12570.1; -; Genomic_DNA.
DR   CCDS; CCDS938.1; -.
DR   RefSeq; NP_778235.1; NM_175065.2.
DR   SMR; Q8IUE6; -.
DR   BioGrid; 130469; 80.
DR   IntAct; Q8IUE6; 57.
DR   MINT; Q8IUE6; -.
DR   STRING; 9606.ENSP00000332790; -.
DR   iPTMnet; Q8IUE6; -.
DR   PhosphoSitePlus; Q8IUE6; -.
DR   SwissPalm; Q8IUE6; -.
DR   BioMuta; HIST2H2AB; -.
DR   DMDM; 74750623; -.
DR   EPD; Q8IUE6; -.
DR   jPOST; Q8IUE6; -.
DR   MassIVE; Q8IUE6; -.
DR   MaxQB; Q8IUE6; -.
DR   PaxDb; Q8IUE6; -.
DR   PeptideAtlas; Q8IUE6; -.
DR   PRIDE; Q8IUE6; -.
DR   ProteomicsDB; 70556; -.
DR   TopDownProteomics; Q8IUE6; -.
DR   DNASU; 317772; -.
DR   Ensembl; ENST00000331128; ENSP00000332790; ENSG00000184270.
DR   GeneID; 317772; -.
DR   KEGG; hsa:317772; -.
DR   UCSC; uc001ete.4; human.
DR   CTD; 317772; -.
DR   DisGeNET; 317772; -.
DR   GeneCards; H2AC21; -.
DR   HGNC; HGNC:20508; HIST2H2AB.
DR   HPA; CAB011483; -.
DR   HPA; HPA041189; -.
DR   MIM; 615014; gene.
DR   neXtProt; NX_Q8IUE6; -.
DR   OpenTargets; ENSG00000184270; -.
DR   PharmGKB; PA134884141; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000153118; -.
DR   HOGENOM; CLU_062828_3_1_1; -.
DR   InParanoid; Q8IUE6; -.
DR   KO; K11251; -.
DR   OMA; NHPLACK; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; Q8IUE6; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   GeneWiki; HIST2H2AB; -.
DR   GenomeRNAi; 317772; -.
DR   Pharos; Q8IUE6; Tdark.
DR   PRO; PR:Q8IUE6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8IUE6; protein.
DR   Bgee; ENSG00000184270; Expressed in kidney and 73 other tissues.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Citrullination; DNA-binding; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   CHAIN           2..130
FT                   /note="Histone H2A type 2-B"
FT                   /id="PRO_0000227505"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         2
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:15010469"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q64522"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         14
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         76
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         96
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         96
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:24352239"
FT   MOD_RES         119
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         119
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         119
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         119
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         120
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         120
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000269|PubMed:15078818,
FT                   ECO:0000269|PubMed:24140421"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:15386022,
FT                   ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16702407,
FT                   ECO:0000269|PubMed:25470042"
FT   VARIANT         53
FT                   /note="A -> T (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035802"
FT   MUTAGEN         2
FT                   /note="S->A: Blocks the inhibition of transcription by
FT                   RPS6KA5/MSK1."
FT                   /evidence="ECO:0000269|PubMed:15010469"
SQ   SEQUENCE   130 AA;  13995 MW;  87932FEA853F5E93 CRC64;
     MSGRGKQGGK ARAKAKSRSS RAGLQFPVGR VHRLLRKGNY AERVGAGAPV YLAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAVRN DEELNKLLGG VTIAQGGVLP NIQAVLLPKK
     TESHKPGKNK
//
ID   H2A2C_HUMAN             Reviewed;         129 AA.
AC   Q16777; Q6DRA7; Q8IUE5;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   26-FEB-2020, entry version 187.
DE   RecName: Full=Histone H2A type 2-C;
DE   AltName: Full=Histone H2A-GL101;
DE   AltName: Full=Histone H2A/q;
GN   Name=HIST2H2AC; Synonyms=H2AFQ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15527963; DOI=10.1016/j.gene.2004.07.036;
RA   Braastad C.D., Hovhannisyan H., van Wijnen A.J., Stein J.L., Stein G.S.;
RT   "Functional characterization of a human histone gene cluster duplication.";
RL   Gene 342:35-40(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-57.
RC   TISSUE=Lymphocyte;
RX   PubMed=1469070; DOI=10.1002/jcb.240500406;
RA   Collart D., Romain P.L., Huebner K., Pockwinse S., Pilapil S.,
RA   Cannizzaro L.A., Lian J.B., Croce C.M., Stein J.L., Stein G.S.;
RT   "A human histone H2B.1 variant gene, located on chromosome 1, utilizes
RT   alternative 3' end processing.";
RL   J. Cell. Biochem. 50:374-385(1992).
RN   [6]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=15078818; DOI=10.1101/gad.1184604;
RA   Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., Takio K.,
RA   Kaneko M., Takeshima Y., Muramatsu M., Ito T.;
RT   "Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in
RT   the early Drosophila embryo.";
RL   Genes Dev. 18:877-888(2004).
RN   [7]
RP   PHOSPHORYLATION AT SER-2, AND MUTAGENESIS OF SER-2.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [8]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S.,
RA   Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [9]
RP   ACETYLATION AT SER-2, CITRULLINATION AT ARG-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15823041; DOI=10.1021/bi047505c;
RA   Hagiwara T., Hidaka Y., Yamada M.;
RT   "Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes.";
RL   Biochemistry 44:5827-5834(2005).
RN   [10]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [11]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=16702407; DOI=10.1101/gad.373706;
RA   Bergink S., Salomons F.A., Hoogstraten D., Groothuis T.A.M., de Waard H.,
RA   Wu J., Yuan L., Citterio E., Houtsmuller A.B., Neefjes J.,
RA   Hoeijmakers J.H.J., Vermeulen W., Dantuma N.P.;
RT   "DNA damage triggers nucleotide excision repair-dependent
RT   monoubiquitylation of histone H2A.";
RL   Genes Dev. 20:1343-1352(2006).
RN   [12]
RP   MASS SPECTROMETRY, AND ACETYLATION AT SER-2 AND LYS-6.
RX   PubMed=16457589; DOI=10.1021/pr050269n;
RA   Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.;
RT   "Precise characterization of human histones in the H2A gene family by top
RT   down mass spectrometry.";
RL   J. Proteome Res. 5:248-253(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16319397; DOI=10.1074/mcp.m500288-mcp200;
RA   Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
RT   "Characterization of histones H2A and H2B variants and their post-
RT   translational modifications by mass spectrometry.";
RL   Mol. Cell. Proteomics 5:541-552(2006).
RN   [14]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [15]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-121 AND SER-123, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [18]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [19]
RP   CROTONYLATION AT LYS-37; LYS-119; LYS-120 AND LYS-125.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [20]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [21]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22713238; DOI=10.4161/cc.20919;
RA   Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L.;
RT   "A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by
RT   RNF168 ubiquitin ligase.";
RL   Cell Cycle 11:2538-2544(2012).
RN   [22]
RP   SUCCINYLATION AT LYS-10 AND LYS-96.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [23]
RP   PHOSPHORYLATION AT THR-121.
RX   PubMed=24140421; DOI=10.1016/j.molcel.2013.09.017;
RA   Kim K., Kim J.M., Kim J.S., Choi J., Lee Y.S., Neamati N., Song J.S.,
RA   Heo K., An W.;
RT   "VprBP has intrinsic kinase activity targeting histone H2A and represses
RT   gene transcription.";
RL   Mol. Cell 52:459-467(2013).
RN   [24]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-10; LYS-37; LYS-75; LYS-76; LYS-96 AND
RP   LYS-119.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [25]
RP   METHYLATION AT GLN-105.
RX   PubMed=24352239; DOI=10.1038/nature12819;
RA   Tessarz P., Santos-Rosa H., Robson S.C., Sylvestersen K.B., Nelson C.J.,
RA   Nielsen M.L., Kouzarides T.;
RT   "Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated
RT   modification.";
RL   Nature 505:564-568(2014).
RN   [26]
RP   UBIQUITINATION AT LYS-120.
RX   PubMed=25470042; DOI=10.1038/nature13955;
RA   Bhatnagar S., Gazin C., Chamberlain L., Ou J., Zhu X., Tushir J.S.,
RA   Virbasius C.M., Lin L., Zhu L.J., Wajapeyee N., Green M.R.;
RT   "TRIM37 is a new histone H2A ubiquitin ligase and breast cancer
RT   oncoprotein.";
RL   Nature 516:116-120(2014).
RN   [27]
RP   DEUBIQUITINATION AT LYS-14 AND LYS-16 BY USP51.
RX   PubMed=27083998; DOI=10.1101/gad.271841.115;
RA   Wang Z., Zhang H., Liu J., Cheruiyot A., Lee J.H., Ordog T., Lou Z.,
RA   You Z., Zhang Z.;
RT   "USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.";
RL   Genes Dev. 30:946-959(2016).
RN   [28]
RP   HYDROXYBUTYRYLATION AT LYS-10; LYS-14; LYS-37; LYS-96 AND LYS-119.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [29]
RP   GLUTARYLATION AT LYS-96; LYS-100; LYS-119 AND LYS-120.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Deiminated on Arg-4 in granulocytes upon calcium entry.
CC       {ECO:0000269|PubMed:15823041}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AK119Ub) by RING1, TRIM37 and
CC       RNF2/RING2 complex gives a specific tag for epigenetic transcriptional
CC       repression and participates in X chromosome inactivation of female
CC       mammals. It is involved in the initiation of both imprinted and random
CC       X inactivation. Ubiquitinated H2A is enriched in inactive X chromosome
CC       chromatin. Ubiquitination of H2A functions downstream of methylation of
CC       'Lys-27' of histone H3 (H3K27me). H2AK119Ub by RNF2/RING2 can also be
CC       induced by ultraviolet and may be involved in DNA repair.
CC       Monoubiquitination of Lys-120 (H2AK119Ub) by TRIM37 may promote
CC       transformation of cells in a number of breast cancers
CC       (PubMed:25470042). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. Deubiquitinated by USP51 at Lys-14 and Lys-16 (H2AK13Ub and
CC       H2AK15Ub, respectively) after damaged DNA is repaired
CC       (PubMed:27083998). H2AK119Ub and ionizing radiation-induced 'Lys-63'-
CC       linked ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901,
CC       ECO:0000269|PubMed:16702407, ECO:0000269|PubMed:18001824,
CC       ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:22713238,
CC       ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:24352239,
CC       ECO:0000269|PubMed:25470042, ECO:0000269|PubMed:27083998}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription. {ECO:0000269|PubMed:15010469,
CC       ECO:0000269|PubMed:15078818, ECO:0000269|PubMed:15823041,
CC       ECO:0000269|PubMed:16457589, ECO:0000269|PubMed:24140421}.
CC   -!- PTM: Symmetric dimethylation on Arg-4 by the PRDM1/PRMT5 complex may
CC       play a crucial role in the germ-cell lineage.
CC       {ECO:0000250|UniProtKB:P22752}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (PubMed:24352239).
CC       {ECO:0000269|PubMed:24352239}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- MASS SPECTROMETRY: Mass=13890.8; Method=Electrospray; Note=Monoisotopic
CC       with N-acetylserine.; Evidence={ECO:0000269|PubMed:16457589};
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY131973; AAN59959.1; -; Genomic_DNA.
DR   EMBL; AY648852; AAT68255.1; -; Genomic_DNA.
DR   EMBL; AL591493; CAI12569.1; -; Genomic_DNA.
DR   EMBL; BC060324; AAH60324.1; -; mRNA.
DR   EMBL; X57985; CAA41050.1; -; Genomic_DNA.
DR   CCDS; CCDS937.1; -.
DR   PIR; I37466; I37466.
DR   RefSeq; NP_003508.1; NM_003517.2.
DR   SMR; Q16777; -.
DR   BioGrid; 113934; 129.
DR   CORUM; Q16777; -.
DR   IntAct; Q16777; 34.
DR   MINT; Q16777; -.
DR   STRING; 9606.ENSP00000332194; -.
DR   iPTMnet; Q16777; -.
DR   PhosphoSitePlus; Q16777; -.
DR   SwissPalm; Q16777; -.
DR   BioMuta; HIST2H2AC; -.
DR   DMDM; 47117890; -.
DR   EPD; Q16777; -.
DR   jPOST; Q16777; -.
DR   MassIVE; Q16777; -.
DR   MaxQB; Q16777; -.
DR   PaxDb; Q16777; -.
DR   PeptideAtlas; Q16777; -.
DR   PRIDE; Q16777; -.
DR   ProteomicsDB; 61066; -.
DR   TopDownProteomics; Q16777; -.
DR   DNASU; 8338; -.
DR   Ensembl; ENST00000331380; ENSP00000332194; ENSG00000184260.
DR   GeneID; 8338; -.
DR   KEGG; hsa:8338; -.
DR   UCSC; uc001etd.4; human.
DR   CTD; 8338; -.
DR   DisGeNET; 8338; -.
DR   GeneCards; H2AC20; -.
DR   HGNC; HGNC:4738; HIST2H2AC.
DR   HPA; HPA041189; -.
DR   MIM; 602797; gene.
DR   neXtProt; NX_Q16777; -.
DR   OpenTargets; ENSG00000184260; -.
DR   PharmGKB; PA29115; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000153118; -.
DR   HOGENOM; CLU_062828_3_1_1; -.
DR   InParanoid; Q16777; -.
DR   KO; K11251; -.
DR   OMA; RNDEELX; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; Q16777; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   GeneWiki; HIST2H2AC; -.
DR   GenomeRNAi; 8338; -.
DR   Pharos; Q16777; Tbio.
DR   PRO; PR:Q16777; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q16777; protein.
DR   Bgee; ENSG00000184260; Expressed in stomach and 87 other tissues.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Citrullination; DNA-binding; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:15823041,
FT                   ECO:0000269|PubMed:16457589"
FT   CHAIN           2..129
FT                   /note="Histone H2A type 2-C"
FT                   /id="PRO_0000055238"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:15823041,
FT                   ECO:0000269|PubMed:16457589"
FT   MOD_RES         2
FT                   /note="Phosphoserine; by RPS6KA5"
FT                   /evidence="ECO:0000250|UniProtKB:P0C0S8"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15823041"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q64523"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16457589"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         14
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         37
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         75
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         76
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         96
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         96
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         96
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         100
FT                   /note="N6-glutaryllysine"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:24352239"
FT   MOD_RES         119
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         119
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         119
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         119
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         120
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         120
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000269|PubMed:15078818, ECO:0000269|PubMed:24140421"
FT   MOD_RES         123
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         125
FT                   /note="N6-crotonyllysine"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22713238,
FT                   ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:15386022,
FT                   ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16702407,
FT                   ECO:0000269|PubMed:25470042"
FT   MUTAGEN         2
FT                   /note="S->A: Blocks the inhibition of transcription by
FT                   RPS6KA5/MSK1."
FT                   /evidence="ECO:0000269|PubMed:15010469"
SQ   SEQUENCE   129 AA;  13988 MW;  358AE20D1C531724 CRC64;
     MSGRGKQGGK ARAKAKSRSS RAGLQFPVGR VHRLLRKGNY AERVGAGAPV YMAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGK VTIAQGGVLP NIQAVLLPKK
     TESHKAKSK
//
ID   H2AB1_HUMAN             Reviewed;         115 AA.
AC   P0C5Y9; A0PK90; P98176; Q5TZB2; Q6FG78; Q96PR7;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 1.
DT   26-FEB-2020, entry version 109.
DE   RecName: Full=Histone H2A-Bbd type 1 {ECO:0000305};
DE   AltName: Full=H2A Barr body-deficient {ECO:0000303|PubMed:20008104};
DE            Short=H2A.B {ECO:0000303|PubMed:24336483};
DE            Short=H2A.Bbd {ECO:0000303|PubMed:20008104};
GN   Name=H2AB1 {ECO:0000312|HGNC:HGNC:22516};
GN   Synonyms=H2AFB1 {ECO:0000312|HGNC:HGNC:22516};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8528212; DOI=10.1093/hmg/4.7.1217;
RA   Naylor J.A., Buck D., Green P.M., Williamson H., Bentley D., Giannelli F.;
RT   "Investigation of the factor VIII intron 22 repeated region (int22h) and
RT   the associated inversion junctions.";
RL   Hum. Mol. Genet. 4:1217-1224(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, DOMAIN, AND SUBUNIT.
RX   PubMed=15257289; DOI=10.1038/sj.emboj.7600316;
RA   Bao Y., Konesky K., Park Y.-J., Rosu S., Dyer P.N., Rangasamy D.,
RA   Tremethick D.J., Laybourn P.J., Luger K.;
RT   "Nucleosomes containing the histone variant H2A.Bbd organize only 118 base
RT   pairs of DNA.";
RL   EMBO J. 23:3314-3324(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=16287874; DOI=10.1128/mcb.25.23.10639-10651.2005;
RA   Okuwaki M., Kato K., Shimahara H., Tate S., Nagata K.;
RT   "Assembly and disassembly of nucleosome core particles containing histone
RT   variants by human nucleosome assembly protein I.";
RL   Mol. Cell. Biol. 25:10639-10651(2005).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=16957777; DOI=10.1038/sj.emboj.7601310;
RA   Doyen C.M., Montel F., Gautier T., Menoni H., Claudet C.,
RA   Delacour-Larose M., Angelov D., Hamiche A., Bednar J.,
RA   Faivre-Moskalenko C., Bouvet P., Dimitrov S.;
RT   "Dissection of the unusual structural and functional properties of the
RT   variant H2A.Bbd nucleosome.";
RL   EMBO J. 25:4234-4244(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=17591702; DOI=10.1128/mcb.00376-07;
RA   Menoni H., Gasparutto D., Hamiche A., Cadet J., Dimitrov S., Bouvet P.,
RA   Angelov D.;
RT   "ATP-dependent chromatin remodeling is required for base excision repair in
RT   conventional but not in variant H2A.Bbd nucleosomes.";
RL   Mol. Cell. Biol. 27:5949-5956(2007).
RN   [9]
RP   FUNCTION.
RX   PubMed=17726088; DOI=10.1096/fj.07-9255com;
RA   Eirin-Lopez J.M., Ishibashi T., Ausio J.;
RT   "H2A.Bbd: a quickly evolving hypervariable mammalian histone that
RT   destabilizes nucleosomes in an acetylation-independent way.";
RL   FASEB J. 22:316-326(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=18329190; DOI=10.1016/j.gene.2008.02.003;
RA   Gonzalez-Romero R., Mendez J., Ausio J., Eirin-Lopez J.M.;
RT   "Quickly evolving histones, nucleosome stability and chromatin folding: all
RT   about histone H2A.Bbd.";
RL   Gene 413:1-7(2008).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20008104; DOI=10.1093/nar/gkp1129;
RA   Ishibashi T., Li A., Eirin-Lopez J.M., Zhao M., Missiaen K., Abbott D.W.,
RA   Meistrich M., Hendzel M.J., Ausio J.;
RT   "H2A.Bbd: an X-chromosome-encoded histone involved in mammalian
RT   spermiogenesis.";
RL   Nucleic Acids Res. 38:1780-1789(2010).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22795134; DOI=10.1016/j.molcel.2012.06.011;
RA   Tolstorukov M.Y., Goldman J.A., Gilbert C., Ogryzko V., Kingston R.E.,
RA   Park P.J.;
RT   "Histone variant H2A.Bbd is associated with active transcription and mRNA
RT   processing in human cells.";
RL   Mol. Cell 47:596-607(2012).
RN   [13]
RP   FUNCTION.
RX   PubMed=24753410; DOI=10.1093/nar/gku303;
RA   Sansoni V., Casas-Delucchi C.S., Rajan M., Schmidt A., Boenisch C.,
RA   Thomae A.W., Staege M.S., Hake S.B., Cardoso M.C., Imhof A.;
RT   "The histone variant H2A.Bbd is enriched at sites of DNA synthesis.";
RL   Nucleic Acids Res. 42:6405-6420(2014).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=24336483; DOI=10.1038/srep03510;
RA   Arimura Y., Kimura H., Oda T., Sato K., Osakabe A., Tachiwana H., Sato Y.,
RA   Kinugasa Y., Ikura T., Sugiyama M., Sato M., Kurumizaka H.;
RT   "Structural basis of a nucleosome containing histone H2A.B/H2A.Bbd that
RT   transiently associates with reorganized chromatin.";
RL   Sci. Rep. 3:3510-3510(2013).
RN   [15]
RP   ERRATUM.
RX   PubMed=26166249; DOI=10.1038/srep09628;
RA   Arimura Y., Kimura H., Oda T., Sato K., Osakabe A., Tachiwana H., Sato Y.,
RA   Kinugasa Y., Ikura T., Sugiyama M., Sato M., Kurumizaka H.;
RT   "Corrigendum: Structural basis of a nucleosome containing histone
RT   H2A.B/H2A.Bbd that transiently associates with reorganized chromatin.";
RL   Sci. Rep. 5:9628-9628(2015).
CC   -!- FUNCTION: Atypical histone H2A which can replace conventional H2A in
CC       some nucleosomes and is associated with active transcription and mRNA
CC       processing (PubMed:22795134). Nucleosomes wrap and compact DNA into
CC       chromatin, limiting DNA accessibility to the cellular machineries which
CC       require DNA as a template. Histones thereby play a central role in
CC       transcription regulation, DNA repair, DNA replication and chromosomal
CC       stability (PubMed:15257289, PubMed:16287874, PubMed:16957777,
CC       PubMed:17591702, PubMed:17726088, PubMed:18329190, PubMed:22795134).
CC       Nucleosomes containing this histone are less rigid and organize less
CC       DNA than canonical nucleosomes in vivo (PubMed:15257289,
CC       PubMed:16957777, PubMed:17591702, PubMed:24336483). They are enriched
CC       in actively transcribed genes and associate with the elongating form of
CC       RNA polymerase (PubMed:17591702, PubMed:24753410). They associate with
CC       spliceosome components and are required for mRNA splicing
CC       (PubMed:22795134). {ECO:0000269|PubMed:15257289,
CC       ECO:0000269|PubMed:16287874, ECO:0000269|PubMed:16957777,
CC       ECO:0000269|PubMed:17591702, ECO:0000269|PubMed:17726088,
CC       ECO:0000269|PubMed:18329190, ECO:0000269|PubMed:22795134,
CC       ECO:0000269|PubMed:24336483, ECO:0000269|PubMed:24753410}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. May be incorporated into a proportion of
CC       nucleosomes, replacing one or more H2A molecules.
CC       {ECO:0000269|PubMed:15257289, ECO:0000269|PubMed:16957777}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20008104,
CC       ECO:0000269|PubMed:24336483}. Chromosome {ECO:0000269|PubMed:20008104,
CC       ECO:0000269|PubMed:22795134, ECO:0000269|PubMed:24336483}.
CC       Note=Associated with the active X chromosome and with autosomes, while
CC       it is absent from the inactive X chromosome and excluded from Barr
CC       bodies. {ECO:0000269|PubMed:20008104}.
CC   -!- TISSUE SPECIFICITY: Present in mature sperm.
CC       {ECO:0000269|PubMed:20008104}.
CC   -!- DOMAIN: The docking domain is responsible for the weaker
CC       heterodimerization with H2B. {ECO:0000269|PubMed:15257289}.
CC   -!- MISCELLANEOUS: In contrast to other H2A histones, it does not contain
CC       the conserved residues that are the target of post-translational
CC       modifications. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   -!- CAUTION: Although related to variant histone H2AB1 in mouse (AC
CC       Q9CQ70), it is unclear whether human and mouse H2AB1 proteins are
CC       involved in similar processes. In mouse, variant histone H2AB1 is
CC       specifically required to direct the transformation of dissociating
CC       nucleosomes to protamine in male germ cells during spermatogenesis. It
CC       is however unclear whether human protein, which participates to mRNA
CC       processing and is associated with active transcription, is also
CC       involved in nucleosomes to protamine replacement (PubMed:22795134).
CC       {ECO:0000269|PubMed:22795134}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Histone H2A entry;
CC       URL="https://en.wikipedia.org/wiki/Histone_H2A";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X86012; CAA59998.1; -; Genomic_DNA.
DR   EMBL; CR542230; CAG47026.1; -; mRNA.
DR   EMBL; BX842559; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC128034; AAI28035.1; -; mRNA.
DR   CCDS; CCDS35458.1; -.
DR   PIR; I37901; I37901.
DR   RefSeq; NP_001017990.1; NM_001017990.1.
DR   SMR; P0C5Y9; -.
DR   BioGrid; 138883; 2.
DR   STRING; 9606.ENSP00000484261; -.
DR   iPTMnet; P0C5Y9; -.
DR   PhosphoSitePlus; P0C5Y9; -.
DR   BioMuta; H2AFB1; -.
DR   DMDM; 161784332; -.
DR   PaxDb; P0C5Y9; -.
DR   PeptideAtlas; P0C5Y9; -.
DR   PRIDE; P0C5Y9; -.
DR   ProteomicsDB; 52313; -.
DR   Ensembl; ENST00000620016; ENSP00000484261; ENSG00000274183.
DR   GeneID; 474382; -.
DR   KEGG; hsa:474382; -.
DR   UCSC; uc004fmu.5; human.
DR   CTD; 474382; -.
DR   GeneCards; H2AB1; -.
DR   HGNC; HGNC:22516; H2AB1.
DR   MIM; 301037; gene.
DR   neXtProt; NX_P0C5Y9; -.
DR   PharmGKB; PA134862083; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000163020; -.
DR   HOGENOM; CLU_062828_3_2_1; -.
DR   InParanoid; P0C5Y9; -.
DR   KO; K11251; -.
DR   OMA; QMERGLW; -.
DR   OrthoDB; 1012220at2759; -.
DR   PhylomeDB; P0C5Y9; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   GeneWiki; H2AFB1; -.
DR   GenomeRNAi; 474382; -.
DR   Pharos; P0C5Y9; Tdark.
DR   PRO; PR:P0C5Y9; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P0C5Y9; protein.
DR   Bgee; ENSG00000274183; Expressed in testis and 67 other tissues.
DR   Genevisible; P0C5Y9; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0035327; C:transcriptionally active chromatin; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0006397; P:mRNA processing; IMP:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   1: Evidence at protein level;
KW   Chromosome; DNA-binding; mRNA processing; Nucleosome core; Nucleus;
KW   Reference proteome.
FT   CHAIN           1..115
FT                   /note="Histone H2A-Bbd type 1"
FT                   /id="PRO_0000312805"
FT   REGION          87..115
FT                   /note="Docking domain"
FT                   /evidence="ECO:0000269|PubMed:15257289"
FT   CONFLICT        109
FT                   /note="Q -> K (in Ref. 4; AAI28035)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   115 AA;  12697 MW;  57CA60C8C2F5744B CRC64;
     MPRRRRRRGS SGAGGRGRTC SRTVRAELSF SVSQVERSLR EGHYAQRLSR TAPVYLAAVI
     EYLTAKVPEL AGNEAQNSGE RNITPLLLDM VVHNDRLLST LFNTTTISQV APGED
//
ID   H2AB2_HUMAN             Reviewed;         115 AA.
AC   P0C5Z0; A1L4E4; P98176; Q5TZB2; Q6FG78; Q96PR7;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 1.
DT   26-FEB-2020, entry version 98.
DE   RecName: Full=Histone H2A-Bbd type 2/3;
DE   AltName: Full=H2A Barr body-deficient;
DE            Short=H2A.Bbd;
GN   Name=H2AB2 {ECO:0000312|HGNC:HGNC:18298};
GN   Synonyms=H2AFB2 {ECO:0000312|HGNC:HGNC:18298};
GN   and
GN   Name=H2AB3 {ECO:0000312|HGNC:HGNC:14455};
GN   Synonyms=H2ABBD, H2AFB, H2AFB3 {ECO:0000312|HGNC:HGNC:14455};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=11266453; DOI=10.1083/jcb.152.2.375;
RA   Chadwick B.P., Willard H.F.;
RT   "A novel chromatin protein, distantly related to histone H2A, is largely
RT   excluded from the inactive X chromosome.";
RL   J. Cell Biol. 152:375-384(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=15257289; DOI=10.1038/sj.emboj.7600316;
RA   Bao Y., Konesky K., Park Y.-J., Rosu S., Dyer P.N., Rangasamy D.,
RA   Tremethick D.J., Laybourn P.J., Luger K.;
RT   "Nucleosomes containing the histone variant H2A.Bbd organize only 118 base
RT   pairs of DNA.";
RL   EMBO J. 23:3314-3324(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=16287874; DOI=10.1128/mcb.25.23.10639-10651.2005;
RA   Okuwaki M., Kato K., Shimahara H., Tate S., Nagata K.;
RT   "Assembly and disassembly of nucleosome core particles containing histone
RT   variants by human nucleosome assembly protein I.";
RL   Mol. Cell. Biol. 25:10639-10651(2005).
RN   [7]
RP   FUNCTION.
RX   PubMed=16957777; DOI=10.1038/sj.emboj.7601310;
RA   Doyen C.M., Montel F., Gautier T., Menoni H., Claudet C.,
RA   Delacour-Larose M., Angelov D., Hamiche A., Bednar J.,
RA   Faivre-Moskalenko C., Bouvet P., Dimitrov S.;
RT   "Dissection of the unusual structural and functional properties of the
RT   variant H2A.Bbd nucleosome.";
RL   EMBO J. 25:4234-4244(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=17591702; DOI=10.1128/mcb.00376-07;
RA   Menoni H., Gasparutto D., Hamiche A., Cadet J., Dimitrov S., Bouvet P.,
RA   Angelov D.;
RT   "ATP-dependent chromatin remodeling is required for base excision repair in
RT   conventional but not in variant H2A.Bbd nucleosomes.";
RL   Mol. Cell. Biol. 27:5949-5956(2007).
RN   [9]
RP   FUNCTION.
RX   PubMed=17726088; DOI=10.1096/fj.07-9255com;
RA   Eirin-Lopez J.M., Ishibashi T., Ausio J.;
RT   "H2A.Bbd: a quickly evolving hypervariable mammalian histone that
RT   destabilizes nucleosomes in an acetylation-independent way.";
RL   FASEB J. 22:316-326(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=18329190; DOI=10.1016/j.gene.2008.02.003;
RA   Gonzalez-Romero R., Mendez J., Ausio J., Eirin-Lopez J.M.;
RT   "Quickly evolving histones, nucleosome stability and chromatin folding: all
RT   about histone H2A.Bbd.";
RL   Gene 413:1-7(2008).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20008104; DOI=10.1093/nar/gkp1129;
RA   Ishibashi T., Li A., Eirin-Lopez J.M., Zhao M., Missiaen K., Abbott D.W.,
RA   Meistrich M., Hendzel M.J., Ausio J.;
RT   "H2A.Bbd: an X-chromosome-encoded histone involved in mammalian
RT   spermiogenesis.";
RL   Nucleic Acids Res. 38:1780-1789(2010).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22795134; DOI=10.1016/j.molcel.2012.06.011;
RA   Tolstorukov M.Y., Goldman J.A., Gilbert C., Ogryzko V., Kingston R.E.,
RA   Park P.J.;
RT   "Histone variant H2A.Bbd is associated with active transcription and mRNA
RT   processing in human cells.";
RL   Mol. Cell 47:596-607(2012).
CC   -!- FUNCTION: Atypical histone H2A which can replace conventional H2A in
CC       some nucleosomes and is associated with active transcription and mRNA
CC       processing. Nucleosomes wrap and compact DNA into chromatin, limiting
CC       DNA accessibility to the cellular machineries which require DNA as a
CC       template. Histones thereby play a central role in transcription
CC       regulation, DNA repair, DNA replication and chromosomal stability.
CC       Nucleosomes containing this histone are less rigid and organize less
CC       DNA than canonical nucleosomes in vivo. They are enriched in actively
CC       transcribed genes and associate with the elongating form of RNA
CC       polymerase. They associate with spliceosome components and are required
CC       for mRNA splicing. May participate in spermatogenesis.
CC       {ECO:0000269|PubMed:15257289, ECO:0000269|PubMed:16287874,
CC       ECO:0000269|PubMed:16957777, ECO:0000269|PubMed:17591702,
CC       ECO:0000269|PubMed:17726088, ECO:0000269|PubMed:18329190,
CC       ECO:0000269|PubMed:22795134}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. May be incorporated into a proportion of
CC       nucleosomes, replacing one or more H2A molecules.
CC   -!- INTERACTION:
CC       P62807:HIST1H2BI; NbExp=4; IntAct=EBI-13318575, EBI-354552;
CC       U3KQK0:HIST1H2BN; NbExp=4; IntAct=EBI-13318575, EBI-12142839;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20008104}. Chromosome
CC       {ECO:0000269|PubMed:20008104, ECO:0000269|PubMed:22795134}.
CC       Note=Associated with the active X chromosome and with autosomes, while
CC       it is absent from the inactive X chromosome and excluded from Barr
CC       bodies. {ECO:0000269|PubMed:20008104}.
CC   -!- TISSUE SPECIFICITY: Present in mature sperm.
CC       {ECO:0000269|PubMed:20008104}.
CC   -!- DOMAIN: The docking domain is responsible for the weaker
CC       heterodimerization with H2B. {ECO:0000269|PubMed:15257289}.
CC   -!- MISCELLANEOUS: In contrast to other H2A histones, it does not contain
CC       the conserved residues that are the target of post-translational
CC       modifications.
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Histone H2A entry;
CC       URL="https://en.wikipedia.org/wiki/Histone_H2A";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF254576; AAL01652.1; -; mRNA.
DR   EMBL; BX276110; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX682237; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471172; EAW72649.1; -; Genomic_DNA.
DR   EMBL; BC101409; AAI01410.1; -; mRNA.
DR   EMBL; BC101415; AAI01416.1; -; mRNA.
DR   EMBL; BC101417; AAI01418.1; -; mRNA.
DR   EMBL; BC101418; AAI01419.1; -; mRNA.
DR   EMBL; BC130510; AAI30511.1; -; mRNA.
DR   EMBL; BC130512; AAI30513.1; -; mRNA.
DR   EMBL; BC134365; AAI34366.1; -; mRNA.
DR   CCDS; CCDS35461.1; -.
DR   CCDS; CCDS35464.1; -.
DR   RefSeq; NP_001017991.1; NM_001017991.2.
DR   RefSeq; NP_542451.1; NM_080720.1.
DR   PDB; 6A7U; X-ray; 2.60 A; A=2-115.
DR   PDBsum; 6A7U; -.
DR   SMR; P0C5Z0; -.
DR   BioGrid; 123748; 1.
DR   IntAct; P0C5Z0; 6.
DR   STRING; 9606.ENSP00000482564; -.
DR   iPTMnet; P0C5Z0; -.
DR   PhosphoSitePlus; P0C5Z0; -.
DR   BioMuta; H2AFB3; -.
DR   DMDM; 161784333; -.
DR   PaxDb; P0C5Z0; -.
DR   PeptideAtlas; P0C5Z0; -.
DR   PRIDE; P0C5Z0; -.
DR   ProteomicsDB; 52314; -.
DR   DNASU; 474381; -.
DR   Ensembl; ENST00000354514; ENSP00000346509; ENSG00000277858.
DR   Ensembl; ENST00000615853; ENSP00000482564; ENSG00000277745.
DR   GeneID; 474381; -.
DR   GeneID; 83740; -.
DR   KEGG; hsa:474381; -.
DR   KEGG; hsa:83740; -.
DR   UCSC; uc004fnh.5; human.
DR   CTD; 474381; -.
DR   CTD; 83740; -.
DR   GeneCards; H2AB2; -.
DR   GeneCards; H2AB3; -.
DR   HGNC; HGNC:18298; H2AB2.
DR   HGNC; HGNC:14455; H2AB3.
DR   MIM; 300445; gene.
DR   MIM; 301038; gene.
DR   neXtProt; NX_P0C5Z0; -.
DR   PharmGKB; PA29101; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000163020; -.
DR   HOGENOM; CLU_062828_3_2_1; -.
DR   InParanoid; P0C5Z0; -.
DR   KO; K11251; -.
DR   OMA; DMAVHNN; -.
DR   OrthoDB; 1516933at2759; -.
DR   PhylomeDB; P0C5Z0; -.
DR   TreeFam; TF300137; -.
DR   GeneWiki; H2AFB2; -.
DR   GeneWiki; H2AFB3; -.
DR   Pharos; P0C5Z0; Tdark.
DR   PRO; PR:P0C5Z0; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P0C5Z0; protein.
DR   Bgee; ENSG00000277745; Expressed in testis and 73 other tissues.
DR   Genevisible; P0C5Z0; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0035327; C:transcriptionally active chromatin; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0006397; P:mRNA processing; IMP:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromosome; DNA-binding; mRNA processing; Nucleosome core;
KW   Nucleus; Reference proteome.
FT   CHAIN           1..115
FT                   /note="Histone H2A-Bbd type 2/3"
FT                   /id="PRO_0000055321"
FT   REGION          87..115
FT                   /note="Docking domain"
FT   HELIX           22..26
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   HELIX           32..41
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   STRAND          45..48
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   HELIX           51..77
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   STRAND          81..83
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   HELIX           85..92
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   STRAND          93..95
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   HELIX           98..100
FT                   /evidence="ECO:0000244|PDB:6A7U"
SQ   SEQUENCE   115 AA;  12713 MW;  F7CA7588C2F57451 CRC64;
     MPRRRRRRGS SGAGGRGRTC SRTVRAELSF SVSQVERSLR EGHYAQRLSR TAPVYLAAVI
     EYLTAKVLEL AGNEAQNSGE RNITPLLLDM VVHNDRLLST LFNTTTISQV APGED
//
ID   H2AJ_HUMAN              Reviewed;         129 AA.
AC   Q9BTM1; Q9NV63;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   26-FEB-2020, entry version 146.
DE   RecName: Full=Histone H2A.J;
DE            Short=H2a/j;
GN   Name=H2AFJ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BTM1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BTM1-2; Sequence=VSP_034750;
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AXK119ub) gives a specific tag
CC       for epigenetic transcriptional repression. Following DNA double-strand
CC       breaks (DSBs), it is ubiquitinated through 'Lys-63' linkage of
CC       ubiquitin moieties (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylation on Ser-2 (H2AS1ph) is enhanced during mitosis.
CC       Phosphorylation on Ser-2 by RPS6KA5/MSK1 directly represses
CC       transcription. Acetylation of H3 inhibits Ser-2 phosphorylation by
CC       RPS6KA5/MSK1. Phosphorylation at Thr-121 (H2AT120ph) by DCAF1 is
CC       present in the regulatory region of many tumor suppresor genes and
CC       down-regulates their transcription (By similarity). {ECO:0000250}.
CC   -!- PTM: Glutamine methylation at Gln-105 (H2AQ104me) by FBL is
CC       specifically dedicated to polymerase I. It is present at 35S ribosomal
CC       DNA locus and impairs binding of the FACT complex (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK001765; BAA91894.1; -; mRNA.
DR   EMBL; CH471094; EAW96326.1; -; Genomic_DNA.
DR   EMBL; BC003602; AAH03602.1; -; mRNA.
DR   CCDS; CCDS31752.1; -. [Q9BTM1-1]
DR   RefSeq; NP_808760.1; NM_177925.3. [Q9BTM1-1]
DR   PDB; 4EDU; X-ray; 2.58 A; T=31-46.
DR   PDBsum; 4EDU; -.
DR   SMR; Q9BTM1; -.
DR   BioGrid; 120884; 14.
DR   IntAct; Q9BTM1; 17.
DR   MINT; Q9BTM1; -.
DR   STRING; 9606.ENSP00000438553; -.
DR   iPTMnet; Q9BTM1; -.
DR   PhosphoSitePlus; Q9BTM1; -.
DR   SwissPalm; Q9BTM1; -.
DR   BioMuta; H2AFJ; -.
DR   DMDM; 74733131; -.
DR   jPOST; Q9BTM1; -.
DR   MassIVE; Q9BTM1; -.
DR   MaxQB; Q9BTM1; -.
DR   PaxDb; Q9BTM1; -.
DR   PeptideAtlas; Q9BTM1; -.
DR   PRIDE; Q9BTM1; -.
DR   ProteomicsDB; 78997; -. [Q9BTM1-1]
DR   ProteomicsDB; 78998; -. [Q9BTM1-2]
DR   TopDownProteomics; Q9BTM1-1; -. [Q9BTM1-1]
DR   DNASU; 55766; -.
DR   Ensembl; ENST00000389078; ENSP00000373730; ENSG00000246705. [Q9BTM1-1]
DR   Ensembl; ENST00000544848; ENSP00000438553; ENSG00000246705. [Q9BTM1-1]
DR   GeneID; 55766; -.
DR   KEGG; hsa:55766; -.
DR   UCSC; uc009zia.4; human. [Q9BTM1-1]
DR   CTD; 55766; -.
DR   DisGeNET; 55766; -.
DR   GeneCards; H2AJ; -.
DR   HGNC; HGNC:14456; H2AFJ.
DR   HPA; HPA041189; -.
DR   neXtProt; NX_Q9BTM1; -.
DR   OpenTargets; ENSG00000246705; -.
DR   PharmGKB; PA29108; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000153118; -.
DR   HOGENOM; CLU_062828_3_1_1; -.
DR   InParanoid; Q9BTM1; -.
DR   KO; K11251; -.
DR   OMA; TESHHYK; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; Q9BTM1; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   GeneWiki; H2AFJ; -.
DR   GenomeRNAi; 55766; -.
DR   Pharos; Q9BTM1; Tdark.
DR   PRO; PR:Q9BTM1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9BTM1; protein.
DR   Bgee; ENSG00000246705; Expressed in left testis and 205 other tissues.
DR   ExpressionAtlas; Q9BTM1; baseline and differential.
DR   Genevisible; Q9BTM1; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosome; DNA-binding;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..129
FT                   /note="Histone H2A.J"
FT                   /id="PRO_0000344247"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R1M2"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R1M2"
FT   MOD_RES         105
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by DCAF1"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         119..129
FT                   /note="KKTESQKTKSK -> VCEHSGPSSGKIPSDRAELGAGSVCGHIFQKVE (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_034750"
SQ   SEQUENCE   129 AA;  14019 MW;  E35049617B456D45 CRC64;
     MSGRGKQGGK VRAKAKSRSS RAGLQFPVGR VHRLLRKGNY AERVGAGAPV YLAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGK VTIAQGGVLP NIQAVLLPKK
     TESQKTKSK
//
ID   H2AV_HUMAN              Reviewed;         128 AA.
AC   Q71UI9; A6NFA8; A6NKY0; A6NN01; A8MQC5; Q59GV8; Q6PK98;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 153.
DE   RecName: Full=Histone H2A.V;
DE   AltName: Full=H2A.F/Z;
GN   Name=H2AFV; Synonyms=H2AV;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Groitl P., Wolf H., Niller H.H.;
RT   "Novel human member of the variant histone family.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Kidney, Ovarian adenocarcinoma, Prostatic carcinoma, Skin, and
RC   Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   MASS SPECTROMETRY.
RX   PubMed=16457589; DOI=10.1021/pr050269n;
RA   Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.;
RT   "Precise characterization of human histones in the H2A gene family by top
RT   down mass spectrometry.";
RL   J. Proteome Res. 5:248-253(2006).
CC   -!- FUNCTION: Variant histone H2A which replaces conventional H2A in a
CC       subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin,
CC       limiting DNA accessibility to the cellular machineries which require
CC       DNA as a template. Histones thereby play a central role in
CC       transcription regulation, DNA repair, DNA replication and chromosomal
CC       stability. DNA accessibility is regulated via a complex set of post-
CC       translational modifications of histones, also called histone code, and
CC       nucleosome remodeling. May be involved in the formation of constitutive
CC       heterochromatin. May be required for chromosome segregation during cell
CC       division (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA. H2A or its variant H2AFV forms a heterodimer with H2B (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q71UI9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q71UI9-2; Sequence=VSP_042855;
CC       Name=3;
CC         IsoId=Q71UI9-3; Sequence=VSP_044633;
CC       Name=4;
CC         IsoId=Q71UI9-4; Sequence=VSP_045232;
CC       Name=5;
CC         IsoId=Q71UI9-5; Sequence=VSP_046783;
CC   -!- PTM: Monoubiquitination of Lys-122 gives a specific tag for epigenetic
CC       transcriptional repression. {ECO:0000250}.
CC   -!- PTM: Acetylated on Lys-5, Lys-8 and Lys-12 during interphase.
CC       Acetylation disappears at mitosis (By similarity). {ECO:0000250}.
CC   -!- MASS SPECTROMETRY: Mass=13369.4; Method=Electrospray;
CC       Note=Monoisotopic, not modified.;
CC       Evidence={ECO:0000269|PubMed:16457589};
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92238.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF081192; AAC31938.1; -; mRNA.
DR   EMBL; AK023973; BAG51243.1; -; mRNA.
DR   EMBL; AB209001; BAD92238.1; ALT_INIT; mRNA.
DR   EMBL; AC004854; AAS00365.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61075.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61077.1; -; Genomic_DNA.
DR   EMBL; BC000098; AAH00098.1; -; mRNA.
DR   EMBL; BC004274; AAH04274.3; -; mRNA.
DR   EMBL; BC014885; AAH14885.1; -; mRNA.
DR   EMBL; BC070169; AAH70169.1; -; mRNA.
DR   EMBL; BE742590; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BU543626; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS47581.1; -. [Q71UI9-5]
DR   CCDS; CCDS5495.1; -. [Q71UI9-2]
DR   CCDS; CCDS5496.1; -. [Q71UI9-1]
DR   CCDS; CCDS5497.1; -. [Q71UI9-4]
DR   CCDS; CCDS5498.1; -. [Q71UI9-3]
DR   RefSeq; NP_036544.1; NM_012412.4. [Q71UI9-1]
DR   RefSeq; NP_619541.1; NM_138635.3. [Q71UI9-2]
DR   RefSeq; NP_958844.1; NM_201436.2. [Q71UI9-4]
DR   RefSeq; NP_958924.1; NM_201516.2. [Q71UI9-5]
DR   RefSeq; NP_958925.1; NM_201517.2. [Q71UI9-3]
DR   PDB; 3WAA; X-ray; 3.20 A; C/G=1-128.
DR   PDBsum; 3WAA; -.
DR   SMR; Q71UI9; -.
DR   BioGrid; 125150; 63.
DR   IntAct; Q71UI9; 21.
DR   MINT; Q71UI9; -.
DR   STRING; 9606.ENSP00000308405; -.
DR   iPTMnet; Q71UI9; -.
DR   PhosphoSitePlus; Q71UI9; -.
DR   SwissPalm; Q71UI9; -.
DR   BioMuta; H2AFV; -.
DR   DMDM; 74749787; -.
DR   EPD; Q71UI9; -.
DR   jPOST; Q71UI9; -.
DR   MassIVE; Q71UI9; -.
DR   MaxQB; Q71UI9; -.
DR   PaxDb; Q71UI9; -.
DR   PeptideAtlas; Q71UI9; -.
DR   PRIDE; Q71UI9; -.
DR   ProteomicsDB; 1035; -.
DR   ProteomicsDB; 1437; -.
DR   ProteomicsDB; 1947; -.
DR   ProteomicsDB; 68632; -. [Q71UI9-1]
DR   ProteomicsDB; 68633; -. [Q71UI9-2]
DR   TopDownProteomics; Q71UI9-1; -. [Q71UI9-1]
DR   TopDownProteomics; Q71UI9-3; -. [Q71UI9-3]
DR   TopDownProteomics; Q71UI9-4; -. [Q71UI9-4]
DR   DNASU; 94239; -.
DR   Ensembl; ENST00000222690; ENSP00000222690; ENSG00000105968. [Q71UI9-2]
DR   Ensembl; ENST00000308153; ENSP00000308405; ENSG00000105968. [Q71UI9-1]
DR   Ensembl; ENST00000349299; ENSP00000342714; ENSG00000105968. [Q71UI9-3]
DR   Ensembl; ENST00000350771; ENSP00000340708; ENSG00000105968. [Q71UI9-4]
DR   Ensembl; ENST00000381124; ENSP00000370516; ENSG00000105968. [Q71UI9-5]
DR   GeneID; 94239; -.
DR   KEGG; hsa:94239; -.
DR   UCSC; uc003tlz.3; human. [Q71UI9-1]
DR   CTD; 94239; -.
DR   DisGeNET; 94239; -.
DR   GeneCards; H2AZ2; -.
DR   HGNC; HGNC:20664; H2AFV.
DR   HPA; HPA057236; -.
DR   neXtProt; NX_Q71UI9; -.
DR   OpenTargets; ENSG00000105968; -.
DR   PharmGKB; PA134895050; -.
DR   eggNOG; KOG1757; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00900000140979; -.
DR   HOGENOM; CLU_062828_2_4_1; -.
DR   InParanoid; Q71UI9; -.
DR   KO; K11251; -.
DR   OMA; KQRTQHN; -.
DR   OrthoDB; 1465889at2759; -.
DR   PhylomeDB; Q71UI9; -.
DR   TreeFam; TF354232; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   ChiTaRS; H2AFV; human.
DR   GeneWiki; H2AFV; -.
DR   GenomeRNAi; 94239; -.
DR   Pharos; Q71UI9; Tdark.
DR   PRO; PR:Q71UI9; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q71UI9; protein.
DR   Bgee; ENSG00000105968; Expressed in substantia nigra and 230 other tissues.
DR   ExpressionAtlas; Q71UI9; baseline and differential.
DR   Genevisible; Q71UI9; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   CDD; cd00074; H2A; 1.
DR   DisProt; DP02301; -.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosome; DNA-binding;
KW   Nucleosome core; Nucleus; Polymorphism; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..128
FT                   /note="Histone H2A.V"
FT                   /id="PRO_0000239068"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3THW5"
FT   MOD_RES         8
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3THW5"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3THW5"
FT   VAR_SEQ         1..27
FT                   /note="MAGGKAGKDSGKAKAKAVSRSQRAGLQ -> M (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045232"
FT   VAR_SEQ         28..65
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_044633"
FT   VAR_SEQ         67..128
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_046783"
FT   VAR_SEQ         109..128
FT                   /note="GVIPHIHKSLIGKKGQQKTA -> EKRRCS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042855"
FT   VARIANT         125
FT                   /note="Q -> R (in dbSNP:rs1802437)"
FT                   /id="VAR_059312"
FT   HELIX           20..23
FT                   /evidence="ECO:0000244|PDB:3WAA"
FT   HELIX           30..38
FT                   /evidence="ECO:0000244|PDB:3WAA"
FT   HELIX           49..75
FT                   /evidence="ECO:0000244|PDB:3WAA"
FT   TURN            76..78
FT                   /evidence="ECO:0000244|PDB:3WAA"
FT   STRAND          80..82
FT                   /evidence="ECO:0000244|PDB:3WAA"
FT   HELIX           84..93
FT                   /evidence="ECO:0000244|PDB:3WAA"
FT   HELIX           95..100
FT                   /evidence="ECO:0000244|PDB:3WAA"
FT   STRAND          103..105
FT                   /evidence="ECO:0000244|PDB:3WAA"
FT   HELIX           116..118
FT                   /evidence="ECO:0000244|PDB:3WAA"
SQ   SEQUENCE   128 AA;  13509 MW;  1F3C388F6854041C CRC64;
     MAGGKAGKDS GKAKAKAVSR SQRAGLQFPV GRIHRHLKTR TTSHGRVGAT AAVYSAAILE
     YLTAEVLELA GNASKDLKVK RITPRHLQLA IRGDEELDSL IKATIAGGGV IPHIHKSLIG
     KKGQQKTA
//
ID   H2AW_HUMAN              Reviewed;         372 AA.
AC   Q9P0M6; Q5SQT2;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 182.
DE   RecName: Full=Core histone macro-H2A.2;
DE            Short=Histone macroH2A2;
DE            Short=mH2A2;
GN   Name=H2AFY2; Synonyms=MACROH2A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=11331621; DOI=10.1093/hmg/10.10.1101;
RA   Chadwick B.P., Willard H.F.;
RT   "Histone H2A variants and the inactive X chromosome: identification of a
RT   second macroH2A variant.";
RL   Hum. Mol. Genet. 10:1101-1113(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=11262398; DOI=10.1074/jbc.m010919200;
RA   Costanzi C., Pehrson J.R.;
RT   "MACROH2A2, a new member of the MACROH2A core histone family.";
RL   J. Biol. Chem. 276:21776-21784(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15621527; DOI=10.1016/j.devcel.2004.10.019;
RA   Zhang R., Poustovoitov M.V., Ye X., Santos H.A., Chen W., Daganzo S.M.,
RA   Erzberger J.P., Serebriiskii I.G., Canutescu A.A., Dunbrack R.L.,
RA   Pehrson J.R., Berger J.M., Kaufman P.D., Adams P.D.;
RT   "Formation of MacroH2A-containing senescence-associated heterochromatin
RT   foci and senescence driven by ASF1a and HIRA.";
RL   Dev. Cell 8:19-30(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-239, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [9]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-239, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Variant histone H2A which replaces conventional H2A in a
CC       subset of nucleosomes where it represses transcription. Nucleosomes
CC       wrap and compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template. Histones thereby
CC       play a central role in transcription regulation, DNA repair, DNA
CC       replication and chromosomal stability. DNA accessibility is regulated
CC       via a complex set of post-translational modifications of histones, also
CC       called histone code, and nucleosome remodeling. May be involved in
CC       stable X chromosome inactivation. {ECO:0000269|PubMed:15621527}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11262398,
CC       ECO:0000269|PubMed:11331621, ECO:0000269|PubMed:15621527}. Chromosome
CC       {ECO:0000269|PubMed:11262398, ECO:0000269|PubMed:11331621,
CC       ECO:0000269|PubMed:15621527}. Note=Enriched in inactive X chromosome
CC       chromatin (PubMed:11331621, PubMed:11262398) and in senescence-
CC       associated heterochromatin (PubMed:15621527).
CC       {ECO:0000269|PubMed:11262398, ECO:0000269|PubMed:11331621,
CC       ECO:0000269|PubMed:15621527}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF336304; AAK52471.1; -; mRNA.
DR   EMBL; AF151534; AAF72101.1; -; mRNA.
DR   EMBL; AK022776; BAB14239.1; -; mRNA.
DR   EMBL; AL731540; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016172; AAH16172.1; -; mRNA.
DR   CCDS; CCDS7296.1; -.
DR   RefSeq; NP_061119.1; NM_018649.2.
DR   PDB; 2XD7; X-ray; 2.09 A; A/B/C/D=177-369.
DR   PDB; 6FY5; X-ray; 1.65 A; A/B=178-372.
DR   PDBsum; 2XD7; -.
DR   PDBsum; 6FY5; -.
DR   SMR; Q9P0M6; -.
DR   BioGrid; 120686; 124.
DR   DIP; DIP-48563N; -.
DR   IntAct; Q9P0M6; 100.
DR   MINT; Q9P0M6; -.
DR   STRING; 9606.ENSP00000362352; -.
DR   iPTMnet; Q9P0M6; -.
DR   PhosphoSitePlus; Q9P0M6; -.
DR   BioMuta; H2AFY2; -.
DR   DMDM; 12585260; -.
DR   EPD; Q9P0M6; -.
DR   jPOST; Q9P0M6; -.
DR   MassIVE; Q9P0M6; -.
DR   MaxQB; Q9P0M6; -.
DR   PaxDb; Q9P0M6; -.
DR   PeptideAtlas; Q9P0M6; -.
DR   PRIDE; Q9P0M6; -.
DR   ProteomicsDB; 83580; -.
DR   DNASU; 55506; -.
DR   Ensembl; ENST00000373255; ENSP00000362352; ENSG00000099284.
DR   GeneID; 55506; -.
DR   KEGG; hsa:55506; -.
DR   UCSC; uc001jqm.4; human.
DR   CTD; 55506; -.
DR   DisGeNET; 55506; -.
DR   GeneCards; MACROH2A2; -.
DR   HGNC; HGNC:14453; H2AFY2.
DR   HPA; HPA035865; -.
DR   HPA; HPA041189; -.
DR   MIM; 616141; gene.
DR   neXtProt; NX_Q9P0M6; -.
DR   OpenTargets; ENSG00000099284; -.
DR   PharmGKB; PA29118; -.
DR   eggNOG; ENOG410IV3A; Eukaryota.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; KOG2633; Eukaryota.
DR   eggNOG; COG2110; LUCA.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000158120; -.
DR   InParanoid; Q9P0M6; -.
DR   KO; K11251; -.
DR   OMA; NIPQWGS; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; Q9P0M6; -.
DR   TreeFam; TF332276; -.
DR   ChiTaRS; H2AFY2; human.
DR   EvolutionaryTrace; Q9P0M6; -.
DR   GeneWiki; H2AFY2; -.
DR   GenomeRNAi; 55506; -.
DR   Pharos; Q9P0M6; Tbio.
DR   PRO; PR:Q9P0M6; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9P0M6; protein.
DR   Bgee; ENSG00000099284; Expressed in embryo and 225 other tissues.
DR   ExpressionAtlas; Q9P0M6; baseline and differential.
DR   Genevisible; Q9P0M6; HS.
DR   GO; GO:0001740; C:Barr body; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0007549; P:dosage compensation; IDA:MGI.
DR   GO; GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProtKB.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:1901837; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; IGI:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:UniProtKB.
DR   CDD; cd00074; H2A; 1.
DR   CDD; cd02904; Macro_H2A_like; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR021171; Core_histone_macro-H2A.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR035796; Macro_H2A.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   Pfam; PF01661; Macro; 1.
DR   PIRSF; PIRSF037942; Core_histone_macro-H2A; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00506; A1pp; 1.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS51154; MACRO; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromatin regulator; Chromosome; DNA-binding;
KW   Isopeptide bond; Nucleosome core; Nucleus; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..372
FT                   /note="Core histone macro-H2A.2"
FT                   /id="PRO_0000055320"
FT   DOMAIN          2..117
FT                   /note="Histone H2A"
FT   DOMAIN          184..370
FT                   /note="Macro"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00490"
FT   COMPBIAS        118..161
FT                   /note="Lys-rich"
FT   CROSSLNK        239
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   STRAND          183..191
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   STRAND          196..202
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   HELIX           204..209
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   STRAND          213..219
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   HELIX           227..252
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   STRAND          260..264
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   STRAND          266..277
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   HELIX           286..302
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   TURN            303..305
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   STRAND          307..311
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   HELIX           323..339
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   STRAND          348..353
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   HELIX           356..366
FT                   /evidence="ECO:0000244|PDB:6FY5"
FT   STRAND          369..371
FT                   /evidence="ECO:0000244|PDB:6FY5"
SQ   SEQUENCE   372 AA;  40058 MW;  C4B35CD156031AF1 CRC64;
     MSGRSGKKKM SKLSRSARAG VIFPVGRLMR YLKKGTFKYR ISVGAPVYMA AVIEYLAAEI
     LELAGNAARD NKKARIAPRH ILLAVANDEE LNQLLKGVTI ASGGVLPRIH PELLAKKRGT
     KGKSETILSP PPEKRGRKAT SGKKGGKKSK AAKPRTSKKS KPKDSDKEGT SNSTSEDGPG
     DGFTILSSKS LVLGQKLSLT QSDISHIGSM RVEGIVHPTT AEIDLKEDIG KALEKAGGKE
     FLETVKELRK SQGPLEVAEA AVSQSSGLAA KFVIHCHIPQ WGSDKCEEQL EETIKNCLSA
     AEDKKLKSVA FPPFPSGRNC FPKQTAAQVT LKAISAHFDD SSASSLKNVY FLLFDSESIG
     IYVQEMAKLD AK
//
ID   H2AX_HUMAN              Reviewed;         143 AA.
AC   P16104; Q4ZGJ7; Q6IAS5;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 208.
DE   RecName: Full=Histone H2AX;
DE            Short=H2a/x;
DE   AltName: Full=Histone H2A.X;
GN   Name=H2AX {ECO:0000312|HGNC:HGNC:4739};
GN   Synonyms=H2AFX {ECO:0000312|HGNC:HGNC:4739};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2587254; DOI=10.1093/nar/17.22.9113;
RA   Mannironi C., Bonner W.M., Hatch C.L.;
RT   "H2A.X. a histone isoprotein with a conserved C-terminal sequence, is
RT   encoded by a novel mRNA with both DNA replication type and polyA 3'
RT   processing signals.";
RL   Nucleic Acids Res. 17:9113-9126(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION AT SER-140, AND MUTAGENESIS OF GLN-141.
RX   PubMed=9488723; DOI=10.1074/jbc.273.10.5858;
RA   Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M.;
RT   "DNA double-stranded breaks induce histone H2AX phosphorylation on serine
RT   139.";
RL   J. Biol. Chem. 273:5858-5868(1998).
RN   [6]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140.
RX   PubMed=10477747; DOI=10.1083/jcb.146.5.905;
RA   Rogakou E.P., Boon C., Redon C., Bonner W.M.;
RT   "Megabase chromatin domains involved in DNA double-strand breaks in vivo.";
RL   J. Cell Biol. 146:905-916(1999).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140.
RX   PubMed=10959836; DOI=10.1016/s0960-9822(00)00610-2;
RA   Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M.,
RA   Bonner W.M.;
RT   "A critical role for histone H2AX in recruitment of repair factors to
RT   nuclear foci after DNA damage.";
RL   Curr. Biol. 10:886-895(2000).
RN   [8]
RP   PHOSPHORYLATION AT SER-140.
RX   PubMed=10734083; DOI=10.1074/jbc.275.13.9390;
RA   Rogakou E.P., Nieves-Neira W., Boon C., Pommier Y., Bonner W.M.;
RT   "Initiation of DNA fragmentation during apoptosis induces phosphorylation
RT   of H2AX histone at serine 139.";
RL   J. Biol. Chem. 275:9390-9395(2000).
RN   [9]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140.
RX   PubMed=11673449; DOI=10.1074/jbc.c100569200;
RA   Ward I.M., Chen J.;
RT   "Histone H2AX is phosphorylated in an ATR-dependent manner in response to
RT   replicational stress.";
RL   J. Biol. Chem. 276:47759-47762(2001).
RN   [10]
RP   FUNCTION, INTERACTION WITH NBN AND BRCA1, SUBCELLULAR LOCATION, AND
RP   PHOSPHORYLATION AT SER-140.
RX   PubMed=12419185; DOI=10.1016/s0960-9822(02)01259-9;
RA   Kobayashi J., Tauchi H., Sakamoto S., Nakamura A., Morishima K.,
RA   Matsuura S., Kobayashi T., Tamai K., Tanimoto K., Komatsu K.;
RT   "NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT
RT   domain.";
RL   Curr. Biol. 12:1846-1851(2002).
RN   [11]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140.
RX   PubMed=12697768; DOI=10.1074/jbc.c300117200;
RA   Ward I.M., Minn K., Jorda K.G., Chen J.;
RT   "Accumulation of checkpoint protein 53BP1 at DNA breaks involves its
RT   binding to phosphorylated histone H2AX.";
RL   J. Biol. Chem. 278:19579-19582(2003).
RN   [12]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140.
RX   PubMed=12660252; DOI=10.1074/jbc.m300198200;
RA   Furuta T., Takemura H., Liao Z.-Y., Aune G.J., Redon C., Sedelnikova O.A.,
RA   Pilch D.R., Rogakou E.P., Celeste A., Chen H.T., Nussenzweig A.,
RA   Aladjem M.I., Bonner W.M., Pommier Y.;
RT   "Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1
RT   in response to replication-dependent DNA double-strand breaks induced by
RT   mammalian DNA topoisomerase I cleavage complexes.";
RL   J. Biol. Chem. 278:20303-20312(2003).
RN   [13]
RP   FUNCTION, INTERACTION WITH MDC1 AND TP53BP1, SUBCELLULAR LOCATION, AND
RP   PHOSPHORYLATION AT SER-140.
RX   PubMed=12607005; DOI=10.1038/nature01446;
RA   Stewart G.S., Wang B., Bignell C.R., Taylor A.M.R., Elledge S.J.;
RT   "MDC1 is a mediator of the mammalian DNA damage checkpoint.";
RL   Nature 421:961-966(2003).
RN   [14]
RP   PHOSPHORYLATION AT SER-140.
RX   PubMed=14627815; DOI=10.1093/nar/gkg921;
RA   Park E.-J., Chan D.W., Park J.-H., Oettinger M.A., Kwon J.;
RT   "DNA-PK is activated by nucleosomes and phosphorylates H2AX within the
RT   nucleosomes in an acetylation-dependent manner.";
RL   Nucleic Acids Res. 31:6819-6827(2003).
RN   [15]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-140.
RX   PubMed=15059890; DOI=10.1158/0008-5472.can-03-3207;
RA   Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Loebrich M., Jeggo P.A.;
RT   "ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure
RT   to ionizing radiation.";
RL   Cancer Res. 64:2390-2396(2004).
RN   [16]
RP   FUNCTION, INTERACTION WITH MDC1 AND NBN, AND SUBCELLULAR LOCATION.
RX   PubMed=15201865; DOI=10.1038/sj.emboj.7600269;
RA   Lukas C., Melander F., Stucki M., Falck J., Bekker-Jensen S., Goldberg M.,
RA   Lerenthal Y., Jackson S.P., Bartek J., Lukas J.;
RT   "Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-
RT   dependent chromatin retention.";
RL   EMBO J. 23:2674-2683(2004).
RN   [17]
RP   PHOSPHORYLATION AT SER-140.
RX   PubMed=15489221; DOI=10.1074/jbc.m406879200;
RA   Kurz E.U., Douglas P., Lees-Miller S.P.;
RT   "Doxorubicin activates ATM-dependent phosphorylation of multiple downstream
RT   targets in part through the generation of reactive oxygen species.";
RL   J. Biol. Chem. 279:53272-53281(2004).
RN   [18]
RP   INTERACTION WITH DHX9, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT
RP   SER-140.
RX   PubMed=15613478; DOI=10.1074/jbc.m411444200;
RA   Mischo H.E., Hemmerich P., Grosse F., Zhang S.;
RT   "Actinomycin D induces histone gamma-H2AX foci and complex formation of
RT   gamma-H2AX with Ku70 and nuclear DNA helicase II.";
RL   J. Biol. Chem. 280:9586-9594(2005).
RN   [19]
RP   DEPHOSPHORYLATION.
RX   PubMed=16310392; DOI=10.1016/j.molcel.2005.10.003;
RA   Chowdhury D., Keogh M.-C., Ishii H., Peterson C.L., Buratowski S.,
RA   Lieberman J.;
RT   "gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA
RT   double-strand break repair.";
RL   Mol. Cell 20:801-809(2005).
RN   [20]
RP   INTERACTION WITH ARRB2.
RX   PubMed=16820410; DOI=10.1242/jcs.03046;
RA   Neuhaus E.M., Mashukova A., Barbour J., Wolters D., Hatt H.;
RT   "Novel function of beta-arrestin2 in the nucleus of mature spermatozoa.";
RL   J. Cell Sci. 119:3047-3056(2006).
RN   [21]
RP   UBIQUITINATION.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [22]
RP   UBIQUITINATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [24]
RP   UBIQUITINATION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C.,
RA   Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A.,
RA   Byrd P.J., Stankovic T., Taylor A.M.R., Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [25]
RP   UBIQUITINATION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J.,
RA   Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to
RT   allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [26]
RP   PHOSPHORYLATION AT TYR-143, AND MUTAGENESIS OF TYR-143.
RX   PubMed=19092802; DOI=10.1038/nature07668;
RA   Xiao A., Li H., Shechter D., Ahn S.H., Fabrizio L.A., Erdjument-Bromage H.,
RA   Ishibe-Murakami S., Wang B., Tempst P., Hofmann K., Patel D.J.,
RA   Elledge S.J., Allis C.D.;
RT   "WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase
RT   activity.";
RL   Nature 457:57-62(2009).
RN   [27]
RP   PHOSPHORYLATION AT TYR-143, AND MUTAGENESIS OF TYR-143.
RX   PubMed=19234442; DOI=10.1038/nature07849;
RA   Cook P.J., Ju B.G., Telese F., Wang X., Glass C.K., Rosenfeld M.G.;
RT   "Tyrosine dephosphorylation of H2AX modulates apoptosis and survival
RT   decisions.";
RL   Nature 458:591-596(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [30]
RP   UBIQUITINATION AT LYS-14 AND LYS-16 BY RNF168.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage signaling.";
RL   Cell 150:1182-1195(2012).
RN   [31]
RP   INTERACTION WITH EPSTEIN-BARR VIRUS PROTEIN EBNA6 (MICROBIAL INFECTION),
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=24429368; DOI=10.1128/jvi.03568-13;
RA   Jha H.C., Aj M.P., Saha A., Banerjee S., Lu J., Robertson E.S.;
RT   "Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.";
RL   J. Virol. 88:3776-3788(2014).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-135, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [33]
RP   INTERACTION WITH WRAP53.
RX   PubMed=26734725; DOI=10.1080/19491034.2015.1106675;
RA   Rassoolzadeh H., Coucoravas C., Farnebo M.;
RT   "The proximity ligation assay reveals that at DNA double-strand breaks
RT   WRAP53beta associates with gammaH2AX and controls interactions between RNF8
RT   and MDC1.";
RL   Nucleus 6:417-424(2015).
RN   [34]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-128 AND LYS-135, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [35]
RP   INTERACTION WITH WRAP53.
RX   PubMed=27715493; DOI=10.1080/15476286.2016.1243647;
RA   Coucoravas C., Dhanjal S., Henriksson S., Boehm S., Farnebo M.;
RT   "Phosphorylation of the Cajal body protein WRAP53beta by ATM promotes its
RT   involvement in the DNA damage response.";
RL   RNA Biol. 14:804-813(2017).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 134-143, AND PHOSPHORYLATION AT
RP   SER-140.
RX   PubMed=22154951; DOI=10.1016/j.jsb.2011.11.022;
RA   Shao Z., Li F., Sy S.M., Yan W., Zhang Z., Gong D., Wen B., Huen M.S.,
RA   Gong Q., Wu J., Shi Y.;
RT   "Specific recognition of phosphorylated tail of H2AX by the tandem BRCT
RT   domains of MCPH1 revealed by complex structure.";
RL   J. Struct. Biol. 177:459-468(2012).
CC   -!- FUNCTION: Variant histone H2A which replaces conventional H2A in a
CC       subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin,
CC       limiting DNA accessibility to the cellular machineries which require
CC       DNA as a template. Histones thereby play a central role in
CC       transcription regulation, DNA repair, DNA replication and chromosomal
CC       stability. DNA accessibility is regulated via a complex set of post-
CC       translational modifications of histones, also called histone code, and
CC       nucleosome remodeling. Required for checkpoint-mediated arrest of cell
CC       cycle progression in response to low doses of ionizing radiation and
CC       for efficient repair of DNA double strand breaks (DSBs) specifically
CC       when modified by C-terminal phosphorylation.
CC       {ECO:0000269|PubMed:10959836, ECO:0000269|PubMed:12419185,
CC       ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:15201865}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA
CC       (Probable). Interacts with numerous proteins required for DNA damage
CC       signaling and repair when phosphorylated on Ser-140 (PubMed:12419185,
CC       PubMed:12607005, PubMed:15201865). These include MDC1, TP53BP1, BRCA1
CC       and the MRN complex, composed of MRE11, RAD50, and NBN
CC       (PubMed:12419185, PubMed:12607005, PubMed:15201865). Interaction with
CC       the MRN complex is mediated at least in part by NBN (PubMed:12419185).
CC       Also interacts with DHX9/NDHII when phosphorylated on Ser-140 and MCPH1
CC       when phosphorylated at Ser-140 or Tyr-143 (PubMed:15613478). Interacts
CC       with ARRB2; the interaction is detected in the nucleus upon OR1D2
CC       stimulation (PubMed:16820410). Interacts with WRAP53/TCAB1
CC       (PubMed:26734725, PubMed:27715493). {ECO:0000269|PubMed:12419185,
CC       ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:15201865,
CC       ECO:0000269|PubMed:15613478, ECO:0000269|PubMed:16820410,
CC       ECO:0000269|PubMed:26734725, ECO:0000269|PubMed:27715493, ECO:0000305}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Epstein-Barr virus
CC       protein EBNA6. {ECO:0000269|PubMed:24429368}.
CC   -!- INTERACTION:
CC       Q9Z0X1:Aifm1 (xeno); NbExp=2; IntAct=EBI-494830, EBI-5326677;
CC       P46933-1:Apbb1 (xeno); NbExp=2; IntAct=EBI-494830, EBI-15759525;
CC       P38398:BRCA1; NbExp=4; IntAct=EBI-494830, EBI-349905;
CC       Q6P4T3:Eya3 (xeno); NbExp=2; IntAct=EBI-494830, EBI-15759383;
CC       P58876:HIST1H2BD; NbExp=2; IntAct=EBI-494830, EBI-4409942;
CC       P62805:HIST1H4K; NbExp=4; IntAct=EBI-494830, EBI-302023;
CC       Q16695:HIST3H3; NbExp=12; IntAct=EBI-494830, EBI-358900;
CC       P02545:LMNA; NbExp=3; IntAct=EBI-494830, EBI-351935;
CC       P45983:MAPK8; NbExp=3; IntAct=EBI-494830, EBI-286483;
CC       Q14676:MDC1; NbExp=21; IntAct=EBI-494830, EBI-495644;
CC       P49959:MRE11; NbExp=7; IntAct=EBI-494830, EBI-396513;
CC       O60934:NBN; NbExp=14; IntAct=EBI-494830, EBI-494844;
CC       Q6ZW49-1:PAXIP1; NbExp=7; IntAct=EBI-494830, EBI-7521368;
CC       O15297:PPM1D; NbExp=3; IntAct=EBI-494830, EBI-1551512;
CC       P51532:SMARCA4; NbExp=9; IntAct=EBI-494830, EBI-302489;
CC       Q15554:TERF2; NbExp=4; IntAct=EBI-494830, EBI-706637;
CC       Q12888:TP53BP1; NbExp=6; IntAct=EBI-494830, EBI-396540;
CC       Q99986:VRK1; NbExp=3; IntAct=EBI-494830, EBI-1769146;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12419185,
CC       ECO:0000269|PubMed:12660252, ECO:0000269|PubMed:12697768,
CC       ECO:0000269|PubMed:15613478, ECO:0000269|PubMed:24429368}. Chromosome
CC       {ECO:0000269|PubMed:10959836, ECO:0000269|PubMed:11673449,
CC       ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:12660252,
CC       ECO:0000269|PubMed:15059890, ECO:0000269|PubMed:15201865,
CC       ECO:0000269|PubMed:15613478}.
CC   -!- DEVELOPMENTAL STAGE: Synthesized in G1 as well as in S-phase.
CC   -!- DOMAIN: The [ST]-Q motif constitutes a recognition sequence for kinases
CC       from the PI3/PI4-kinase family.
CC   -!- PTM: Phosphorylated on Ser-140 (to form gamma-H2AX or H2AX139ph) in
CC       response to DNA double strand breaks (DSBs) generated by exogenous
CC       genotoxic agents and by stalled replication forks, and may also occur
CC       during meiotic recombination events and immunoglobulin class switching
CC       in lymphocytes. Phosphorylation can extend up to several thousand
CC       nucleosomes from the actual site of the DSB and may mark the
CC       surrounding chromatin for recruitment of proteins required for DNA
CC       damage signaling and repair. Widespread phosphorylation may also serve
CC       to amplify the damage signal or aid repair of persistent lesions.
CC       Phosphorylation of Ser-140 (H2AX139ph) in response to ionizing
CC       radiation is mediated by both ATM and PRKDC while defects in DNA
CC       replication induce Ser-140 phosphorylation (H2AX139ph) subsequent to
CC       activation of ATR and PRKDC. Dephosphorylation of Ser-140 by PP2A is
CC       required for DNA DSB repair. In meiosis, Ser-140 phosphorylation
CC       (H2AX139ph) may occur at synaptonemal complexes during leptotene as an
CC       ATM-dependent response to the formation of programmed DSBs by SPO11.
CC       Ser-140 phosphorylation (H2AX139ph) may subsequently occurs at
CC       unsynapsed regions of both autosomes and the XY bivalent during
CC       zygotene, downstream of ATR and BRCA1 activation. Ser-140
CC       phosphorylation (H2AX139ph) may also be required for transcriptional
CC       repression of unsynapsed chromatin and meiotic sex chromosome
CC       inactivation (MSCI), whereby the X and Y chromosomes condense in
CC       pachytene to form the heterochromatic XY-body. During immunoglobulin
CC       class switch recombination in lymphocytes, Ser-140 phosphorylation
CC       (H2AX139ph) may occur at sites of DNA-recombination subsequent to
CC       activation of the activation-induced cytidine deaminase AICDA.
CC       Phosphorylation at Tyr-143 (H2AXY142ph) by BAZ1B/WSTF determines the
CC       relative recruitment of either DNA repair or pro-apoptotic factors.
CC       Phosphorylation at Tyr-143 (H2AXY142ph) favors the recruitment of
CC       APBB1/FE65 and pro-apoptosis factors such as MAPK8/JNK1, triggering
CC       apoptosis. In contrast, dephosphorylation of Tyr-143 by EYA proteins
CC       (EYA1, EYA2, EYA3 or EYA4) favors the recruitment of MDC1-containing
CC       DNA repair complexes to the tail of phosphorylated Ser-140 (H2AX139ph).
CC       {ECO:0000269|PubMed:10477747, ECO:0000269|PubMed:10734083,
CC       ECO:0000269|PubMed:10959836, ECO:0000269|PubMed:11673449,
CC       ECO:0000269|PubMed:12419185, ECO:0000269|PubMed:12607005,
CC       ECO:0000269|PubMed:12660252, ECO:0000269|PubMed:12697768,
CC       ECO:0000269|PubMed:14627815, ECO:0000269|PubMed:15059890,
CC       ECO:0000269|PubMed:15489221, ECO:0000269|PubMed:15613478,
CC       ECO:0000269|PubMed:19092802, ECO:0000269|PubMed:19234442,
CC       ECO:0000269|PubMed:22154951, ECO:0000269|PubMed:9488723}.
CC   -!- PTM: Monoubiquitination of Lys-120 (H2AXK119ub) by RING1 and RNF2/RING2
CC       complex gives a specific tag for epigenetic transcriptional repression
CC       (By similarity). Following DNA double-strand breaks (DSBs), it is
CC       ubiquitinated through 'Lys-63' linkage of ubiquitin moieties by the E2
CC       ligase UBE2N and the E3 ligases RNF8 and RNF168, leading to the
CC       recruitment of repair proteins to sites of DNA damage. Ubiquitination
CC       at Lys-14 and Lys-16 (H2AK13Ub and H2AK15Ub, respectively) in response
CC       to DNA damage is initiated by RNF168 that mediates monoubiquitination
CC       at these 2 sites, and 'Lys-63'-linked ubiquitin are then conjugated to
CC       monoubiquitin; RNF8 is able to extend 'Lys-63'-linked ubiquitin chains
CC       in vitro. H2AK119Ub and ionizing radiation-induced 'Lys-63'-linked
CC       ubiquitination (H2AK13Ub and H2AK15Ub) are distinct events.
CC       {ECO:0000250, ECO:0000269|PubMed:18001824, ECO:0000269|PubMed:18001825,
CC       ECO:0000269|PubMed:19203578, ECO:0000269|PubMed:19203579,
CC       ECO:0000269|PubMed:22980979}.
CC   -!- PTM: Acetylation at Lys-37 increases in S and G2 phases. This
CC       modification has been proposed to play a role in DNA double-strand
CC       break repair (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/h2afx/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/H2AFXID40783ch11q23.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X14850; CAA32968.1; -; mRNA.
DR   EMBL; CR457079; CAG33360.1; -; mRNA.
DR   EMBL; DQ015918; AAY22178.1; -; Genomic_DNA.
DR   EMBL; BC004915; AAH04915.1; -; mRNA.
DR   EMBL; BC011694; AAH11694.1; -; mRNA.
DR   EMBL; BC013416; AAH13416.1; -; mRNA.
DR   CCDS; CCDS8410.1; -.
DR   PIR; S07631; S07631.
DR   RefSeq; NP_002096.1; NM_002105.2.
DR   PDB; 1YDP; X-ray; 1.90 A; P=78-86.
DR   PDB; 2AZM; X-ray; 2.41 A; C/D=134-143.
DR   PDB; 2D31; X-ray; 3.20 A; C/F=78-86.
DR   PDB; 2DYP; X-ray; 2.50 A; C=78-86.
DR   PDB; 3SHV; X-ray; 2.10 A; C/D=134-143.
DR   PDB; 3SQD; X-ray; 2.15 A; C/D=134-143.
DR   PDB; 3SZM; X-ray; 2.63 A; I/J/K/L/M/N/O/P=134-143.
DR   PDB; 3U3Z; X-ray; 1.50 A; B=140-143.
DR   PDBsum; 1YDP; -.
DR   PDBsum; 2AZM; -.
DR   PDBsum; 2D31; -.
DR   PDBsum; 2DYP; -.
DR   PDBsum; 3SHV; -.
DR   PDBsum; 3SQD; -.
DR   PDBsum; 3SZM; -.
DR   PDBsum; 3U3Z; -.
DR   SMR; P16104; -.
DR   BioGrid; 109268; 416.
DR   CORUM; P16104; -.
DR   DIP; DIP-33604N; -.
DR   ELM; P16104; -.
DR   IntAct; P16104; 281.
DR   MINT; P16104; -.
DR   STRING; 9606.ENSP00000434024; -.
DR   iPTMnet; P16104; -.
DR   PhosphoSitePlus; P16104; -.
DR   SwissPalm; P16104; -.
DR   BioMuta; H2AFX; -.
DR   DMDM; 121992; -.
DR   EPD; P16104; -.
DR   jPOST; P16104; -.
DR   MassIVE; P16104; -.
DR   MaxQB; P16104; -.
DR   PaxDb; P16104; -.
DR   PeptideAtlas; P16104; -.
DR   PRIDE; P16104; -.
DR   ProteomicsDB; 53286; -.
DR   TopDownProteomics; P16104; -.
DR   Ensembl; ENST00000375167; ENSP00000364310; ENSG00000188486.
DR   Ensembl; ENST00000530167; ENSP00000434024; ENSG00000188486.
DR   GeneID; 3014; -.
DR   KEGG; hsa:3014; -.
DR   UCSC; uc001pvg.4; human.
DR   CTD; 3014; -.
DR   DisGeNET; 3014; -.
DR   GeneCards; H2AX; -.
DR   HGNC; HGNC:4739; H2AX.
DR   HPA; CAB012264; -.
DR   HPA; HPA041189; -.
DR   HPA; HPA051647; -.
DR   MIM; 601772; gene.
DR   neXtProt; NX_P16104; -.
DR   OpenTargets; ENSG00000188486; -.
DR   PharmGKB; PA29116; -.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00950000182829; -.
DR   HOGENOM; CLU_062828_3_1_1; -.
DR   InParanoid; P16104; -.
DR   KO; K11251; -.
DR   OMA; VEMDAMS; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; P16104; -.
DR   TreeFam; TF300137; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   SIGNOR; P16104; -.
DR   ChiTaRS; H2AFX; human.
DR   EvolutionaryTrace; P16104; -.
DR   GeneWiki; H2AFX; -.
DR   GenomeRNAi; 3014; -.
DR   Pharos; P16104; Tbio.
DR   PRO; PR:P16104; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P16104; protein.
DR   Bgee; ENSG00000188486; Expressed in embryo and 224 other tissues.
DR   Genevisible; P16104; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0000794; C:condensed nuclear chromosome; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0001673; C:male germ cell nucleus; IEA:Ensembl.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005657; C:replication fork; IEA:Ensembl.
DR   GO; GO:0090734; C:site of DNA damage; IMP:UniProtKB.
DR   GO; GO:0035861; C:site of double-strand break; IDA:MGI.
DR   GO; GO:0001741; C:XY body; IEA:Ensembl.
DR   GO; GO:0003684; F:damaged DNA binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:BHF-UCL.
DR   GO; GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0090398; P:cellular senescence; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0000077; P:DNA damage checkpoint; IDA:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; NAS:UniProtKB.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006334; P:nucleosome assembly; NAS:UniProtKB.
DR   GO; GO:0045739; P:positive regulation of DNA repair; NAS:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; NAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell cycle; Chromosome; DNA damage;
KW   DNA recombination; DNA repair; DNA-binding; Host-virus interaction;
KW   Isopeptide bond; Meiosis; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P27661"
FT   CHAIN           2..143
FT                   /note="Histone H2AX"
FT                   /id="PRO_0000055242"
FT   MOTIF           140..141
FT                   /note="[ST]-Q motif"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P27661"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P27661"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27661"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27661"
FT   MOD_RES         37
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27661"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P27661"
FT   MOD_RES         140
FT                   /note="Phosphoserine; by ATM, ATR and PRKDC"
FT                   /evidence="ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000269|PubMed:10477747, ECO:0000269|PubMed:10734083,
FT                   ECO:0000269|PubMed:10959836, ECO:0000269|PubMed:11673449,
FT                   ECO:0000269|PubMed:12419185, ECO:0000269|PubMed:12607005,
FT                   ECO:0000269|PubMed:12660252, ECO:0000269|PubMed:12697768,
FT                   ECO:0000269|PubMed:14627815, ECO:0000269|PubMed:15059890,
FT                   ECO:0000269|PubMed:15489221, ECO:0000269|PubMed:15613478,
FT                   ECO:0000269|PubMed:22154951, ECO:0000269|PubMed:9488723"
FT   MOD_RES         143
FT                   /note="Phosphotyrosine; by WSTF"
FT                   /evidence="ECO:0000269|PubMed:19092802,
FT                   ECO:0000269|PubMed:19234442"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22980979"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:22980979"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P27661"
FT   CROSSLNK        128
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        135
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   MUTAGEN         141
FT                   /note="Q->N: Reduced phosphorylation of S-140 in response
FT                   to DNA damage."
FT                   /evidence="ECO:0000269|PubMed:9488723"
FT   MUTAGEN         143
FT                   /note="Y->F: Displays a reduced apoptotic response. S-140
FT                   phosphorylation is reduced."
FT                   /evidence="ECO:0000269|PubMed:19092802,
FT                   ECO:0000269|PubMed:19234442"
FT   CONFLICT        78
FT                   /note="R -> L (in Ref. 2; CAG33360)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   143 AA;  15145 MW;  D4683775C2E6C3A9 CRC64;
     MSGRGKTGGK ARAKAKSRSS RAGLQFPVGR VHRLLRKGHY AERVGAGAPV YLAAVLEYLT
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DEELNKLLGG VTIAQGGVLP NIQAVLLPKK
     TSATVGPKAP SGGKKATQAS QEY
//
ID   H2AY_HUMAN              Reviewed;         372 AA.
AC   O75367; O75377; Q503A8; Q7Z5E3; Q96D41; Q9H8P3; Q9UP96;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   26-FEB-2020, entry version 203.
DE   RecName: Full=Core histone macro-H2A.1;
DE            Short=Histone macroH2A1;
DE            Short=mH2A1;
DE   AltName: Full=Histone H2A.y;
DE            Short=H2A/y;
DE   AltName: Full=Medulloblastoma antigen MU-MB-50.205;
GN   Name=MACROH2A1 {ECO:0000312|HGNC:HGNC:4740};
GN   Synonyms=H2AFY {ECO:0000312|HGNC:HGNC:4740};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=9714746; DOI=10.1016/s0167-4781(98)00098-0;
RA   Lee Y., Hong M., Kim J.W., Hong Y.M., Choe Y.-K., Chang S.Y., Lee K.S.,
RA   Choe I.S.;
RT   "Isolation of cDNA clones encoding human histone macroH2A1 subtypes.";
RL   Biochim. Biophys. Acta 1399:73-77(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=9653160; DOI=10.1073/pnas.95.14.8175;
RA   Mao M., Fu G., Wu J.-S., Zhang Q.-H., Zhou J., Kan L.-X., Huang Q.-H.,
RA   He K.-L., Gu B.-W., Han Z.-G., Shen Y., Gu J., Yu Y.-P., Xu S.-H.,
RA   Wang Y.-X., Chen S.-J., Chen Z.;
RT   "Identification of genes expressed in human CD34(+) hematopoietic
RT   stem/progenitor cells by expressed sequence tags and efficient full-length
RT   cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8175-8180(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovary;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-372 (ISOFORM 3).
RC   TISSUE=Medulloblastoma;
RX   PubMed=12800201; DOI=10.1002/ijc.11208;
RA   Behrends U., Schneider I., Roessler S., Frauenknecht H., Golbeck A.,
RA   Lechner B., Eigenstetter G., Zobywalski C., Mueller-Weihrich S.,
RA   Graubner U., Schmid I., Sackerer D., Spaeth M., Goetz C., Prantl F.,
RA   Asmuss H.-P., Bise K., Mautner J.;
RT   "Novel tumor antigens identified by autologous antibody screening of
RT   childhood medulloblastoma cDNA libraries.";
RL   Int. J. Cancer 106:244-251(2003).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9634239; DOI=10.1038/31275;
RA   Costanzi C., Pehrson J.R.;
RT   "Histone macroH2A1 is concentrated in the inactive X chromosome of female
RT   mammals.";
RL   Nature 393:599-601(1998).
RN   [8]
RP   FUNCTION.
RX   PubMed=12718888; DOI=10.1016/s1097-2765(03)00100-x;
RA   Angelov D., Molla A., Perche P.-Y., Hans F., Cote J., Khochbin S.,
RA   Bouvet P., Dimitrov S.;
RT   "The histone variant macroH2A interferes with transcription factor binding
RT   and SWI/SNF nucleosome remodeling.";
RL   Mol. Cell 11:1033-1041(2003).
RN   [9]
RP   UBIQUITINATION AT LYS-116 AND LYS-117, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16129414; DOI=10.1016/j.bbrc.2005.08.046;
RA   Ogawa Y., Ono T., Wakata Y., Okawa K., Tagami H., Shibahara K.;
RT   "Histone variant macroH2A1.2 is mono-ubiquitinated at its histone domain.";
RL   Biochem. Biophys. Res. Commun. 336:204-209(2005).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15621527; DOI=10.1016/j.devcel.2004.10.019;
RA   Zhang R., Poustovoitov M.V., Ye X., Santos H.A., Chen W., Daganzo S.M.,
RA   Erzberger J.P., Serebriiskii I.G., Canutescu A.A., Dunbrack R.L.,
RA   Pehrson J.R., Berger J.M., Kaufman P.D., Adams P.D.;
RT   "Formation of MacroH2A-containing senescence-associated heterochromatin
RT   foci and senescence driven by ASF1a and HIRA.";
RL   Dev. Cell 8:19-30(2005).
RN   [11]
RP   FUNCTION, AND BINDING OF THE MACRO DOMAIN TO ADP-RIBOSE (ISOFORM 1).
RX   PubMed=15902274; DOI=10.1038/sj.emboj.7600664;
RA   Karras G.I., Kustatscher G., Buhecha H.R., Allen M.D., Pugieux C., Sait F.,
RA   Bycroft M., Ladurner A.G.;
RT   "The macro domain is an ADP-ribose binding module.";
RL   EMBO J. 24:1911-1920(2005).
RN   [12]
RP   IDENTIFICATION IN A COMPLEX WITH CULLIN3 AND SPOP, UBIQUITINATION,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15897469; DOI=10.1073/pnas.0408918102;
RA   Hernandez-Munoz I., Lund A.H., van der Stoop P., Boutsma E., Muijrers I.,
RA   Verhoeven E., Nusinow D.A., Panning B., Marahrens Y., van Lohuizen M.;
RT   "Stable X chromosome inactivation involves the PRC1 Polycomb complex and
RT   requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7635-7640(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-129 AND THR-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   FUNCTION.
RX   PubMed=16428466; DOI=10.1128/mcb.26.3.1156-1164.2006;
RA   Doyen C.-M., An W., Angelov D., Bondarenko V., Mietton F., Studitsky V.M.,
RA   Hamiche A., Roeder R.G., Bouvet P., Dimitrov S.;
RT   "Mechanism of polymerase II transcription repression by the histone variant
RT   macroH2A.";
RL   Mol. Cell. Biol. 26:1156-1164(2006).
RN   [15]
RP   METHYLATION AT LYS-18 AND LYS-123, PHOSPHORYLATION AT THR-129, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16210244; DOI=10.1074/mcp.m500285-mcp200;
RA   Chu F., Nusinow D.A., Chalkley R.J., Plath K., Panning B., Burlingame A.L.;
RT   "Mapping post-translational modifications of the histone variant MacroH2A1
RT   using tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 5:194-203(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-129, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-170 AND THR-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-129; SER-170; SER-173 AND
RP   THR-178, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-129 AND THR-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   LACK OF ADP-RIBOSE GLYCOHYDROLASE ACTIVITY.
RX   PubMed=23474714; DOI=10.1038/nsmb.2521;
RA   Rosenthal F., Feijs K.L., Frugier E., Bonalli M., Forst A.H., Imhof R.,
RA   Winkler H.C., Fischer D., Caflisch A., Hassa P.O., Luescher B.,
RA   Hottiger M.O.;
RT   "Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases.";
RL   Nat. Struct. Mol. Biol. 20:502-507(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-129 AND SER-170, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   FUNCTION (ISOFORMS 1 AND 2), AND ALTERNATIVE SPLICING (ISOFORMS 1 AND 2).
RX   PubMed=23022728; DOI=10.1038/nsmb.2390;
RA   Dardenne E., Pierredon S., Driouch K., Gratadou L., Lacroix-Triki M.,
RA   Espinoza M.P., Zonta E., Germann S., Mortada H., Villemin J.P.,
RA   Dutertre M., Lidereau R., Vagner S., Auboeuf D.;
RT   "Splicing switch of an epigenetic regulator by RNA helicases promotes
RT   tumor-cell invasiveness.";
RL   Nat. Struct. Mol. Biol. 19:1139-1146(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-129; SER-170; SER-173 AND
RP   THR-178, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-123; LYS-167; LYS-189 AND
RP   LYS-323, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 1-120 IN COMPLEX WITH THE
RP   NUCLEOSOME CORE PARTICLE, AND FUNCTION.
RX   PubMed=16107708; DOI=10.1128/mcb.25.17.7616-7624.2005;
RA   Chakravarthy S., Gundimella S.K., Caron C., Perche P.-Y., Pehrson J.R.,
RA   Khochbin S., Luger K.;
RT   "Structural characterization of the histone variant macroH2A.";
RL   Mol. Cell. Biol. 25:7616-7624(2005).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.54 ANGSTROMS) OF 162-372 (ISOFORM 1), X-RAY
RP   CRYSTALLOGRAPHY (2.92 ANGSTROMS) OF 161-372 (ISOFORM 2), AND BINDING TO
RP   ADP-RIBOSE AND O-ACETYL-ADP-RIBOSE (ISOFORM 1).
RX   PubMed=15965484; DOI=10.1038/nsmb956;
RA   Kustatscher G., Hothorn M., Pugieux C., Scheffzek K., Ladurner A.G.;
RT   "Splicing regulates NAD metabolite binding to histone macroH2A.";
RL   Nat. Struct. Mol. Biol. 12:624-625(2005).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.43 ANGSTROMS) OF 172-186 IN COMPLEXES WITH SPOP,
RP   SUBUNIT, AND UBIQUITINATION.
RX   PubMed=19818708; DOI=10.1016/j.molcel.2009.09.022;
RA   Zhuang M., Calabrese M.F., Liu J., Waddell M.B., Nourse A., Hammel M.,
RA   Miller D.J., Walden H., Duda D.M., Seyedin S.N., Hoggard T., Harper J.W.,
RA   White K.P., Schulman B.A.;
RT   "Structures of SPOP-substrate complexes: insights into molecular
RT   architectures of BTB-Cul3 ubiquitin ligases.";
RL   Mol. Cell 36:39-50(2009).
CC   -!- FUNCTION: Variant histone H2A which replaces conventional H2A in a
CC       subset of nucleosomes where it represses transcription
CC       (PubMed:12718888, PubMed:15621527, PubMed:16428466). Nucleosomes wrap
CC       and compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template. Histones thereby
CC       play a central role in transcription regulation, DNA repair, DNA
CC       replication and chromosomal stability. DNA accessibility is regulated
CC       via a complex set of post-translational modifications of histones, also
CC       called histone code, and nucleosome remodeling. Involved in stable X
CC       chromosome inactivation (PubMed:15897469). Inhibits the binding of
CC       transcription factors, including NF-kappa-B, and interferes with the
CC       activity of remodeling SWI/SNF complexes (PubMed:12718888,
CC       PubMed:16428466). Inhibits histone acetylation by EP300 and recruits
CC       class I HDACs, which induces a hypoacetylated state of chromatin
CC       (PubMed:16428466, PubMed:16107708). {ECO:0000269|PubMed:12718888,
CC       ECO:0000269|PubMed:15621527, ECO:0000269|PubMed:15897469,
CC       ECO:0000269|PubMed:16107708, ECO:0000269|PubMed:16428466}.
CC   -!- FUNCTION: [Isoform 1]: Binds ADP-ribose and O-acetyl-ADP-ribose, and
CC       may be involved in ADP-ribose-mediated chromatin modulation
CC       (PubMed:15902274). Increases the expression of genes involved in redox
CC       metabolism, including SOD3 (PubMed:23022728).
CC       {ECO:0000269|PubMed:15902274, ECO:0000269|PubMed:23022728}.
CC   -!- FUNCTION: [Isoform 2]: Represses SOD3 gene expression.
CC       {ECO:0000269|PubMed:23022728}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. Interacts with HDAC1 and HDAC2 (By
CC       similarity). Interacts with SPOP. Part of a complex consisting of
CC       MACROH2A1, CUL3 and SPOP. {ECO:0000250, ECO:0000269|PubMed:15897469,
CC       ECO:0000269|PubMed:16107708, ECO:0000269|PubMed:19818708}.
CC   -!- INTERACTION:
CC       P46100:ATRX; NbExp=2; IntAct=EBI-6249599, EBI-396461;
CC       P04626:ERBB2; NbExp=6; IntAct=EBI-2868511, EBI-641062;
CC       A1L162:ERICH2; NbExp=5; IntAct=EBI-2868511, EBI-2682520;
CC       U3KQK0:HIST1H2BN; NbExp=4; IntAct=EBI-2868511, EBI-12142839;
CC       P61244:MAX; NbExp=2; IntAct=EBI-2868511, EBI-751711;
CC       O95271:TNKS; NbExp=6; IntAct=EBI-6249599, EBI-1105254;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15621527,
CC       ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:9634239}. Chromosome
CC       {ECO:0000269|PubMed:15621527, ECO:0000269|PubMed:15897469,
CC       ECO:0000269|PubMed:9634239}. Note=Enriched in inactive X chromosome
CC       chromatin and in senescence-associated heterochromatin.
CC       {ECO:0000269|PubMed:15621527, ECO:0000269|PubMed:15897469,
CC       ECO:0000269|PubMed:9634239}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=2; Synonyms=mH2A1.2 {ECO:0000303|PubMed:23022728};
CC         IsoId=O75367-1; Sequence=Displayed;
CC       Name=1; Synonyms=mH2A1.1 {ECO:0000303|PubMed:23022728};
CC         IsoId=O75367-2; Sequence=VSP_002056;
CC       Name=3;
CC         IsoId=O75367-3; Sequence=VSP_038379;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9714746}.
CC   -!- PTM: Monoubiquitinated at either Lys-116 or Lys-117. May also be
CC       polyubiquitinated. Ubiquitination is mediated by the CUL3/SPOP E3
CC       complex and does not promote proteasomal degradation. Instead, it is
CC       required for enrichment in inactive X chromosome chromatin.
CC       {ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:16129414,
CC       ECO:0000269|PubMed:19818708}.
CC   -!- MISCELLANEOUS: [Isoform 2]: The preferential expression of isoform 2
CC       over that of isoform 1 requires the presence of DDX5/DDX17.
CC       {ECO:0000269|PubMed:23022728}.
CC   -!- MISCELLANEOUS: [Isoform 1]: Specifically binds ADP-ribose and O-acetyl-
CC       ADP-ribose. Important residues for binding are Asp-203, Gly-224, Gly-
CC       314 and Phe-348. Preferentially expressed over isoform 2 in the absence
CC       of DDX5/DDX17. {ECO:0000269|PubMed:15902274,
CC       ECO:0000269|PubMed:23022728}.
CC   -!- CAUTION: [Isoform 1]: In contrast to other Macro-domain containing
CC       proteins, lacks ADP-ribose glycohydrolase activity.
CC       {ECO:0000269|PubMed:23474714}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF041483; AAC33433.1; -; mRNA.
DR   EMBL; AF044286; AAC33434.1; -; mRNA.
DR   EMBL; AF054174; AAC39908.1; -; mRNA.
DR   EMBL; AK023409; BAB14565.1; -; mRNA.
DR   EMBL; AC026691; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013331; AAH13331.1; -; mRNA.
DR   EMBL; BC095406; AAH95406.1; -; mRNA.
DR   EMBL; AY134746; AAN08620.1; -; mRNA.
DR   CCDS; CCDS4183.1; -. [O75367-3]
DR   CCDS; CCDS4184.1; -. [O75367-2]
DR   CCDS; CCDS4185.1; -. [O75367-1]
DR   RefSeq; NP_001035248.1; NM_001040158.1. [O75367-3]
DR   RefSeq; NP_004884.1; NM_004893.2. [O75367-3]
DR   RefSeq; NP_613075.1; NM_138609.2. [O75367-2]
DR   RefSeq; NP_613258.2; NM_138610.2. [O75367-1]
DR   RefSeq; XP_011542031.1; XM_011543729.2. [O75367-1]
DR   RefSeq; XP_011542032.1; XM_011543730.2. [O75367-3]
DR   PDB; 1U35; X-ray; 3.00 A; C/G=1-120.
DR   PDB; 1ZR3; X-ray; 1.66 A; A/B/C/D=162-372.
DR   PDB; 1ZR5; X-ray; 2.92 A; A/B=161-372.
DR   PDB; 2F8N; X-ray; 2.90 A; G=1-120.
DR   PDB; 2FXK; X-ray; 2.54 A; A/B=162-372.
DR   PDB; 3HQH; X-ray; 2.30 A; M=167-181.
DR   PDB; 3HSV; X-ray; 1.43 A; M=172-186.
DR   PDB; 3IID; X-ray; 1.90 A; A=162-372.
DR   PDB; 3IIF; X-ray; 2.10 A; A/B/C=162-372.
DR   PDB; 3IVB; X-ray; 1.75 A; M=167-181.
DR   PDB; 5IIT; X-ray; 2.13 A; A/B/C/D=181-369.
DR   PDB; 5LNC; X-ray; 3.29 A; A/B=182-369.
DR   PDBsum; 1U35; -.
DR   PDBsum; 1ZR3; -.
DR   PDBsum; 1ZR5; -.
DR   PDBsum; 2F8N; -.
DR   PDBsum; 2FXK; -.
DR   PDBsum; 3HQH; -.
DR   PDBsum; 3HSV; -.
DR   PDBsum; 3IID; -.
DR   PDBsum; 3IIF; -.
DR   PDBsum; 3IVB; -.
DR   PDBsum; 5IIT; -.
DR   PDBsum; 5LNC; -.
DR   SMR; O75367; -.
DR   BioGrid; 114927; 188.
DR   CORUM; O75367; -.
DR   DIP; DIP-44283N; -.
DR   ELM; O75367; -.
DR   IntAct; O75367; 66.
DR   MINT; O75367; -.
DR   STRING; 9606.ENSP00000423563; -.
DR   iPTMnet; O75367; -.
DR   PhosphoSitePlus; O75367; -.
DR   SwissPalm; O75367; -.
DR   BioMuta; H2AFY; -.
DR   SWISS-2DPAGE; O75367; -.
DR   CPTAC; CPTAC-383; -.
DR   CPTAC; CPTAC-384; -.
DR   EPD; O75367; -.
DR   jPOST; O75367; -.
DR   MassIVE; O75367; -.
DR   MaxQB; O75367; -.
DR   PaxDb; O75367; -.
DR   PeptideAtlas; O75367; -.
DR   PRIDE; O75367; -.
DR   ProteomicsDB; 49934; -. [O75367-1]
DR   ProteomicsDB; 49935; -. [O75367-2]
DR   ProteomicsDB; 49936; -. [O75367-3]
DR   TopDownProteomics; O75367-1; -. [O75367-1]
DR   TopDownProteomics; O75367-2; -. [O75367-2]
DR   DNASU; 9555; -.
DR   Ensembl; ENST00000304332; ENSP00000302572; ENSG00000113648. [O75367-3]
DR   Ensembl; ENST00000312469; ENSP00000310169; ENSG00000113648. [O75367-2]
DR   Ensembl; ENST00000510038; ENSP00000424971; ENSG00000113648. [O75367-1]
DR   Ensembl; ENST00000511689; ENSP00000423563; ENSG00000113648. [O75367-1]
DR   GeneID; 9555; -.
DR   KEGG; hsa:9555; -.
DR   UCSC; uc003lam.2; human. [O75367-1]
DR   CTD; 9555; -.
DR   DisGeNET; 9555; -.
DR   GeneCards; MACROH2A1; -.
DR   HGNC; HGNC:4740; MACROH2A1.
DR   HPA; HPA041189; -.
DR   HPA; HPA050962; -.
DR   MIM; 610054; gene.
DR   neXtProt; NX_O75367; -.
DR   OpenTargets; ENSG00000113648; -.
DR   Orphanet; 1275; Brachydactyly-elbow wrist dysplasia syndrome.
DR   PharmGKB; PA29117; -.
DR   eggNOG; ENOG410IV3A; Eukaryota.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; KOG2633; Eukaryota.
DR   eggNOG; COG2110; LUCA.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00940000159541; -.
DR   HOGENOM; CLU_062828_0_0_1; -.
DR   InParanoid; O75367; -.
DR   KO; K11251; -.
DR   OMA; AVIHPTN; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; O75367; -.
DR   TreeFam; TF332276; -.
DR   ChiTaRS; H2AFY; human.
DR   EvolutionaryTrace; O75367; -.
DR   GeneWiki; H2AFY; -.
DR   GenomeRNAi; 9555; -.
DR   Pharos; O75367; Tbio.
DR   PRO; PR:O75367; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; O75367; protein.
DR   Bgee; ENSG00000113648; Expressed in vagina and 235 other tissues.
DR   ExpressionAtlas; O75367; baseline and differential.
DR   Genevisible; O75367; HS.
DR   GO; GO:0001740; C:Barr body; IDA:UniProtKB.
DR   GO; GO:0000793; C:condensed chromosome; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0000228; C:nuclear chromosome; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005721; C:pericentric heterochromatin; IDA:BHF-UCL.
DR   GO; GO:0001739; C:sex chromatin; TAS:BHF-UCL.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0010385; F:double-stranded methylated DNA binding; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IDA:UniProtKB.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0030291; F:protein serine/threonine kinase inhibitor activity; IMP:UniProtKB.
DR   GO; GO:0000182; F:rDNA binding; IDA:UniProtKB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0007549; P:dosage compensation; IDA:MGI.
DR   GO; GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProtKB.
DR   GO; GO:1902750; P:negative regulation of cell cycle G2/M phase transition; IMP:UniProtKB.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; IMP:UniProtKB.
DR   GO; GO:0061086; P:negative regulation of histone H3-K27 methylation; IMP:UniProtKB.
DR   GO; GO:0051572; P:negative regulation of histone H3-K4 methylation; IMP:UniProtKB.
DR   GO; GO:0033128; P:negative regulation of histone phosphorylation; IMP:UniProtKB.
DR   GO; GO:1904815; P:negative regulation of protein localization to chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IMP:UniProtKB.
DR   GO; GO:1902883; P:negative regulation of response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:1901837; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; IMP:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; NAS:UniProtKB.
DR   GO; GO:0045815; P:positive regulation of gene expression, epigenetic; IMP:UniProtKB.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0034184; P:positive regulation of maintenance of mitotic sister chromatid cohesion; IDA:BHF-UCL.
DR   GO; GO:1902884; P:positive regulation of response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0040029; P:regulation of gene expression, epigenetic; IMP:UniProtKB.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; IMP:UniProtKB.
DR   GO; GO:1902882; P:regulation of response to oxidative stress; IMP:UniProtKB.
DR   CDD; cd00074; H2A; 1.
DR   CDD; cd02904; Macro_H2A_like; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR021171; Core_histone_macro-H2A.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR035796; Macro_H2A.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   Pfam; PF01661; Macro; 1.
DR   PIRSF; PIRSF037942; Core_histone_macro-H2A; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00506; A1pp; 1.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS51154; MACRO; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Chromosome; DNA-binding; Isopeptide bond; Methylation; Nucleosome core;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..372
FT                   /note="Core histone macro-H2A.1"
FT                   /id="PRO_0000055318"
FT   DOMAIN          2..117
FT                   /note="Histone H2A"
FT   DOMAIN          184..370
FT                   /note="Macro"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00490"
FT   COMPBIAS        118..162
FT                   /note="Lys-rich"
FT   MOD_RES         18
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000269|PubMed:16210244"
FT   MOD_RES         116
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZQ8"
FT   MOD_RES         123
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000305|PubMed:16210244"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZQ8"
FT   MOD_RES         129
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:16210244"
FT   MOD_RES         170
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         173
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         178
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   CROSSLNK        116
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16129414"
FT   CROSSLNK        117
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:16129414"
FT   CROSSLNK        123
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        167
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        189
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        323
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         159
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12800201,
FT                   ECO:0000303|PubMed:9653160"
FT                   /id="VSP_038379"
FT   VAR_SEQ         198..229
FT                   /note="NLIHSEISNLAGFEVEAIINPTNADIDLKDDL -> QVVQADIASIDSDAVV
FT                   HPTNTDFYIGGEV (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:9714746"
FT                   /id="VSP_002056"
FT   CONFLICT        186
FT                   /note="L -> F (in Ref. 3; BAB14565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        210
FT                   /note="F -> S (in Ref. 3; BAB14565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        225
FT                   /note="L -> P (in Ref. 1; AAC33433)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        291
FT                   /note="E -> G (in Ref. 5; AAH95406)"
FT                   /evidence="ECO:0000305"
FT   HELIX           15..19
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   HELIX           25..35
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   STRAND          36..38
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   STRAND          39..41
FT                   /evidence="ECO:0000244|PDB:1U35"
FT   HELIX           44..70
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   STRAND          74..76
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   HELIX           78..86
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   HELIX           89..94
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   TURN            95..97
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   STRAND          98..100
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   HELIX           111..113
FT                   /evidence="ECO:0000244|PDB:2F8N"
FT   STRAND          174..177
FT                   /evidence="ECO:0000244|PDB:3IVB"
FT   STRAND          185..190
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   STRAND          196..202
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   HELIX           204..209
FT                   /evidence="ECO:0000244|PDB:1ZR5"
FT   STRAND          213..219
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   HELIX           227..252
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   STRAND          260..264
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   STRAND          268..277
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   HELIX           286..303
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   STRAND          307..311
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   STRAND          315..319
FT                   /evidence="ECO:0000244|PDB:2FXK"
FT   HELIX           323..340
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   STRAND          341..343
FT                   /evidence="ECO:0000244|PDB:1ZR5"
FT   STRAND          348..355
FT                   /evidence="ECO:0000244|PDB:1ZR3"
FT   HELIX           356..367
FT                   /evidence="ECO:0000244|PDB:1ZR3"
SQ   SEQUENCE   372 AA;  39617 MW;  37DED989EF7E69DC CRC64;
     MSSRGGKKKS TKTSRSAKAG VIFPVGRMLR YIKKGHPKYR IGVGAPVYMA AVLEYLTAEI
     LELAGNAARD NKKGRVTPRH ILLAVANDEE LNQLLKGVTI ASGGVLPNIH PELLAKKRGS
     KGKLEAIITP PPAKKAKSPS QKKPVSKKAG GKKGARKSKK KQGEVSKAAS ADSTTEGTPA
     DGFTVLSTKS LFLGQKLNLI HSEISNLAGF EVEAIINPTN ADIDLKDDLG NTLEKKGGKE
     FVEAVLELRK KNGPLEVAGA AVSAGHGLPA KFVIHCNSPV WGADKCEELL EKTVKNCLAL
     ADDKKLKSIA FPSIGSGRNG FPKQTAAQLI LKAISSYFVS TMSSSIKTVY FVLFDSESIG
     IYVQEMAKLD AN
//
ID   H2AZ_HUMAN              Reviewed;         128 AA.
AC   P0C0S5; B2RD56; P17317; Q6I9U0;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 147.
DE   RecName: Full=Histone H2A.Z;
DE            Short=H2A/z;
GN   Name=H2AZ1 {ECO:0000312|HGNC:HGNC:4741};
GN   Synonyms=H2AFZ {ECO:0000312|HGNC:HGNC:4741},
GN   H2AZ {ECO:0000312|HGNC:HGNC:4741};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=3344202; DOI=10.1093/nar/16.3.1113;
RA   Hatch C.L., Bonner W.M.;
RT   "Sequence of cDNAs for mammalian H2A.Z, an evolutionarily diverged but
RT   highly conserved basal histone H2A isoprotein species.";
RL   Nucleic Acids Res. 16:1113-1124(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1697587;
RA   Hatch C.L., Bonner W.M.;
RT   "The human histone H2A.Z gene. Sequence and regulation.";
RL   J. Biol. Chem. 265:15211-15218(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Skeletal muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   UBIQUITINATION AT LYS-122.
RX   PubMed=11835281; DOI=10.1002/bies.10038;
RA   Jason L.J.M., Moore S.C., Lewis J.D., Lindsey G., Ausio J.;
RT   "Histone ubiquitination: a tagging tail unfolds?";
RL   Bioessays 24:166-174(2002).
RN   [9]
RP   FUNCTION.
RX   PubMed=15878876; DOI=10.1074/jbc.m501784200;
RA   Farris S.D., Rubio E.D., Moon J.J., Gombert W.M., Nelson B.H., Krumm A.;
RT   "Transcription-induced chromatin remodeling at the c-myc gene involves the
RT   local exchange of histone H2A.Z.";
RL   J. Biol. Chem. 280:25298-25303(2005).
RN   [10]
RP   MASS SPECTROMETRY.
RX   PubMed=16457589; DOI=10.1021/pr050269n;
RA   Boyne M.T. II, Pesavento J.J., Mizzen C.A., Kelleher N.L.;
RT   "Precise characterization of human histones in the H2A gene family by top
RT   down mass spectrometry.";
RL   J. Proteome Res. 5:248-253(2006).
RN   [11]
RP   ACETYLATION AT LYS-5; LYS-8 AND LYS-12, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5 AND LYS-8, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16319397; DOI=10.1074/mcp.m500288-mcp200;
RA   Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
RT   "Characterization of histones H2A and H2B variants and their post-
RT   translational modifications by mass spectrometry.";
RL   Mol. Cell. Proteomics 5:541-552(2006).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8; LYS-12 AND LYS-14, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   INTERACTION WITH FH.
RX   PubMed=26237645; DOI=10.1038/ncb3209;
RA   Jiang Y., Qian X., Shen J., Wang Y., Li X., Liu R., Xia Y., Chen Q.,
RA   Peng G., Lin S.Y., Lu Z.;
RT   "Local generation of fumarate promotes DNA repair through inhibition of
RT   histone H3 demethylation.";
RL   Nat. Cell Biol. 17:1158-1168(2015).
RN   [15]
RP   INTERACTION WITH PWWP2A.
RX   PubMed=28645917; DOI=10.15252/embj.201695757;
RA   Puenzeler S., Link S., Wagner G., Keilhauer E.C., Kronbeck N.,
RA   Spitzer R.M., Leidescher S., Markaki Y., Mentele E., Regnard C.,
RA   Schneider K., Takahashi D., Kusakabe M., Vardabasso C., Zink L.M.,
RA   Straub T., Bernstein E., Harata M., Leonhardt H., Mann M., Rupp R.A.,
RA   Hake S.B.;
RT   "Multivalent binding of PWWP2A to H2A.Z regulates mitosis and neural crest
RT   differentiation.";
RL   EMBO J. 36:2263-2279(2017).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH THE NUCLEOSOME.
RX   PubMed=11101893; DOI=10.1038/81971;
RA   Suto R.K., Clarkson M.J., Tremethick D.J., Luger K.;
RT   "Crystal structure of a nucleosome core particle containing the variant
RT   histone H2A.Z.";
RL   Nat. Struct. Biol. 7:1121-1124(2000).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.48 ANGSTROMS) OF 19-128 IN COMPLEX WITH ANP32E AND
RP   HISTONE H2B, AND INTERACTION WITH ANP32E.
RX   PubMed=24463511; DOI=10.1038/nature12922;
RA   Obri A., Ouararhni K., Papin C., Diebold M.L., Padmanabhan K., Marek M.,
RA   Stoll I., Roy L., Reilly P.T., Mak T.W., Dimitrov S., Romier C.,
RA   Hamiche A.;
RT   "ANP32E is a histone chaperone that removes H2A.Z from chromatin.";
RL   Nature 505:648-653(2014).
RN   [18]
RP   METHYLATION AT LYS-5 AND LYS-8.
RX   PubMed=23324626; DOI=10.4161/epi.23416;
RA   Binda O., Sevilla A., LeRoy G., Lemischka I.R., Garcia B.A., Richard S.;
RT   "SETD6 monomethylates H2AZ on lysine 7 and is required for the maintenance
RT   of embryonic stem cell self-renewal.";
RL   Epigenetics 8:177-183(2013).
RN   [19]
RP   ACETYLATION AT LYS-5; LYS-8; LYS-12 AND LYS-14, AND MUTAGENESIS OF
RP   5-LYS--LYS-14; 5-LYS--LYS-8 AND 12-LYS--LYS-14.
RX   PubMed=31527837; DOI=10.1038/s41589-019-0354-y;
RA   Semer M., Bidon B., Larnicol A., Caliskan G., Catez P., Egly J.M., Coin F.,
RA   Le May N.;
RT   "DNA repair complex licenses acetylation of H2A.Z.1 by KAT2A during
RT   transcription.";
RL   Nat. Chem. Biol. 15:992-1000(2019).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 19-128 IN COMPLEX WITH H2BC11 AND
RP   VPS72, INTERACTION WITH H2BC11 AND VPS72, AND MUTAGENESIS OF THR-83;
RP   GLY-93; ASP-98 AND ILE-101.
RX   PubMed=26974126; DOI=10.1038/nsmb.3189;
RA   Latrick C.M., Marek M., Ouararhni K., Papin C., Stoll I., Ignatyeva M.,
RA   Obri A., Ennifar E., Dimitrov S., Romier C., Hamiche A.;
RT   "Molecular basis and specificity of H2A.Z-H2B recognition and deposition by
RT   the histone chaperone YL1.";
RL   Nat. Struct. Mol. Biol. 23:309-316(2016).
CC   -!- FUNCTION: Variant histone H2A which replaces conventional H2A in a
CC       subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin,
CC       limiting DNA accessibility to the cellular machineries which require
CC       DNA as a template. Histones thereby play a central role in
CC       transcription regulation, DNA repair, DNA replication and chromosomal
CC       stability. DNA accessibility is regulated via a complex set of post-
CC       translational modifications of histones, also called histone code, and
CC       nucleosome remodeling. May be involved in the formation of constitutive
CC       heterochromatin. May be required for chromosome segregation during cell
CC       division. {ECO:0000269|PubMed:15878876}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA. H2A or its variant H2AZ1 forms a heterodimer with H2B. H2AZ1
CC       interacts with INCENP (By similarity). Interacts (via M6 cassette) with
CC       ANP32E; leading to removal of H2A.Z/H2AZ1 from the nucleosome.
CC       Heterodimer H2BC11 and H2AZ1 interacts with VPS72 (via N-terminal
CC       domain) (PubMed:26974126). Interacts with PWWP2A (PubMed:28645917).
CC       Interacts with FH (when phosphorylated by PRKDC) (PubMed:26237645).
CC       {ECO:0000250|UniProtKB:P0C0S6, ECO:0000269|PubMed:11101893,
CC       ECO:0000269|PubMed:24463511, ECO:0000269|PubMed:26237645,
CC       ECO:0000269|PubMed:26974126, ECO:0000269|PubMed:28645917}.
CC   -!- INTERACTION:
CC       Q9GZN1:ACTR6; NbExp=3; IntAct=EBI-1199859, EBI-769329;
CC       P07954:FH; NbExp=5; IntAct=EBI-1199859, EBI-1050358;
CC       O43257:ZNHIT1; NbExp=5; IntAct=EBI-1199859, EBI-347522;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination of Lys-122 gives a specific tag for epigenetic
CC       transcriptional repression. {ECO:0000269|PubMed:11835281}.
CC   -!- PTM: Acetylated on Lys-5, Lys-8, Lys-12 and Lys-14 by KAT2A; KAT2A is
CC       recruited by the XPC complex in absence of DNA damage
CC       (PubMed:31527837). Acetylated on Lys-5, Lys-8 and Lys-12 during
CC       interphase; acetylation disappears at mitosis (By similarity).
CC       {ECO:0000250|UniProtKB:P0C0S6, ECO:0000269|PubMed:31527837}.
CC   -!- PTM: Monomethylated on Lys-5 and Lys-8 by SETD6. SETD6 predominantly
CC       methylates Lys-8, lys-5 being a possible secondary site.
CC       {ECO:0000269|PubMed:23324626}.
CC   -!- PTM: Not phosphorylated. {ECO:0000250|UniProtKB:P0C0S4}.
CC   -!- MASS SPECTROMETRY: Mass=13413.4; Method=Electrospray;
CC       Note=Monoisotopic, not modified.;
CC       Evidence={ECO:0000269|PubMed:16457589};
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X52317; CAA36553.1; -; mRNA.
DR   EMBL; M37583; AAA35984.1; -; mRNA.
DR   EMBL; L10138; AAC61625.1; -; Genomic_DNA.
DR   EMBL; CR457415; CAG33696.1; -; mRNA.
DR   EMBL; AK315413; BAG37803.1; -; mRNA.
DR   EMBL; AC097460; AAY41013.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06118.1; -; Genomic_DNA.
DR   EMBL; BC018002; AAH18002.1; -; mRNA.
DR   EMBL; BC020936; AAH20936.1; -; mRNA.
DR   EMBL; BC103743; AAI03744.1; -; mRNA.
DR   CCDS; CCDS3654.1; -.
DR   PIR; A35881; A35881.
DR   RefSeq; NP_002097.1; NM_002106.3.
DR   PDB; 1F66; X-ray; 2.60 A; C/G=1-128.
DR   PDB; 3WA9; X-ray; 3.07 A; C/G=1-128.
DR   PDB; 4CAY; X-ray; 1.48 A; A=19-128.
DR   PDB; 4NFT; X-ray; 2.61 A; A/B/C/D=16-114.
DR   PDB; 5B31; X-ray; 2.20 A; G=1-128.
DR   PDB; 5B32; X-ray; 2.35 A; G=1-128.
DR   PDB; 5B33; X-ray; 2.92 A; C/G=1-128.
DR   PDB; 5CHL; X-ray; 1.89 A; B=22-113.
DR   PDB; 5FUG; X-ray; 2.70 A; A/D/G/J=19-128.
DR   PDB; 5Z30; X-ray; 2.45 A; C/G=1-128.
DR   PDBsum; 1F66; -.
DR   PDBsum; 3WA9; -.
DR   PDBsum; 4CAY; -.
DR   PDBsum; 4NFT; -.
DR   PDBsum; 5B31; -.
DR   PDBsum; 5B32; -.
DR   PDBsum; 5B33; -.
DR   PDBsum; 5CHL; -.
DR   PDBsum; 5FUG; -.
DR   PDBsum; 5Z30; -.
DR   SMR; P0C0S5; -.
DR   BioGrid; 109269; 162.
DR   CORUM; P0C0S5; -.
DR   DIP; DIP-38593N; -.
DR   IntAct; P0C0S5; 69.
DR   MINT; P0C0S5; -.
DR   STRING; 9606.ENSP00000296417; -.
DR   iPTMnet; P0C0S5; -.
DR   PhosphoSitePlus; P0C0S5; -.
DR   SwissPalm; P0C0S5; -.
DR   BioMuta; H2AFZ; -.
DR   DMDM; 83288408; -.
DR   EPD; P0C0S5; -.
DR   jPOST; P0C0S5; -.
DR   MassIVE; P0C0S5; -.
DR   MaxQB; P0C0S5; -.
DR   PaxDb; P0C0S5; -.
DR   PeptideAtlas; P0C0S5; -.
DR   PRIDE; P0C0S5; -.
DR   ProteomicsDB; 52295; -.
DR   TopDownProteomics; P0C0S5; -.
DR   DNASU; 3015; -.
DR   Ensembl; ENST00000296417; ENSP00000296417; ENSG00000164032.
DR   GeneID; 3015; -.
DR   KEGG; hsa:3015; -.
DR   UCSC; uc003hvo.2; human.
DR   CTD; 3015; -.
DR   DisGeNET; 3015; -.
DR   GeneCards; H2AZ1; -.
DR   HGNC; HGNC:4741; H2AZ1.
DR   HPA; CAB022549; -.
DR   HPA; HPA057236; -.
DR   MIM; 142763; gene.
DR   neXtProt; NX_P0C0S5; -.
DR   OpenTargets; ENSG00000164032; -.
DR   PharmGKB; PA29119; -.
DR   eggNOG; KOG1757; Eukaryota.
DR   eggNOG; COG5262; LUCA.
DR   GeneTree; ENSGT00900000140979; -.
DR   HOGENOM; CLU_062828_2_2_1; -.
DR   InParanoid; P0C0S5; -.
DR   KO; K11251; -.
DR   OMA; HKSLMNK; -.
DR   OrthoDB; 1504122at2759; -.
DR   PhylomeDB; P0C0S5; -.
DR   TreeFam; TF354232; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   SIGNOR; P0C0S5; -.
DR   ChiTaRS; H2AFZ; human.
DR   EvolutionaryTrace; P0C0S5; -.
DR   GeneWiki; H2AFZ; -.
DR   GenomeRNAi; 3015; -.
DR   Pharos; P0C0S5; Tbio.
DR   PRO; PR:P0C0S5; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P0C0S5; protein.
DR   Bgee; ENSG00000164032; Expressed in myometrium and 238 other tissues.
DR   ExpressionAtlas; P0C0S5; baseline and differential.
DR   Genevisible; P0C0S5; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005719; C:nuclear euchromatin; IDA:UniProtKB.
DR   GO; GO:0005720; C:nuclear heterochromatin; IDA:UniProtKB.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IMP:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   CDD; cd00074; H2A; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR032458; Histone_H2A_CS.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00046; HISTONE_H2A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; DNA-binding; Isopeptide bond;
KW   Methylation; Nucleosome core; Nucleus; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..128
FT                   /note="Histone H2A.Z"
FT                   /id="PRO_0000055297"
FT   REGION          1..17
FT                   /note="Required for interaction with INCENP"
FT                   /evidence="ECO:0000250"
FT   REGION          89..100
FT                   /note="M6 cassette"
FT   REGION          93..103
FT                   /note="Required for interaction with INCENP"
FT                   /evidence="ECO:0000250"
FT   REGION          120..128
FT                   /note="Required for interaction with PWWP2A"
FT                   /evidence="ECO:0000269|PubMed:28645917"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:16319397,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:31527837"
FT   MOD_RES         5
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:23324626"
FT   MOD_RES         8
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:16319397,
FT                   ECO:0000244|PubMed:19608861, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:31527837"
FT   MOD_RES         8
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:23324626"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:31527837"
FT   MOD_RES         14
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:31527837"
FT   CROSSLNK        122
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:11835281"
FT   MUTAGEN         5..14
FT                   /note="KAGKDSGKAK->AAGKDSGAAA: Decreased acetylation by
FT                   KAT2A."
FT                   /evidence="ECO:0000269|PubMed:31527837"
FT   MUTAGEN         5..8
FT                   /note="KAGK->AAGA: Decreased acetylation by KAT2A."
FT                   /evidence="ECO:0000269|PubMed:31527837"
FT   MUTAGEN         12..14
FT                   /note="KAK->AAA: Decreased acetylation by KAT2A."
FT                   /evidence="ECO:0000269|PubMed:31527837"
FT   MUTAGEN         83
FT                   /note="T->I: Decreases interaction with VPS72. Almost
FT                   abolishes interaction with VPS72; when associated with N-
FT                   93. Abolishes interaction with VPS72; when associated with
FT                   N-93 and IG-101."
FT                   /evidence="ECO:0000269|PubMed:26974126"
FT   MUTAGEN         93
FT                   /note="G->N: Decreases interaction with VPS72. Almost
FT                   abolishes interaction with VPS72; when associated with I-
FT                   83. Abolishes interaction with VPS72; when associated with
FT                   I-83 and IG-101."
FT                   /evidence="ECO:0000269|PubMed:26974126"
FT   MUTAGEN         98
FT                   /note="D->N: No effect on interaction with VPS72."
FT                   /evidence="ECO:0000269|PubMed:26974126"
FT   MUTAGEN         101
FT                   /note="I->IG: Abolishes interaction with VPS72; when
FT                   associated with I-83 and N-93."
FT                   /evidence="ECO:0000269|PubMed:26974126"
FT   HELIX           20..23
FT                   /evidence="ECO:0000244|PDB:4CAY"
FT   HELIX           30..39
FT                   /evidence="ECO:0000244|PDB:4CAY"
FT   STRAND          40..42
FT                   /evidence="ECO:0000244|PDB:5Z30"
FT   STRAND          43..45
FT                   /evidence="ECO:0000244|PDB:5CHL"
FT   HELIX           49..76
FT                   /evidence="ECO:0000244|PDB:4CAY"
FT   STRAND          80..82
FT                   /evidence="ECO:0000244|PDB:4CAY"
FT   HELIX           84..92
FT                   /evidence="ECO:0000244|PDB:4CAY"
FT   HELIX           95..106
FT                   /evidence="ECO:0000244|PDB:4CAY"
FT   HELIX           116..118
FT                   /evidence="ECO:0000244|PDB:5B31"
SQ   SEQUENCE   128 AA;  13553 MW;  E024E53818230371 CRC64;
     MAGGKAGKDS GKAKTKAVSR SQRAGLQFPV GRIHRHLKSR TTSHGRVGAT AAVYSAAILE
     YLTAEVLELA GNASKDLKVK RITPRHLQLA IRGDEELDSL IKATIAGGGV IPHIHKSLIG
     KKGQQKTV
//
ID   H2B1A_HUMAN             Reviewed;         127 AA.
AC   Q96A08; B2R544; Q6NZ98; Q6NZA0; Q6NZA1;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 153.
DE   RecName: Full=Histone H2B type 1-A;
DE   AltName: Full=Histone H2B, testis {ECO:0000303|PubMed:12213818};
DE            Short=TSH2B.1;
DE            Short=hTSH2B {ECO:0000303|PubMed:12213818};
DE   AltName: Full=Testis-specific histone H2B {ECO:0000303|PubMed:12213818};
GN   Name=H2BC1 {ECO:0000312|HGNC:HGNC:18730};
GN   Synonyms=HIST1H2BA {ECO:0000312|HGNC:HGNC:18730},
GN   TSH2B {ECO:0000303|PubMed:12213818};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=12213818; DOI=10.1074/jbc.m206065200;
RA   Zalensky A.O., Siino J.S., Gineitis A.A., Zalenskaya I.A., Tomilin N.V.,
RA   Yau P., Bradbury E.M.;
RT   "Human testis/sperm-specific histone H2B (hTSH2B). Molecular cloning and
RT   characterization.";
RL   J. Biol. Chem. 277:43474-43480(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   UBIQUITINATION AT LYS-122.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [8]
RP   ACETYLATION AT LYS-7; LYS-14; LYS-17 AND LYS-22.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [9]
RP   UBIQUITINATION AT LYS-122.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [10]
RP   CROTONYLATION AT LYS-7; LYS-13; LYS-14; LYS-17; LYS-18; LYS-22; LYS-25 AND
RP   LYS-36.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [11]
RP   UBIQUITINATION AT LYS-36.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [12]
RP   ACETYLATION AT LYS-87, METHYLATION AT ARG-81; LYS-87; ARG-88 AND ARG-94,
RP   PHOSPHORYLATION AT SER-86, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=21249133; DOI=10.1371/journal.pone.0015960;
RA   Jufvas A., Stralfors P., Vener A.V.;
RT   "Histone variants and their post-translational modifications in primary
RT   human fat cells.";
RL   PLoS ONE 6:E15960-E15960(2011).
CC   -!- FUNCTION: Variant histone specifically required to direct the
CC       transformation of dissociating nucleosomes to protamine in male germ
CC       cells (By similarity). Entirely replaces classical histone H2B prior
CC       nucleosome to protamine transition and probably acts as a nucleosome
CC       dissociating factor that creates a more dynamic chromatin, facilitating
CC       the large-scale exchange of histones (By similarity). Core component of
CC       nucleosome (By similarity). Nucleosomes wrap and compact DNA into
CC       chromatin, limiting DNA accessibility to the cellular machineries which
CC       require DNA as a template (By similarity). Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability (By similarity). DNA accessibility is
CC       regulated via a complex set of post-translational modifications of
CC       histones, also called histone code, and nucleosome remodeling (By
CC       similarity). Also found in fat cells, its function and the presence of
CC       post-translational modifications specific to such cells are still
CC       unclear (PubMed:21249133). {ECO:0000250|UniProtKB:P70696,
CC       ECO:0000269|PubMed:21249133}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. {ECO:0000250|UniProtKB:P70696}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P70696}.
CC       Chromosome {ECO:0000250|UniProtKB:P70696}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in testis, and the corresponding
CC       protein is also present in mature sperm (at protein level). Also found
CC       in some fat cells. {ECO:0000269|PubMed:12213818,
CC       ECO:0000269|PubMed:21249133}.
CC   -!- PTM: Monoubiquitination at Lys-36 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-122
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:16713563}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Acetylated during spermatogenesis. Acetylated form is most
CC       abundant in spermatogonia compared to spermatocytes and round
CC       spermatids (By similarity). {ECO:0000250|UniProtKB:Q00729}.
CC   -!- PTM: Phosphorylated at Thr-117 in spermatogonia, spermatocytes and
CC       round spermatids. {ECO:0000250|UniProtKB:Q00729}.
CC   -!- PTM: Methylated at Lys-118 in spermatogonia, spermatocytes and round
CC       spermatids. {ECO:0000250|UniProtKB:Q00729}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF397301; AAK84040.1; -; Genomic_DNA.
DR   EMBL; AF531284; AAN06684.1; -; Genomic_DNA.
DR   EMBL; AK312055; BAG34991.1; -; mRNA.
DR   EMBL; AL512384; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471087; EAW55490.1; -; Genomic_DNA.
DR   EMBL; BC066238; AAH66238.1; -; mRNA.
DR   EMBL; BC066239; AAH66239.1; -; mRNA.
DR   EMBL; BC066240; AAH66240.1; -; mRNA.
DR   EMBL; BC066241; AAH66241.1; -; mRNA.
DR   EMBL; BC066242; AAH66242.1; -; mRNA.
DR   EMBL; BC066243; AAH66243.1; -; mRNA.
DR   CCDS; CCDS4563.1; -.
DR   RefSeq; NP_733759.1; NM_170610.2.
DR   PDB; 3WKJ; X-ray; 2.80 A; D/H=1-127.
DR   PDB; 5GSU; X-ray; 3.10 A; D/H=2-127.
DR   PDB; 5GT3; X-ray; 2.91 A; D/H=2-127.
DR   PDB; 6BIY; X-ray; 2.05 A; C=70-82.
DR   PDBsum; 3WKJ; -.
DR   PDBsum; 5GSU; -.
DR   PDBsum; 5GT3; -.
DR   PDBsum; 6BIY; -.
DR   SMR; Q96A08; -.
DR   BioGrid; 129111; 103.
DR   IntAct; Q96A08; 82.
DR   MINT; Q96A08; -.
DR   STRING; 9606.ENSP00000274764; -.
DR   iPTMnet; Q96A08; -.
DR   PhosphoSitePlus; Q96A08; -.
DR   SwissPalm; Q96A08; -.
DR   BioMuta; HIST1H2BA; -.
DR   DMDM; 51316070; -.
DR   EPD; Q96A08; -.
DR   jPOST; Q96A08; -.
DR   MassIVE; Q96A08; -.
DR   MaxQB; Q96A08; -.
DR   PaxDb; Q96A08; -.
DR   PeptideAtlas; Q96A08; -.
DR   PRIDE; Q96A08; -.
DR   ProteomicsDB; 75889; -.
DR   TopDownProteomics; Q96A08; -.
DR   Ensembl; ENST00000274764; ENSP00000274764; ENSG00000146047.
DR   GeneID; 255626; -.
DR   KEGG; hsa:255626; -.
DR   UCSC; uc003nfd.4; human.
DR   CTD; 255626; -.
DR   DisGeNET; 255626; -.
DR   GeneCards; H2BC1; -.
DR   HGNC; HGNC:18730; H2BC1.
DR   HPA; CAB011603; -.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   MIM; 609904; gene.
DR   neXtProt; NX_Q96A08; -.
DR   OpenTargets; ENSG00000146047; -.
DR   PharmGKB; PA134937673; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00980000198546; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; Q96A08; -.
DR   KO; K11252; -.
DR   OMA; THKSGIS; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; Q96A08; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   GeneWiki; HIST1H2BA; -.
DR   GenomeRNAi; 255626; -.
DR   Pharos; Q96A08; Tbio.
DR   PRO; PR:Q96A08; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q96A08; protein.
DR   Bgee; ENSG00000146047; Expressed in right testis and 18 other tissues.
DR   Genevisible; Q96A08; HS.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; IEA:Ensembl.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0000788; C:nuclear nucleosome; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0042393; F:histone binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0071674; P:mononuclear cell migration; IEA:Ensembl.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006337; P:nucleosome disassembly; ISS:UniProtKB.
DR   GO; GO:0031639; P:plasminogen activation; IEA:Ensembl.
DR   GO; GO:0051099; P:positive regulation of binding; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0035093; P:spermatogenesis, exchange of chromosomal proteins; ISS:UniProtKB.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; DNA-binding; Isopeptide bond;
KW   Methylation; Nucleosome core; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..127
FT                   /note="Histone H2B type 1-A"
FT                   /id="PRO_0000071842"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         7
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         7
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         14
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         14
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         18
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         18
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         22
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         22
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         25
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         36
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         36
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         38
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         48
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         59
FT                   /note="N6,N6-dimethyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         81
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000269|PubMed:21249133"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21249133"
FT   MOD_RES         87
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21249133"
FT   MOD_RES         87
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21249133"
FT   MOD_RES         88
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000269|PubMed:21249133"
FT   MOD_RES         94
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000269|PubMed:21249133"
FT   MOD_RES         110
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         117
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         118
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         118
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         122
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   CROSSLNK        7
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        36
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   CROSSLNK        122
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16713563"
FT   CONFLICT        2
FT                   /note="P -> A (in Ref. 6; AAH66243)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        22
FT                   /note="K -> E (in Ref. 6; AAH66241)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80
FT                   /note="S -> P (in Ref. 6; AAH66240)"
FT                   /evidence="ECO:0000305"
FT   HELIX           40..50
FT                   /evidence="ECO:0000244|PDB:3WKJ"
FT   HELIX           58..85
FT                   /evidence="ECO:0000244|PDB:3WKJ"
FT   STRAND          89..91
FT                   /evidence="ECO:0000244|PDB:3WKJ"
FT   HELIX           93..103
FT                   /evidence="ECO:0000244|PDB:3WKJ"
FT   HELIX           108..124
FT                   /evidence="ECO:0000244|PDB:3WKJ"
SQ   SEQUENCE   127 AA;  14167 MW;  3EE4124DA9B3C3E8 CRC64;
     MPEVSSKGAT ISKKGFKKAV VKTQKKEGKK RKRTRKESYS IYIYKVLKQV HPDTGISSKA
     MSIMNSFVTD IFERIASEAS RLAHYSKRST ISSREIQTAV RLLLPGELAK HAVSEGTKAV
     TKYTSSK
//
ID   H2B1B_HUMAN             Reviewed;         126 AA.
AC   P33778; Q4KN36;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 189.
DE   RecName: Full=Histone H2B type 1-B;
DE   AltName: Full=Histone H2B.1;
DE   AltName: Full=Histone H2B.f;
DE            Short=H2B/f;
GN   Name=HIST1H2BB; Synonyms=H2BFF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-f;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY, METHYLATION, AND PHOSPHORYLATION.
RX   PubMed=11709551; DOI=10.1074/jbc.m107894200;
RA   Galasinski S.C., Louie D.F., Gloor K.K., Resing K.A., Ahn N.G.;
RT   "Global regulation of post-translational modifications on core histones.";
RL   J. Biol. Chem. 277:2579-2588(2002).
RN   [5]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [6]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [7]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [8]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13; LYS-16; LYS-17; LYS-21 AND
RP   LYS-24, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [11]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [12]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [13]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [14]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [15]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [16]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [17]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:11709551}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:11709551,
CC       ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57127; CAA40406.1; -; Genomic_DNA.
DR   EMBL; AF531285; AAN06685.1; -; Genomic_DNA.
DR   EMBL; BC096728; AAH96728.1; -; mRNA.
DR   CCDS; CCDS4575.1; -.
DR   PIR; I37445; I37445.
DR   RefSeq; NP_066406.1; NM_021062.2.
DR   PDB; 3X1S; X-ray; 2.81 A; D/H=2-126.
DR   PDB; 3X1U; X-ray; 3.25 A; D/H=3-126.
DR   PDBsum; 3X1S; -.
DR   PDBsum; 3X1U; -.
DR   SMR; P33778; -.
DR   BioGrid; 109271; 313.
DR   CORUM; P33778; -.
DR   DIP; DIP-47505N; -.
DR   IntAct; P33778; 15.
DR   MINT; P33778; -.
DR   STRING; 9606.ENSP00000482674; -.
DR   iPTMnet; P33778; -.
DR   PhosphoSitePlus; P33778; -.
DR   SwissPalm; P33778; -.
DR   BioMuta; HIST1H2BB; -.
DR   DMDM; 462236; -.
DR   jPOST; P33778; -.
DR   MassIVE; P33778; -.
DR   MaxQB; P33778; -.
DR   PaxDb; P33778; -.
DR   PeptideAtlas; P33778; -.
DR   PRIDE; P33778; -.
DR   ProteomicsDB; 54927; -.
DR   TopDownProteomics; P33778; -.
DR   DNASU; 3018; -.
DR   Ensembl; ENST00000615966; ENSP00000482674; ENSG00000276410.
DR   GeneID; 3018; -.
DR   KEGG; hsa:3018; -.
DR   UCSC; uc003nfu.4; human.
DR   CTD; 3018; -.
DR   DisGeNET; 3018; -.
DR   GeneCards; H2BC3; -.
DR   HGNC; HGNC:4751; HIST1H2BB.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 602803; gene.
DR   neXtProt; NX_P33778; -.
DR   OpenTargets; ENSG00000276410; -.
DR   PharmGKB; PA29126; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00980000198570; -.
DR   InParanoid; P33778; -.
DR   KO; K11252; -.
DR   OMA; MATHRRP; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; P33778; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   SIGNOR; P33778; -.
DR   ChiTaRS; HIST1H2BB; human.
DR   GeneWiki; HIST1H2BB; -.
DR   GenomeRNAi; 3018; -.
DR   Pharos; P33778; Tbio.
DR   PRO; PR:P33778; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P33778; protein.
DR   Bgee; ENSG00000276410; Expressed in lung and 67 other tissues.
DR   Genevisible; P33778; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; DNA-binding; Glycoprotein;
KW   Hydroxylation; Isopeptide bond; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 1-B"
FT                   /id="PRO_0000071832"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16713563"
FT   HELIX           39..49
FT                   /evidence="ECO:0000244|PDB:3X1S"
FT   HELIX           57..84
FT                   /evidence="ECO:0000244|PDB:3X1S"
FT   STRAND          88..90
FT                   /evidence="ECO:0000244|PDB:3X1U"
FT   HELIX           92..102
FT                   /evidence="ECO:0000244|PDB:3X1S"
FT   HELIX           105..123
FT                   /evidence="ECO:0000244|PDB:3X1S"
SQ   SEQUENCE   126 AA;  13950 MW;  D2D6B95A9A344EF7 CRC64;
     MPEPSKSAPA PKKGSKKAIT KAQKKDGKKR KRSRKESYSI YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2B1D_HUMAN             Reviewed;         126 AA.
AC   P58876;
DT   20-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 171.
DE   RecName: Full=Histone H2B type 1-D;
DE   AltName: Full=HIRA-interacting protein 2;
DE   AltName: Full=Histone H2B.1 B;
DE   AltName: Full=Histone H2B.b;
DE            Short=H2B/b;
GN   Name=HIST1H2BD; Synonyms=H2BFB, HIRIP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH HIRA.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9710638; DOI=10.1128/mcb.18.9.5546;
RA   Lorain S., Quivy J.-P., Monier-Gavelle F., Scamps C., Lecluse Y.,
RA   Almouzni G., Lipinski M.;
RT   "Core histones and HIRIP3, a novel histone-binding protein, directly
RT   interact with WD repeat protein HIRA.";
RL   Mol. Cell. Biol. 18:5546-5556(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-f;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16;
RP   LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,
RP   UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [7]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [8]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [9]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [10]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16457587; DOI=10.1021/pr050268v;
RA   Siuti N., Roth M.J., Mizzen C.A., Kelleher N.L., Pesavento J.J.;
RT   "Gene-specific characterization of human histone H2B by electron capture
RT   dissociation.";
RL   J. Proteome Res. 5:233-239(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16319397; DOI=10.1074/mcp.m500288-mcp200;
RA   Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
RT   "Characterization of histones H2A and H2B variants and their post-
RT   translational modifications by mass spectrometry.";
RL   Mol. Cell. Proteomics 5:541-552(2006).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [15]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [16]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [19]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [21]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [22]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [23]
RP   ADP-RIBOSYLATION AT SER-7.
RX   PubMed=27723750; DOI=10.1038/nchembio.2180;
RA   Leidecker O., Bonfiglio J.J., Colby T., Zhang Q., Atanassov I., Zaja R.,
RA   Palazzo L., Stockum A., Ahel I., Matic I.;
RT   "Serine is a new target residue for endogenous ADP-ribosylation on
RT   histones.";
RL   Nat. Chem. Biol. 12:998-1000(2016).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [25]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- INTERACTION:
CC       P16104:H2AFX; NbExp=2; IntAct=EBI-4409942, EBI-494830;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:16627869}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: ADP-ribosylated on Ser-7 in response to DNA damage.
CC       {ECO:0000269|PubMed:27723750}.
CC   -!- MISCELLANEOUS: The mouse orthologous protein seems not to exist.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ223353; CAA11277.1; -; mRNA.
DR   EMBL; M60751; AAA63190.1; -; Genomic_DNA.
DR   EMBL; AF531287; AAN06687.1; -; Genomic_DNA.
DR   EMBL; AL353759; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002842; AAH02842.1; -; mRNA.
DR   CCDS; CCDS4587.1; -.
DR   PIR; F40335; F40335.
DR   RefSeq; NP_066407.1; NM_021063.3.
DR   RefSeq; NP_619790.1; NM_138720.2.
DR   SMR; P58876; -.
DR   BioGrid; 109270; 40.
DR   IntAct; P58876; 51.
DR   MINT; P58876; -.
DR   STRING; 9606.ENSP00000289316; -.
DR   iPTMnet; P58876; -.
DR   PhosphoSitePlus; P58876; -.
DR   SwissPalm; P58876; -.
DR   BioMuta; HIST1H2BD; -.
DR   DMDM; 21542074; -.
DR   jPOST; P58876; -.
DR   MassIVE; P58876; -.
DR   MaxQB; P58876; -.
DR   PaxDb; P58876; -.
DR   PeptideAtlas; P58876; -.
DR   PRIDE; P58876; -.
DR   ProteomicsDB; 57105; -.
DR   TopDownProteomics; P58876; -.
DR   Ensembl; ENST00000289316; ENSP00000289316; ENSG00000158373.
DR   Ensembl; ENST00000377777; ENSP00000367008; ENSG00000158373.
DR   GeneID; 3017; -.
DR   KEGG; hsa:3017; -.
DR   UCSC; uc003ngr.4; human.
DR   CTD; 3017; -.
DR   DisGeNET; 3017; -.
DR   DisGeNET; 8339; -.
DR   DisGeNET; 8343; -.
DR   DisGeNET; 8344; -.
DR   DisGeNET; 8346; -.
DR   DisGeNET; 8347; -.
DR   GeneCards; H2BC5; -.
DR   HGNC; HGNC:4747; HIST1H2BD.
DR   HPA; CAB062336; -.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 602799; gene.
DR   neXtProt; NX_P58876; -.
DR   OpenTargets; ENSG00000158373; -.
DR   PharmGKB; PA29122; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00970000193364; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; P58876; -.
DR   KO; K11252; -.
DR   OMA; GEANACC; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; P58876; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; HIST1H2BD; human.
DR   GeneWiki; HIST1H2BD; -.
DR   GenomeRNAi; 3017; -.
DR   Pharos; P58876; Tbio.
DR   PRO; PR:P58876; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P58876; protein.
DR   Bgee; ENSG00000158373; Expressed in endocervix and 193 other tissues.
DR   ExpressionAtlas; P58876; baseline and differential.
DR   Genevisible; P58876; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ADP-ribosylation; Chromosome; Direct protein sequencing;
KW   DNA-binding; Glycoprotein; Hydroxylation; Isopeptide bond; Methylation;
KW   Nucleosome core; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 1-D"
FT                   /id="PRO_0000071827"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522, ECO:0000269|PubMed:16627869"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         7
FT                   /note="ADP-ribosylserine"
FT                   /evidence="ECO:0000269|PubMed:27723750"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563"
SQ   SEQUENCE   126 AA;  13936 MW;  FAE8378A44BE7028 CRC64;
     MPEPTKSAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2B1H_HUMAN             Reviewed;         126 AA.
AC   Q93079; B2R541; Q4VB74;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 185.
DE   RecName: Full=Histone H2B type 1-H;
DE   AltName: Full=Histone H2B.j;
DE            Short=H2B/j;
GN   Name=HIST1H2BH; Synonyms=H2BFJ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9119399; DOI=10.1006/geno.1996.4592;
RA   Albig W., Kioschis P., Poustka A., Meergans K., Doenecke D.;
RT   "Human histone gene organization: nonregular arrangement within a large
RT   cluster.";
RL   Genomics 40:314-322(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16;
RP   LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,
RP   UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [7]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [8]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [9]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [10]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16457587; DOI=10.1021/pr050268v;
RA   Siuti N., Roth M.J., Mizzen C.A., Kelleher N.L., Pesavento J.J.;
RT   "Gene-specific characterization of human histone H2B by electron capture
RT   dissociation.";
RL   J. Proteome Res. 5:233-239(2006).
RN   [12]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [13]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [14]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [15]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [16]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [17]
RP   IDENTIFICATION IN A COMPLEX WITH PPAR9; DTX3L AND STAT1, AND
RP   UBIQUITINATION.
RX   PubMed=26479788; DOI=10.1038/ni.3279;
RA   Zhang Y., Mao D., Roswit W.T., Jin X., Patel A.C., Patel D.A., Agapov E.,
RA   Wang Z., Tidwell R.M., Atkinson J.J., Huang G., McCarthy R., Yu J.,
RA   Yun N.E., Paessler S., Lawson T.G., Omattage N.S., Brett T.J.,
RA   Holtzman M.J.;
RT   "PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C
RT   protease to enhance interferon signaling and control viral infection.";
RL   Nat. Immunol. 16:1215-1227(2015).
RN   [18]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [19]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [20]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers (Probable). The octamer wraps approximately
CC       147 bp of DNA (Probable). Found in a complex with PPAR9; DTX3L AND
CC       STAT1; the interaction is likely to induce DTX3L-mediated
CC       ubiquitination of HIST1H2BH/H2BJ (PubMed:26479788).
CC       {ECO:0000269|PubMed:26479788, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons (PubMed:16627869). Monoubiquitinated by DTX3L upon
CC       encephalomyocarditis virus (EMCV)-mediated infection (PubMed:26479788).
CC       {ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:26479788}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z80781; CAB02543.1; -; Genomic_DNA.
DR   EMBL; AF531291; AAN06691.1; -; Genomic_DNA.
DR   EMBL; AK312052; BAG34988.1; -; mRNA.
DR   EMBL; AL031777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471087; EAW55552.1; -; Genomic_DNA.
DR   EMBL; BC096116; AAH96116.1; -; mRNA.
DR   EMBL; BC096117; AAH96117.1; -; mRNA.
DR   EMBL; BC096118; AAH96118.1; -; mRNA.
DR   EMBL; BC096119; AAH96119.1; -; mRNA.
DR   CCDS; CCDS4601.1; -.
DR   RefSeq; NP_003515.1; NM_003524.2.
DR   SMR; Q93079; -.
DR   BioGrid; 113941; 18.
DR   IntAct; Q93079; 283.
DR   STRING; 9606.ENSP00000479169; -.
DR   iPTMnet; Q93079; -.
DR   PhosphoSitePlus; Q93079; -.
DR   SwissPalm; Q93079; -.
DR   BioMuta; HIST1H2BH; -.
DR   DMDM; 7387739; -.
DR   EPD; Q93079; -.
DR   jPOST; Q93079; -.
DR   MassIVE; Q93079; -.
DR   MaxQB; Q93079; -.
DR   PaxDb; Q93079; -.
DR   PeptideAtlas; Q93079; -.
DR   PRIDE; Q93079; -.
DR   ProteomicsDB; 75706; -.
DR   TopDownProteomics; Q93079; -.
DR   Ensembl; ENST00000619466; ENSP00000479169; ENSG00000275713.
DR   GeneID; 8345; -.
DR   KEGG; hsa:8345; -.
DR   UCSC; uc003nhh.4; human.
DR   CTD; 8345; -.
DR   DisGeNET; 8345; -.
DR   GeneCards; H2BC9; -.
DR   HGNC; HGNC:4755; HIST1H2BH.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 602806; gene.
DR   neXtProt; NX_Q93079; -.
DR   OpenTargets; ENSG00000275713; -.
DR   PharmGKB; PA29130; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00970000193364; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; Q93079; -.
DR   KO; K11252; -.
DR   OMA; LPGELAX; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; Q93079; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; HIST1H2BH; human.
DR   GeneWiki; HIST1H2BH; -.
DR   GenomeRNAi; 8345; -.
DR   Pharos; Q93079; Tbio.
DR   PRO; PR:Q93079; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q93079; protein.
DR   Bgee; ENSG00000275713; Expressed in stomach and 133 other tissues.
DR   Genevisible; Q93079; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0097677; F:STAT family protein binding; IPI:UniProtKB.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Direct protein sequencing; DNA-binding;
KW   Glycoprotein; Hydroxylation; Isopeptide bond; Methylation; Nucleosome core;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 1-H"
FT                   /id="PRO_0000071833"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64478"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563"
SQ   SEQUENCE   126 AA;  13892 MW;  FAE0F79FF4BF703D CRC64;
     MPDPAKSAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2B1K_HUMAN             Reviewed;         126 AA.
AC   O60814; A8K7P7; Q2VPI7;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 182.
DE   RecName: Full=Histone H2B type 1-K;
DE            Short=H2B K;
DE   AltName: Full=HIRA-interacting protein 1;
GN   Name=H2BC12 {ECO:0000312|HGNC:HGNC:13954};
GN   Synonyms=H2BFT {ECO:0000312|HGNC:HGNC:13954}, HIRIP1,
GN   HIST1H2BK {ECO:0000312|HGNC:HGNC:13954};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH HIRA.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9710638; DOI=10.1128/mcb.18.9.5546;
RA   Lorain S., Quivy J.-P., Monier-Gavelle F., Scamps C., Lecluse Y.,
RA   Almouzni G., Lipinski M.;
RT   "Core histones and HIRIP3, a novel histone-binding protein, directly
RT   interact with WD repeat protein HIRA.";
RL   Mol. Cell. Biol. 18:5546-5556(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix, Pancreas, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-21, AND FUNCTION.
RX   PubMed=11859126; DOI=10.4049/jimmunol.168.5.2356;
RA   Kim H.S., Cho J.H., Park H.W., Yoon H., Kim M.S., Kim S.C.;
RT   "Endotoxin-neutralizing antimicrobial proteins of the human placenta.";
RL   J. Immunol. 168:2356-2364(2002).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-13.
RX   PubMed=8620898; DOI=10.1111/j.1432-1033.1996.0086n.x;
RA   Frohm M., Gunne H., Bergman A.-C., Agerberth B., Bergman T., Boman A.,
RA   Liden S., Joernvall H., Boman H.G.;
RT   "Biochemical and antibacterial analysis of human wound and blister fluid.";
RL   Eur. J. Biochem. 237:86-92(1996).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-13, AND FUNCTION.
RX   PubMed=12860195; DOI=10.1016/s0196-9781(03)00114-1;
RA   Tollin M., Bergman P., Svenberg T., Joernvall H., Gudmundsson G.H.,
RA   Agerberth B.;
RT   "Antimicrobial peptides in the first line defence of human colon mucosa.";
RL   Peptides 24:523-530(2003).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-13, AND FUNCTION.
RX   PubMed=15019208; DOI=10.1016/j.peptides.2003.07.028;
RA   Howell S.J., Wilk D., Yadav S.P., Bevins C.L.;
RT   "Antimicrobial polypeptides of the human colonic epithelium.";
RL   Peptides 24:1763-1770(2003).
RN   [11]
RP   PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16;
RP   LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,
RP   UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [12]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [13]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [14]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [15]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [16]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=15951514; DOI=10.1093/nar/gki663;
RA   Tsunaka Y., Kajimura N., Tate S., Morikawa K.;
RT   "Alteration of the nucleosomal DNA path in the crystal structure of a human
RT   nucleosome core particle.";
RL   Nucleic Acids Res. 33:3424-3434(2005).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16457587; DOI=10.1021/pr050268v;
RA   Siuti N., Roth M.J., Mizzen C.A., Kelleher N.L., Pesavento J.J.;
RT   "Gene-specific characterization of human histone H2B by electron capture
RT   dissociation.";
RL   J. Proteome Res. 5:233-239(2006).
RN   [19]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [20]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [21]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [22]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [23]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [24]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [25]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- FUNCTION: Has broad antibacterial activity. May contribute to the
CC       formation of the functional antimicrobial barrier of the colonic
CC       epithelium, and to the bactericidal activity of amniotic fluid.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:16627869}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ223352; CAA11276.1; -; mRNA.
DR   EMBL; AF531294; AAN06694.1; -; Genomic_DNA.
DR   EMBL; AK292062; BAF84751.1; -; mRNA.
DR   EMBL; AL021807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03084.1; -; Genomic_DNA.
DR   EMBL; BC000893; AAH00893.1; -; mRNA.
DR   EMBL; BC051872; AAH51872.1; -; mRNA.
DR   EMBL; BC064959; AAH64959.1; -; mRNA.
DR   EMBL; BC108737; AAI08738.1; -; mRNA.
DR   CCDS; CCDS4621.1; -.
DR   PIR; S65409; S65409.
DR   RefSeq; NP_001299582.1; NM_001312653.1.
DR   RefSeq; NP_542160.1; NM_080593.2.
DR   PDB; 2CV5; X-ray; 2.50 A; D/H=1-126.
DR   PDBsum; 2CV5; -.
DR   SMR; O60814; -.
DR   BioGrid; 124439; 39.
DR   DIP; DIP-48935N; -.
DR   IntAct; O60814; 20.
DR   MINT; O60814; -.
DR   STRING; 9606.ENSP00000349430; -.
DR   iPTMnet; O60814; -.
DR   PhosphoSitePlus; O60814; -.
DR   SwissPalm; O60814; -.
DR   BioMuta; HIST1H2BK; -.
DR   EPD; O60814; -.
DR   jPOST; O60814; -.
DR   MassIVE; O60814; -.
DR   MaxQB; O60814; -.
DR   PaxDb; O60814; -.
DR   PeptideAtlas; O60814; -.
DR   PRIDE; O60814; -.
DR   ProteomicsDB; 49607; -.
DR   TopDownProteomics; O60814; -.
DR   DNASU; 85236; -.
DR   Ensembl; ENST00000356950; ENSP00000349430; ENSG00000197903.
DR   GeneID; 85236; -.
DR   KEGG; hsa:85236; -.
DR   UCSC; uc063mja.1; human.
DR   CTD; 85236; -.
DR   DisGeNET; 85236; -.
DR   GeneCards; H2BC12; -.
DR   HGNC; HGNC:13954; H2BC12.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 615045; gene.
DR   neXtProt; NX_O60814; -.
DR   OpenTargets; ENSG00000197903; -.
DR   PharmGKB; PA134955134; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00980000198570; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; O60814; -.
DR   KO; K11252; -.
DR   OMA; FIYNTHS; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; O60814; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; HIST1H2BK; human.
DR   EvolutionaryTrace; O60814; -.
DR   GeneWiki; HIST1H2BK; -.
DR   GenomeRNAi; 85236; -.
DR   Pharos; O60814; Tbio.
DR   PRO; PR:O60814; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; O60814; protein.
DR   Bgee; ENSG00000197903; Expressed in stomach and 90 other tissues.
DR   ExpressionAtlas; O60814; baseline and differential.
DR   Genevisible; O60814; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IDA:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0002227; P:innate immune response in mucosa; IDA:UniProtKB.
DR   GO; GO:0031640; P:killing of cells of other organism; IDA:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antibiotic; Antimicrobial; Chromosome;
KW   Direct protein sequencing; DNA-binding; Glycoprotein; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527,
FT                   ECO:0000269|PubMed:11859126, ECO:0000269|PubMed:12860195,
FT                   ECO:0000269|PubMed:15019208, ECO:0000269|PubMed:8620898"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 1-K"
FT                   /id="PRO_0000071828"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGP1"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563"
FT   HELIX           39..49
FT                   /evidence="ECO:0000244|PDB:2CV5"
FT   HELIX           57..84
FT                   /evidence="ECO:0000244|PDB:2CV5"
FT   STRAND          88..90
FT                   /evidence="ECO:0000244|PDB:2CV5"
FT   HELIX           92..102
FT                   /evidence="ECO:0000244|PDB:2CV5"
FT   HELIX           105..123
FT                   /evidence="ECO:0000244|PDB:2CV5"
SQ   SEQUENCE   126 AA;  13890 MW;  FAF9279F44BE703D CRC64;
     MPEPAKSAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSAK
//
ID   H2B1L_HUMAN             Reviewed;         126 AA.
AC   Q99880; B2R5A3; Q52LW9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 190.
DE   RecName: Full=Histone H2B type 1-L;
DE   AltName: Full=Histone H2B.c;
DE            Short=H2B/c;
GN   Name=H2BC13 {ECO:0000312|HGNC:HGNC:4748};
GN   Synonyms=H2BFC {ECO:0000312|HGNC:HGNC:4748},
GN   HIST1H2BL {ECO:0000312|HGNC:HGNC:4748};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16;
RP   LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,
RP   UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [7]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [8]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [9]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [10]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16319397; DOI=10.1074/mcp.m500288-mcp200;
RA   Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
RT   "Characterization of histones H2A and H2B variants and their post-
RT   translational modifications by mass spectrometry.";
RL   Mol. Cell. Proteomics 5:541-552(2006).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [14]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [15]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [18]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [19]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [20]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [21]
RP   ADP-RIBOSYLATION AT SER-7.
RX   PubMed=27723750; DOI=10.1038/nchembio.2180;
RA   Leidecker O., Bonfiglio J.J., Colby T., Zhang Q., Atanassov I., Zaja R.,
RA   Palazzo L., Stockum A., Ahel I., Matic I.;
RT   "Serine is a new target residue for endogenous ADP-ribosylation on
RT   histones.";
RL   Nat. Chem. Biol. 12:998-1000(2016).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [23]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:16627869}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: ADP-ribosylated on Ser-7 in response to DNA damage.
CC       {ECO:0000269|PubMed:27723750}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z83740; CAB06035.1; -; Genomic_DNA.
DR   EMBL; AF531295; AAN06695.1; -; Genomic_DNA.
DR   EMBL; AK312114; BAG35050.1; -; mRNA.
DR   EMBL; AL009179; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC093759; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC093761; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS4625.1; -.
DR   RefSeq; NP_003510.1; NM_003519.3.
DR   SMR; Q99880; -.
DR   BioGrid; 113936; 37.
DR   DIP; DIP-38154N; -.
DR   IntAct; Q99880; 41.
DR   MINT; Q99880; -.
DR   STRING; 9606.ENSP00000366618; -.
DR   iPTMnet; Q99880; -.
DR   PhosphoSitePlus; Q99880; -.
DR   SwissPalm; Q99880; -.
DR   BioMuta; HIST1H2BL; -.
DR   DMDM; 7387743; -.
DR   SWISS-2DPAGE; P99060; -.
DR   EPD; Q99880; -.
DR   jPOST; Q99880; -.
DR   MassIVE; Q99880; -.
DR   MaxQB; Q99880; -.
DR   PaxDb; Q99880; -.
DR   PeptideAtlas; Q99880; -.
DR   PRIDE; Q99880; -.
DR   ProteomicsDB; 78517; -.
DR   TopDownProteomics; Q99880; -.
DR   DNASU; 8340; -.
DR   Ensembl; ENST00000377401; ENSP00000366618; ENSG00000185130.
DR   GeneID; 8340; -.
DR   KEGG; hsa:8340; -.
DR   UCSC; uc003njl.4; human.
DR   CTD; 8340; -.
DR   GeneCards; H2BC13; -.
DR   HGNC; HGNC:4748; H2BC13.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 602800; gene.
DR   neXtProt; NX_Q99880; -.
DR   OpenTargets; ENSG00000185130; -.
DR   PharmGKB; PA29123; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00970000193364; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; Q99880; -.
DR   KO; K11252; -.
DR   OMA; SMTETKT; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; Q99880; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   GeneWiki; HIST1H2BL; -.
DR   GenomeRNAi; 8340; -.
DR   Pharos; Q99880; Tdark.
DR   PRO; PR:Q99880; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q99880; protein.
DR   Bgee; ENSG00000185130; Expressed in stomach and 62 other tissues.
DR   Genevisible; Q99880; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ADP-ribosylation; Chromosome; Direct protein sequencing;
KW   DNA-binding; Glycoprotein; Hydroxylation; Isopeptide bond; Methylation;
KW   Nucleosome core; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 1-L"
FT                   /id="PRO_0000071829"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522, ECO:0000269|PubMed:16627869"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         7
FT                   /note="ADP-ribosylserine"
FT                   /evidence="ECO:0000269|PubMed:27723750"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563"
FT   VARIANT         4
FT                   /note="L -> P (in dbSNP:rs200484)"
FT                   /id="VAR_049313"
SQ   SEQUENCE   126 AA;  13952 MW;  EAA150A983C8B03D CRC64;
     MPELAKSAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIASEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2B1M_HUMAN             Reviewed;         126 AA.
AC   Q99879; Q6NWQ3;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 185.
DE   RecName: Full=Histone H2B type 1-M;
DE   AltName: Full=Histone H2B.e;
DE            Short=H2B/e;
GN   Name=H2BC14 {ECO:0000312|HGNC:HGNC:4750};
GN   Synonyms=H2BFE {ECO:0000312|HGNC:HGNC:4750},
GN   HIST1H2BM {ECO:0000312|HGNC:HGNC:4750};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 59-73, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [6]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [7]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [8]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [9]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16457587; DOI=10.1021/pr050268v;
RA   Siuti N., Roth M.J., Mizzen C.A., Kelleher N.L., Pesavento J.J.;
RT   "Gene-specific characterization of human histone H2B by electron capture
RT   dissociation.";
RL   J. Proteome Res. 5:233-239(2006).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-13; LYS-16; LYS-17; LYS-21
RP   AND LYS-24, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [13]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [14]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [15]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [16]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [17]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [18]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [19]
RP   ADP-RIBOSYLATION AT SER-7.
RX   PubMed=27723750; DOI=10.1038/nchembio.2180;
RA   Leidecker O., Bonfiglio J.J., Colby T., Zhang Q., Atanassov I., Zaja R.,
RA   Palazzo L., Stockum A., Ahel I., Matic I.;
RT   "Serine is a new target residue for endogenous ADP-ribosylation on
RT   histones.";
RL   Nat. Chem. Biol. 12:998-1000(2016).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [21]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] TYR-110.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: ADP-ribosylated on Ser-7 in response to DNA damage.
CC       {ECO:0000269|PubMed:27723750}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z83738; CAB06033.1; -; Genomic_DNA.
DR   EMBL; AF531296; AAN06696.1; -; Genomic_DNA.
DR   EMBL; AL049822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC066244; AAH66244.1; -; mRNA.
DR   EMBL; BC067486; AAH67486.1; -; mRNA.
DR   EMBL; BC067487; AAH67487.1; -; mRNA.
DR   EMBL; BC067488; AAH67488.1; -; mRNA.
DR   EMBL; BC067489; AAH67489.1; -; mRNA.
DR   CCDS; CCDS4629.1; -.
DR   RefSeq; NP_003512.1; NM_003521.2.
DR   SMR; Q99879; -.
DR   BioGrid; 113938; 20.
DR   CORUM; Q99879; -.
DR   IntAct; Q99879; 33.
DR   STRING; 9606.ENSP00000477907; -.
DR   iPTMnet; Q99879; -.
DR   PhosphoSitePlus; Q99879; -.
DR   SwissPalm; Q99879; -.
DR   BioMuta; HIST1H2BM; -.
DR   DMDM; 7387742; -.
DR   EPD; Q99879; -.
DR   jPOST; Q99879; -.
DR   MassIVE; Q99879; -.
DR   MaxQB; Q99879; -.
DR   PaxDb; Q99879; -.
DR   PeptideAtlas; Q99879; -.
DR   PRIDE; Q99879; -.
DR   ProteomicsDB; 78516; -.
DR   TopDownProteomics; Q99879; -.
DR   Ensembl; ENST00000621112; ENSP00000477907; ENSG00000273703.
DR   GeneID; 8342; -.
DR   KEGG; hsa:8342; -.
DR   UCSC; uc003njo.4; human.
DR   CTD; 8342; -.
DR   DisGeNET; 8342; -.
DR   GeneCards; H2BC14; -.
DR   HGNC; HGNC:4750; H2BC14.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 602802; gene.
DR   neXtProt; NX_Q99879; -.
DR   OpenTargets; ENSG00000273703; -.
DR   PharmGKB; PA29125; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00970000193364; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; Q99879; -.
DR   KO; K11252; -.
DR   OMA; HHEMGIS; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; Q99879; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   GeneWiki; HIST1H2BM; -.
DR   GenomeRNAi; 8342; -.
DR   Pharos; Q99879; Tdark.
DR   PRO; PR:Q99879; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q99879; protein.
DR   Bgee; ENSG00000273703; Expressed in stomach and 65 other tissues.
DR   Genevisible; Q99879; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ADP-ribosylation; Chromosome; Direct protein sequencing;
KW   DNA-binding; Glycoprotein; Hydroxylation; Isopeptide bond; Methylation;
KW   Nucleosome core; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 1-M"
FT                   /id="PRO_0000071831"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         7
FT                   /note="ADP-ribosylserine"
FT                   /evidence="ECO:0000269|PubMed:27723750"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P10854"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:P10854"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16713563"
FT   VARIANT         110
FT                   /note="H -> Y (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036205"
FT   CONFLICT        76
FT                   /note="G -> R (in Ref. 4; AAH67487)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   126 AA;  13989 MW;  EB394C60B42C202A CRC64;
     MPEPVKSAPV PKKGSKKAIN KAQKKDGKKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2B1N_HUMAN             Reviewed;         126 AA.
AC   Q99877; B2R5L4; Q494S8; Q96FB7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 185.
DE   RecName: Full=Histone H2B type 1-N;
DE   AltName: Full=Histone H2B.d;
DE            Short=H2B/d;
GN   Name=H2BC15 {ECO:0000312|HGNC:HGNC:4749};
GN   Synonyms=H2BFD {ECO:0000312|HGNC:HGNC:4749},
GN   HIST1H2BN {ECO:0000312|HGNC:HGNC:4749};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16;
RP   LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,
RP   UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [8]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [9]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [10]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [11]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16319397; DOI=10.1074/mcp.m500288-mcp200;
RA   Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
RT   "Characterization of histones H2A and H2B variants and their post-
RT   translational modifications by mass spectrometry.";
RL   Mol. Cell. Proteomics 5:541-552(2006).
RN   [13]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [14]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [15]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [16]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [17]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [18]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [19]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [20]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:16627869}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z83336; CAB05938.1; -; Genomic_DNA.
DR   EMBL; AF531297; AAN06697.1; -; Genomic_DNA.
DR   EMBL; AK312228; BAG35161.1; -; mRNA.
DR   EMBL; Z98744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03114.1; -; Genomic_DNA.
DR   EMBL; BC011372; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC101411; AAI01412.1; -; mRNA.
DR   EMBL; BC101412; AAI01413.1; -; mRNA.
DR   EMBL; BC101413; AAI01414.1; -; mRNA.
DR   CCDS; CCDS4633.1; -.
DR   RefSeq; NP_003511.1; NM_003520.3.
DR   SMR; Q99877; -.
DR   BioGrid; 113937; 25.
DR   IntAct; Q99877; 20.
DR   MINT; Q99877; -.
DR   STRING; 9606.ENSP00000483903; -.
DR   iPTMnet; Q99877; -.
DR   PhosphoSitePlus; Q99877; -.
DR   SwissPalm; Q99877; -.
DR   BioMuta; HIST1H2BN; -.
DR   DMDM; 7387741; -.
DR   jPOST; Q99877; -.
DR   MassIVE; Q99877; -.
DR   MaxQB; Q99877; -.
DR   PaxDb; Q99877; -.
DR   PeptideAtlas; Q99877; -.
DR   PRIDE; Q99877; -.
DR   ProteomicsDB; 78514; -.
DR   TopDownProteomics; Q99877; -.
DR   DNASU; 8341; -.
DR   Ensembl; ENST00000396980; ENSP00000380177; ENSG00000233822.
DR   Ensembl; ENST00000449538; ENSP00000446031; ENSG00000233822.
DR   Ensembl; ENST00000612898; ENSP00000483903; ENSG00000233822.
DR   GeneID; 8341; -.
DR   KEGG; hsa:8341; -.
DR   UCSC; uc003njt.2; human.
DR   CTD; 8341; -.
DR   DisGeNET; 8341; -.
DR   GeneCards; H2BC15; -.
DR   HGNC; HGNC:4749; H2BC15.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 602801; gene.
DR   neXtProt; NX_Q99877; -.
DR   OpenTargets; ENSG00000233822; -.
DR   PharmGKB; PA29124; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00970000193364; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; Q99877; -.
DR   KO; K11252; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; Q99877; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; HIST1H2BN; human.
DR   GeneWiki; HIST1H2BN; -.
DR   GenomeRNAi; 8341; -.
DR   Pharos; Q99877; Tbio.
DR   PRO; PR:Q99877; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q99877; protein.
DR   Bgee; ENSG00000233822; Expressed in stomach and 88 other tissues.
DR   ExpressionAtlas; Q99877; baseline and differential.
DR   Genevisible; Q99877; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Direct protein sequencing; DNA-binding;
KW   Glycoprotein; Hydroxylation; Isopeptide bond; Methylation; Nucleosome core;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 1-N"
FT                   /id="PRO_0000071830"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563"
SQ   SEQUENCE   126 AA;  13922 MW;  FAEB278D44BE702F CRC64;
     MPEPSKSAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2B2C_HUMAN             Reviewed;         193 AA.
AC   Q6DN03; B7Z677;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 109.
DE   RecName: Full=Putative histone H2B type 2-C;
DE   AltName: Full=Histone H2B.t;
DE            Short=H2B/t;
GN   Name=HIST2H2BC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15527963; DOI=10.1016/j.gene.2004.07.036;
RA   Braastad C.D., Hovhannisyan H., van Wijnen A.J., Stein J.L., Stein G.S.;
RT   "Functional characterization of a human histone gene cluster duplication.";
RL   Gene 342:35-40(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [5]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [6]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [7]
RP   SUCCINYLATION AT LYS-35.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [8]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58 AND LYS-86.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [9]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [10]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35 AND LYS-86.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [11]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44 AND LYS-47.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- MISCELLANEOUS: The mouse orthologous protein seems not to exist.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   -!- CAUTION: Could be the product of a pseudogene. In contrast to other H2B
CC       histones, it does not contain the conserved residue in C-terminus that
CC       is the target of monoubiquitination. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY656810; AAT72343.1; -; Genomic_DNA.
DR   EMBL; AY131977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK299891; BAH13163.1; -; mRNA.
DR   SMR; Q6DN03; -.
DR   IntAct; Q6DN03; 27.
DR   MINT; Q6DN03; -.
DR   iPTMnet; Q6DN03; -.
DR   PhosphoSitePlus; Q6DN03; -.
DR   SwissPalm; Q6DN03; -.
DR   BioMuta; HGNC:20516; -.
DR   DMDM; 74709215; -.
DR   EPD; Q6DN03; -.
DR   jPOST; Q6DN03; -.
DR   MassIVE; Q6DN03; -.
DR   MaxQB; Q6DN03; -.
DR   PeptideAtlas; Q6DN03; -.
DR   PRIDE; Q6DN03; -.
DR   ProteomicsDB; 66237; -.
DR   HGNC; HGNC:20516; HIST2H2BC.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   neXtProt; NX_Q6DN03; -.
DR   InParanoid; Q6DN03; -.
DR   Pharos; Q6DN03; Tdark.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; Q6DN03; protein.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   5: Uncertain;
KW   Acetylation; Chromosome; DNA-binding; Hydroxylation; Isopeptide bond;
KW   Methylation; Nucleosome core; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..193
FT                   /note="Putative histone H2B type 2-C"
FT                   /id="PRO_0000244824"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
SQ   SEQUENCE   193 AA;  21472 MW;  1AA494C8A167792B CRC64;
     MPEPAKFAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSI YVYKVLKRVH PDTGIWCKAM
     GIMNSFLNDI FERIAGEASR LAHYNKRSTI TSRRSRRPCA CCCPASWPST PCPRAPRRSP
     STPAPSESLP GPGARSLPPS LPPRVAGCFV SKGSFQGHLT TSVKESFLCC QSQLMFLASR
     LVNFRRAHNT KHR
//
ID   H2B2D_HUMAN             Reviewed;         164 AA.
AC   Q6DRA6;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 104.
DE   RecName: Full=Putative histone H2B type 2-D;
GN   Name=HIST2H2BD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15527963; DOI=10.1016/j.gene.2004.07.036;
RA   Braastad C.D., Hovhannisyan H., van Wijnen A.J., Stein J.L., Stein G.S.;
RT   "Functional characterization of a human histone gene cluster duplication.";
RL   Gene 342:35-40(2004).
RN   [3]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [4]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [5]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [6]
RP   SUCCINYLATION AT LYS-35.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [7]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58 AND LYS-86.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [8]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [9]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35 AND LYS-86.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [10]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44 AND LYS-47.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- MISCELLANEOUS: The mouse orthologous protein seems not to exist.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   -!- CAUTION: Could be the product of a pseudogene. In contrast to other H2B
CC       histones, it does not contain the conserved residue in C-terminus that
CC       is the target of monoubiquitination. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY131978; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY648853; AAT68256.1; -; Genomic_DNA.
DR   SMR; Q6DRA6; -.
DR   iPTMnet; Q6DRA6; -.
DR   PhosphoSitePlus; Q6DRA6; -.
DR   SwissPalm; Q6DRA6; -.
DR   BioMuta; HGNC:20517; -.
DR   DMDM; 74709219; -.
DR   EPD; Q6DRA6; -.
DR   jPOST; Q6DRA6; -.
DR   MassIVE; Q6DRA6; -.
DR   MaxQB; Q6DRA6; -.
DR   PRIDE; Q6DRA6; -.
DR   ProteomicsDB; 66254; -.
DR   DisGeNET; 337874; -.
DR   HGNC; HGNC:20517; HIST2H2BD.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   neXtProt; NX_Q6DRA6; -.
DR   InParanoid; Q6DRA6; -.
DR   Pharos; Q6DRA6; Tdark.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; Q6DRA6; protein.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   5: Uncertain;
KW   Acetylation; Chromosome; DNA-binding; Hydroxylation; Isopeptide bond;
KW   Methylation; Nucleosome core; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..164
FT                   /note="Putative histone H2B type 2-D"
FT                   /id="PRO_0000244825"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
SQ   SEQUENCE   164 AA;  18018 MW;  1361A7840661B6A7 CRC64;
     MPEPAKFAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSI YVYKVLKRVH PDTGIWCKAM
     GIMNSFLNDI FERIAGEASR LAHYNKRSTI TSRRSRRPCA CCCPASWPST PCPRAPRRSP
     STPAPSESLP GPGARSLPPS LPPRVAGCFV SKGSFQGHLT PLVK
//
ID   H2B2E_HUMAN             Reviewed;         126 AA.
AC   Q16778; A3KMC7; A8K110; Q4KMY1; Q5QNX0; Q9UE88;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 195.
DE   RecName: Full=Histone H2B type 2-E;
DE   AltName: Full=Histone H2B-GL105;
DE   AltName: Full=Histone H2B.q;
DE            Short=H2B/q;
GN   Name=HIST2H2BE; Synonyms=H2BFQ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lymphocyte;
RX   PubMed=1469070; DOI=10.1002/jcb.240500406;
RA   Collart D., Romain P.L., Huebner K., Pockwinse S., Pilapil S.,
RA   Cannizzaro L.A., Lian J.B., Croce C.M., Stein J.L., Stein G.S.;
RT   "A human histone H2B.1 variant gene, located on chromosome 1, utilizes
RT   alternative 3' end processing.";
RL   J. Cell. Biochem. 50:374-385(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-21, AND FUNCTION.
RX   PubMed=11859126; DOI=10.4049/jimmunol.168.5.2356;
RA   Kim H.S., Cho J.H., Park H.W., Yoon H., Kim M.S., Kim S.C.;
RT   "Endotoxin-neutralizing antimicrobial proteins of the human placenta.";
RL   J. Immunol. 168:2356-2364(2002).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-13.
RX   PubMed=8620898; DOI=10.1111/j.1432-1033.1996.0086n.x;
RA   Frohm M., Gunne H., Bergman A.-C., Agerberth B., Bergman T., Boman A.,
RA   Liden S., Joernvall H., Boman H.G.;
RT   "Biochemical and antibacterial analysis of human wound and blister fluid.";
RL   Eur. J. Biochem. 237:86-92(1996).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-13, AND FUNCTION.
RX   PubMed=12860195; DOI=10.1016/s0196-9781(03)00114-1;
RA   Tollin M., Bergman P., Svenberg T., Joernvall H., Gudmundsson G.H.,
RA   Agerberth B.;
RT   "Antimicrobial peptides in the first line defence of human colon mucosa.";
RL   Peptides 24:523-530(2003).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-13, AND FUNCTION.
RX   PubMed=15019208; DOI=10.1016/j.peptides.2003.07.028;
RA   Howell S.J., Wilk D., Yadav S.P., Bevins C.L.;
RT   "Antimicrobial polypeptides of the human colonic epithelium.";
RL   Peptides 24:1763-1770(2003).
RN   [12]
RP   PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16;
RP   LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,
RP   UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-126.
RC   TISSUE=Liver;
RX   PubMed=1993178; DOI=10.1021/bi00220a024;
RA   Collart D., Ramsey-Ewing A., Bortell R., Lian J., Stein J., Stein G.;
RT   "Isolation and characterization of a cDNA from a human histone H2B gene
RT   which is reciprocally expressed in relation to replication-dependent H2B
RT   histone genes during HL60 cell differentiation.";
RL   Biochemistry 30:1610-1617(1991).
RN   [14]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [15]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [16]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [17]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16457587; DOI=10.1021/pr050268v;
RA   Siuti N., Roth M.J., Mizzen C.A., Kelleher N.L., Pesavento J.J.;
RT   "Gene-specific characterization of human histone H2B by electron capture
RT   dissociation.";
RL   J. Proteome Res. 5:233-239(2006).
RN   [19]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [20]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [21]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [22]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [23]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [24]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [25]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [26]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- FUNCTION: Has broad antibacterial activity. May contribute to the
CC       formation of the functional antimicrobial barrier of the colonic
CC       epithelium, and to the bactericidal activity of amniotic fluid.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:16627869}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57985; CAA41051.1; -; Genomic_DNA.
DR   EMBL; AY131979; AAN59961.1; -; Genomic_DNA.
DR   EMBL; CR541895; CAG46693.1; -; mRNA.
DR   EMBL; AK289725; BAF82414.1; -; mRNA.
DR   EMBL; AL591493; CAI12568.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53605.1; -; Genomic_DNA.
DR   EMBL; BC005827; AAH05827.1; -; mRNA.
DR   EMBL; BC069193; AAH69193.1; -; mRNA.
DR   EMBL; BC096121; AAH96121.1; -; mRNA.
DR   EMBL; BC098112; AAH98112.1; -; mRNA.
DR   EMBL; BC098289; AAH98289.1; -; mRNA.
DR   EMBL; BC107084; AAI07085.1; -; mRNA.
DR   EMBL; BC107085; AAI07086.1; -; mRNA.
DR   EMBL; M60756; AAA63192.1; -; mRNA.
DR   CCDS; CCDS936.1; -.
DR   PIR; I37467; I37467.
DR   PIR; S65409; S65409.
DR   RefSeq; NP_003519.1; NM_003528.2.
DR   PDB; 4NFT; X-ray; 2.61 A; A/B/C/D=34-126.
DR   PDB; 6A7U; X-ray; 2.60 A; A=1-126.
DR   PDBsum; 4NFT; -.
DR   PDBsum; 6A7U; -.
DR   SMR; Q16778; -.
DR   BioGrid; 113945; 143.
DR   CORUM; Q16778; -.
DR   DIP; DIP-39324N; -.
DR   IntAct; Q16778; 186.
DR   MINT; Q16778; -.
DR   STRING; 9606.ENSP00000358151; -.
DR   iPTMnet; Q16778; -.
DR   PhosphoSitePlus; Q16778; -.
DR   SwissPalm; Q16778; -.
DR   BioMuta; HIST2H2BE; -.
DR   DMDM; 7387736; -.
DR   EPD; Q16778; -.
DR   jPOST; Q16778; -.
DR   MassIVE; Q16778; -.
DR   MaxQB; Q16778; -.
DR   PaxDb; Q16778; -.
DR   PeptideAtlas; Q16778; -.
DR   PRIDE; Q16778; -.
DR   ProteomicsDB; 61067; -.
DR   TopDownProteomics; Q16778; -.
DR   DNASU; 8349; -.
DR   Ensembl; ENST00000369155; ENSP00000358151; ENSG00000184678.
DR   GeneID; 8349; -.
DR   KEGG; hsa:8349; -.
DR   UCSC; uc001etc.4; human.
DR   CTD; 8349; -.
DR   DisGeNET; 8349; -.
DR   GeneCards; H2BC21; -.
DR   HGNC; HGNC:4760; HIST2H2BE.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 601831; gene.
DR   neXtProt; NX_Q16778; -.
DR   OpenTargets; ENSG00000184678; -.
DR   PharmGKB; PA29135; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00980000198570; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; Q16778; -.
DR   KO; K11252; -.
DR   OMA; DIFDRMA; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; Q16778; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; HIST2H2BE; human.
DR   GeneWiki; HIST2H2BE; -.
DR   GenomeRNAi; 8349; -.
DR   Pharos; Q16778; Tbio.
DR   PRO; PR:Q16778; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q16778; protein.
DR   Bgee; ENSG00000184678; Expressed in stomach and 223 other tissues.
DR   Genevisible; Q16778; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0002227; P:innate immune response in mucosa; IDA:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antibiotic; Antimicrobial; Chromosome;
KW   Direct protein sequencing; DNA-binding; Glycoprotein; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527,
FT                   ECO:0000269|PubMed:11859126, ECO:0000269|PubMed:12860195,
FT                   ECO:0000269|PubMed:15019208, ECO:0000269|PubMed:8620898"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 2-E"
FT                   /id="PRO_0000071835"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64524"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563"
FT   CONFLICT        5
FT                   /note="A -> S (in Ref. 7; AAH98112/AAH98289)"
FT                   /evidence="ECO:0000305"
FT   HELIX           39..49
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   HELIX           57..84
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   STRAND          88..90
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   HELIX           92..100
FT                   /evidence="ECO:0000244|PDB:6A7U"
FT   HELIX           107..123
FT                   /evidence="ECO:0000244|PDB:6A7U"
SQ   SEQUENCE   126 AA;  13920 MW;  0410A881ABBE6647 CRC64;
     MPEPAKSAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSI YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2B2F_HUMAN             Reviewed;         126 AA.
AC   Q5QNW6; A8K0U9; B4DLA9;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 140.
DE   RecName: Full=Histone H2B type 2-F;
GN   Name=HIST2H2BF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [5]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [6]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [7]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16319397; DOI=10.1074/mcp.m500288-mcp200;
RA   Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
RT   "Characterization of histones H2A and H2B variants and their post-
RT   translational modifications by mass spectrometry.";
RL   Mol. Cell. Proteomics 5:541-552(2006).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-16; LYS-17 AND LYS-21, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [11]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [12]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [15]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [16]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [17]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-21, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [19]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5QNW6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5QNW6-2; Sequence=VSP_043431;
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK289664; BAF82353.1; -; mRNA.
DR   EMBL; AK296916; BAG59471.1; -; mRNA.
DR   EMBL; AL591493; CAI12558.1; -; Genomic_DNA.
DR   EMBL; BC110793; AAI10794.1; -; mRNA.
DR   CCDS; CCDS30846.1; -. [Q5QNW6-1]
DR   CCDS; CCDS53359.1; -. [Q5QNW6-2]
DR   RefSeq; NP_001019770.1; NM_001024599.4. [Q5QNW6-1]
DR   RefSeq; NP_001154806.1; NM_001161334.1. [Q5QNW6-2]
DR   PDB; 6MUO; EM; 3.60 A; D/H=34-125.
DR   PDB; 6MUP; EM; 3.50 A; D/H=34-125.
DR   PDBsum; 6MUO; -.
DR   PDBsum; 6MUP; -.
DR   SMR; Q5QNW6; -.
DR   BioGrid; 136811; 23.
DR   IntAct; Q5QNW6; 73.
DR   MINT; Q5QNW6; -.
DR   STRING; 9606.ENSP00000445831; -.
DR   iPTMnet; Q5QNW6; -.
DR   PhosphoSitePlus; Q5QNW6; -.
DR   SwissPalm; Q5QNW6; -.
DR   BioMuta; HIST2H2BF; -.
DR   DMDM; 74743113; -.
DR   jPOST; Q5QNW6; -.
DR   MassIVE; Q5QNW6; -.
DR   MaxQB; Q5QNW6; -.
DR   PaxDb; Q5QNW6; -.
DR   PeptideAtlas; Q5QNW6; -.
DR   PRIDE; Q5QNW6; -.
DR   ProteomicsDB; 63624; -. [Q5QNW6-1]
DR   ProteomicsDB; 63625; -. [Q5QNW6-2]
DR   TopDownProteomics; Q5QNW6-1; -. [Q5QNW6-1]
DR   TopDownProteomics; Q5QNW6-2; -. [Q5QNW6-2]
DR   Ensembl; ENST00000369167; ENSP00000358164; ENSG00000203814. [Q5QNW6-1]
DR   Ensembl; ENST00000545683; ENSP00000445831; ENSG00000203814. [Q5QNW6-2]
DR   GeneID; 440689; -.
DR   KEGG; hsa:440689; -.
DR   UCSC; uc001esr.5; human. [Q5QNW6-1]
DR   CTD; 440689; -.
DR   DisGeNET; 440689; -.
DR   GeneCards; H2BC18; -.
DR   HGNC; HGNC:24700; HIST2H2BF.
DR   HPA; CAB007814; -.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   neXtProt; NX_Q5QNW6; -.
DR   OpenTargets; ENSG00000203814; -.
DR   PharmGKB; PA145148722; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00970000193364; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; Q5QNW6; -.
DR   KO; K11252; -.
DR   OMA; RSKENWH; -.
DR   OrthoDB; 866496at2759; -.
DR   PhylomeDB; Q5QNW6; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; HIST2H2BF; human.
DR   GeneWiki; HIST2H2BF; -.
DR   GenomeRNAi; 440689; -.
DR   Pharos; Q5QNW6; Tdark.
DR   PRO; PR:Q5QNW6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5QNW6; protein.
DR   Bgee; ENSG00000203814; Expressed in stomach and 86 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosome; DNA-binding;
KW   Glycoprotein; Hydroxylation; Isopeptide bond; Methylation; Nucleosome core;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 2-F"
FT                   /id="PRO_0000244826"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16283522"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16713563"
FT   VAR_SEQ         126
FT                   /note="K -> KLIGPILWK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043431"
FT   HELIX           39..49
FT                   /evidence="ECO:0000244|PDB:6MUP"
FT   TURN            57..59
FT                   /evidence="ECO:0000244|PDB:6MUP"
FT   HELIX           60..67
FT                   /evidence="ECO:0000244|PDB:6MUP"
FT   HELIX           70..75
FT                   /evidence="ECO:0000244|PDB:6MUP"
FT   HELIX           78..84
FT                   /evidence="ECO:0000244|PDB:6MUP"
FT   HELIX           93..102
FT                   /evidence="ECO:0000244|PDB:6MUP"
FT   HELIX           107..116
FT                   /evidence="ECO:0000244|PDB:6MUP"
FT   TURN            117..122
FT                   /evidence="ECO:0000244|PDB:6MUP"
SQ   SEQUENCE   126 AA;  13920 MW;  E951DF3D7E97C106 CRC64;
     MPDPAKSAPA PKKGSKKAVT KVQKKDGKKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LAHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2B3B_HUMAN             Reviewed;         126 AA.
AC   Q8N257; A4FU05; Q3ZCP6; Q5TA30;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 158.
DE   RecName: Full=Histone H2B type 3-B;
DE   AltName: Full=H2B type 12;
GN   Name=HIST3H2BB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   TISSUE=Tongue;
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16;
RP   LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,
RP   UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [7]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [8]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [9]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [10]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16319397; DOI=10.1074/mcp.m500288-mcp200;
RA   Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J.;
RT   "Characterization of histones H2A and H2B variants and their post-
RT   translational modifications by mass spectrometry.";
RL   Mol. Cell. Proteomics 5:541-552(2006).
RN   [12]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [13]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [14]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [15]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [16]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [17]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [18]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [19]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:16627869}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY131981; AAN59962.1; -; Genomic_DNA.
DR   EMBL; AK091220; BAC03613.1; -; mRNA.
DR   EMBL; AL139288; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471098; EAW69879.1; -; Genomic_DNA.
DR   EMBL; BC100855; AAI00856.1; -; mRNA.
DR   EMBL; BC100856; AAI00857.1; -; mRNA.
DR   EMBL; BC100857; AAI00858.2; -; mRNA.
DR   EMBL; BC100858; AAI00859.1; -; mRNA.
DR   EMBL; BC137467; AAI37468.1; -; mRNA.
DR   EMBL; BC137468; AAI37469.1; -; mRNA.
DR   CCDS; CCDS1574.1; -.
DR   RefSeq; NP_778225.1; NM_175055.2.
DR   PDB; 6BIZ; X-ray; 2.10 A; C=68-82.
DR   PDBsum; 6BIZ; -.
DR   SMR; Q8N257; -.
DR   BioGrid; 126106; 22.
DR   CORUM; Q8N257; -.
DR   IntAct; Q8N257; 4.
DR   STRING; 9606.ENSP00000479284; -.
DR   iPTMnet; Q8N257; -.
DR   PhosphoSitePlus; Q8N257; -.
DR   SwissPalm; Q8N257; -.
DR   BioMuta; HIST3H2BB; -.
DR   DMDM; 51701598; -.
DR   jPOST; Q8N257; -.
DR   MassIVE; Q8N257; -.
DR   MaxQB; Q8N257; -.
DR   PaxDb; Q8N257; -.
DR   PeptideAtlas; Q8N257; -.
DR   PRIDE; Q8N257; -.
DR   ProteomicsDB; 71655; -.
DR   TopDownProteomics; Q8N257; -.
DR   Ensembl; ENST00000620438; ENSP00000479284; ENSG00000196890.
DR   Ensembl; ENST00000647549; ENSP00000496342; ENSG00000285449.
DR   GeneID; 128312; -.
DR   KEGG; hsa:128312; -.
DR   UCSC; uc001hsz.4; human.
DR   CTD; 128312; -.
DR   DisGeNET; 128312; -.
DR   GeneCards; H2BU1; -.
DR   HGNC; HGNC:20514; HIST3H2BB.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   MIM; 615046; gene.
DR   neXtProt; NX_Q8N257; -.
DR   OpenTargets; ENSG00000196890; -.
DR   PharmGKB; PA134875583; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00980000198570; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; Q8N257; -.
DR   KO; K11252; -.
DR   OMA; FERITME; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; Q8N257; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; HIST3H2BB; human.
DR   GeneWiki; HIST3H2BB; -.
DR   GenomeRNAi; 128312; -.
DR   Pharos; Q8N257; Tbio.
DR   PRO; PR:Q8N257; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8N257; protein.
DR   Bgee; ENSG00000196890; Expressed in ectocervix and 71 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Direct protein sequencing;
KW   DNA-binding; Glycoprotein; Hydroxylation; Isopeptide bond; Methylation;
KW   Nucleosome core; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   CHAIN           2..126
FT                   /note="Histone H2B type 3-B"
FT                   /id="PRO_0000071837"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563"
SQ   SEQUENCE   126 AA;  13908 MW;  F1E12FE400DCF25E CRC64;
     MPDPSKSAPA PKKGSKKAVT KAQKKDGKKR KRGRKESYSI YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIASEASR LAHYNKRSTI TSREVQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSSK
//
ID   H2BFM_HUMAN             Reviewed;         154 AA.
AC   P0C1H6; A6NP82;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 2.
DT   26-FEB-2020, entry version 103.
DE   RecName: Full=Histone H2B type F-M;
DE   AltName: Full=Histone H2B.s;
DE            Short=H2B/s;
GN   Name=H2BW2 {ECO:0000312|HGNC:HGNC:27867};
GN   Synonyms=H2BFM {ECO:0000312|HGNC:HGNC:27867};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- MISCELLANEOUS: In contrast to other H2B histones, it does not contain
CC       the conserved residue in C-terminus that is the target of
CC       monoubiquitination.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK093522; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z73497; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS55468.1; -.
DR   RefSeq; NP_001157888.1; NM_001164416.1.
DR   RefSeq; XP_006724703.1; XM_006724640.2.
DR   RefSeq; XP_011529224.1; XM_011530922.2.
DR   SMR; P0C1H6; -.
DR   BioGrid; 130376; 1.
DR   STRING; 9606.ENSP00000347119; -.
DR   PhosphoSitePlus; P0C1H6; -.
DR   BioMuta; H2BFM; -.
DR   DMDM; 110279004; -.
DR   MassIVE; P0C1H6; -.
DR   PaxDb; P0C1H6; -.
DR   PeptideAtlas; P0C1H6; -.
DR   PRIDE; P0C1H6; -.
DR   ProteomicsDB; 52297; -.
DR   Ensembl; ENST00000355016; ENSP00000347119; ENSG00000101812.
DR   Ensembl; ENST00000598335; ENSP00000482611; ENSG00000101812.
DR   GeneID; 286436; -.
DR   KEGG; hsa:286436; -.
DR   CTD; 286436; -.
DR   DisGeNET; 286436; -.
DR   GeneCards; H2BW2; -.
DR   HGNC; HGNC:27867; H2BW2.
DR   neXtProt; NX_P0C1H6; -.
DR   OpenTargets; ENSG00000101812; -.
DR   PharmGKB; PA142671702; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00980000198546; -.
DR   HOGENOM; CLU_075666_3_0_1; -.
DR   InParanoid; P0C1H6; -.
DR   KO; K11252; -.
DR   OMA; HRRHANR; -.
DR   OrthoDB; 1536672at2759; -.
DR   GeneWiki; H2BFM; -.
DR   GenomeRNAi; 286436; -.
DR   Pharos; P0C1H6; Tdark.
DR   PRO; PR:P0C1H6; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P0C1H6; protein.
DR   Bgee; ENSG00000101812; Expressed in testis and 25 other tissues.
DR   ExpressionAtlas; P0C1H6; baseline and differential.
DR   Genevisible; P0C1H6; HS.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   1: Evidence at protein level;
KW   Chromosome; DNA-binding; Nucleosome core; Nucleus; Reference proteome.
FT   CHAIN           1..154
FT                   /note="Histone H2B type F-M"
FT                   /id="PRO_0000244827"
SQ   SEQUENCE   154 AA;  17001 MW;  700C131F5F5818B0 CRC64;
     MAAASAMAEA SSETTSEEGQ SIQEPKEANS TKAQKQKRRG CRGSRRRHAN RRGDSFGDSF
     TPYFPRVLKQ VHQGLSLSQE AVSVMDSMIH DILDRIATEA GQLAHYTKRV TITSRDIQMA
     VRLLLPGKMG KLAEAQGTNA ALRTSLCAIW QQRK
//
ID   H2BFS_HUMAN             Reviewed;         126 AA.
AC   P57053; A0AVF9; Q5R2W0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 175.
DE   RecName: Full=Histone H2B type F-S;
DE   AltName: Full=Histone H2B.s;
DE            Short=H2B/s;
GN   Name=H2BFS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Shimizu N., Kudoh J., Shibuya K.;
RT   "Genomic structure of putative H2B histone family protein gene.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-21, AND FUNCTION.
RX   PubMed=11859126; DOI=10.4049/jimmunol.168.5.2356;
RA   Kim H.S., Cho J.H., Park H.W., Yoon H., Kim M.S., Kim S.C.;
RT   "Endotoxin-neutralizing antimicrobial proteins of the human placenta.";
RL   J. Immunol. 168:2356-2364(2002).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-13.
RX   PubMed=8620898; DOI=10.1111/j.1432-1033.1996.0086n.x;
RA   Frohm M., Gunne H., Bergman A.-C., Agerberth B., Bergman T., Boman A.,
RA   Liden S., Joernvall H., Boman H.G.;
RT   "Biochemical and antibacterial analysis of human wound and blister fluid.";
RL   Eur. J. Biochem. 237:86-92(1996).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-13, AND FUNCTION.
RX   PubMed=12860195; DOI=10.1016/s0196-9781(03)00114-1;
RA   Tollin M., Bergman P., Svenberg T., Joernvall H., Gudmundsson G.H.,
RA   Agerberth B.;
RT   "Antimicrobial peptides in the first line defence of human colon mucosa.";
RL   Peptides 24:523-530(2003).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-13, AND FUNCTION.
RX   PubMed=15019208; DOI=10.1016/j.peptides.2003.07.028;
RA   Howell S.J., Wilk D., Yadav S.P., Bevins C.L.;
RT   "Antimicrobial polypeptides of the human colonic epithelium.";
RL   Peptides 24:1763-1770(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16;
RP   LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,
RP   UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [8]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile
RT   twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [9]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and their
RT   roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [10]
RP   ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
RX   PubMed=16283522; DOI=10.1007/s11010-005-8285-1;
RA   Golebiowski F., Kasprzak K.S.;
RT   "Inhibition of core histones acetylation by carcinogenic nickel(II).";
RL   Mol. Cell. Biochem. 279:133-139(2005).
RN   [11]
RP   UBIQUITINATION AT LYS-121.
RX   PubMed=16713563; DOI=10.1016/j.cell.2006.04.029;
RA   Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.;
RT   "Histone H2B monoubiquitination functions cooperatively with FACT to
RT   regulate elongation by RNA polymerase II.";
RL   Cell 125:703-717(2006).
RN   [12]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND
RP   LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [13]
RP   UBIQUITINATION AT LYS-35.
RX   PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015;
RA   Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.;
RT   "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase
RT   for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.";
RL   Mol. Cell 43:132-144(2011).
RN   [14]
RP   SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [15]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP49.
RX   PubMed=23824326; DOI=10.1101/gad.211037.112;
RA   Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S.,
RA   Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M.,
RA   Giles K.E., Ma L., Wang H.;
RT   "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA
RT   splicing.";
RL   Genes Dev. 27:1581-1595(2013).
RN   [16]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [17]
RP   BUTYRYLATION AT LYS-6 AND LYS-21.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [18]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86;
RP   LYS-117 AND LYS-121.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [19]
RP   GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND
RP   LYS-121.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- FUNCTION: Has broad antibacterial activity. May contribute to the
CC       formation of the functional antimicrobial barrier of the colonic
CC       epithelium, and to the bactericidal activity of amniotic fluid.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is
CC       required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me)
CC       methylation and transcription activation at specific gene loci, such as
CC       HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121
CC       (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with
CC       the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub
CC       also acts as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set of
CC       exons. {ECO:0000269|PubMed:16627869}.
CC   -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress
CC       promotes transcription (By similarity). Phosphorylated on Ser-15
CC       (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic
CC       chromatin condensation. Also phosphorylated on Ser-15 in response to
CC       DNA double strand breaks (DSBs), and in correlation with somatic
CC       hypermutation and immunoglobulin class-switch recombination.
CC       {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}.
CC   -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121.
CC       It fluctuates in response to extracellular glucose, and associates with
CC       transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB041017; BAD74065.1; -; Genomic_DNA.
DR   EMBL; AP001751; BAA95538.1; -; Genomic_DNA.
DR   PIR; S65409; S65409.
DR   RefSeq; XP_006723981.1; XM_006723918.3.
DR   SMR; P57053; -.
DR   BioGrid; 3195446; 4.
DR   IntAct; P57053; 69.
DR   STRING; 9606.ENSP00000481622; -.
DR   iPTMnet; P57053; -.
DR   PhosphoSitePlus; P57053; -.
DR   SwissPalm; P57053; -.
DR   BioMuta; H2BFS; -.
DR   DMDM; 9973351; -.
DR   EPD; P57053; -.
DR   jPOST; P57053; -.
DR   MassIVE; P57053; -.
DR   MaxQB; P57053; -.
DR   PeptideAtlas; P57053; -.
DR   PRIDE; P57053; -.
DR   ProteomicsDB; 56969; -.
DR   TopDownProteomics; P57053; -.
DR   Ensembl; ENST00000599962; ENSP00000481622; ENSG00000234289.
DR   GeneID; 102724334; -.
DR   KEGG; hsa:102724334; -.
DR   UCSC; uc002zdj.2; human.
DR   DisGeNET; 102724334; -.
DR   DisGeNET; 54145; -.
DR   GeneCards; H2BS1; -.
DR   HGNC; HGNC:4762; H2BFS.
DR   HPA; HPA042205; -.
DR   HPA; HPA043013; -.
DR   HPA; HPA048671; -.
DR   neXtProt; NX_P57053; -.
DR   OpenTargets; ENSG00000234289; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00980000198570; -.
DR   HOGENOM; CLU_075666_2_1_1; -.
DR   InParanoid; P57053; -.
DR   OMA; WANMEAQ; -.
DR   OrthoDB; 1536672at2759; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   Pharos; P57053; Tbio.
DR   PRO; PR:P57053; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; P57053; protein.
DR   Bgee; ENSG00000234289; Expressed in blood and 91 other tissues.
DR   Genevisible; P57053; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0002227; P:innate immune response in mucosa; IDA:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Antibiotic; Antimicrobial; Chromosome;
KW   Direct protein sequencing; DNA-binding; Glycoprotein; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P23527,
FT                   ECO:0000269|PubMed:11859126, ECO:0000269|PubMed:12860195,
FT                   ECO:0000269|PubMed:15019208, ECO:0000269|PubMed:8620898"
FT   CHAIN           2..126
FT                   /note="Histone H2B type F-S"
FT                   /id="PRO_0000071838"
FT   MOD_RES         2
FT                   /note="N-acetylproline"
FT                   /evidence="ECO:0000250|UniProtKB:P23527"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         12
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         12
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         12
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         15
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:12757711"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         16
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         17
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         21
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         21
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16283522,
FT                   ECO:0000269|PubMed:16627869"
FT   MOD_RES         21
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         21
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P33778"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         25
FT                   /note="N6-(2-hydroxyisobutyryl)lysine"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         35
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         35
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         35
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         37
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q64475"
FT   MOD_RES         44
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         44
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         47
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         47
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         58
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         86
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         86
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         86
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         87
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96A08"
FT   MOD_RES         109
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         109
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         109
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869"
FT   MOD_RES         116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         117
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         117
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         117
FT                   /note="N6-malonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         117
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00729"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         121
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         121
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         121
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         121
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CARBOHYD        113
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P62807"
FT   CROSSLNK        6
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P58876"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q5QNW6"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:21726816"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:16307923,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563"
SQ   SEQUENCE   126 AA;  13944 MW;  8B1431CB76B9005E CRC64;
     MPEPAKSAPA PKKGSKKAVT KAQKKDGRKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIAGEASR LPHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT
     KYTSAK
//
ID   H2BWT_HUMAN             Reviewed;         175 AA.
AC   Q7Z2G1; B1AK72; Q147W3;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   26-FEB-2020, entry version 122.
DE   RecName: Full=Histone H2B type W-T;
DE   AltName: Full=H2B histone family member W testis-specific;
GN   Name=H2BFWT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, AND VARIANT HIS-123.
RC   TISSUE=Testis;
RX   PubMed=15475252; DOI=10.1016/j.ygeno.2004.06.001;
RA   Churikov D., Siino J., Svetlova M., Zhang K., Gineitis A., Bradbury E.M.,
RA   Zalensky A.;
RT   "Novel human testis-specific histone H2B encoded by the interrupted gene on
RT   the X chromosome.";
RL   Genomics 84:745-756(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-123.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=16449661; DOI=10.1128/mcb.26.4.1518-1526.2006;
RA   Boulard M., Gautier T., Mbele G.O., Gerson V., Hamiche A., Angelov D.,
RA   Bouvet P., Dimitrov S.;
RT   "The NH2 tail of the novel histone variant H2BFWT exhibits properties
RT   distinct from conventional H2B with respect to the assembly of mitotic
RT   chromosomes.";
RL   Mol. Cell. Biol. 26:1518-1526(2006).
CC   -!- FUNCTION: Atypical histone H2B. Nucleosomes containing it are
CC       structurally and dynamically indistinguishable from those containing
CC       conventional H2B. However, unlike conventional H2B, does not recruit
CC       chromosome condensation factors and does not participate in the
CC       assembly of mitotic chromosomes. May be important for telomere
CC       function. {ECO:0000269|PubMed:16449661}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000269|PubMed:15475252}.
CC       Chromosome {ECO:0000269|PubMed:15475252}.
CC   -!- TISSUE SPECIFICITY: Testis-specific. Present in sperm cells (at protein
CC       level). {ECO:0000269|PubMed:15475252}.
CC   -!- MISCELLANEOUS: In contrast to other H2B histones, it does not contain
CC       the conserved residue in C-terminus that is the target of
CC       monoubiquitination.
CC   -!- MISCELLANEOUS: Ortholog in primates, but not in rodents.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY283369; AAP37489.1; -; Genomic_DNA.
DR   EMBL; AY283370; AAP37490.1; -; mRNA.
DR   EMBL; AL034485; CAI43100.2; -; Genomic_DNA.
DR   EMBL; CH471120; EAX02765.1; -; Genomic_DNA.
DR   EMBL; BC038109; AAH38109.1; -; mRNA.
DR   EMBL; BC118604; AAI18605.1; -; mRNA.
DR   EMBL; BC121816; AAI21817.1; -; mRNA.
DR   CCDS; CCDS35362.1; -.
DR   RefSeq; NP_001002916.3; NM_001002916.4.
DR   SMR; Q7Z2G1; -.
DR   BioGrid; 127727; 12.
DR   IntAct; Q7Z2G1; 1.
DR   STRING; 9606.ENSP00000354723; -.
DR   iPTMnet; Q7Z2G1; -.
DR   PhosphoSitePlus; Q7Z2G1; -.
DR   BioMuta; H2BFWT; -.
DR   DMDM; 223590216; -.
DR   PaxDb; Q7Z2G1; -.
DR   PRIDE; Q7Z2G1; -.
DR   ProteomicsDB; 68958; -.
DR   Ensembl; ENST00000217926; ENSP00000354723; ENSG00000123569.
DR   Ensembl; ENST00000611083; ENSP00000482103; ENSG00000123569.
DR   GeneID; 158983; -.
DR   KEGG; hsa:158983; -.
DR   UCSC; uc004elr.4; human.
DR   CTD; 158983; -.
DR   DisGeNET; 158983; -.
DR   GeneCards; H2BW1; -.
DR   HGNC; HGNC:27252; H2BFWT.
DR   HPA; HPA056289; -.
DR   MIM; 300507; gene.
DR   neXtProt; NX_Q7Z2G1; -.
DR   PharmGKB; PA134930988; -.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   HOGENOM; CLU_075666_3_0_1; -.
DR   InParanoid; Q7Z2G1; -.
DR   KO; K11252; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; Q7Z2G1; -.
DR   TreeFam; TF300212; -.
DR   GeneWiki; H2BFWT; -.
DR   GenomeRNAi; 158983; -.
DR   Pharos; Q7Z2G1; Tdark.
DR   PRO; PR:Q7Z2G1; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q7Z2G1; protein.
DR   Bgee; ENSG00000123569; Expressed in testis and 5 other tissues.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   1: Evidence at protein level;
KW   Chromosome; DNA-binding; Membrane; Nucleosome core; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..175
FT                   /note="Histone H2B type W-T"
FT                   /id="PRO_0000244828"
FT   VARIANT         87
FT                   /note="R -> W (in dbSNP:rs17332043)"
FT                   /id="VAR_049315"
FT   VARIANT         123
FT                   /note="R -> H (in dbSNP:rs553509)"
FT                   /evidence="ECO:0000269|PubMed:15475252,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_054318"
SQ   SEQUENCE   175 AA;  19618 MW;  C47C922CBBE96BCC CRC64;
     MLRTEVPRLP RSTTAIVWSC HLMATASAMA GPSSETTSEE QLITQEPKEA NSTTSQKQSK
     QRKRGRHGPR RCHSNCRGDS FATYFRRVLK QVHQGLSLSR EAVSVMDSLV HDILDRIATE
     AGRLARSTKR QTITAWETRM AVRLLLPGQM GKLAESEGTK AVLRTSLYAI QQQRK
//
ID   H31_HUMAN               Reviewed;         136 AA.
AC   P68431; A0PJT7; A5PLR1; P02295; P02296; P16106; Q6ISV8; Q6NWP8; Q6NWP9;
AC   Q6NXU4; Q71DJ3; Q93081;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 180.
DE   RecName: Full=Histone H3.1;
DE   AltName: Full=Histone H3/a;
DE   AltName: Full=Histone H3/b;
DE   AltName: Full=Histone H3/c;
DE   AltName: Full=Histone H3/d;
DE   AltName: Full=Histone H3/f;
DE   AltName: Full=Histone H3/h;
DE   AltName: Full=Histone H3/i;
DE   AltName: Full=Histone H3/j;
DE   AltName: Full=Histone H3/k;
DE   AltName: Full=Histone H3/l;
GN   Name=H3C1 {ECO:0000312|HGNC:HGNC:4766}; Synonyms=H3FA, HIST1H3A;
GN   and
GN   Name=H3C2 {ECO:0000312|HGNC:HGNC:4776}; Synonyms=H3FL, HIST1H3B;
GN   and
GN   Name=H3C3 {ECO:0000312|HGNC:HGNC:4768}; Synonyms=H3FC HIST1H3C;
GN   and
GN   Name=H3C4 {ECO:0000312|HGNC:HGNC:4767}; Synonyms=H3FB, HIST1H3D;
GN   and
GN   Name=H3C6 {ECO:0000312|HGNC:HGNC:4769}; Synonyms=H3FD, HIST1H3E;
GN   and
GN   Name=H3C7 {ECO:0000312|HGNC:HGNC:4773}; Synonyms=H3FI, HIST1H3F;
GN   and
GN   Name=H3C8 {ECO:0000312|HGNC:HGNC:4772}; Synonyms=H3FH, HIST1H3G;
GN   and
GN   Name=H3C10 {ECO:0000312|HGNC:HGNC:4775}; Synonyms=H3FK, HIST1H3H;
GN   and
GN   Name=H3C11 {ECO:0000312|HGNC:HGNC:4771}; Synonyms=H3FF, HIST1H3I;
GN   and
GN   Name=H3C12 {ECO:0000312|HGNC:HGNC:4774}; Synonyms=H3FJ, HIST1H3J;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H3C2).
RX   PubMed=6647026; DOI=10.1093/nar/11.21.7409;
RA   Zhong R., Roeder R.G., Heintz N.;
RT   "The primary structure and expression of four cloned human histone genes.";
RL   Nucleic Acids Res. 11:7409-7425(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3013246; DOI=10.1139/o86-039;
RA   Marashi F., Helms S., Shiels A., Silverstein S., Greenspan D.S., Stein G.,
RA   Stein J.;
RT   "Enhancer-facilitated expression of prokaryotic and eukaryotic genes using
RT   human histone gene 5' regulatory sequences.";
RL   Biochem. Cell Biol. 64:277-289(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H3C6).
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-f;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8227173; DOI=10.1002/jcb.240520402;
RA   Kardalinou E., Eick S., Albig W., Doenecke D.;
RT   "Association of a human H1 histone gene with an H2A pseudogene and genes
RT   encoding H2B.1 and H3.1 histones.";
RL   J. Cell. Biochem. 52:375-383(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RA   Runge D., Eick S., Doenecke D.;
RT   "Expression of human histone h1.1 and the nearby core histones.";
RL   Submitted (OCT-1994) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H3C11).
RX   PubMed=9031620; DOI=10.1016/s0378-1119(96)00582-3;
RA   Albig W., Meergans T., Doenecke D.;
RT   "Characterization of the H1.5 gene completes the set of human H1 subtype
RT   genes.";
RL   Gene 184:141-148(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H3C4; H3C7 AND H3C8).
RX   PubMed=9119399; DOI=10.1006/geno.1996.4592;
RA   Albig W., Kioschis P., Poustka A., Meergans K., Doenecke D.;
RT   "Human histone gene organization: nonregular arrangement within a large
RT   cluster.";
RL   Genomics 40:314-322(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H3C10 AND H3C12).
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H3C1; H3C2; H3C3; H3C4; H3C6; H3C7;
RP   H3C8; H3C10; H3C11; H3C12).
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Caudate nucleus, Stomach, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Spleen;
RX   PubMed=7309716; DOI=10.1093/oxfordjournals.jbchem.a133573;
RA   Ohe Y., Iwai K.;
RT   "Human spleen histone H3. Isolation and amino acid sequence.";
RL   J. Biochem. 90:1205-1211(1981).
RN   [15]
RP   PROTEIN SEQUENCE OF 2-20, METHYLATION AT LYS-10; LYS-28 AND LYS-37,
RP   PHOSPHORYLATION AT THR-4; SER-11 AND SER-29, ACETYLATION AT LYS-10 AND
RP   LYS-15, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16185088; DOI=10.1021/bi050906n;
RA   Garcia B.A., Barber C.M., Hake S.B., Ptak C., Turner F.B., Busby S.A.,
RA   Shabanowitz J., Moran R.G., Allis C.D., Hunt D.F.;
RT   "Modifications of human histone H3 variants during mitosis.";
RL   Biochemistry 44:13202-13213(2005).
RN   [16]
RP   PROTEIN SEQUENCE OF 58-64; 117-120 AND 124-135, AND PHOSPHORYLATION AT
RP   SER-11 AND SER-29.
RX   PubMed=10464286; DOI=10.1074/jbc.274.36.25543;
RA   Goto H., Tomono Y., Ajiro K., Kosako H., Fujita M., Sakurai M., Okawa K.,
RA   Iwamatsu A., Okigaki T., Takahashi T., Inagaki M.;
RT   "Identification of a novel phosphorylation site on histone H3 coupled with
RT   mitotic chromosome condensation.";
RL   J. Biol. Chem. 274:25543-25549(1999).
RN   [17]
RP   METHYLATION AT LYS-10.
RX   PubMed=11242053; DOI=10.1038/35065132;
RA   Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T.;
RT   "Methylation of histone H3 lysine 9 creates a binding site for HP1
RT   proteins.";
RL   Nature 410:116-120(2001).
RN   [18]
RP   PHOSPHORYLATION AT SER-11 AND SER-29.
RX   PubMed=11856369; DOI=10.1046/j.1356-9597.2001.00498.x;
RA   Goto H., Yasui Y., Nigg E.A., Inagaki M.;
RT   "Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic
RT   chromosome condensation.";
RL   Genes Cells 7:11-17(2002).
RN   [19]
RP   PHOSPHORYLATION AT SER-11 AND THR-12.
RX   PubMed=12560483; DOI=10.1093/nar/gkg176;
RA   Preuss U., Landsberg G., Scheidtmann K.H.;
RT   "Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by
RT   Dlk/ZIP kinase.";
RL   Nucleic Acids Res. 31:878-885(2003).
RN   [20]
RP   METHYLATION AT ARG-18.
RX   PubMed=15471871; DOI=10.1074/jbc.m410021200;
RA   Ananthanarayanan M., Li S., Balasubramaniyan N., Suchy F.J., Walsh M.J.;
RT   "Ligand-dependent activation of the farnesoid X-receptor directs arginine
RT   methylation of histone H3 by CARM1.";
RL   J. Biol. Chem. 279:54348-54357(2004).
RN   [21]
RP   METHYLATION AT LYS-80.
RX   PubMed=15525939; DOI=10.1038/nature03114;
RA   Huyen Y., Zgheib O., Ditullio R.A. Jr., Gorgoulis V.G., Zacharatos P.,
RA   Petty T.J., Sheston E.A., Mellert H.S., Stavridi E.S., Halazonetis T.D.;
RT   "Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand
RT   breaks.";
RL   Nature 432:406-411(2004).
RN   [22]
RP   CITRULLINATION AT ARG-9 AND ARG-18, AND METHYLATION AT ARG-18.
RX   PubMed=15345777; DOI=10.1126/science.1101400;
RA   Wang Y., Wysocka J., Sayegh J., Lee Y.-H., Perlin J.R., Leonelli L.,
RA   Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S.,
RA   Stallcup M.R., Allis C.D., Coonrod S.A.;
RT   "Human PAD4 regulates histone arginine methylation levels via
RT   demethylimination.";
RL   Science 306:279-283(2004).
RN   [23]
RP   PHOSPHORYLATION AT THR-4; SER-11 AND SER-29.
RX   PubMed=15681610; DOI=10.1101/gad.1267105;
RA   Dai J., Sultan S., Taylor S.S., Higgins J.M.G.;
RT   "The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation
RT   and normal metaphase chromosome alignment.";
RL   Genes Dev. 19:472-488(2005).
RN   [24]
RP   PHOSPHORYLATION AT SER-29.
RX   PubMed=15684425; DOI=10.1074/jbc.m410521200;
RA   Choi H.S., Choi B.Y., Cho Y.-Y., Zhu F., Bode A.M., Dong Z.;
RT   "Phosphorylation of Ser28 in histone H3 mediated by mixed lineage kinase-
RT   like mitogen-activated protein triple kinase alpha.";
RL   J. Biol. Chem. 280:13545-13553(2005).
RN   [25]
RP   METHYLATION AT LYS-37 AND LYS-38, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15983376; DOI=10.1073/pnas.0503189102;
RA   Coon J.J., Ueberheide B., Syka J.E.P., Dryhurst D.D., Ausio J.,
RA   Shabanowitz J., Hunt D.F.;
RT   "Protein identification using sequential ion/ion reactions and tandem mass
RT   spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:9463-9468(2005).
RN   [26]
RP   ACETYLATION AT LYS-10; LYS-15; LYS-19 AND LYS-24, METHYLATION AT LYS-5;
RP   LYS-10; LYS-19; LYS-28; LYS-37; LYS-65; LYS-80 AND LYS-123, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16267050; DOI=10.1074/jbc.m509266200;
RA   Hake S.B., Garcia B.A., Duncan E.M., Kauer M., Dellaire G., Shabanowitz J.,
RA   Bazett-Jones D.P., Allis C.D., Hunt D.F.;
RT   "Expression patterns and post-translational modifications associated with
RT   mammalian histone H3 variants.";
RL   J. Biol. Chem. 281:559-568(2006).
RN   [27]
RP   METHYLATION AT LYS-5 AND LYS-10, ACETYLATION AT LYS-10; LYS-15 AND LYS-24,
RP   PHOSPHORYLATION AT SER-11 AND SER-29, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16457588; DOI=10.1021/pr050266a;
RA   Thomas C.E., Kelleher N.L., Mizzen C.A.;
RT   "Mass spectrometric characterization of human histone H3: a bird's eye
RT   view.";
RL   J. Proteome Res. 5:240-247(2006).
RN   [28]
RP   UBIQUITINATION.
RX   PubMed=16678110; DOI=10.1016/j.molcel.2006.03.035;
RA   Wang H., Zhai L., Xu J., Joo H.-Y., Jackson S., Erdjument-Bromage H.,
RA   Tempst P., Xiong Y., Zhang Y.;
RT   "Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase
RT   facilitates cellular response to DNA damage.";
RL   Mol. Cell 22:383-394(2006).
RN   [29]
RP   ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28, METHYLATION AT
RP   LYS-28; LYS-37 AND LYS-80, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200;
RA   Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P.,
RA   Grauslund M., Hansen A.M., Jensen O.N.;
RT   "Quantitative proteomic analysis of post-translational modifications of
RT   human histones.";
RL   Mol. Cell. Proteomics 5:1314-1325(2006).
RN   [30]
RP   ACETYLATION AT LYS-10 AND LYS-15, METHYLATION AT ARG-18, AND CITRULLINATION
RP   AT ARG-18.
RX   PubMed=16497732; DOI=10.1210/me.2005-0365;
RA   Miao F., Li S., Chavez V., Lanting L., Natarajan R.;
RT   "Coactivator-associated arginine methyltransferase-1 enhances nuclear
RT   factor-kappaB-mediated gene transcription through methylation of histone H3
RT   at arginine 17.";
RL   Mol. Endocrinol. 20:1562-1573(2006).
RN   [31]
RP   CITRULLINATION AT ARG-3; ARG-9; ARG-18 AND ARG-27.
RX   PubMed=16567635; DOI=10.1073/pnas.0509639103;
RA   Arita K., Shimizu T., Hashimoto H., Hidaka Y., Yamada M., Sato M.;
RT   "Structural basis for histone N-terminal recognition by human
RT   peptidylarginine deiminase 4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5291-5296(2006).
RN   [32]
RP   METHYLATION AT ARG-3 BY PRMT6.
RX   PubMed=18079182; DOI=10.1101/gad.447007;
RA   Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y., Hsieh J.,
RA   Bauer U.M.;
RT   "PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4
RT   trimethylation.";
RL   Genes Dev. 21:3369-3380(2007).
RN   [33]
RP   ACETYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28; LYS-37;
RP   LYS-57 AND LYS-80, METHYLATION AT LYS-5; LYS-10; LYS-19; LYS-24; LYS-28;
RP   LYS-37; LYS-57; LYS-65; LYS-80 AND LYS-123, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17194708; DOI=10.1074/jbc.m607900200;
RA   Garcia B.A., Hake S.B., Diaz R.L., Kauer M., Morris S.A., Recht J.,
RA   Shabanowitz J., Mishra N., Strahl B.D., Allis C.D., Hunt D.F.;
RT   "Organismal differences in post-translational modifications in histones H3
RT   and H4.";
RL   J. Biol. Chem. 282:7641-7655(2007).
RN   [34]
RP   ACETYLATION AT LYS-37.
RX   PubMed=17189264; DOI=10.1074/jbc.m607909200;
RA   Morris S.A., Rao B., Garcia B.A., Hake S.B., Diaz R.L., Shabanowitz J.,
RA   Hunt D.F., Allis C.D., Lieb J.D., Strahl B.D.;
RT   "Identification of histone H3 lysine 36 acetylation as a highly conserved
RT   histone modification.";
RL   J. Biol. Chem. 282:7632-7640(2007).
RN   [35]
RP   METHYLATION AT ARG-3 BY PRMT6.
RX   PubMed=17898714; DOI=10.1038/nature06166;
RA   Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M.,
RA   Schuchlautz H., Luescher B., Amati B.;
RT   "Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are
RT   mutually exclusive.";
RL   Nature 449:933-937(2007).
RN   [36]
RP   PHOSPHORYLATION AT THR-12 BY CHEK1.
RX   PubMed=18243098; DOI=10.1016/j.cell.2007.12.013;
RA   Shimada M., Niida H., Zineldeen D.H., Tagami H., Tanaka M., Saito H.,
RA   Nakanishi M.;
RT   "Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced
RT   transcriptional repression.";
RL   Cell 132:221-232(2008).
RN   [37]
RP   METHYLATION AT ARG-3 BY PRMT6.
RX   PubMed=18077460; DOI=10.1074/jbc.c700192200;
RA   Iberg A.N., Espejo A., Cheng D., Kim D., Michaud-Levesque J., Richard S.,
RA   Bedford M.T.;
RT   "Arginine methylation of the histone H3 tail impedes effector binding.";
RL   J. Biol. Chem. 283:3006-3010(2008).
RN   [38]
RP   PHOSPHORYLATION AT THR-12.
RX   PubMed=18066052; DOI=10.1038/ncb1668;
RA   Metzger E., Yin N., Wissmann M., Kunowska N., Fischer K., Friedrichs N.,
RA   Patnaik D., Higgins J.M., Potier N., Scheidtmann K.H., Buettner R.,
RA   Schule R.;
RT   "Phosphorylation of histone H3 at threonine 11 establishes a novel
RT   chromatin mark for transcriptional regulation.";
RL   Nat. Cell Biol. 10:53-60(2008).
RN   [39]
RP   ACETYLATION AT LYS-116 AND LYS-123.
RX   PubMed=19520870; DOI=10.1074/jbc.m109.003202;
RA   Manohar M., Mooney A.M., North J.A., Nakkula R.J., Picking J.W., Edon A.,
RA   Fishel R., Poirier M.G., Ottesen J.J.;
RT   "Acetylation of histone H3 at the nucleosome dyad alters DNA-histone
RT   binding.";
RL   J. Biol. Chem. 284:23312-23321(2009).
RN   [40]
RP   PHOSPHORYLATION AT TYR-42.
RX   PubMed=19783980; DOI=10.1038/nature08448;
RA   Dawson M.A., Bannister A.J., Gottgens B., Foster S.D., Bartke T.,
RA   Green A.R., Kouzarides T.;
RT   "JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin.";
RL   Nature 461:819-822(2009).
RN   [41]
RP   PHOSPHORYLATION AT SER-58 AND THR-81.
RX   PubMed=20850016; DOI=10.1016/j.cell.2010.08.020;
RA   Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S., Butter F.,
RA   Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G., Mann M.;
RT   "Quantitative interaction proteomics and genome-wide profiling of
RT   epigenetic histone marks and their readers.";
RL   Cell 142:967-980(2010).
RN   [42]
RP   PHOSPHORYLATION AT THR-7.
RX   PubMed=20228790; DOI=10.1038/nature08839;
RA   Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N.,
RA   Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N.,
RA   Beisenherz-Huss C., Gunther T., Buettner R., Schule R.;
RT   "Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at
RT   histone H3K4.";
RL   Nature 464:792-796(2010).
RN   [43]
RP   CROTONYLATION AT LYS-5; LYS-10; LYS-19; LYS-24; LYS-28 AND LYS-57.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [44]
RP   METHYLATION AT LYS-57.
RX   PubMed=22387026; DOI=10.1016/j.molcel.2012.01.019;
RA   Yu Y., Song C., Zhang Q., Dimaggio P.A., Garcia B.A., York A., Carey M.F.,
RA   Grunstein M.;
RT   "Histone H3 lysine 56 methylation regulates DNA replication through its
RT   interaction with PCNA.";
RL   Mol. Cell 46:7-17(2012).
RN   [45]
RP   CAUTION.
RX   PubMed=22483618; DOI=10.1016/j.molcel.2012.03.002;
RA   Herranz N., Dave N., Millanes-Romero A., Morey L., Diaz V.M.,
RA   Lorenz-Fonfria V., Gutierrez-Gallego R., Jeronimo C., Di Croce L.,
RA   Garcia de Herreros A., Peiro S.;
RT   "Lysyl oxidase-like 2 deaminates lysine 4 in histone H3.";
RL   Mol. Cell 46:369-376(2012).
RN   [46]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [47]
RP   RETRACTION.
RX   PubMed=27392148; DOI=10.1016/j.molcel.2016.06.013;
RA   Herranz N., Dave N., Millanes-Romero A., Morey L., Diaz V.M.,
RA   Lorenz-Fonfria V., Gutierrez-Gallego R., Jeronimo C., Di Croce L.,
RA   Garcia de Herreros A., Peiro S.;
RL   Mol. Cell 63:180-180(2016).
RN   [48]
RP   SUCCINYLATION AT LYS-15; LYS-57; LYS-80 AND LYS-123.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [49]
RP   INVOLVEMENT IN GLM, AND VARIANT GLM MET-28.
RX   PubMed=22286216; DOI=10.1038/ng.1102;
RG   St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project;
RA   Wu G., Broniscer A., McEachron T.A., Lu C., Paugh B.S., Becksfort J.,
RA   Qu C., Ding L., Huether R., Parker M., Zhang J., Gajjar A., Dyer M.A.,
RA   Mullighan C.G., Gilbertson R.J., Mardis E.R., Wilson R.K., Downing J.R.,
RA   Ellison D.W., Zhang J., Baker S.J.;
RT   "Somatic histone H3 alterations in pediatric diffuse intrinsic pontine
RT   gliomas and non-brainstem glioblastomas.";
RL   Nat. Genet. 44:251-253(2012).
RN   [50]
RP   ACETYLATION AT LYS-123.
RX   PubMed=23415232; DOI=10.1016/j.cell.2013.01.032;
RA   Tropberger P., Pott S., Keller C., Kamieniarz-Gdula K., Caron M.,
RA   Richter F., Li G., Mittler G., Liu E.T., Buhler M., Margueron R.,
RA   Schneider R.;
RT   "Regulation of transcription through acetylation of H3K122 on the lateral
RT   surface of the histone octamer.";
RL   Cell 152:859-872(2013).
RN   [51]
RP   ALLYSINE AT LYS-5.
RX   PubMed=27735137; DOI=10.1111/febs.13922;
RA   Herranz N., Dave N., Millanes-Romero A., Pascual-Reguant L., Morey L.,
RA   Diaz V.M., Lorenz-Fonfria V., Gutierrez-Gallego R., Jeronimo C.,
RA   Iturbide A., Di Croce L., Garcia de Herreros A., Peiro S.;
RT   "Lysyl oxidase-like 2 (LOXL2) oxidizes trimethylated lysine 4 in histone
RT   H3.";
RL   FEBS J. 283:4263-4273(2016).
RN   [52]
RP   BUTYRYLATION AT LYS-10; LYS-19 AND LYS-24.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [53]
RP   HYDROXYBUTYRYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28;
RP   LYS-57; LYS-80 AND LYS-123.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [54]
RP   HYDROXYBUTYRYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28;
RP   LYS-37; LYS-57; LYS-65; LYS-80 AND LYS-123.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [55]
RP   SUCCINYLATION AT LYS-123, AND DESUSUCCINYLATION.
RX   PubMed=27436229; DOI=10.1038/ncomms12235;
RA   Li L., Shi L., Yang S., Yan R., Zhang D., Yang J., He L., Li W., Yi X.,
RA   Sun L., Liang J., Cheng Z., Shi L., Shang Y., Yu W.;
RT   "SIRT7 is a histone desuccinylase that functionally links to chromatin
RT   compaction and genome stability.";
RL   Nat. Commun. 7:12235-12235(2016).
RN   [56]
RP   INVOLVEMENT IN SOFT TISSUE SARCOMAS, VARIANTS ILE-37 AND MET-37, AND
RP   CHARACTERIZATION OF VARIANTS ILE-37 AND MET-37.
RX   PubMed=27174990; DOI=10.1126/science.aac7272;
RA   Lu C., Jain S.U., Hoelper D., Bechet D., Molden R.C., Ran L., Murphy D.,
RA   Venneti S., Hameed M., Pawel B.R., Wunder J.S., Dickson B.C.,
RA   Lundgren S.M., Jani K.S., De Jay N., Papillon-Cavanagh S., Andrulis I.L.,
RA   Sawyer S.L., Grynspan D., Turcotte R.E., Nadaf J., Fahiminiyah S.,
RA   Muir T.W., Majewski J., Thompson C.B., Chi P., Garcia B.A., Allis C.D.,
RA   Jabado N., Lewis P.W.;
RT   "Histone H3K36 mutations promote sarcomagenesis through altered histone
RT   methylation landscape.";
RL   Science 352:844-849(2016).
RN   [57]
RP   ADP-RIBOSYLATION AT SER-11 AND SER-29.
RX   PubMed=28190768; DOI=10.1016/j.molcel.2017.01.003;
RA   Bonfiglio J.J., Fontana P., Zhang Q., Colby T., Gibbs-Seymour I.,
RA   Atanassov I., Bartlett E., Zaja R., Ahel I., Matic I.;
RT   "Serine ADP-ribosylation depends on HPF1.";
RL   Mol. Cell 0:0-0(2017).
RN   [58]
RP   SUCCINYLATION AT LYS-80.
RX   PubMed=29211711; DOI=10.1038/nature25003;
RA   Wang Y., Guo Y.R., Liu K., Yin Z., Liu R., Xia Y., Tan L., Yang P.,
RA   Lee J.H., Li X.J., Hawke D., Zheng Y., Qian X., Lyu J., He J., Xing D.,
RA   Tao Y.J., Lu Z.;
RT   "KAT2A coupled with the alpha-KGDH complex acts as a histone H3
RT   succinyltransferase.";
RL   Nature 552:273-277(2017).
RN   [59]
RP   ADP-RIBOSYLATION AT SER-11.
RX   PubMed=30257210; DOI=10.1016/j.celrep.2018.08.092;
RA   Bartlett E., Bonfiglio J.J., Prokhorova E., Colby T., Zobel F., Ahel I.,
RA   Matic I.;
RT   "Interplay of histone marks with serine ADP-ribosylation.";
RL   Cell Rep. 24:3488-3502(2018).
RN   [60]
RP   ADP-RIBOSYLATION AT SER-11 AND SER-29.
RX   PubMed=29480802; DOI=10.7554/elife.34334;
RA   Palazzo L., Leidecker O., Prokhorova E., Dauben H., Matic I., Ahel I.;
RT   "Serine is the major residue for ADP-ribosylation upon DNA damage.";
RL   Elife 7:0-0(2018).
RN   [61]
RP   GLUTARYLATION AT LYS-15; LYS-19; LYS-24; LYS-28; LYS-57; LYS-80; LYS-116
RP   AND LYS-123.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 8-15 IN COMPLEX WITH YWHAZ.
RX   PubMed=16246723; DOI=10.1016/j.molcel.2005.08.032;
RA   Macdonald N., Welburn J.P.I., Noble M.E.M., Nguyen A., Yaffe M.B.,
RA   Clynes D., Moggs J.G., Orphanides G., Thomson S., Edmunds J.W.,
RA   Clayton A.L., Endicott J.A., Mahadevan L.C.;
RT   "Molecular basis for the recognition of phosphorylated and
RT   phosphoacetylated histone h3 by 14-3-3.";
RL   Mol. Cell 20:199-211(2005).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 2-20 IN COMPLEX WITH CHD1.
RX   PubMed=16372014; DOI=10.1038/nature04290;
RA   Flanagan J.F., Mi L.-Z., Chruszcz M., Cymborowski M., Clines K.L., Kim Y.,
RA   Minor W., Rastinejad F., Khorasanizadeh S.;
RT   "Double chromodomains cooperate to recognize the methylated histone H3
RT   tail.";
RL   Nature 438:1181-1185(2005).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=15951514; DOI=10.1093/nar/gki663;
RA   Tsunaka Y., Kajimura N., Tate S., Morikawa K.;
RT   "Alteration of the nucleosomal DNA path in the crystal structure of a human
RT   nucleosome core particle.";
RL   Nucleic Acids Res. 33:3424-3434(2005).
RN   [65]
RP   CHARACTERIZATION OF VARIANT GLM MET-28.
RX   PubMed=23603901; DOI=10.1101/gad.217778.113;
RA   Chan K.M., Fang D., Gan H., Hashizume R., Yu C., Schroeder M., Gupta N.,
RA   Mueller S., James C.D., Jenkins R., Sarkaria J., Zhang Z.;
RT   "The histone H3.3K27M mutation in pediatric glioma reprograms H3K27
RT   methylation and gene expression.";
RL   Genes Dev. 27:985-990(2013).
RN   [66]
RP   VARIANT MET-37.
RX   PubMed=28067913; DOI=10.1038/ng.3757;
RA   Papillon-Cavanagh S., Lu C., Gayden T., Mikael L.G., Bechet D.,
RA   Karamboulas C., Ailles L., Karamchandani J., Marchione D.M., Garcia B.A.,
RA   Weinreb I., Goldstein D., Lewis P.W., Dancu O.M., Dhaliwal S., Stecho W.,
RA   Howlett C.J., Mymryk J.S., Barrett J.W., Nichols A.C., Allis C.D.,
RA   Majewski J., Jabado N.;
RT   "Impaired H3K36 methylation defines a subset of head and neck squamous cell
RT   carcinomas.";
RL   Nat. Genet. 49:180-185(2017).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA. {ECO:0000269|PubMed:16246723, ECO:0000269|PubMed:16372014}.
CC   -!- INTERACTION:
CC       O43918:AIRE; NbExp=20; IntAct=EBI-79722, EBI-1753081;
CC       Q9Y294:ASF1A; NbExp=10; IntAct=EBI-79722, EBI-749553;
CC       Q9NPI1:BRD7; NbExp=2; IntAct=EBI-79722, EBI-711221;
CC       P83916:CBX1; NbExp=12; IntAct=EBI-79722, EBI-78129;
CC       Q13185:CBX3; NbExp=5; IntAct=EBI-79722, EBI-78176;
CC       P45973:CBX5; NbExp=10; IntAct=EBI-79722, EBI-78219;
CC       Q9Y232:CDYL; NbExp=5; IntAct=EBI-79722, EBI-1387386;
CC       Q9UER7-1:DAXX; NbExp=6; IntAct=EBI-79722, EBI-287635;
CC       Q8WXX5:DNAJC9; NbExp=13; IntAct=EBI-79722, EBI-2349100;
CC       Q8WUP2:FBLIM1; NbExp=11; IntAct=EBI-79722, EBI-3864120;
CC       P62805:HIST1H4K; NbExp=7; IntAct=EBI-79722, EBI-302023;
CC       P42858:HTT; NbExp=2; IntAct=EBI-79722, EBI-466029;
CC       Q9UNL4:ING4; NbExp=3; IntAct=EBI-79722, EBI-2866661;
CC       P38991:IPL1 (xeno); NbExp=2; IntAct=EBI-79722, EBI-9319;
CC       O75164:KDM4A; NbExp=7; IntAct=EBI-79722, EBI-936709;
CC       Q03164:KMT2A; NbExp=11; IntAct=EBI-79722, EBI-591370;
CC       Q9Y468:L3MBTL1; NbExp=2; IntAct=EBI-79722, EBI-1265089;
CC       P49736:MCM2; NbExp=6; IntAct=EBI-79722, EBI-374819;
CC       Q99549:MPHOSPH8; NbExp=5; IntAct=EBI-79722, EBI-2653928;
CC       P49321:NASP; NbExp=6; IntAct=EBI-79722, EBI-716205;
CC       P49321-2:NASP; NbExp=16; IntAct=EBI-79722, EBI-7038920;
CC       Q9BVI0:PHF20; NbExp=6; IntAct=EBI-79722, EBI-2560802;
CC       A8MW92:PHF20L1; NbExp=2; IntAct=EBI-79722, EBI-2560834;
CC       P14618-1:PKM; NbExp=3; IntAct=EBI-79722, EBI-4304679;
CC       Q8WTS6:SETD7; NbExp=3; IntAct=EBI-79722, EBI-1268586;
CC       P25554:SGF29 (xeno); NbExp=11; IntAct=EBI-79722, EBI-21678;
CC       Q96ES7:SGF29; NbExp=25; IntAct=EBI-79722, EBI-743117;
CC       Q12888:TP53BP1; NbExp=5; IntAct=EBI-79722, EBI-396540;
CC       P61964:WDR5; NbExp=11; IntAct=EBI-79722, EBI-540834;
CC       P63104:YWHAZ; NbExp=3; IntAct=EBI-79722, EBI-347088;
CC       Q8R5C8:Zmynd11 (xeno); NbExp=4; IntAct=EBI-79722, EBI-647813;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- DEVELOPMENTAL STAGE: Expressed during S phase, then expression strongly
CC       decreases as cell division slows down during the process of
CC       differentiation.
CC   -!- PTM: Acetylation is generally linked to gene activation. Acetylation on
CC       Lys-10 (H3K9ac) impairs methylation at Arg-9 (H3R8me2s). Acetylation on
CC       Lys-19 (H3K18ac) and Lys-24 (H3K24ac) favors methylation at Arg-18
CC       (H3R17me). Acetylation at Lys-123 (H3K122ac) by EP300/p300 plays a
CC       central role in chromatin structure: localizes at the surface of the
CC       histone octamer and stimulates transcription, possibly by promoting
CC       nucleosome instability. {ECO:0000269|PubMed:11242053,
CC       ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871,
CC       ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
CC       ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732,
CC       ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:17194708,
CC       ECO:0000269|PubMed:19520870, ECO:0000269|PubMed:23415232}.
CC   -!- PTM: Citrullination at Arg-9 (H3R8ci) and/or Arg-18 (H3R17ci) by PADI4
CC       impairs methylation and represses transcription.
CC       {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871,
CC       ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16567635}.
CC   -!- PTM: Asymmetric dimethylation at Arg-18 (H3R17me2a) by CARM1 is linked
CC       to gene activation. Symmetric dimethylation at Arg-9 (H3R8me2s) by
CC       PRMT5 is linked to gene repression. Asymmetric dimethylation at Arg-3
CC       (H3R2me2a) by PRMT6 is linked to gene repression and is mutually
CC       exclusive with H3 Lys-5 methylation (H3K4me2 and H3K4me3). H3R2me2a is
CC       present at the 3' of genes regardless of their transcription state and
CC       is enriched on inactive promoters, while it is absent on active
CC       promoters. {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871,
CC       ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588,
CC       ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17194708,
CC       ECO:0000269|PubMed:17898714, ECO:0000269|PubMed:18077460,
CC       ECO:0000269|PubMed:18079182}.
CC   -!- PTM: Methylation at Lys-5 (H3K4me), Lys-37 (H3K36me) and Lys-80
CC       (H3K79me) are linked to gene activation. Methylation at Lys-5 (H3K4me)
CC       facilitates subsequent acetylation of H3 and H4. Methylation at Lys-80
CC       (H3K79me) is associated with DNA double-strand break (DSB) responses
CC       and is a specific target for TP53BP1. Methylation at Lys-10 (H3K9me)
CC       and Lys-28 (H3K27me) are linked to gene repression. Methylation at Lys-
CC       10 (H3K9me) is a specific target for HP1 proteins (CBX1, CBX3 and CBX5)
CC       and prevents subsequent phosphorylation at Ser-11 (H3S10ph) and
CC       acetylation of H3 and H4. Methylation at Lys-5 (H3K4me) and Lys-80
CC       (H3K79me) require preliminary monoubiquitination of H2B at 'Lys-120'.
CC       Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me) are enriched in
CC       inactive X chromosome chromatin. Monomethylation at Lys-57 (H3K56me1)
CC       by EHMT2/G9A in G1 phase promotes interaction with PCNA and is required
CC       for DNA replication. {ECO:0000269|PubMed:10464286,
CC       ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:11856369,
CC       ECO:0000269|PubMed:12560483, ECO:0000269|PubMed:15525939,
CC       ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:15983376,
CC       ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
CC       ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732,
CC       ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:17189264,
CC       ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:22387026}.
CC   -!- PTM: Phosphorylated at Thr-4 (H3T3ph) by HASPIN during prophase and
CC       dephosphorylated during anaphase. Phosphorylation at Ser-11 (H3S10ph)
CC       by AURKB is crucial for chromosome condensation and cell-cycle
CC       progression during mitosis and meiosis. In addition phosphorylation at
CC       Ser-11 (H3S10ph) by RPS6KA4 and RPS6KA5 is important during interphase
CC       because it enables the transcription of genes following external
CC       stimulation, like mitogens, stress, growth factors or UV irradiation
CC       and result in the activation of genes, such as c-fos and c-jun.
CC       Phosphorylation at Ser-11 (H3S10ph), which is linked to gene
CC       activation, prevents methylation at Lys-10 (H3K9me) but facilitates
CC       acetylation of H3 and H4. Phosphorylation at Ser-11 (H3S10ph) by AURKB
CC       mediates the dissociation of HP1 proteins (CBX1, CBX3 and CBX5) from
CC       heterochromatin. Phosphorylation at Ser-11 (H3S10ph) is also an
CC       essential regulatory mechanism for neoplastic cell transformation.
CC       Phosphorylated at Ser-29 (H3S28ph) by MAP3K20 isoform 1, RPS6KA5 or
CC       AURKB during mitosis or upon ultraviolet B irradiation. Phosphorylation
CC       at Thr-7 (H3T6ph) by PRKCB is a specific tag for epigenetic
CC       transcriptional activation that prevents demethylation of Lys-5
CC       (H3K4me) by LSD1/KDM1A. At centromeres, specifically phosphorylated at
CC       Thr-12 (H3T11ph) from prophase to early anaphase, by DAPK3 and PKN1.
CC       Phosphorylation at Thr-12 (H3T11ph) by PKN1 is a specific tag for
CC       epigenetic transcriptional activation that promotes demethylation of
CC       Lys-10 (H3K9me) by KDM4C/JMJD2C. Phosphorylation at Thr-12 (H3T11ph) by
CC       chromatin-associated CHEK1 regulates the transcription of cell cycle
CC       regulatory genes by modulating acetylation of Lys-10 (H3K9ac).
CC       Phosphorylation at Tyr-42 (H3Y41ph) by JAK2 promotes exclusion of CBX5
CC       (HP1 alpha) from chromatin. {ECO:0000269|PubMed:10464286,
CC       ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:11856369,
CC       ECO:0000269|PubMed:12560483, ECO:0000269|PubMed:15681610,
CC       ECO:0000269|PubMed:15684425, ECO:0000269|PubMed:16185088,
CC       ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588,
CC       ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16627869,
CC       ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:18066052,
CC       ECO:0000269|PubMed:18243098, ECO:0000269|PubMed:19783980,
CC       ECO:0000269|PubMed:20228790, ECO:0000269|PubMed:20850016}.
CC   -!- PTM: Monoubiquitinated by RAG1 in lymphoid cells, monoubiquitination is
CC       required for V(D)J recombination (By similarity). Ubiquitinated by the
CC       CUL4-DDB-RBX1 complex in response to ultraviolet irradiation. This may
CC       weaken the interaction between histones and DNA and facilitate DNA
CC       accessibility to repair proteins. {ECO:0000250|UniProtKB:Q6LED0,
CC       ECO:0000269|PubMed:16678110}.
CC   -!- PTM: Lysine deamination at Lys-5 (H3K4all) to form allysine is mediated
CC       by LOXL2. Allysine formation by LOXL2 only takes place on H3K4me3 and
CC       results in gene repression. {ECO:0000269|PubMed:27735137}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes with
CC       histone acetylation. It is present during late spermatogenesis.
CC       {ECO:0000250|UniProtKB:P68433}.
CC   -!- PTM: Succinylation at Lys-80 (H3K79succ) by KAT2A takes place with a
CC       maximum frequency around the transcription start sites of genes
CC       (PubMed:29211711). It gives a specific tag for epigenetic transcription
CC       activation (PubMed:29211711). Desuccinylation at Lys-123 (H3K122succ)
CC       by SIRT7 in response to DNA damage promotes chromatin condensation and
CC       double-strand breaks (DSBs) repair (PubMed:27436229).
CC       {ECO:0000269|PubMed:27436229, ECO:0000269|PubMed:29211711}.
CC   -!- PTM: Serine ADP-ribosylation constitutes the primary form of ADP-
CC       ribosylation of proteins in response to DNA damage (PubMed:30257210).
CC       Serine ADP-ribosylation at Ser-11 (H3S10ADPr) is mutually exclusive
CC       with phosphorylation at Ser-11 (H3S10ph) and impairs acetylation at
CC       Lys-10 (H3K9ac) (PubMed:30257210). {ECO:0000269|PubMed:30257210}.
CC   -!- DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant
CC       central nervous system neoplasms derived from glial cells. They
CC       comprise astrocytomas and glioblastoma multiforme that are derived from
CC       astrocytes, oligodendrogliomas derived from oligodendrocytes and
CC       ependymomas derived from ependymocytes. {ECO:0000269|PubMed:22286216}.
CC       Note=The gene represented in this entry is involved in disease
CC       pathogenesis. HIST1H3B mutations affecting residue Lys-28 involved in
CC       post-translational modifications of histone H3.1 are recurrent in
CC       malignant, aggressive gliomas including pediatric non-brain stem
CC       glioblastoma and diffuse intrinsic pontine glioma (DIPG)
CC       (PubMed:22286216). The mechanism through which mutations lead to
CC       tumorigenesis involves altered histone methylation, impaired regulation
CC       of Polycomb repressive complex 2 (PRC2) activity, and aberrant
CC       epigenetic regulation of gene expression (PubMed:23603901).
CC       {ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23603901}.
CC   -!- DISEASE: Note=HIST1H3B or HIST1H3C mutations affecting residue Lys-37
CC       of histone H3.1 are involved in the pathogenesis of pediatric
CC       undifferentiated soft tissue sarcomas. The mechanism through which
CC       mutations lead to tumorigenesis involves altered histones methylation
CC       with gain of global H3K27 methylation, altered Polycomb repressive
CC       complex 1 (PRC1) activity, aberrant epigenetic regulation of gene
CC       expression and impaired differentiation of mesenchimal progenitor
CC       cells. {ECO:0000269|PubMed:27174990}.
CC   -!- MISCELLANEOUS: This histone is only present in mammals and is enriched
CC       in acetylation of Lys-15 and dimethylation of Lys-10 (H3K9me2).
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   -!- CAUTION: The original paper reporting lysine deamination at Lys-5 by
CC       LOXL2 has been retracted due to inappropriate manipulation of figure
CC       data (PubMed:22483618, PubMed:27392148). However, this modification was
CC       confirmed in a subsequent publication (PubMed:27735137).
CC       {ECO:0000269|PubMed:27735137, ECO:0000305|PubMed:22483618,
CC       ECO:0000305|PubMed:27392148}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00090; CAA24952.1; -; Genomic_DNA.
DR   EMBL; M26150; AAA52651.1; -; Genomic_DNA.
DR   EMBL; M60746; AAA63185.1; -; Genomic_DNA.
DR   EMBL; X57128; CAA40407.1; -; Genomic_DNA.
DR   EMBL; Z46261; CAA86403.1; -; Genomic_DNA.
DR   EMBL; X83550; CAA58540.1; -; Genomic_DNA.
DR   EMBL; Z80784; CAB02546.1; -; Genomic_DNA.
DR   EMBL; Z80785; CAB02547.1; -; Genomic_DNA.
DR   EMBL; Z80786; CAB02548.1; -; Genomic_DNA.
DR   EMBL; Z83735; CAB06030.1; -; Genomic_DNA.
DR   EMBL; Z83737; CAB06032.1; -; Genomic_DNA.
DR   EMBL; AF531274; AAN10051.1; -; Genomic_DNA.
DR   EMBL; AF531275; AAN10052.1; -; Genomic_DNA.
DR   EMBL; AF531276; AAN10053.1; -; Genomic_DNA.
DR   EMBL; AF531277; AAN10054.1; -; Genomic_DNA.
DR   EMBL; AF531278; AAN10055.1; -; Genomic_DNA.
DR   EMBL; AF531279; AAN10056.1; -; Genomic_DNA.
DR   EMBL; AF531280; AAN10057.1; -; Genomic_DNA.
DR   EMBL; AF531281; AAN10058.1; -; Genomic_DNA.
DR   EMBL; AF531282; AAN10059.1; -; Genomic_DNA.
DR   EMBL; AF531283; AAN10060.1; -; Genomic_DNA.
DR   EMBL; AK311991; BAG34929.1; -; mRNA.
DR   EMBL; AK313905; BAG36628.1; -; mRNA.
DR   EMBL; AK314142; BAG36832.1; -; mRNA.
DR   EMBL; AK316611; BAG38198.1; -; mRNA.
DR   EMBL; CR542014; CAG46811.1; -; mRNA.
DR   EMBL; CR542011; CAG46808.1; -; mRNA.
DR   EMBL; CR541983; CAG46780.1; -; mRNA.
DR   EMBL; CR541858; CAG46656.1; -; mRNA.
DR   EMBL; Z98744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL009179; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC031333; AAH31333.1; -; mRNA.
DR   EMBL; BC066245; AAH66245.1; -; mRNA.
DR   EMBL; BC066246; AAH66246.1; -; mRNA.
DR   EMBL; BC066247; AAH66247.1; -; mRNA.
DR   EMBL; BC066884; AAH66884.1; -; mRNA.
DR   EMBL; BC067490; AAH67490.1; -; mRNA.
DR   EMBL; BC067491; AAH67491.1; -; mRNA.
DR   EMBL; BC067492; AAH67492.1; -; mRNA.
DR   EMBL; BC067493; AAH67493.1; -; mRNA.
DR   EMBL; BC069133; AAH69133.1; -; mRNA.
DR   EMBL; BC069303; AAH69303.1; -; mRNA.
DR   EMBL; BC069305; AAH69305.2; -; mRNA.
DR   EMBL; BC069818; AAH69818.1; -; mRNA.
DR   EMBL; BC096128; AAH96128.1; -; mRNA.
DR   EMBL; BC096129; AAH96129.1; -; mRNA.
DR   EMBL; BC096130; AAH96130.1; -; mRNA.
DR   EMBL; BC096131; AAH96131.1; -; mRNA.
DR   EMBL; BC096132; AAH96132.1; -; mRNA.
DR   EMBL; BC096133; AAH96133.1; -; mRNA.
DR   EMBL; BC096134; AAH96134.1; -; mRNA.
DR   EMBL; BC099630; AAH99630.1; -; mRNA.
DR   EMBL; BC127610; AAI27611.1; -; mRNA.
DR   EMBL; BC143046; AAI43047.1; -; mRNA.
DR   EMBL; BC148243; AAI48244.1; -; mRNA.
DR   EMBL; BC148250; AAI48251.1; -; mRNA.
DR   CCDS; CCDS4570.1; -.
DR   CCDS; CCDS4573.1; -.
DR   CCDS; CCDS4576.1; -.
DR   CCDS; CCDS4590.1; -.
DR   CCDS; CCDS4596.1; -.
DR   CCDS; CCDS4600.1; -.
DR   CCDS; CCDS4602.1; -.
DR   CCDS; CCDS4627.1; -.
DR   CCDS; CCDS4636.1; -.
DR   CCDS; CCDS4638.1; -.
DR   PIR; I37446; HSHU3.
DR   RefSeq; NP_003520.1; NM_003529.2.
DR   RefSeq; NP_003521.2; NM_003530.4.
DR   RefSeq; NP_003522.1; NM_003531.2.
DR   RefSeq; NP_003523.1; NM_003532.2.
DR   RefSeq; NP_003524.1; NM_003533.2.
DR   RefSeq; NP_003525.1; NM_003534.2.
DR   RefSeq; NP_003526.1; NM_003535.2.
DR   RefSeq; NP_003527.1; NM_003536.2.
DR   RefSeq; NP_003528.1; NM_003537.3.
DR   RefSeq; NP_066298.1; NM_021018.2.
DR   PDB; 1CS9; NMR; -; A=131-136.
DR   PDB; 1CT6; NMR; -; A=131-136.
DR   PDB; 1O9S; X-ray; 1.75 A; K/L=2-10.
DR   PDB; 1Q3L; X-ray; 1.64 A; P=2-16.
DR   PDB; 2B2T; X-ray; 2.45 A; D=2-20.
DR   PDB; 2B2U; X-ray; 2.95 A; D=2-16.
DR   PDB; 2B2V; X-ray; 2.65 A; D=2-16.
DR   PDB; 2B2W; X-ray; 2.40 A; D=2-20.
DR   PDB; 2C1J; X-ray; 2.60 A; C/D=8-15.
DR   PDB; 2C1N; X-ray; 2.00 A; C/E=8-15.
DR   PDB; 2CO0; X-ray; 2.25 A; B/D=2-16.
DR   PDB; 2CV5; X-ray; 2.50 A; A/E=1-136.
DR   PDB; 2FSA; X-ray; 1.90 A; P=2-16.
DR   PDB; 2KWJ; NMR; -; B=2-21.
DR   PDB; 2KWK; NMR; -; B=2-21.
DR   PDB; 2L75; NMR; -; B=2-14.
DR   PDB; 2LBM; NMR; -; C=2-16.
DR   PDB; 2LGG; NMR; -; B=2-13.
DR   PDB; 2M0O; NMR; -; B=32-42.
DR   PDB; 2NDF; NMR; -; B=13-25.
DR   PDB; 2NDG; NMR; -; B=13-25.
DR   PDB; 2OQ6; X-ray; 2.00 A; C/D=8-15.
DR   PDB; 2OT7; X-ray; 2.14 A; C/D=8-15.
DR   PDB; 2OX0; X-ray; 1.95 A; C/D=8-15.
DR   PDB; 2RI7; X-ray; 1.45 A; P=2-10.
DR   PDB; 2RR4; NMR; -; B=2-11.
DR   PDB; 2UXN; X-ray; 2.72 A; E=2-22.
DR   PDB; 2V85; X-ray; 2.00 A; D/E=2-13.
DR   PDB; 2V89; X-ray; 1.10 A; D/E=2-10.
DR   PDB; 2VNF; X-ray; 1.76 A; B/D=2-11.
DR   PDB; 2VPG; X-ray; 1.60 A; P/R=2-19.
DR   PDB; 2X0L; X-ray; 3.00 A; C=6-17.
DR   PDB; 3A1B; X-ray; 2.29 A; A=2-21.
DR   PDB; 3AFA; X-ray; 2.50 A; A/E=1-136.
DR   PDB; 3AVR; X-ray; 1.80 A; B=18-39.
DR   PDB; 3AYW; X-ray; 2.90 A; A/E=1-136.
DR   PDB; 3AZE; X-ray; 3.00 A; A/E=1-136.
DR   PDB; 3AZF; X-ray; 2.70 A; A/E=1-136.
DR   PDB; 3AZG; X-ray; 2.40 A; A/E=1-136.
DR   PDB; 3AZH; X-ray; 3.49 A; A/E=1-136.
DR   PDB; 3AZI; X-ray; 2.70 A; A/E=1-136.
DR   PDB; 3AZJ; X-ray; 2.89 A; A/E=1-136.
DR   PDB; 3AZK; X-ray; 3.20 A; A/E=1-136.
DR   PDB; 3AZL; X-ray; 2.70 A; A/E=1-136.
DR   PDB; 3AZM; X-ray; 2.89 A; A/E=1-136.
DR   PDB; 3AZN; X-ray; 3.00 A; A/E=1-136.
DR   PDB; 3B95; X-ray; 2.99 A; P=2-16.
DR   PDB; 3FDT; X-ray; 2.00 A; T=2-16.
DR   PDB; 3KMT; X-ray; 1.78 A; G/H/I=26-33.
DR   PDB; 3KQI; X-ray; 1.78 A; B=2-13.
DR   PDB; 3LQI; X-ray; 1.92 A; R/S/T=2-10.
DR   PDB; 3LQJ; X-ray; 1.90 A; Q/T=2-10.
DR   PDB; 3MP1; X-ray; 2.60 A; P=2-6.
DR   PDB; 3O34; X-ray; 1.90 A; B=14-33.
DR   PDB; 3O35; X-ray; 1.76 A; D/E=24-32.
DR   PDB; 3O37; X-ray; 2.00 A; E/F/G/H=2-11.
DR   PDB; 3QJ6; X-ray; 2.30 A; T=74-84.
DR   PDB; 3RIG; X-ray; 2.00 A; C/D=5-16.
DR   PDB; 3RIY; X-ray; 1.55 A; C/D=5-16.
DR   PDB; 3SOU; X-ray; 1.80 A; D/E=2-10.
DR   PDB; 3SOW; X-ray; 1.95 A; C/D=2-10.
DR   PDB; 3U31; X-ray; 2.20 A; B=5-14.
DR   PDB; 3U3D; X-ray; 2.40 A; B=5-14.
DR   PDB; 3U4S; X-ray; 2.15 A; C/D=8-15.
DR   PDB; 3U5N; X-ray; 1.95 A; C/D=2-21.
DR   PDB; 3U5O; X-ray; 2.70 A; I/J/K/L/M/N/O/P=2-23.
DR   PDB; 3U5P; X-ray; 2.80 A; I/J/K/L/M/N/O/P=2-29.
DR   PDB; 3UEE; X-ray; 2.61 A; B/D=2-13.
DR   PDB; 3UEF; X-ray; 2.45 A; B/D=2-13.
DR   PDB; 3UIG; X-ray; 2.40 A; P/Q=2-16.
DR   PDB; 3UII; X-ray; 2.60 A; P/Q=2-11.
DR   PDB; 3UIK; X-ray; 2.70 A; P/Q=2-11.
DR   PDB; 3V43; X-ray; 1.47 A; Q=2-19.
DR   PDB; 3W96; X-ray; 3.00 A; A/E=1-136.
DR   PDB; 3W97; X-ray; 3.20 A; A/E=1-136.
DR   PDB; 3W98; X-ray; 3.42 A; A/E=29-136.
DR   PDB; 3W99; X-ray; 3.00 A; A/E=1-136.
DR   PDB; 3WA9; X-ray; 3.07 A; A/E=1-136.
DR   PDB; 3WAA; X-ray; 3.20 A; A/E=1-136.
DR   PDB; 3WKJ; X-ray; 2.80 A; A/E=1-136.
DR   PDB; 3X1S; X-ray; 2.81 A; A/E=2-136.
DR   PDB; 3X1T; X-ray; 2.81 A; A/E=2-136.
DR   PDB; 3X1U; X-ray; 3.25 A; A/E=2-136.
DR   PDB; 3X1V; X-ray; 2.92 A; A/E=2-136.
DR   PDB; 3ZG6; X-ray; 2.20 A; F=5-14.
DR   PDB; 3ZVY; X-ray; 1.95 A; C/D=2-9.
DR   PDB; 4A0J; X-ray; 2.80 A; C/D=2-7.
DR   PDB; 4A0N; X-ray; 2.74 A; C=2-7.
DR   PDB; 4A7J; X-ray; 1.90 A; B=1-16.
DR   PDB; 4BD3; NMR; -; B=32-42.
DR   PDB; 4C1Q; X-ray; 2.30 A; C=2-10.
DR   PDB; 4F4U; X-ray; 2.00 A; C/D=5-16.
DR   PDB; 4F56; X-ray; 1.70 A; C/D=5-16.
DR   PDB; 4FWF; X-ray; 2.70 A; E=2-21.
DR   PDB; 4HON; X-ray; 1.80 A; F/G=7-16.
DR   PDB; 4I51; X-ray; 1.90 A; C/D=4-12.
DR   PDB; 4L7X; X-ray; 1.35 A; U=2-13.
DR   PDB; 4LK9; X-ray; 1.60 A; B=2-22.
DR   PDB; 4LKA; X-ray; 1.61 A; B=2-22.
DR   PDB; 4LLB; X-ray; 2.50 A; C/D=2-22.
DR   PDB; 4LXL; X-ray; 1.87 A; D=8-15.
DR   PDB; 4N4H; X-ray; 2.30 A; B=22-43.
DR   PDB; 4QBQ; X-ray; 2.41 A; P=2-9.
DR   PDB; 4QBR; X-ray; 1.90 A; E/P=2-8.
DR   PDB; 4QBS; X-ray; 1.80 A; P=2-8.
DR   PDB; 4TN7; X-ray; 2.20 A; E/F=30-44.
DR   PDB; 4U68; X-ray; 1.80 A; D/E/F=5-15.
DR   PDB; 4UP0; X-ray; 1.28 A; F=2-16.
DR   PDB; 4UY4; X-ray; 1.86 A; C/D=2-7.
DR   PDB; 4X3K; X-ray; 1.45 A; C/D=24-30.
DR   PDB; 4Y6L; X-ray; 1.60 A; C/D=7-13.
DR   PDB; 4YHP; X-ray; 2.53 A; P/Q=2-17.
DR   PDB; 4YHZ; X-ray; 2.30 A; P=2-13.
DR   PDB; 4YM5; X-ray; 4.00 A; A/E=1-136.
DR   PDB; 4YM6; X-ray; 3.51 A; A/E=1-136.
DR   PDB; 4Z0R; X-ray; 1.75 A; D=2-16.
DR   PDB; 4Z2M; X-ray; 2.98 A; G/I=35-136.
DR   PDB; 5AV5; X-ray; 2.40 A; A/E=1-136.
DR   PDB; 5AV6; X-ray; 2.20 A; A/E=1-136.
DR   PDB; 5AV8; X-ray; 2.20 A; A/E=1-136.
DR   PDB; 5AV9; X-ray; 2.20 A; A/E=1-136.
DR   PDB; 5AVB; X-ray; 2.40 A; A/E=1-136.
DR   PDB; 5AVC; X-ray; 2.40 A; A/E=1-136.
DR   PDB; 5B24; X-ray; 3.60 A; A/E=1-136.
DR   PDB; 5B2I; X-ray; 3.00 A; A/E=1-136.
DR   PDB; 5B2J; X-ray; 2.60 A; A/E=1-136.
DR   PDB; 5B31; X-ray; 2.20 A; A/E=1-136.
DR   PDB; 5C11; X-ray; 2.80 A; B=2-11.
DR   PDB; 5C13; X-ray; 2.10 A; D/F/H/P=2-11.
DR   PDB; 5C3I; X-ray; 3.50 A; B/F/J/N/R/V=1-136.
DR   PDB; 5CPI; X-ray; 2.90 A; A/E=1-136.
DR   PDB; 5CPJ; X-ray; 3.15 A; A/E=1-136.
DR   PDB; 5CPK; X-ray; 2.63 A; A/E=1-136.
DR   PDB; 5D6Y; X-ray; 2.29 A; a/b/c/d=20-29.
DR   PDB; 5DAH; X-ray; 2.61 A; C/D=20-30.
DR   PDB; 5FB0; X-ray; 2.70 A; D/F=2-16.
DR   PDB; 5FB1; X-ray; 2.10 A; C=2-16.
DR   PDB; 5FFV; X-ray; 1.30 A; C/D=10-20.
DR   PDB; 5GH9; X-ray; 1.45 A; B=45-58.
DR   PDB; 5GSE; X-ray; 3.14 A; A/E/K/O=1-136.
DR   PDB; 5GSU; X-ray; 3.10 A; A/E=2-136.
DR   PDB; 5GT0; X-ray; 2.82 A; A/E=2-136.
DR   PDB; 5GT3; X-ray; 2.91 A; A/E=2-136.
DR   PDB; 5GTC; X-ray; 2.70 A; A/E=1-136.
DR   PDB; 5H6Q; X-ray; 2.53 A; C=2-21.
DR   PDB; 5H6R; X-ray; 2.60 A; C=2-21.
DR   PDB; 5HJB; X-ray; 2.70 A; B=4-9.
DR   PDB; 5HJC; X-ray; 2.60 A; B=16-24.
DR   PDB; 5HJD; X-ray; 2.81 A; B/D/F/H/I/J/L/M=15-21.
DR   PDB; 5HYN; X-ray; 2.95 A; D/I/O/T=22-34.
DR   PDB; 5IQL; X-ray; 2.10 A; B=25-32.
DR   PDB; 5J3V; X-ray; 3.05 A; C/D=12-28.
DR   PDB; 5J9S; X-ray; 2.70 A; B=16-40.
DR   PDB; 5JHN; X-ray; 1.67 A; F/G=4-14.
DR   PDB; 5JIN; X-ray; 1.85 A; F/G=4-14.
DR   PDB; 5JIY; X-ray; 1.48 A; F/G=4-14.
DR   PDB; 5JJ0; X-ray; 1.72 A; F/G=4-14.
DR   PDB; 5JRG; X-ray; 2.50 A; A/E=1-136.
DR   PDB; 5KJH; X-ray; 2.27 A; D=23-33, E=19-38.
DR   PDB; 5KJI; X-ray; 2.71 A; E=19-38.
DR   PDB; 5KKL; X-ray; 2.94 A; B=23-27.
DR   PDB; 5LUG; X-ray; 1.70 A; E/F/G/H=2-11.
DR   PDB; 5M5G; X-ray; 2.27 A; D=23-33.
DR   PDB; 5MR8; X-ray; 1.74 A; C=2-10.
DR   PDB; 5NNC; X-ray; 2.22 A; C/D=5-21.
DR   PDB; 5NND; X-ray; 1.82 A; D/E=5-21.
DR   PDB; 5OY3; X-ray; 2.14 A; B=18-34.
DR   PDB; 5SVX; X-ray; 1.56 A; B=2-12.
DR   PDB; 5SVY; X-ray; 1.05 A; B=2-12.
DR   PDB; 5SZB; X-ray; 1.20 A; H=2-19.
DR   PDB; 5SZC; X-ray; 1.19 A; H=2-19.
DR   PDB; 5T0K; X-ray; 1.70 A; P/Q=2-16.
DR   PDB; 5T0M; X-ray; 1.90 A; C/P=2-16.
DR   PDB; 5T1G; X-ray; 1.90 A; B=39-53.
DR   PDB; 5T1I; X-ray; 1.60 A; C=39-53.
DR   PDB; 5T8R; X-ray; 2.40 A; E/G=2-11.
DR   PDB; 5TBN; NMR; -; C=2-12.
DR   PDB; 5TDR; X-ray; 1.42 A; B=2-12.
DR   PDB; 5TDW; X-ray; 1.70 A; B=2-12.
DR   PDB; 5U2J; X-ray; 1.60 A; C/D=2-17.
DR   PDB; 5V21; X-ray; 2.42 A; B=30-44.
DR   PDB; 5V22; X-ray; 2.40 A; B=30-44.
DR   PDB; 5VA6; X-ray; 2.40 A; C/D=20-37.
DR   PDB; 5VAB; X-ray; 1.70 A; F=2-11.
DR   PDB; 5VGE; X-ray; 2.60 A; C=41-49.
DR   PDB; 5VNB; X-ray; 2.40 A; K=22-31.
DR   PDB; 5WFC; X-ray; 2.28 A; D=23-33.
DR   PDB; 5WLE; X-ray; 1.95 A; C=2-13.
DR   PDB; 5WVO; X-ray; 2.00 A; D=2-37.
DR   PDB; 5WXG; X-ray; 1.70 A; P=2-8.
DR   PDB; 5WXH; X-ray; 1.30 A; D/P=2-8.
DR   PDB; 5WYI; X-ray; 2.00 A; E=120-127.
DR   PDB; 5X60; X-ray; 2.69 A; C=2-21.
DR   PDB; 5XF3; X-ray; 2.60 A; A/E=1-136.
DR   PDB; 5XF4; X-ray; 2.87 A; A/E=1-136.
DR   PDB; 5XF5; X-ray; 2.82 A; A/E=1-136.
DR   PDB; 5XFQ; X-ray; 2.40 A; E/F=30-42.
DR   PDB; 5XFR; X-ray; 2.25 A; C/D=34-41.
DR   PDB; 5XNV; X-ray; 2.70 A; B=25-32.
DR   PDB; 5XTZ; X-ray; 2.10 A; E=23-32.
DR   PDB; 5Y0C; X-ray; 2.09 A; A/E=1-136.
DR   PDB; 5Y0D; X-ray; 1.99 A; A/E=1-136.
DR   PDB; 5Y20; X-ray; 2.41 A; P=2-8.
DR   PDB; 5Y2F; X-ray; 2.53 A; C=6-14.
DR   PDB; 5Z23; X-ray; 2.73 A; A/E=1-75, A/E=116-136.
DR   PDB; 5Z30; X-ray; 2.45 A; A/E=1-136.
DR   PDB; 6AXJ; X-ray; 2.38 A; E/F/G/H=22-32.
DR   PDB; 6AZE; X-ray; 2.45 A; P=2-7.
DR   PDB; 6BHD; X-ray; 1.25 A; B=4-20.
DR   PDB; 6BHE; X-ray; 1.35 A; B=4-20.
DR   PDB; 6BHG; X-ray; 1.45 A; B=4-20.
DR   PDB; 6BHH; X-ray; 1.85 A; B=4-20.
DR   PDB; 6BHI; X-ray; 1.40 A; B=5-20.
DR   PDB; 6D07; X-ray; 2.10 A; C/D=2-16.
DR   PDB; 6D08; X-ray; 2.10 A; C/D=2-16.
DR   PDB; 6E83; NMR; -; A=2-13.
DR   PDB; 6E86; NMR; -; A=2-9.
DR   PDB; 6F6D; X-ray; 1.82 A; B=18-34.
DR   PDB; 6HKT; X-ray; 9.70 A; A/E/K/O/U/Y/a/e/k/o/u/y=1-136.
DR   PDB; 6HTS; EM; 4.80 A; I/M=1-136.
DR   PDB; 6IIS; X-ray; 2.36 A; E/F=34-41.
DR   PDB; 6IIT; X-ray; 2.10 A; E/F=34-41.
DR   PDB; 6IQ4; X-ray; 2.25 A; A/E=39-136.
DR   PDB; 6JR0; X-ray; 2.50 A; A/E=1-136.
DR   PDB; 6JR1; X-ray; 2.40 A; A/E=1-136.
DR   PDB; 6MIL; X-ray; 1.93 A; B/D=2-20.
DR   PDB; 6MIM; X-ray; 2.52 A; B/D=6-14.
DR   PDB; 6MIN; X-ray; 1.90 A; B=6-12.
DR   PDB; 6MIO; X-ray; 1.85 A; B=6-12.
DR   PDB; 6MIQ; X-ray; 1.75 A; C=6-12.
DR   PDB; 6R8Y; EM; 4.30 A; A/E=1-136.
DR   PDB; 6R8Z; EM; 3.90 A; A/E=1-136.
DR   PDB; 6R90; EM; 4.50 A; A/E=1-136.
DR   PDB; 6R91; EM; 4.10 A; A/E=1-136.
DR   PDB; 6R92; EM; 4.80 A; A/E=1-136.
DR   PDB; 6R93; EM; 4.00 A; A/E=1-136.
DR   PDB; 6R94; EM; 3.50 A; A/E=1-136.
DR   PDB; 6UHG; X-ray; 1.60 A; QQQ=2-16.
DR   PDBsum; 1CS9; -.
DR   PDBsum; 1CT6; -.
DR   PDBsum; 1O9S; -.
DR   PDBsum; 1Q3L; -.
DR   PDBsum; 2B2T; -.
DR   PDBsum; 2B2U; -.
DR   PDBsum; 2B2V; -.
DR   PDBsum; 2B2W; -.
DR   PDBsum; 2C1J; -.
DR   PDBsum; 2C1N; -.
DR   PDBsum; 2CO0; -.
DR   PDBsum; 2CV5; -.
DR   PDBsum; 2FSA; -.
DR   PDBsum; 2KWJ; -.
DR   PDBsum; 2KWK; -.
DR   PDBsum; 2L75; -.
DR   PDBsum; 2LBM; -.
DR   PDBsum; 2LGG; -.
DR   PDBsum; 2M0O; -.
DR   PDBsum; 2NDF; -.
DR   PDBsum; 2NDG; -.
DR   PDBsum; 2OQ6; -.
DR   PDBsum; 2OT7; -.
DR   PDBsum; 2OX0; -.
DR   PDBsum; 2RI7; -.
DR   PDBsum; 2RR4; -.
DR   PDBsum; 2UXN; -.
DR   PDBsum; 2V85; -.
DR   PDBsum; 2V89; -.
DR   PDBsum; 2VNF; -.
DR   PDBsum; 2VPG; -.
DR   PDBsum; 2X0L; -.
DR   PDBsum; 3A1B; -.
DR   PDBsum; 3AFA; -.
DR   PDBsum; 3AVR; -.
DR   PDBsum; 3AYW; -.
DR   PDBsum; 3AZE; -.
DR   PDBsum; 3AZF; -.
DR   PDBsum; 3AZG; -.
DR   PDBsum; 3AZH; -.
DR   PDBsum; 3AZI; -.
DR   PDBsum; 3AZJ; -.
DR   PDBsum; 3AZK; -.
DR   PDBsum; 3AZL; -.
DR   PDBsum; 3AZM; -.
DR   PDBsum; 3AZN; -.
DR   PDBsum; 3B95; -.
DR   PDBsum; 3FDT; -.
DR   PDBsum; 3KMT; -.
DR   PDBsum; 3KQI; -.
DR   PDBsum; 3LQI; -.
DR   PDBsum; 3LQJ; -.
DR   PDBsum; 3MP1; -.
DR   PDBsum; 3O34; -.
DR   PDBsum; 3O35; -.
DR   PDBsum; 3O37; -.
DR   PDBsum; 3QJ6; -.
DR   PDBsum; 3RIG; -.
DR   PDBsum; 3RIY; -.
DR   PDBsum; 3SOU; -.
DR   PDBsum; 3SOW; -.
DR   PDBsum; 3U31; -.
DR   PDBsum; 3U3D; -.
DR   PDBsum; 3U4S; -.
DR   PDBsum; 3U5N; -.
DR   PDBsum; 3U5O; -.
DR   PDBsum; 3U5P; -.
DR   PDBsum; 3UEE; -.
DR   PDBsum; 3UEF; -.
DR   PDBsum; 3UIG; -.
DR   PDBsum; 3UII; -.
DR   PDBsum; 3UIK; -.
DR   PDBsum; 3V43; -.
DR   PDBsum; 3W96; -.
DR   PDBsum; 3W97; -.
DR   PDBsum; 3W98; -.
DR   PDBsum; 3W99; -.
DR   PDBsum; 3WA9; -.
DR   PDBsum; 3WAA; -.
DR   PDBsum; 3WKJ; -.
DR   PDBsum; 3X1S; -.
DR   PDBsum; 3X1T; -.
DR   PDBsum; 3X1U; -.
DR   PDBsum; 3X1V; -.
DR   PDBsum; 3ZG6; -.
DR   PDBsum; 3ZVY; -.
DR   PDBsum; 4A0J; -.
DR   PDBsum; 4A0N; -.
DR   PDBsum; 4A7J; -.
DR   PDBsum; 4BD3; -.
DR   PDBsum; 4C1Q; -.
DR   PDBsum; 4F4U; -.
DR   PDBsum; 4F56; -.
DR   PDBsum; 4FWF; -.
DR   PDBsum; 4HON; -.
DR   PDBsum; 4I51; -.
DR   PDBsum; 4L7X; -.
DR   PDBsum; 4LK9; -.
DR   PDBsum; 4LKA; -.
DR   PDBsum; 4LLB; -.
DR   PDBsum; 4LXL; -.
DR   PDBsum; 4N4H; -.
DR   PDBsum; 4QBQ; -.
DR   PDBsum; 4QBR; -.
DR   PDBsum; 4QBS; -.
DR   PDBsum; 4TN7; -.
DR   PDBsum; 4U68; -.
DR   PDBsum; 4UP0; -.
DR   PDBsum; 4UY4; -.
DR   PDBsum; 4X3K; -.
DR   PDBsum; 4Y6L; -.
DR   PDBsum; 4YHP; -.
DR   PDBsum; 4YHZ; -.
DR   PDBsum; 4YM5; -.
DR   PDBsum; 4YM6; -.
DR   PDBsum; 4Z0R; -.
DR   PDBsum; 4Z2M; -.
DR   PDBsum; 5AV5; -.
DR   PDBsum; 5AV6; -.
DR   PDBsum; 5AV8; -.
DR   PDBsum; 5AV9; -.
DR   PDBsum; 5AVB; -.
DR   PDBsum; 5AVC; -.
DR   PDBsum; 5B24; -.
DR   PDBsum; 5B2I; -.
DR   PDBsum; 5B2J; -.
DR   PDBsum; 5B31; -.
DR   PDBsum; 5C11; -.
DR   PDBsum; 5C13; -.
DR   PDBsum; 5C3I; -.
DR   PDBsum; 5CPI; -.
DR   PDBsum; 5CPJ; -.
DR   PDBsum; 5CPK; -.
DR   PDBsum; 5D6Y; -.
DR   PDBsum; 5DAH; -.
DR   PDBsum; 5FB0; -.
DR   PDBsum; 5FB1; -.
DR   PDBsum; 5FFV; -.
DR   PDBsum; 5GH9; -.
DR   PDBsum; 5GSE; -.
DR   PDBsum; 5GSU; -.
DR   PDBsum; 5GT0; -.
DR   PDBsum; 5GT3; -.
DR   PDBsum; 5GTC; -.
DR   PDBsum; 5H6Q; -.
DR   PDBsum; 5H6R; -.
DR   PDBsum; 5HJB; -.
DR   PDBsum; 5HJC; -.
DR   PDBsum; 5HJD; -.
DR   PDBsum; 5HYN; -.
DR   PDBsum; 5IQL; -.
DR   PDBsum; 5J3V; -.
DR   PDBsum; 5J9S; -.
DR   PDBsum; 5JHN; -.
DR   PDBsum; 5JIN; -.
DR   PDBsum; 5JIY; -.
DR   PDBsum; 5JJ0; -.
DR   PDBsum; 5JRG; -.
DR   PDBsum; 5KJH; -.
DR   PDBsum; 5KJI; -.
DR   PDBsum; 5KKL; -.
DR   PDBsum; 5LUG; -.
DR   PDBsum; 5M5G; -.
DR   PDBsum; 5MR8; -.
DR   PDBsum; 5NNC; -.
DR   PDBsum; 5NND; -.
DR   PDBsum; 5OY3; -.
DR   PDBsum; 5SVX; -.
DR   PDBsum; 5SVY; -.
DR   PDBsum; 5SZB; -.
DR   PDBsum; 5SZC; -.
DR   PDBsum; 5T0K; -.
DR   PDBsum; 5T0M; -.
DR   PDBsum; 5T1G; -.
DR   PDBsum; 5T1I; -.
DR   PDBsum; 5T8R; -.
DR   PDBsum; 5TBN; -.
DR   PDBsum; 5TDR; -.
DR   PDBsum; 5TDW; -.
DR   PDBsum; 5U2J; -.
DR   PDBsum; 5V21; -.
DR   PDBsum; 5V22; -.
DR   PDBsum; 5VA6; -.
DR   PDBsum; 5VAB; -.
DR   PDBsum; 5VGE; -.
DR   PDBsum; 5VNB; -.
DR   PDBsum; 5WFC; -.
DR   PDBsum; 5WLE; -.
DR   PDBsum; 5WVO; -.
DR   PDBsum; 5WXG; -.
DR   PDBsum; 5WXH; -.
DR   PDBsum; 5WYI; -.
DR   PDBsum; 5X60; -.
DR   PDBsum; 5XF3; -.
DR   PDBsum; 5XF4; -.
DR   PDBsum; 5XF5; -.
DR   PDBsum; 5XFQ; -.
DR   PDBsum; 5XFR; -.
DR   PDBsum; 5XNV; -.
DR   PDBsum; 5XTZ; -.
DR   PDBsum; 5Y0C; -.
DR   PDBsum; 5Y0D; -.
DR   PDBsum; 5Y20; -.
DR   PDBsum; 5Y2F; -.
DR   PDBsum; 5Z23; -.
DR   PDBsum; 5Z30; -.
DR   PDBsum; 6AXJ; -.
DR   PDBsum; 6AZE; -.
DR   PDBsum; 6BHD; -.
DR   PDBsum; 6BHE; -.
DR   PDBsum; 6BHG; -.
DR   PDBsum; 6BHH; -.
DR   PDBsum; 6BHI; -.
DR   PDBsum; 6D07; -.
DR   PDBsum; 6D08; -.
DR   PDBsum; 6E83; -.
DR   PDBsum; 6E86; -.
DR   PDBsum; 6F6D; -.
DR   PDBsum; 6HKT; -.
DR   PDBsum; 6HTS; -.
DR   PDBsum; 6IIS; -.
DR   PDBsum; 6IIT; -.
DR   PDBsum; 6IQ4; -.
DR   PDBsum; 6JR0; -.
DR   PDBsum; 6JR1; -.
DR   PDBsum; 6MIL; -.
DR   PDBsum; 6MIM; -.
DR   PDBsum; 6MIN; -.
DR   PDBsum; 6MIO; -.
DR   PDBsum; 6MIQ; -.
DR   PDBsum; 6R8Y; -.
DR   PDBsum; 6R8Z; -.
DR   PDBsum; 6R90; -.
DR   PDBsum; 6R91; -.
DR   PDBsum; 6R92; -.
DR   PDBsum; 6R93; -.
DR   PDBsum; 6R94; -.
DR   PDBsum; 6UHG; -.
DR   SMR; P68431; -.
DR   BioGrid; 113946; 655.
DR   BioGrid; 113947; 14.
DR   BioGrid; 113948; 14.
DR   BioGrid; 113949; 205.
DR   BioGrid; 113950; 8.
DR   BioGrid; 113951; 8.
DR   BioGrid; 113952; 7.
DR   BioGrid; 113953; 11.
DR   BioGrid; 113954; 26.
DR   BioGrid; 114458; 11.
DR   CORUM; P68431; -.
DR   DIP; DIP-29371N; -.
DR   ELM; P68431; -.
DR   IntAct; P68431; 446.
DR   MINT; P68431; -.
DR   STRING; 9606.ENSP00000484841; -.
DR   BindingDB; P68431; -.
DR   iPTMnet; P68431; -.
DR   PhosphoSitePlus; P68431; -.
DR   SwissPalm; P68431; -.
DR   BioMuta; HIST1H3A; -.
DR   DMDM; 55977055; -.
DR   EPD; P68431; -.
DR   jPOST; P68431; -.
DR   MassIVE; P68431; -.
DR   MaxQB; P68431; -.
DR   PaxDb; P68431; -.
DR   PeptideAtlas; P68431; -.
DR   PRIDE; P68431; -.
DR   ProteomicsDB; 57541; -.
DR   TopDownProteomics; P68431; -.
DR   ABCD; P68431; -.
DR   DNASU; 8350; -.
DR   DNASU; 8352; -.
DR   DNASU; 8353; -.
DR   DNASU; 8355; -.
DR   DNASU; 8356; -.
DR   DNASU; 8357; -.
DR   Ensembl; ENST00000356476; ENSP00000366999; ENSG00000197409.
DR   Ensembl; ENST00000359303; ENSP00000352252; ENSG00000197153.
DR   Ensembl; ENST00000369163; ENSP00000358160; ENSG00000278828.
DR   Ensembl; ENST00000612966; ENSP00000484658; ENSG00000287080.
DR   Ensembl; ENST00000613854; ENSP00000480826; ENSG00000275714.
DR   Ensembl; ENST00000614378; ENSP00000484638; ENSG00000273983.
DR   Ensembl; ENST00000614911; ENSP00000482271; ENSG00000274750.
DR   Ensembl; ENST00000616365; ENSP00000483283; ENSG00000275379.
DR   Ensembl; ENST00000618052; ENSP00000484095; ENSG00000277775.
DR   Ensembl; ENST00000621411; ENSP00000484841; ENSG00000286522.
DR   Ensembl; ENST00000634733; ENSP00000489282; ENSG00000274750.
DR   GeneID; 8350; -.
DR   GeneID; 8351; -.
DR   GeneID; 8352; -.
DR   GeneID; 8353; -.
DR   GeneID; 8354; -.
DR   GeneID; 8355; -.
DR   GeneID; 8356; -.
DR   GeneID; 8357; -.
DR   GeneID; 8358; -.
DR   GeneID; 8968; -.
DR   KEGG; hsa:8350; -.
DR   KEGG; hsa:8351; -.
DR   KEGG; hsa:8352; -.
DR   KEGG; hsa:8353; -.
DR   KEGG; hsa:8354; -.
DR   KEGG; hsa:8355; -.
DR   KEGG; hsa:8356; -.
DR   KEGG; hsa:8357; -.
DR   KEGG; hsa:8358; -.
DR   KEGG; hsa:8968; -.
DR   UCSC; uc003nfp.2; human.
DR   CTD; 8350; -.
DR   CTD; 8351; -.
DR   CTD; 8352; -.
DR   CTD; 8353; -.
DR   CTD; 8354; -.
DR   CTD; 8355; -.
DR   CTD; 8356; -.
DR   CTD; 8357; -.
DR   CTD; 8358; -.
DR   CTD; 8968; -.
DR   DisGeNET; 8350; -.
DR   DisGeNET; 8351; -.
DR   DisGeNET; 8352; -.
DR   DisGeNET; 8353; -.
DR   DisGeNET; 8354; -.
DR   DisGeNET; 8355; -.
DR   DisGeNET; 8356; -.
DR   DisGeNET; 8357; -.
DR   DisGeNET; 8358; -.
DR   DisGeNET; 8968; -.
DR   GeneCards; H3C1; -.
DR   GeneCards; H3C10; -.
DR   GeneCards; H3C11; -.
DR   GeneCards; H3C12; -.
DR   GeneCards; H3C2; -.
DR   GeneCards; H3C3; -.
DR   GeneCards; H3C4; -.
DR   GeneCards; H3C6; -.
DR   GeneCards; H3C7; -.
DR   GeneCards; H3C8; -.
DR   HGNC; HGNC:4766; H3C1.
DR   HGNC; HGNC:4775; H3C10.
DR   HGNC; HGNC:4771; H3C11.
DR   HGNC; HGNC:4774; H3C12.
DR   HGNC; HGNC:4776; H3C2.
DR   HGNC; HGNC:4768; H3C3.
DR   HGNC; HGNC:4767; H3C4.
DR   HGNC; HGNC:4769; H3C6.
DR   HGNC; HGNC:4773; H3C7.
DR   HGNC; HGNC:4772; H3C8.
DR   HPA; CAB070190; -.
DR   HPA; HPA042570; -.
DR   MalaCards; H3C1; -.
DR   MalaCards; H3C2; -.
DR   MIM; 137800; phenotype.
DR   MIM; 602810; gene.
DR   MIM; 602811; gene.
DR   MIM; 602812; gene.
DR   MIM; 602813; gene.
DR   MIM; 602814; gene.
DR   MIM; 602815; gene.
DR   MIM; 602816; gene.
DR   MIM; 602817; gene.
DR   MIM; 602818; gene.
DR   MIM; 602819; gene.
DR   neXtProt; NX_P68431; -.
DR   OpenTargets; ENSG00000197153; -.
DR   OpenTargets; ENSG00000197409; -.
DR   OpenTargets; ENSG00000273983; -.
DR   OpenTargets; ENSG00000274750; -.
DR   OpenTargets; ENSG00000275379; -.
DR   OpenTargets; ENSG00000275714; -.
DR   OpenTargets; ENSG00000277775; -.
DR   OpenTargets; ENSG00000278828; -.
DR   PharmGKB; PA29148; -.
DR   eggNOG; KOG1745; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00960000186578; -.
DR   HOGENOM; CLU_078295_4_0_1; -.
DR   InParanoid; P68431; -.
DR   KO; K11253; -.
DR   OMA; TEFANEM; -.
DR   OrthoDB; 1564596at2759; -.
DR   PhylomeDB; P68431; -.
DR   TreeFam; TF314241; -.
DR   Reactome; R-HSA-1266695; Interleukin-7 signaling.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-3214842; HDMs demethylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-3247509; Chromatin modifying enzymes.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SIGNOR; P68431; -.
DR   ChiTaRS; HIST1H3B; human.
DR   ChiTaRS; HIST1H3F; human.
DR   ChiTaRS; HIST1H3H; human.
DR   ChiTaRS; HIST1H3J; human.
DR   EvolutionaryTrace; P68431; -.
DR   GeneWiki; HIST1H3A; -.
DR   GeneWiki; HIST1H3B; -.
DR   GeneWiki; HIST1H3C; -.
DR   GeneWiki; HIST1H3D; -.
DR   GeneWiki; HIST1H3E; -.
DR   GeneWiki; HIST1H3F; -.
DR   GeneWiki; HIST1H3G; -.
DR   GeneWiki; HIST1H3H; -.
DR   GeneWiki; HIST1H3I; -.
DR   GeneWiki; HIST1H3J; -.
DR   Pharos; P68431; Tbio.
DR   PRO; PR:P68431; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P68431; protein.
DR   Bgee; ENSG00000197153; Expressed in stomach and 42 other tissues.
DR   Genevisible; P68431; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0000228; C:nuclear chromosome; IDA:UniProtKB.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0006325; P:chromatin organization; TAS:Reactome.
DR   GO; GO:0000183; P:chromatin silencing at rDNA; TAS:Reactome.
DR   GO; GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0038111; P:interleukin-7-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0060968; P:regulation of gene silencing; IDA:BHF-UCL.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0032200; P:telomere organization; TAS:BHF-UCL.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   PANTHER; PTHR11426; PTHR11426; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00322; HISTONE_H3_1; 1.
DR   PROSITE; PS00959; HISTONE_H3_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Chromosome; Citrullination;
KW   Direct protein sequencing; Disease mutation; DNA-binding; Hydroxylation;
KW   Methylation; Nucleosome core; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:16185088"
FT   CHAIN           2..136
FT                   /note="Histone H3.1"
FT                   /id="PRO_0000221245"
FT   MOD_RES         3
FT                   /note="Asymmetric dimethylarginine; by PRMT6; alternate"
FT                   /evidence="ECO:0000269|PubMed:17898714,
FT                   ECO:0000269|PubMed:18077460, ECO:0000269|PubMed:18079182"
FT   MOD_RES         3
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:16567635"
FT   MOD_RES         4
FT                   /note="Phosphothreonine; by HASPIN"
FT                   /evidence="ECO:0000269|PubMed:15681610,
FT                   ECO:0000269|PubMed:16185088"
FT   MOD_RES         5
FT                   /note="Allysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27735137"
FT   MOD_RES         5
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708"
FT   MOD_RES         5
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708"
FT   MOD_RES         5
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         5
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708"
FT   MOD_RES         5
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         5
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708"
FT   MOD_RES         7
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:20228790"
FT   MOD_RES         9
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15345777,
FT                   ECO:0000269|PubMed:16567635"
FT   MOD_RES         9
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         10
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:11242053,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708"
FT   MOD_RES         10
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:11242053,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588,
FT                   ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         10
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         10
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         10
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:11242053,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708"
FT   MOD_RES         11
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000269|PubMed:28190768,
FT                   ECO:0000269|PubMed:29480802"
FT   MOD_RES         11
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC, RPS6KA3,
FT                   RPS6KA4 and RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:10464286,
FT                   ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:12560483,
FT                   ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16457588"
FT   MOD_RES         12
FT                   /note="Phosphothreonine; by PKC and CHEK1"
FT                   /evidence="ECO:0000269|PubMed:12560483,
FT                   ECO:0000269|PubMed:18066052, ECO:0000269|PubMed:18243098"
FT   MOD_RES         15
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         15
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         15
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588,
FT                   ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         15
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         15
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         18
FT                   /note="Asymmetric dimethylarginine; by CARM1; alternate"
FT                   /evidence="ECO:0000269|PubMed:15345777,
FT                   ECO:0000269|PubMed:15471871, ECO:0000269|PubMed:16497732"
FT   MOD_RES         18
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15345777,
FT                   ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16567635"
FT   MOD_RES         19
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         19
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         19
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:17194708"
FT   MOD_RES         19
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         19
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         19
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         19
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         24
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         24
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708"
FT   MOD_RES         27
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000269|PubMed:16567635"
FT   MOD_RES         28
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         28
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         28
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         28
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         28
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         28
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         28
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         28
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         29
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000269|PubMed:28190768,
FT                   ECO:0000269|PubMed:29480802"
FT   MOD_RES         29
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC and
FT                   RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:10464286,
FT                   ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:15681610,
FT                   ECO:0000269|PubMed:15684425, ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16457588"
FT   MOD_RES         37
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15983376,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:17194708"
FT   MOD_RES         37
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15983376,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:17194708"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17189264,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         37
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15983376,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:17194708"
FT   MOD_RES         38
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000269|PubMed:15983376"
FT   MOD_RES         42
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:19783980"
FT   MOD_RES         57
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:22387026"
FT   MOD_RES         57
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         57
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         57
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708"
FT   MOD_RES         57
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         57
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         57
FT                   /note="N6-methyllysine; by EHMT2; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:22387026"
FT   MOD_RES         57
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20850016"
FT   MOD_RES         65
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         65
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         80
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         80
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15525939,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         80
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         80
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708"
FT   MOD_RES         80
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         80
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15525939,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16627869,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         80
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435,
FT                   ECO:0000269|PubMed:29211711"
FT   MOD_RES         81
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20850016"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71DI3"
FT   MOD_RES         116
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19520870"
FT   MOD_RES         116
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         123
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         123
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19520870,
FT                   ECO:0000269|PubMed:23415232"
FT   MOD_RES         123
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         123
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         123
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435,
FT                   ECO:0000269|PubMed:27436229"
FT   VARIANT         28
FT                   /note="K -> M (in GLM; non-brain stem pediatric
FT                   glioblastoma and diffuse intrinsic pontine glioma; somatic
FT                   mutation; results in a global decrease of H3K27me3 levels;
FT                   dbSNP:rs1057519904)"
FT                   /evidence="ECO:0000269|PubMed:22286216,
FT                   ECO:0000269|PubMed:23603901"
FT                   /id="VAR_079018"
FT   VARIANT         37
FT                   /note="K -> I (probable disease-associated mutation found
FT                   in pediatric undifferentiated soft tissue sarcoma samples;
FT                   somatic mutation; results in global decrease of H3K36me2
FT                   and H3K36me3 levels and increased H3K27me3 levels)"
FT                   /evidence="ECO:0000269|PubMed:27174990"
FT                   /id="VAR_079019"
FT   VARIANT         37
FT                   /note="K -> M (probable disease-associated mutation found
FT                   in pediatric undifferentiated soft tissue sarcoma samples;
FT                   somatic mutation; also found in a subset of human
FT                   papillomavirus-negative head and neck squamous cell
FT                   carcinomas; results in global decrease of H3K36me2 and
FT                   H3K36me3 levels and increased H3K27me3 levels)"
FT                   /evidence="ECO:0000269|PubMed:27174990,
FT                   ECO:0000269|PubMed:28067913"
FT                   /id="VAR_079020"
FT   CONFLICT        70
FT                   /note="R -> C (in Ref. 13; AAH67493)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        100
FT                   /note="Y -> T (in Ref. 7; CAB02546)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        122
FT                   /note="P -> L (in Ref. 13; AAH66884)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        135
FT                   /note="Missing (in Ref. 2; AAA52651)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..7
FT                   /evidence="ECO:0000244|PDB:5SVY"
FT   STRAND          9..15
FT                   /evidence="ECO:0000244|PDB:5WVO"
FT   STRAND          25..27
FT                   /evidence="ECO:0000244|PDB:4X3K"
FT   STRAND          32..34
FT                   /evidence="ECO:0000244|PDB:5VA6"
FT   STRAND          35..37
FT                   /evidence="ECO:0000244|PDB:5V22"
FT   STRAND          45..49
FT                   /evidence="ECO:0000244|PDB:5T1I"
FT   HELIX           50..58
FT                   /evidence="ECO:0000244|PDB:5C3I"
FT   HELIX           65..77
FT                   /evidence="ECO:0000244|PDB:5Y0D"
FT   STRAND          80..82
FT                   /evidence="ECO:0000244|PDB:5AV6"
FT   HELIX           87..114
FT                   /evidence="ECO:0000244|PDB:5Y0D"
FT   STRAND          118..120
FT                   /evidence="ECO:0000244|PDB:5Y0D"
FT   HELIX           122..132
FT                   /evidence="ECO:0000244|PDB:5Y0D"
SQ   SEQUENCE   136 AA;  15404 MW;  9B89008EA50A0EF6 CRC64;
     MARTKQTARK STGGKAPRKQ LATKAARKSA PATGGVKKPH RYRPGTVALR EIRRYQKSTE
     LLIRKLPFQR LVREIAQDFK TDLRFQSSAV MALQEACEAY LVGLFEDTNL CAIHAKRVTI
     MPKDIQLARR IRGERA
//
ID   H31T_HUMAN              Reviewed;         136 AA.
AC   Q16695; B2R5K3; Q6FGU4;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 194.
DE   RecName: Full=Histone H3.1t;
DE            Short=H3/t;
DE            Short=H3t;
DE   AltName: Full=H3/g;
GN   Name=HIST3H3; Synonyms=H3FT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8834248; DOI=10.1007/bf02267072;
RA   Albig W., Ebentheuer J., Klobeck H., Kunz J., Doenecke D.;
RT   "A solitary human H3 histone gene on chromosome 1.";
RL   Hum. Genet. 97:486-491(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-19 AND LYS-24, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   PHOSPHORYLATION AT SER-58 AND THR-81.
RX   PubMed=20850016; DOI=10.1016/j.cell.2010.08.020;
RA   Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S., Butter F.,
RA   Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G., Mann M.;
RT   "Quantitative interaction proteomics and genome-wide profiling of
RT   epigenetic histone marks and their readers.";
RL   Cell 142:967-980(2010).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- INTERACTION:
CC       Q96GD4:AURKB; NbExp=8; IntAct=EBI-358900, EBI-624291;
CC       P45973:CBX5; NbExp=2; IntAct=EBI-358900, EBI-78219;
CC       P16104:H2AFX; NbExp=12; IntAct=EBI-358900, EBI-494830;
CC       P04908:HIST1H2AE; NbExp=2; IntAct=EBI-358900, EBI-358971;
CC       P62805:HIST1H4K; NbExp=3; IntAct=EBI-358900, EBI-302023;
CC       Q71DI3:HIST2H3D; NbExp=2; IntAct=EBI-358900, EBI-750650;
CC       O60341:KDM1A; NbExp=2; IntAct=EBI-358900, EBI-710124;
CC       O75164:KDM4A; NbExp=6; IntAct=EBI-358900, EBI-936709;
CC       P49321-2:NASP; NbExp=4; IntAct=EBI-358900, EBI-7038920;
CC       Q9UHJ3:SFMBT1; NbExp=4; IntAct=EBI-358900, EBI-747398;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- TISSUE SPECIFICITY: Expressed in testicular cells.
CC   -!- DEVELOPMENTAL STAGE: Expressed during S phase, then expression strongly
CC       decreases as cell division slows down during the process of
CC       differentiation.
CC   -!- PTM: Acetylation is generally linked to gene activation. Acetylation on
CC       Lys-10 (H3K9ac) impairs methylation at Arg-9 (H3R8me2s). Acetylation on
CC       Lys-19 (H3K18ac) and Lys-24 (H3K24ac) favors methylation at Arg-18
CC       (H3R17me). Acetylation at Lys-123 (H3K122ac) by EP300/p300 plays a
CC       central role in chromatin structure: localizes at the surface of the
CC       histone octamer and stimulates transcription, possibly by promoting
CC       nucleosome instability (By similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Citrullination at Arg-9 (H3R8ci) and/or Arg-18 (H3R17ci) by PADI4
CC       impairs methylation and represses transcription.
CC       {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Asymmetric dimethylation at Arg-18 (H3R17me2a) by CARM1 is linked
CC       to gene activation. Symmetric dimethylation at Arg-9 (H3R8me2s) by
CC       PRMT5 is linked to gene repression. Asymmetric dimethylation at Arg-3
CC       (H3R2me2a) by PRMT6 is linked to gene repression and is mutually
CC       exclusive with H3 Lys-5 methylation (H3K4me2 and H3K4me3). H3R2me2a is
CC       present at the 3' of genes regardless of their transcription state and
CC       is enriched on inactive promoters, while it is absent on active
CC       promoters (By similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Methylation at Lys-5 (H3K4me), Lys-37 (H3K36me) and Lys-80
CC       (H3K79me) are linked to gene activation. Methylation at Lys-5 (H3K4me)
CC       facilitates subsequent acetylation of H3 and H4. Methylation at Lys-80
CC       (H3K79me) is associated with DNA double-strand break (DSB) responses
CC       and is a specific target for TP53BP1. Methylation at Lys-10 (H3K9me)
CC       and Lys-28 (H3K27me) are linked to gene repression. Methylation at Lys-
CC       10 (H3K9me) is a specific target for HP1 proteins (CBX1, CBX3 and CBX5)
CC       and prevents subsequent phosphorylation at Ser-11 (H3S10ph) and
CC       acetylation of H3 and H4. Methylation at Lys-5 (H3K4me) and Lys-80
CC       (H3K79me) require preliminary monoubiquitination of H2B at 'Lys-120'.
CC       Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me) are enriched in
CC       inactive X chromosome chromatin. Monomethylation at Lys-57 (H3K56me1)
CC       by EHMT2/G9A in G1 phase promotes interaction with PCNA and is required
CC       for DNA replication (By similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Phosphorylated at Thr-4 (H3T3ph) by HASPIN during prophase and
CC       dephosphorylated during anaphase. Phosphorylation at Ser-11 (H3S10ph)
CC       by AURKB is crucial for chromosome condensation and cell-cycle
CC       progression during mitosis and meiosis. In addition phosphorylation at
CC       Ser-11 (H3S10ph) by RPS6KA4 and RPS6KA5 is important during interphase
CC       because it enables the transcription of genes following external
CC       stimulation, like mitogens, stress, growth factors or UV irradiation
CC       and result in the activation of genes, such as c-fos and c-jun.
CC       Phosphorylation at Ser-11 (H3S10ph), which is linked to gene
CC       activation, prevents methylation at Lys-10 (H3K9me) but facilitates
CC       acetylation of H3 and H4. Phosphorylation at Ser-11 (H3S10ph) by AURKB
CC       mediates the dissociation of HP1 proteins (CBX1, CBX3 and CBX5) from
CC       heterochromatin. Phosphorylation at Ser-11 (H3S10ph) is also an
CC       essential regulatory mechanism for neoplastic cell transformation.
CC       Phosphorylated at Ser-29 (H3S28ph) by MAP3K20 isoform 1, RPS6KA5 or
CC       AURKB during mitosis or upon ultraviolet B irradiation. Phosphorylation
CC       at Thr-7 (H3T6ph) by PRKCB is a specific tag for epigenetic
CC       transcriptional activation that prevents demethylation of Lys-5
CC       (H3K4me) by LSD1/KDM1A. At centromeres, specifically phosphorylated at
CC       Thr-12 (H3T11ph) from prophase to early anaphase, by DAPK3 and PKN1.
CC       Phosphorylation at Thr-12 (H3T11ph) by PKN1 is a specific tag for
CC       epigenetic transcriptional activation that promotes demethylation of
CC       Lys-10 (H3K9me) by KDM4C/JMJD2C. Phosphorylation at Tyr-42 (H3Y41ph) by
CC       JAK2 promotes exclusion of CBX5 (HP1 alpha) from chromatin (By
CC       similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Lysine deamination at Lys-5 (H3K4all) to form allysine is mediated
CC       by LOXL2. Allysine formation by LOXL2 only takes place on H3K4me3 and
CC       results in gene repression (By similarity).
CC       {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes with
CC       histone acetylation. It is present during late spermatogenesis.
CC       {ECO:0000250|UniProtKB:P68433}.
CC   -!- PTM: Succinylation at Lys-80 (H3K79succ) by KAT2A takes place with a
CC       maximum frequency around the transcription start sites of genes. It
CC       gives a specific tag for epigenetic transcription activation.
CC       Desuccinylation at Lys-123 (H3K122succ) by SIRT7 in response to DNA
CC       damage promotes chromatin condensation and double-strand breaks (DSBs)
CC       repair. {ECO:0000250|UniProtKB:P68431}.
CC   -!- PTM: Serine ADP-ribosylation constitutes the primary form of ADP-
CC       ribosylation of proteins in response to DNA damage. Serine ADP-
CC       ribosylation at Ser-11 (H3S10ADPr) is mutually exclusive with
CC       phosphorylation at Ser-11 (H3S10ph) and impairs acetylation at Lys-10
CC       (H3K9ac). {ECO:0000250|UniProtKB:P68431}.
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z49861; CAA90020.1; -; Genomic_DNA.
DR   EMBL; AF531308; AAN39284.1; -; Genomic_DNA.
DR   EMBL; CR542013; CAG46810.1; -; mRNA.
DR   EMBL; AK312217; BAG35150.1; -; mRNA.
DR   EMBL; AL139288; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471098; EAW69877.1; -; Genomic_DNA.
DR   EMBL; BC069079; AAH69079.1; -; mRNA.
DR   EMBL; BC101837; AAI01838.1; -; mRNA.
DR   EMBL; BC101839; AAI01840.1; -; mRNA.
DR   CCDS; CCDS1572.1; -.
DR   PIR; S57473; S57473.
DR   RefSeq; NP_003484.1; NM_003493.2.
DR   PDB; 2V1D; X-ray; 3.10 A; C=2-22.
DR   PDB; 2YBP; X-ray; 2.02 A; C/D=31-42.
DR   PDB; 2YBS; X-ray; 2.32 A; C/D=31-42.
DR   PDB; 3A6N; X-ray; 2.70 A; A/E=1-136.
DR   PDB; 3T6R; X-ray; 1.95 A; D=2-8.
DR   PDB; 4V2V; X-ray; 2.00 A; C/D=26-30.
DR   PDB; 4V2W; X-ray; 1.81 A; C=17-36.
DR   PDB; 6OIE; X-ray; 2.08 A; C/D=2-20.
DR   PDBsum; 2V1D; -.
DR   PDBsum; 2YBP; -.
DR   PDBsum; 2YBS; -.
DR   PDBsum; 3A6N; -.
DR   PDBsum; 3T6R; -.
DR   PDBsum; 4V2V; -.
DR   PDBsum; 4V2W; -.
DR   PDBsum; 6OIE; -.
DR   SMR; Q16695; -.
DR   BioGrid; 113895; 242.
DR   DIP; DIP-922N; -.
DR   IntAct; Q16695; 159.
DR   MINT; Q16695; -.
DR   STRING; 9606.ENSP00000355657; -.
DR   iPTMnet; Q16695; -.
DR   PhosphoSitePlus; Q16695; -.
DR   SwissPalm; Q16695; -.
DR   BioMuta; HIST3H3; -.
DR   DMDM; 18202512; -.
DR   EPD; Q16695; -.
DR   jPOST; Q16695; -.
DR   MassIVE; Q16695; -.
DR   MaxQB; Q16695; -.
DR   PaxDb; Q16695; -.
DR   PeptideAtlas; Q16695; -.
DR   PRIDE; Q16695; -.
DR   ProteomicsDB; 61035; -.
DR   TopDownProteomics; Q16695; -.
DR   DNASU; 8290; -.
DR   Ensembl; ENST00000366696; ENSP00000355657; ENSG00000168148.
DR   Ensembl; ENST00000644869; ENSP00000494070; ENSG00000285435.
DR   GeneID; 8290; -.
DR   KEGG; hsa:8290; -.
DR   UCSC; uc001hsx.1; human.
DR   CTD; 8290; -.
DR   DisGeNET; 8290; -.
DR   GeneCards; H3-4; -.
DR   HGNC; HGNC:4778; HIST3H3.
DR   HPA; CAB001386; -.
DR   HPA; CAB003812; -.
DR   HPA; HPA042570; -.
DR   MIM; 602820; gene.
DR   neXtProt; NX_Q16695; -.
DR   OpenTargets; ENSG00000168148; -.
DR   PharmGKB; PA29153; -.
DR   eggNOG; KOG1745; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00960000186578; -.
DR   HOGENOM; CLU_078295_4_0_1; -.
DR   InParanoid; Q16695; -.
DR   KO; K11253; -.
DR   OMA; VTIMRRT; -.
DR   OrthoDB; 1564596at2759; -.
DR   PhylomeDB; Q16695; -.
DR   TreeFam; TF314241; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   SIGNOR; Q16695; -.
DR   EvolutionaryTrace; Q16695; -.
DR   GeneWiki; HIST3H3; -.
DR   GenomeRNAi; 8290; -.
DR   Pharos; Q16695; Tbio.
DR   PRO; PR:Q16695; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q16695; protein.
DR   Bgee; ENSG00000168148; Expressed in right testis and 60 other tissues.
DR   Genevisible; Q16695; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0016233; P:telomere capping; TAS:Reactome.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   PANTHER; PTHR11426; PTHR11426; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00322; HISTONE_H3_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Chromosome; Citrullination;
KW   DNA-binding; Hydroxylation; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..136
FT                   /note="Histone H3.1t"
FT                   /id="PRO_0000221248"
FT   MOD_RES         3
FT                   /note="Asymmetric dimethylarginine; by PRMT6; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         3
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         4
FT                   /note="Phosphothreonine; by HASPIN"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="Allysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         5
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         7
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         9
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         9
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         10
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         10
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         10
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         11
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         11
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC, RPS6KA3,
FT                   RPS6KA4 and RPS6KA5"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         12
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         15
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         15
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         15
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         15
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         15
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         18
FT                   /note="Asymmetric dimethylarginine; by CARM1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         18
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         19
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         19
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         19
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         19
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         24
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         24
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         24
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         24
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         27
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         28
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         28
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         28
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         28
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         29
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         29
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC and
FT                   RPS6KA5"
FT                   /evidence="ECO:0000244|PubMed:18691976"
FT   MOD_RES         37
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         37
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         37
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         37
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         38
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         42
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         57
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         57
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         57
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         57
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         57
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         57
FT                   /note="N6-methyllysine; by EHMT2; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         57
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20850016"
FT   MOD_RES         65
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         65
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         80
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         80
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         80
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         80
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         80
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         80
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         80
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         81
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20850016"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71DI3"
FT   MOD_RES         116
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         116
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         123
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         123
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         123
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         123
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   HELIX           3..5
FT                   /evidence="ECO:0000244|PDB:2V1D"
FT   HELIX           46..57
FT                   /evidence="ECO:0000244|PDB:3A6N"
FT   HELIX           65..76
FT                   /evidence="ECO:0000244|PDB:3A6N"
FT   TURN            77..79
FT                   /evidence="ECO:0000244|PDB:3A6N"
FT   STRAND          80..82
FT                   /evidence="ECO:0000244|PDB:3A6N"
FT   HELIX           87..114
FT                   /evidence="ECO:0000244|PDB:3A6N"
FT   STRAND          118..120
FT                   /evidence="ECO:0000244|PDB:3A6N"
FT   HELIX           122..131
FT                   /evidence="ECO:0000244|PDB:3A6N"
SQ   SEQUENCE   136 AA;  15508 MW;  37375A2C3A377B2B CRC64;
     MARTKQTARK STGGKAPRKQ LATKVARKSA PATGGVKKPH RYRPGTVALR EIRRYQKSTE
     LLIRKLPFQR LMREIAQDFK TDLRFQSSAV MALQEACESY LVGLFEDTNL CVIHAKRVTI
     MPKDIQLARR IRGERA
//
ID   H33_HUMAN               Reviewed;         136 AA.
AC   P84243; P06351; P33155; Q5VV55; Q5VV56; Q66I33; Q9V3W4;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 172.
DE   RecName: Full=Histone H3.3;
GN   Name=H3-3A {ECO:0000312|HGNC:HGNC:4764}; Synonyms=H3.3A, H3F3, H3F3A;
GN   ORFNames=PP781;
GN   and
GN   Name=H3-3B {ECO:0000312|HGNC:HGNC:4765}; Synonyms=H3.3B, H3F3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (H3-3A).
RC   TISSUE=Fibroblast;
RX   PubMed=2859593; DOI=10.1073/pnas.82.9.2834;
RA   Wells D., Kedes L.;
RT   "Structure of a human histone cDNA: evidence that basally expressed histone
RT   genes have intervening sequences and encode polyadenylylated mRNAs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:2834-2838(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (H3-3A).
RX   PubMed=3031613; DOI=10.1093/nar/15.7.2871;
RA   Wells D., Hoffman D., Kedes L.;
RT   "Unusual structure, evolutionary conservation of non-coding sequences and
RT   numerous pseudogenes characterize the human H3.3 histone multigene
RT   family.";
RL   Nucleic Acids Res. 15:2871-2889(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H3-3B).
RC   TISSUE=Testis;
RX   PubMed=8586426; DOI=10.1006/geno.1995.9878;
RA   Albig W., Bramlage B., Gruber K., Klobeck H.-G., Kunz J., Doenecke D.;
RT   "The human replacement histone H3.3B gene (H3F3B).";
RL   Genomics 30:264-272(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (H3-3B).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (H3-3A AND H3-3B).
RC   TISSUE=Bone marrow, Brain, Colon, Eye, Lung, Muscle, Spinal cord, Testis,
RC   and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PARTIAL PROTEIN SEQUENCE, METHYLATION AT LYS-10; LYS-28 AND LYS-37, AND
RP   ACETYLATION AT LYS-15 AND LYS-24.
RX   PubMed=7309716; DOI=10.1093/oxfordjournals.jbchem.a133573;
RA   Ohe Y., Iwai K.;
RT   "Human spleen histone H3. Isolation and amino acid sequence.";
RL   J. Biochem. 90:1205-1211(1981).
RN   [9]
RP   PROTEIN SEQUENCE OF 28-41, METHYLATION AT LYS-5; LYS-10; LYS-28 AND LYS-37,
RP   PHOSPHORYLATION AT THR-4; SER-11; SER-29 AND SER-32, ACETYLATION AT LYS-10
RP   AND LYS-15, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16185088; DOI=10.1021/bi050906n;
RA   Garcia B.A., Barber C.M., Hake S.B., Ptak C., Turner F.B., Busby S.A.,
RA   Shabanowitz J., Moran R.G., Allis C.D., Hunt D.F.;
RT   "Modifications of human histone H3 variants during mitosis.";
RL   Biochemistry 44:13202-13213(2005).
RN   [10]
RP   PROTEIN SEQUENCE OF 58-64; 117-120 AND 124-135, AND PHOSPHORYLATION AT
RP   SER-11 AND SER-29.
RX   PubMed=10464286; DOI=10.1074/jbc.274.36.25543;
RA   Goto H., Tomono Y., Ajiro K., Kosako H., Fujita M., Sakurai M., Okawa K.,
RA   Iwamatsu A., Okigaki T., Takahashi T., Inagaki M.;
RT   "Identification of a novel phosphorylation site on histone H3 coupled with
RT   mitotic chromosome condensation.";
RL   J. Biol. Chem. 274:25543-25549(1999).
RN   [11]
RP   METHYLATION AT LYS-10.
RX   PubMed=11242053; DOI=10.1038/35065132;
RA   Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T.;
RT   "Methylation of histone H3 lysine 9 creates a binding site for HP1
RT   proteins.";
RL   Nature 410:116-120(2001).
RN   [12]
RP   PHOSPHORYLATION AT SER-11 AND SER-29.
RX   PubMed=11856369; DOI=10.1046/j.1356-9597.2001.00498.x;
RA   Goto H., Yasui Y., Nigg E.A., Inagaki M.;
RT   "Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic
RT   chromosome condensation.";
RL   Genes Cells 7:11-17(2002).
RN   [13]
RP   PHOSPHORYLATION AT SER-11 AND THR-12.
RX   PubMed=12560483; DOI=10.1093/nar/gkg176;
RA   Preuss U., Landsberg G., Scheidtmann K.H.;
RT   "Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by
RT   Dlk/ZIP kinase.";
RL   Nucleic Acids Res. 31:878-885(2003).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH HIRA.
RX   PubMed=14718166; DOI=10.1016/s0092-8674(03)01064-x;
RA   Tagami H., Ray-Gallet D., Almouzni G., Nakatani Y.;
RT   "Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways
RT   dependent or independent of DNA synthesis.";
RL   Cell 116:51-61(2004).
RN   [15]
RP   METHYLATION AT ARG-18.
RX   PubMed=15471871; DOI=10.1074/jbc.m410021200;
RA   Ananthanarayanan M., Li S., Balasubramaniyan N., Suchy F.J., Walsh M.J.;
RT   "Ligand-dependent activation of the farnesoid X-receptor directs arginine
RT   methylation of histone H3 by CARM1.";
RL   J. Biol. Chem. 279:54348-54357(2004).
RN   [16]
RP   METHYLATION AT LYS-80.
RX   PubMed=15525939; DOI=10.1038/nature03114;
RA   Huyen Y., Zgheib O., Ditullio R.A. Jr., Gorgoulis V.G., Zacharatos P.,
RA   Petty T.J., Sheston E.A., Mellert H.S., Stavridi E.S., Halazonetis T.D.;
RT   "Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand
RT   breaks.";
RL   Nature 432:406-411(2004).
RN   [17]
RP   CITRULLINATION AT ARG-9 AND ARG-18, AND METHYLATION AT ARG-18.
RX   PubMed=15345777; DOI=10.1126/science.1101400;
RA   Wang Y., Wysocka J., Sayegh J., Lee Y.-H., Perlin J.R., Leonelli L.,
RA   Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S.,
RA   Stallcup M.R., Allis C.D., Coonrod S.A.;
RT   "Human PAD4 regulates histone arginine methylation levels via
RT   demethylimination.";
RL   Science 306:279-283(2004).
RN   [18]
RP   FUNCTION.
RX   PubMed=15776021; DOI=10.1038/sj.embor.7400366;
RA   Chow C.-M., Georgiou A., Szutorisz H., Maia e Silva A., Pombo A.,
RA   Barahona I., Dargelos E., Canzonetta C., Dillon N.;
RT   "Variant histone H3.3 marks promoters of transcriptionally active genes
RT   during mammalian cell division.";
RL   EMBO Rep. 6:354-360(2005).
RN   [19]
RP   PHOSPHORYLATION AT THR-4; SER-11 AND SER-29.
RX   PubMed=15681610; DOI=10.1101/gad.1267105;
RA   Dai J., Sultan S., Taylor S.S., Higgins J.M.G.;
RT   "The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation
RT   and normal metaphase chromosome alignment.";
RL   Genes Dev. 19:472-488(2005).
RN   [20]
RP   PHOSPHORYLATION AT SER-29.
RX   PubMed=15684425; DOI=10.1074/jbc.m410521200;
RA   Choi H.S., Choi B.Y., Cho Y.-Y., Zhu F., Bode A.M., Dong Z.;
RT   "Phosphorylation of Ser28 in histone H3 mediated by mixed lineage kinase-
RT   like mitogen-activated protein triple kinase alpha.";
RL   J. Biol. Chem. 280:13545-13553(2005).
RN   [21]
RP   PHOSPHORYLATION AT SER-11; SER-29 AND SER-32, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15851689; DOI=10.1073/pnas.0502413102;
RA   Hake S.B., Garcia B.A., Kauer M., Baker S.P., Shabanowitz J., Hunt D.F.,
RA   Allis C.D.;
RT   "Serine 31 phosphorylation of histone variant H3.3 is specific to regions
RT   bordering centromeres in metaphase chromosomes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:6344-6349(2005).
RN   [22]
RP   FUNCTION.
RX   PubMed=16258499; DOI=10.1038/sj.embor.7400561;
RA   Daury L., Chailleux C., Bonvallet J., Trouche D.;
RT   "Histone H3.3 deposition at E2F-regulated genes is linked to
RT   transcription.";
RL   EMBO Rep. 7:66-71(2006).
RN   [23]
RP   ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28, METHYLATION AT
RP   LYS-5; LYS-10; LYS-19; LYS-28; LYS-37; LYS-65; LYS-80 AND LYS-123, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16267050; DOI=10.1074/jbc.m509266200;
RA   Hake S.B., Garcia B.A., Duncan E.M., Kauer M., Dellaire G., Shabanowitz J.,
RA   Bazett-Jones D.P., Allis C.D., Hunt D.F.;
RT   "Expression patterns and post-translational modifications associated with
RT   mammalian histone H3 variants.";
RL   J. Biol. Chem. 281:559-568(2006).
RN   [24]
RP   METHYLATION AT LYS-5 AND LYS-10, ACETYLATION AT LYS-10, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=16457588; DOI=10.1021/pr050266a;
RA   Thomas C.E., Kelleher N.L., Mizzen C.A.;
RT   "Mass spectrometric characterization of human histone H3: a bird's eye
RT   view.";
RL   J. Proteome Res. 5:240-247(2006).
RN   [25]
RP   ACETYLATION AT LYS-10 AND LYS-15, METHYLATION AT ARG-18, AND CITRULLINATION
RP   AT ARG-18.
RX   PubMed=16497732; DOI=10.1210/me.2005-0365;
RA   Miao F., Li S., Chavez V., Lanting L., Natarajan R.;
RT   "Coactivator-associated arginine methyltransferase-1 enhances nuclear
RT   factor-kappaB-mediated gene transcription through methylation of histone H3
RT   at arginine 17.";
RL   Mol. Endocrinol. 20:1562-1573(2006).
RN   [26]
RP   METHYLATION AT ARG-3 BY PRMT6.
RX   PubMed=18079182; DOI=10.1101/gad.447007;
RA   Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y., Hsieh J.,
RA   Bauer U.M.;
RT   "PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4
RT   trimethylation.";
RL   Genes Dev. 21:3369-3380(2007).
RN   [27]
RP   CITRULLINATION AT ARG-3; ARG-9; ARG-18 AND ARG-27.
RX   PubMed=16567635; DOI=10.1073/pnas.0509639103;
RA   Arita K., Shimizu T., Hashimoto H., Hidaka Y., Yamada M., Sato M.;
RT   "Structural basis for histone N-terminal recognition by human
RT   peptidylarginine deiminase 4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5291-5296(2006).
RN   [28]
RP   ACETYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28; LYS-37;
RP   LYS-57 AND LYS-80, METHYLATION AT LYS-5; LYS-10; LYS-19; LYS-24; LYS-28;
RP   LYS-37; LYS-57; LYS-65; LYS-80 AND LYS-123, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17194708; DOI=10.1074/jbc.m607900200;
RA   Garcia B.A., Hake S.B., Diaz R.L., Kauer M., Morris S.A., Recht J.,
RA   Shabanowitz J., Mishra N., Strahl B.D., Allis C.D., Hunt D.F.;
RT   "Organismal differences in post-translational modifications in histones H3
RT   and H4.";
RL   J. Biol. Chem. 282:7641-7655(2007).
RN   [29]
RP   ACETYLATION AT LYS-37.
RX   PubMed=17189264; DOI=10.1074/jbc.m607909200;
RA   Morris S.A., Rao B., Garcia B.A., Hake S.B., Diaz R.L., Shabanowitz J.,
RA   Hunt D.F., Allis C.D., Lieb J.D., Strahl B.D.;
RT   "Identification of histone H3 lysine 36 acetylation as a highly conserved
RT   histone modification.";
RL   J. Biol. Chem. 282:7632-7640(2007).
RN   [30]
RP   METHYLATION AT ARG-3 BY PRMT6.
RX   PubMed=17898714; DOI=10.1038/nature06166;
RA   Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M.,
RA   Schuchlautz H., Luescher B., Amati B.;
RT   "Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are
RT   mutually exclusive.";
RL   Nature 449:933-937(2007).
RN   [31]
RP   METHYLATION AT ARG-3 BY PRMT6.
RX   PubMed=18077460; DOI=10.1074/jbc.c700192200;
RA   Iberg A.N., Espejo A., Cheng D., Kim D., Michaud-Levesque J., Richard S.,
RA   Bedford M.T.;
RT   "Arginine methylation of the histone H3 tail impedes effector binding.";
RL   J. Biol. Chem. 283:3006-3010(2008).
RN   [32]
RP   PHOSPHORYLATION AT THR-12.
RX   PubMed=18066052; DOI=10.1038/ncb1668;
RA   Metzger E., Yin N., Wissmann M., Kunowska N., Fischer K., Friedrichs N.,
RA   Patnaik D., Higgins J.M., Potier N., Scheidtmann K.H., Buettner R.,
RA   Schule R.;
RT   "Phosphorylation of histone H3 at threonine 11 establishes a novel
RT   chromatin mark for transcriptional regulation.";
RL   Nat. Cell Biol. 10:53-60(2008).
RN   [33]
RP   ACETYLATION AT LYS-116 AND LYS-123.
RX   PubMed=19520870; DOI=10.1074/jbc.m109.003202;
RA   Manohar M., Mooney A.M., North J.A., Nakkula R.J., Picking J.W., Edon A.,
RA   Fishel R., Poirier M.G., Ottesen J.J.;
RT   "Acetylation of histone H3 at the nucleosome dyad alters DNA-histone
RT   binding.";
RL   J. Biol. Chem. 284:23312-23321(2009).
RN   [34]
RP   PHOSPHORYLATION AT TYR-42.
RX   PubMed=19783980; DOI=10.1038/nature08448;
RA   Dawson M.A., Bannister A.J., Gottgens B., Foster S.D., Bartke T.,
RA   Green A.R., Kouzarides T.;
RT   "JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin.";
RL   Nature 461:819-822(2009).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-28, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [37]
RP   PHOSPHORYLATION AT SER-58 AND THR-81.
RX   PubMed=20850016; DOI=10.1016/j.cell.2010.08.020;
RA   Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S., Butter F.,
RA   Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G., Mann M.;
RT   "Quantitative interaction proteomics and genome-wide profiling of
RT   epigenetic histone marks and their readers.";
RL   Cell 142:967-980(2010).
RN   [38]
RP   PHOSPHORYLATION AT THR-7.
RX   PubMed=20228790; DOI=10.1038/nature08839;
RA   Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N.,
RA   Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N.,
RA   Beisenherz-Huss C., Gunther T., Buettner R., Schule R.;
RT   "Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at
RT   histone H3K4.";
RL   Nature 464:792-796(2010).
RN   [39]
RP   CROTONYLATION AT LYS-5; LYS-10; LYS-19; LYS-24; LYS-28 AND LYS-57.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [40]
RP   METHYLATION AT LYS-57.
RX   PubMed=22387026; DOI=10.1016/j.molcel.2012.01.019;
RA   Yu Y., Song C., Zhang Q., Dimaggio P.A., Garcia B.A., York A., Carey M.F.,
RA   Grunstein M.;
RT   "Histone H3 lysine 56 methylation regulates DNA replication through its
RT   interaction with PCNA.";
RL   Mol. Cell 46:7-17(2012).
RN   [41]
RP   CAUTION.
RX   PubMed=22483618; DOI=10.1016/j.molcel.2012.03.002;
RA   Herranz N., Dave N., Millanes-Romero A., Morey L., Diaz V.M.,
RA   Lorenz-Fonfria V., Gutierrez-Gallego R., Jeronimo C., Di Croce L.,
RA   Garcia de Herreros A., Peiro S.;
RT   "Lysyl oxidase-like 2 deaminates lysine 4 in histone H3.";
RL   Mol. Cell 46:369-376(2012).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [43]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-28, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [44]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [45]
RP   RETRACTION.
RX   PubMed=27392148; DOI=10.1016/j.molcel.2016.06.013;
RA   Herranz N., Dave N., Millanes-Romero A., Morey L., Diaz V.M.,
RA   Lorenz-Fonfria V., Gutierrez-Gallego R., Jeronimo C., Di Croce L.,
RA   Garcia de Herreros A., Peiro S.;
RL   Mol. Cell 63:180-180(2016).
RN   [46]
RP   SUCCINYLATION AT LYS-15; LYS-57; LYS-80 AND LYS-123.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [47]
RP   INVOLVEMENT IN GLM, AND VARIANT GLM MET-28.
RX   PubMed=22286216; DOI=10.1038/ng.1102;
RG   St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project;
RA   Wu G., Broniscer A., McEachron T.A., Lu C., Paugh B.S., Becksfort J.,
RA   Qu C., Ding L., Huether R., Parker M., Zhang J., Gajjar A., Dyer M.A.,
RA   Mullighan C.G., Gilbertson R.J., Mardis E.R., Wilson R.K., Downing J.R.,
RA   Ellison D.W., Zhang J., Baker S.J.;
RT   "Somatic histone H3 alterations in pediatric diffuse intrinsic pontine
RT   gliomas and non-brainstem glioblastomas.";
RL   Nat. Genet. 44:251-253(2012).
RN   [48]
RP   INVOLVEMENT IN GLM, AND VARIANTS GLM MET-28; ARG-35 AND VAL-35.
RX   PubMed=22286061; DOI=10.1038/nature10833;
RA   Schwartzentruber J., Korshunov A., Liu X.Y., Jones D.T., Pfaff E.,
RA   Jacob K., Sturm D., Fontebasso A.M., Quang D.A., Toenjes M., Hovestadt V.,
RA   Albrecht S., Kool M., Nantel A., Konermann C., Lindroth A., Jaeger N.,
RA   Rausch T., Ryzhova M., Korbel J.O., Hielscher T., Hauser P., Garami M.,
RA   Klekner A., Bognar L., Ebinger M., Schuhmann M.U., Scheurlen W., Pekrun A.,
RA   Fruehwald M.C., Roggendorf W., Kramm C., Duerken M., Atkinson J.,
RA   Lepage P., Montpetit A., Zakrzewska M., Zakrzewski K., Liberski P.P.,
RA   Dong Z., Siegel P., Kulozik A.E., Zapatka M., Guha A., Malkin D.,
RA   Felsberg J., Reifenberger G., von Deimling A., Ichimura K., Collins V.P.,
RA   Witt H., Milde T., Witt O., Zhang C., Castelo-Branco P., Lichter P.,
RA   Faury D., Tabori U., Plass C., Majewski J., Pfister S.M., Jabado N.;
RT   "Driver mutations in histone H3.3 and chromatin remodelling genes in
RT   paediatric glioblastoma.";
RL   Nature 482:226-231(2012).
RN   [49]
RP   INVOLVEMENT IN GLM, AND CHARACTERIZATION OF VARIANT GLM VAL-35.
RX   PubMed=23539269; DOI=10.1158/2159-8290.cd-12-0426;
RA   Bjerke L., Mackay A., Nandhabalan M., Burford A., Jury A., Popov S.,
RA   Bax D.A., Carvalho D., Taylor K.R., Vinci M., Bajrami I., McGonnell I.M.,
RA   Lord C.J., Reis R.M., Hargrave D., Ashworth A., Workman P., Jones C.;
RT   "Histone H3.3. mutations drive pediatric glioblastoma through upregulation
RT   of MYCN.";
RL   Cancer Discov. 3:512-519(2013).
RN   [50]
RP   ACETYLATION AT LYS-123.
RX   PubMed=23415232; DOI=10.1016/j.cell.2013.01.032;
RA   Tropberger P., Pott S., Keller C., Kamieniarz-Gdula K., Caron M.,
RA   Richter F., Li G., Mittler G., Liu E.T., Buhler M., Margueron R.,
RA   Schneider R.;
RT   "Regulation of transcription through acetylation of H3K122 on the lateral
RT   surface of the histone octamer.";
RL   Cell 152:859-872(2013).
RN   [51]
RP   INVOLVEMENT IN BONE AND CARTILAGE NEOPLASMS, AND VARIANTS TRP-35 AND
RP   MET-37.
RX   PubMed=24162739; DOI=10.1038/ng.2814;
RA   Behjati S., Tarpey P.S., Presneau N., Scheipl S., Pillay N., Van Loo P.,
RA   Wedge D.C., Cooke S.L., Gundem G., Davies H., Nik-Zainal S., Martin S.,
RA   McLaren S., Goodie V., Robinson B., Butler A., Teague J.W., Halai D.,
RA   Khatri B., Myklebost O., Baumhoer D., Jundt G., Hamoudi R., Tirabosco R.,
RA   Amary M.F., Futreal P.A., Stratton M.R., Campbell P.J., Flanagan A.M.;
RT   "Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant
RT   cell tumor of bone.";
RL   Nat. Genet. 45:1479-1482(2013).
RN   [52]
RP   ALLYSINE AT LYS-5.
RX   PubMed=27735137; DOI=10.1111/febs.13922;
RA   Herranz N., Dave N., Millanes-Romero A., Pascual-Reguant L., Morey L.,
RA   Diaz V.M., Lorenz-Fonfria V., Gutierrez-Gallego R., Jeronimo C.,
RA   Iturbide A., Di Croce L., Garcia de Herreros A., Peiro S.;
RT   "Lysyl oxidase-like 2 (LOXL2) oxidizes trimethylated lysine 4 in histone
RT   H3.";
RL   FEBS J. 283:4263-4273(2016).
RN   [53]
RP   BUTYRYLATION AT LYS-10; LYS-19 AND LYS-24.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [54]
RP   HYDROXYBUTYRYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28;
RP   LYS-57; LYS-80 AND LYS-123.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [55]
RP   HYDROXYBUTYRYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28;
RP   LYS-37; LYS-57; LYS-65; LYS-80 AND LYS-123.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [56]
RP   SUCCINYLATION AT LYS-123, AND DESUSUCCINYLATION.
RX   PubMed=27436229; DOI=10.1038/ncomms12235;
RA   Li L., Shi L., Yang S., Yan R., Zhang D., Yang J., He L., Li W., Yi X.,
RA   Sun L., Liang J., Cheng Z., Shi L., Shang Y., Yu W.;
RT   "SIRT7 is a histone desuccinylase that functionally links to chromatin
RT   compaction and genome stability.";
RL   Nat. Commun. 7:12235-12235(2016).
RN   [57]
RP   MUTAGENESIS OF ARG-43.
RX   PubMed=27016736; DOI=10.1093/nar/gkw202;
RA   Kujirai T., Horikoshi N., Sato K., Maehara K., Machida S., Osakabe A.,
RA   Kimura H., Ohkawa Y., Kurumizaka H.;
RT   "Structure and function of human histone H3.Y nucleosome.";
RL   Nucleic Acids Res. 44:6127-6141(2016).
RN   [58]
RP   ADP-RIBOSYLATION AT SER-11 AND SER-29.
RX   PubMed=28190768; DOI=10.1016/j.molcel.2017.01.003;
RA   Bonfiglio J.J., Fontana P., Zhang Q., Colby T., Gibbs-Seymour I.,
RA   Atanassov I., Bartlett E., Zaja R., Ahel I., Matic I.;
RT   "Serine ADP-ribosylation depends on HPF1.";
RL   Mol. Cell 0:0-0(2017).
RN   [59]
RP   SUCCINYLATION AT LYS-80.
RX   PubMed=29211711; DOI=10.1038/nature25003;
RA   Wang Y., Guo Y.R., Liu K., Yin Z., Liu R., Xia Y., Tan L., Yang P.,
RA   Lee J.H., Li X.J., Hawke D., Zheng Y., Qian X., Lyu J., He J., Xing D.,
RA   Tao Y.J., Lu Z.;
RT   "KAT2A coupled with the alpha-KGDH complex acts as a histone H3
RT   succinyltransferase.";
RL   Nature 552:273-277(2017).
RN   [60]
RP   ADP-RIBOSYLATION AT SER-11.
RX   PubMed=30257210; DOI=10.1016/j.celrep.2018.08.092;
RA   Bartlett E., Bonfiglio J.J., Prokhorova E., Colby T., Zobel F., Ahel I.,
RA   Matic I.;
RT   "Interplay of histone marks with serine ADP-ribosylation.";
RL   Cell Rep. 24:3488-3502(2018).
RN   [61]
RP   ADP-RIBOSYLATION AT SER-11 AND SER-29.
RX   PubMed=29480802; DOI=10.7554/elife.34334;
RA   Palazzo L., Leidecker O., Prokhorova E., Dauben H., Matic I., Ahel I.;
RT   "Serine is the major residue for ADP-ribosylation upon DNA damage.";
RL   Elife 7:0-0(2018).
RN   [62]
RP   GLUTARYLATION AT LYS-15; LYS-19; LYS-24; LYS-28; LYS-57; LYS-80; LYS-116
RP   AND LYS-123.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 20-43 IN COMPLEX WITH ZMYND11.
RX   PubMed=24590075; DOI=10.1038/nature13045;
RA   Wen H., Li Y., Xi Y., Jiang S., Stratton S., Peng D., Tanaka K., Ren Y.,
RA   Xia Z., Wu J., Li B., Barton M.C., Li W., Li H., Shi X.;
RT   "ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour
RT   suppression.";
RL   Nature 508:263-268(2014).
RN   [64]
RP   CHARACTERIZATION OF VARIANT GLM MET-28.
RX   PubMed=23603901; DOI=10.1101/gad.217778.113;
RA   Chan K.M., Fang D., Gan H., Hashizume R., Yu C., Schroeder M., Gupta N.,
RA   Mueller S., James C.D., Jenkins R., Sarkaria J., Zhang Z.;
RT   "The histone H3.3K27M mutation in pediatric glioma reprograms H3K27
RT   methylation and gene expression.";
RL   Genes Dev. 27:985-990(2013).
RN   [65]
RP   CHARACTERIZATION OF VARIANTS GLM MET-28; ARG-35 AND VAL-35.
RX   PubMed=23539183; DOI=10.1126/science.1232245;
RA   Lewis P.W., Mueller M.M., Koletsky M.S., Cordero F., Lin S.,
RA   Banaszynski L.A., Garcia B.A., Muir T.W., Becher O.J., Allis C.D.;
RT   "Inhibition of PRC2 activity by a gain-of-function H3 mutation found in
RT   pediatric glioblastoma.";
RL   Science 340:857-861(2013).
RN   [66]
RP   CHARACTERIZATION OF VARIANT MET-37.
RX   PubMed=27174990; DOI=10.1126/science.aac7272;
RA   Lu C., Jain S.U., Hoelper D., Bechet D., Molden R.C., Ran L., Murphy D.,
RA   Venneti S., Hameed M., Pawel B.R., Wunder J.S., Dickson B.C.,
RA   Lundgren S.M., Jani K.S., De Jay N., Papillon-Cavanagh S., Andrulis I.L.,
RA   Sawyer S.L., Grynspan D., Turcotte R.E., Nadaf J., Fahiminiyah S.,
RA   Muir T.W., Majewski J., Thompson C.B., Chi P., Garcia B.A., Allis C.D.,
RA   Jabado N., Lewis P.W.;
RT   "Histone H3K36 mutations promote sarcomagenesis through altered histone
RT   methylation landscape.";
RL   Science 352:844-849(2016).
RN   [67]
RP   VARIANT MET-37.
RX   PubMed=28067913; DOI=10.1038/ng.3757;
RA   Papillon-Cavanagh S., Lu C., Gayden T., Mikael L.G., Bechet D.,
RA   Karamboulas C., Ailles L., Karamchandani J., Marchione D.M., Garcia B.A.,
RA   Weinreb I., Goldstein D., Lewis P.W., Dancu O.M., Dhaliwal S., Stecho W.,
RA   Howlett C.J., Mymryk J.S., Barrett J.W., Nichols A.C., Allis C.D.,
RA   Majewski J., Jabado N.;
RT   "Impaired H3K36 methylation defines a subset of head and neck squamous cell
RT   carcinomas.";
RL   Nat. Genet. 49:180-185(2017).
CC   -!- FUNCTION: Variant histone H3 which replaces conventional H3 in a wide
CC       range of nucleosomes in active genes. Constitutes the predominant form
CC       of histone H3 in non-dividing cells and is incorporated into chromatin
CC       independently of DNA synthesis. Deposited at sites of nucleosomal
CC       displacement throughout transcribed genes, suggesting that it
CC       represents an epigenetic imprint of transcriptionally active chromatin.
CC       Nucleosomes wrap and compact DNA into chromatin, limiting DNA
CC       accessibility to the cellular machineries which require DNA as a
CC       template. Histones thereby play a central role in transcription
CC       regulation, DNA repair, DNA replication and chromosomal stability. DNA
CC       accessibility is regulated via a complex set of post-translational
CC       modifications of histones, also called histone code, and nucleosome
CC       remodeling. {ECO:0000269|PubMed:14718166, ECO:0000269|PubMed:15776021,
CC       ECO:0000269|PubMed:16258499}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA. Interacts with HIRA, a chaperone required for its incorporation
CC       into nucleosomes. Interacts with ZMYND11; when trimethylated at 'Lys-
CC       36' (H3.3K36me3). {ECO:0000269|PubMed:14718166,
CC       ECO:0000269|PubMed:24590075}.
CC   -!- INTERACTION:
CC       Q9NVP2:ASF1B; NbExp=4; IntAct=EBI-120658, EBI-1055650;
CC       P45973:CBX5; NbExp=2; IntAct=EBI-120658, EBI-78219;
CC       Q13111:CHAF1A; NbExp=2; IntAct=EBI-120658, EBI-1020839;
CC       Q9UER7:DAXX; NbExp=4; IntAct=EBI-120658, EBI-77321;
CC       Q9UER7-1:DAXX; NbExp=21; IntAct=EBI-120658, EBI-287635;
CC       Q9Y6K1:DNMT3A; NbExp=7; IntAct=EBI-120658, EBI-923653;
CC       P62805:HIST1H4K; NbExp=12; IntAct=EBI-120658, EBI-302023;
CC       P49321-2:NASP; NbExp=3; IntAct=EBI-120658, EBI-7038920;
CC       Q8IZL8:PELP1; NbExp=11; IntAct=EBI-120658, EBI-716449;
CC       Q9VK33:Sfmbt (xeno); NbExp=15; IntAct=EBI-120658, EBI-117801;
CC       Q5VWG9:TAF3; NbExp=3; IntAct=EBI-120658, EBI-1560087;
CC       Q8R5C8:Zmynd11 (xeno); NbExp=6; IntAct=EBI-120658, EBI-647813;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout the cell cycle independently
CC       of DNA synthesis.
CC   -!- DOMAIN: Specific interaction of trimethylated form at 'Lys-36'
CC       (H3.3K36me3) with ZMYND11 is mediated by the encapsulation of Ser-32
CC       residue with a composite pocket formed by the tandem bromo-PWWP
CC       domains. {ECO:0000269|PubMed:24590075}.
CC   -!- PTM: Acetylation is generally linked to gene activation. Acetylation on
CC       Lys-10 (H3K9ac) impairs methylation at Arg-9 (H3R8me2s). Acetylation on
CC       Lys-19 (H3K18ac) and Lys-24 (H3K24ac) favors methylation at Arg-18
CC       (H3R17me). Acetylation at Lys-123 (H3K122ac) by EP300/p300 plays a
CC       central role in chromatin structure: localizes at the surface of the
CC       histone octamer and stimulates transcription, possibly by promoting
CC       nucleosome instability. {ECO:0000269|PubMed:11242053,
CC       ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871,
CC       ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
CC       ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732,
CC       ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:19520870,
CC       ECO:0000269|PubMed:23415232, ECO:0000269|PubMed:7309716}.
CC   -!- PTM: Citrullination at Arg-9 (H3R8ci) and/or Arg-18 (H3R17ci) by PADI4
CC       impairs methylation and represses transcription.
CC       {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871,
CC       ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16567635}.
CC   -!- PTM: Asymmetric dimethylation at Arg-18 (H3R17me2a) by CARM1 is linked
CC       to gene activation. Symmetric dimethylation at Arg-9 (H3R8me2s) by
CC       PRMT5 is linked to gene repression. Asymmetric dimethylation at Arg-3
CC       (H3R2me2a) by PRMT6 is linked to gene repression and is mutually
CC       exclusive with H3 Lys-5 methylation (H3K4me2 and H3K4me3). H3R2me2a is
CC       present at the 3' of genes regardless of their transcription state and
CC       is enriched on inactive promoters, while it is absent on active
CC       promoters. {ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:15471871,
CC       ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
CC       ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732,
CC       ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:17898714,
CC       ECO:0000269|PubMed:18077460, ECO:0000269|PubMed:18079182}.
CC   -!- PTM: Specifically enriched in modifications associated with active
CC       chromatin such as methylation at Lys-5 (H3K4me), Lys-37 and Lys-80.
CC       Methylation at Lys-5 (H3K4me) facilitates subsequent acetylation of H3
CC       and H4. Methylation at Lys-80 (H3K79me) is associated with DNA double-
CC       strand break (DSB) responses and is a specific target for TP53BP1.
CC       Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me), which are linked
CC       to gene repression, are underrepresented. Methylation at Lys-10
CC       (H3K9me) is a specific target for HP1 proteins (CBX1, CBX3 and CBX5)
CC       and prevents subsequent phosphorylation at Ser-11 (H3S10ph) and
CC       acetylation of H3 and H4. Methylation at Lys-5 (H3K4me) and Lys-80
CC       (H3K79me) require preliminary monoubiquitination of H2B at 'Lys-120'.
CC       Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me) are enriched in
CC       inactive X chromosome chromatin. Monomethylation at Lys-57 (H3K56me1)
CC       by EHMT2/G9A in G1 phase promotes interaction with PCNA and is required
CC       for DNA replication. {ECO:0000269|PubMed:10464286,
CC       ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:11856369,
CC       ECO:0000269|PubMed:12560483, ECO:0000269|PubMed:15525939,
CC       ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:15851689,
CC       ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
CC       ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732,
CC       ECO:0000269|PubMed:17189264, ECO:0000269|PubMed:17194708,
CC       ECO:0000269|PubMed:22387026, ECO:0000269|PubMed:7309716}.
CC   -!- PTM: Phosphorylated at Thr-4 (H3T3ph) by HASPIN during prophase and
CC       dephosphorylated during anaphase. Phosphorylation at Ser-11 (H3S10ph)
CC       by AURKB is crucial for chromosome condensation and cell-cycle
CC       progression during mitosis and meiosis. In addition phosphorylation at
CC       Ser-11 (H3S10ph) by RPS6KA4 and RPS6KA5 is important during interphase
CC       because it enables the transcription of genes following external
CC       stimulation, like mitogens, stress, growth factors or UV irradiation
CC       and result in the activation of genes, such as c-fos and c-jun.
CC       Phosphorylation at Ser-11 (H3S10ph), which is linked to gene
CC       activation, prevents methylation at Lys-10 (H3K9me) but facilitates
CC       acetylation of H3 and H4. Phosphorylation at Ser-11 (H3S10ph) by AURKB
CC       mediates the dissociation of HP1 proteins (CBX1, CBX3 and CBX5) from
CC       heterochromatin. Phosphorylation at Ser-11 (H3S10ph) is also an
CC       essential regulatory mechanism for neoplastic cell transformation.
CC       Phosphorylated at Ser-29 (H3S28ph) by MAP3K20 isoform 1, RPS6KA5 or
CC       AURKB during mitosis or upon ultraviolet B irradiation. Phosphorylation
CC       at Thr-7 (H3T6ph) by PRKCB is a specific tag for epigenetic
CC       transcriptional activation that prevents demethylation of Lys-5
CC       (H3K4me) by LSD1/KDM1A. At centromeres, specifically phosphorylated at
CC       Thr-12 (H3T11ph) from prophase to early anaphase, by DAPK3 and PKN1.
CC       Phosphorylation at Thr-12 (H3T11ph) by PKN1 is a specific tag for
CC       epigenetic transcriptional activation that promotes demethylation of
CC       Lys-10 (H3K9me) by KDM4C/JMJD2C. Phosphorylation at Tyr-42 (H3Y41ph) by
CC       JAK2 promotes exclusion of CBX5 (HP1 alpha) from chromatin.
CC       Phosphorylation on Ser-32 (H3S31ph) is specific to regions bordering
CC       centromeres in metaphase chromosomes. {ECO:0000269|PubMed:10464286,
CC       ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:11856369,
CC       ECO:0000269|PubMed:12560483, ECO:0000269|PubMed:15681610,
CC       ECO:0000269|PubMed:15684425, ECO:0000269|PubMed:15851689,
CC       ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
CC       ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:16497732,
CC       ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:18066052,
CC       ECO:0000269|PubMed:19783980, ECO:0000269|PubMed:20228790,
CC       ECO:0000269|PubMed:20850016, ECO:0000269|PubMed:7309716}.
CC   -!- PTM: Ubiquitinated. Monoubiquitinated by RAG1 in lymphoid cells,
CC       monoubiquitination is required for V(D)J recombination (By similarity).
CC       {ECO:0000250|UniProtKB:P84245}.
CC   -!- PTM: Lysine deamination at Lys-5 (H3K4all) to form allysine is mediated
CC       by LOXL2. Allysine formation by LOXL2 only takes place on H3K4me3 and
CC       results in gene repression. {ECO:0000269|PubMed:27735137}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes with
CC       histone acetylation. It is present during late spermatogenesis.
CC       {ECO:0000250|UniProtKB:P68433}.
CC   -!- PTM: Succinylation at Lys-80 (H3K79succ) by KAT2A takes place with a
CC       maximum frequency around the transcription start sites of genes
CC       (PubMed:29211711). It gives a specific tag for epigenetic transcription
CC       activation (PubMed:29211711). Desuccinylation at Lys-123 (H3K122succ)
CC       by SIRT7 in response to DNA damage promotes chromatin condensation and
CC       double-strand breaks (DSBs) repair (PubMed:27436229).
CC       {ECO:0000269|PubMed:27436229, ECO:0000269|PubMed:29211711}.
CC   -!- PTM: Serine ADP-ribosylation constitutes the primary form of ADP-
CC       ribosylation of proteins in response to DNA damage (PubMed:29480802).
CC       Serine ADP-ribosylation at Ser-11 (H3S10ADPr) is mutually exclusive
CC       with phosphorylation at Ser-11 (H3S10ph) and impairs acetylation at
CC       Lys-10 (H3K9ac) (PubMed:30257210). {ECO:0000269|PubMed:29480802,
CC       ECO:0000269|PubMed:30257210}.
CC   -!- DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant
CC       central nervous system neoplasms derived from glial cells. They
CC       comprise astrocytomas and glioblastoma multiforme that are derived from
CC       astrocytes, oligodendrogliomas derived from oligodendrocytes and
CC       ependymomas derived from ependymocytes. {ECO:0000269|PubMed:22286061,
CC       ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539269}. Note=The
CC       gene represented in this entry is involved in disease pathogenesis.
CC       H3F3A mutations affecting residues involved in post-translational
CC       modifications of histone H3.3 are recurrent in malignant, aggressive
CC       gliomas including glioblastoma multiforme (GBM) and diffuse intrinsic
CC       pontine glioma (DIPG) (PubMed:22286061, PubMed:22286216). The mechanism
CC       through which mutations lead to tumorigenesis involves altered histones
CC       methylation, impaired regulation of Polycomb repressive complex 2
CC       (PRC2) activity, and aberrant epigenetic regulation of gene expression
CC       (PubMed:23539269, PubMed:23539183, PubMed:23603901).
CC       {ECO:0000269|PubMed:22286061, ECO:0000269|PubMed:22286216,
CC       ECO:0000269|PubMed:23539183, ECO:0000269|PubMed:23539269,
CC       ECO:0000269|PubMed:23603901}.
CC   -!- DISEASE: Note=H3F3A and H3F3B mutations affecting residues involved in
CC       post-translational modifications of histone H3.3 are implicated in the
CC       pathogenesis of some bone and cartilage neoplasms. Mutations have been
CC       found with high prevalence in chondroblastoma and giant cell tumors of
CC       bone, and with low frequency in osteosarcoma, conventional
CC       chondrosarcoma and clear cell chondrosarcoma. Chondroblastoma samples
CC       frequently carry a H3F3B mutation affecting residue Lys-37 (H3K36),
CC       although H3F3A is mutated in some cases. Most giant cell tumors of bone
CC       harbor H3F3A mutations affecting residue Gly-35 (H3G34).
CC       {ECO:0000269|PubMed:24162739}.
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   -!- CAUTION: The original paper reporting lysine deamination at Lys-5 by
CC       LOXL2 has been retracted due to inappropriate manipulation of figure
CC       data (PubMed:22483618, PubMed:27392148). However, this modification was
CC       confirmed in a subsequent publication (PubMed:27735137).
CC       {ECO:0000269|PubMed:27735137, ECO:0000305|PubMed:22483618,
CC       ECO:0000305|PubMed:27392148}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Histone H3 entry;
CC       URL="https://en.wikipedia.org/wiki/Histone_H3";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M11354; AAA52653.1; -; mRNA.
DR   EMBL; M11353; AAA52654.1; -; mRNA.
DR   EMBL; Z48950; CAA88778.1; -; Genomic_DNA.
DR   EMBL; X05855; CAA29288.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X05856; CAA29288.1; JOINED; Genomic_DNA.
DR   EMBL; X05857; CAA29288.1; JOINED; Genomic_DNA.
DR   EMBL; AF218029; AAG17271.1; -; mRNA.
DR   EMBL; BX537379; CAD97621.1; -; mRNA.
DR   EMBL; AL512343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001124; AAH01124.1; -; mRNA.
DR   EMBL; BC006497; AAH06497.1; -; mRNA.
DR   EMBL; BC012813; AAH12813.1; -; mRNA.
DR   EMBL; BC017558; AAH17558.1; -; mRNA.
DR   EMBL; BC029405; AAH29405.1; -; mRNA.
DR   EMBL; BC038989; AAH38989.1; -; mRNA.
DR   EMBL; BC066901; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC067757; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC081560; AAH81560.1; -; mRNA.
DR   EMBL; BC081561; AAH81561.1; -; mRNA.
DR   EMBL; BC095447; AAH95447.1; -; mRNA.
DR   EMBL; BC108701; AAI08702.1; -; mRNA.
DR   CCDS; CCDS11729.1; -.
DR   CCDS; CCDS1550.1; -.
DR   PIR; A27501; HSHU33.
DR   RefSeq; NP_002098.1; NM_002107.4.
DR   RefSeq; NP_005315.1; NM_005324.4.
DR   PDB; 2L43; NMR; -; A=2-13.
DR   PDB; 3ASK; X-ray; 2.90 A; P/Q/R=2-14.
DR   PDB; 3ASL; X-ray; 1.41 A; B=2-12.
DR   PDB; 3AV2; X-ray; 2.80 A; A/E=1-136.
DR   PDB; 3JVK; X-ray; 1.80 A; C=13-20.
DR   PDB; 3MUK; X-ray; 1.75 A; D=22-29.
DR   PDB; 3MUL; X-ray; 1.65 A; D=13-20.
DR   PDB; 3QL9; X-ray; 0.93 A; C=2-16.
DR   PDB; 3QLA; X-ray; 1.60 A; C/F=2-16.
DR   PDB; 3QLC; X-ray; 2.50 A; C/D=2-16.
DR   PDB; 3WTP; X-ray; 2.67 A; E=1-136.
DR   PDB; 4GNE; X-ray; 1.47 A; B=2-8.
DR   PDB; 4GNF; X-ray; 1.55 A; C=2-16.
DR   PDB; 4GNG; X-ray; 1.73 A; B/F=2-16.
DR   PDB; 4GU0; X-ray; 3.10 A; E/F=2-27.
DR   PDB; 4GUR; X-ray; 2.51 A; C=2-22.
DR   PDB; 4GUS; X-ray; 2.23 A; C=2-22.
DR   PDB; 4GY5; X-ray; 2.96 A; E/F=2-18.
DR   PDB; 4H9N; X-ray; 1.95 A; A=2-136.
DR   PDB; 4H9O; X-ray; 2.05 A; A=2-136.
DR   PDB; 4H9P; X-ray; 2.20 A; A=2-136.
DR   PDB; 4H9Q; X-ray; 1.95 A; A=2-136.
DR   PDB; 4H9R; X-ray; 2.20 A; A=2-136.
DR   PDB; 4H9S; X-ray; 2.60 A; A/B=2-136.
DR   PDB; 4HGA; X-ray; 2.80 A; B=1-136.
DR   PDB; 4L58; X-ray; 1.48 A; B=2-13.
DR   PDB; 4N4I; X-ray; 2.00 A; B=20-43.
DR   PDB; 4O62; X-ray; 1.78 A; D=2-12.
DR   PDB; 4QQ4; X-ray; 1.75 A; C/D=2-16.
DR   PDB; 4TMP; X-ray; 2.30 A; B/D=2-12.
DR   PDB; 4U7T; X-ray; 2.90 A; F/G=2-13.
DR   PDB; 4W5A; X-ray; 2.60 A; C/D/F=2-16.
DR   PDB; 5B32; X-ray; 2.35 A; A/E=1-136.
DR   PDB; 5B33; X-ray; 2.92 A; A/E=1-136.
DR   PDB; 5BNV; X-ray; 2.79 A; A/D=58-136.
DR   PDB; 5BNX; X-ray; 2.31 A; A=58-136.
DR   PDB; 5DWQ; X-ray; 2.36 A; F/G=14-31.
DR   PDB; 5DX0; X-ray; 2.05 A; F/G/H/I=14-31.
DR   PDB; 5JA4; X-ray; 2.42 A; A=58-136.
DR   PDB; 5JJY; X-ray; 2.05 A; B=30-43.
DR   PDB; 5JLB; X-ray; 1.50 A; B=30-43.
DR   PDB; 5KDM; X-ray; 3.50 A; A=2-136.
DR   PDB; 5X7X; X-ray; 2.18 A; A/E=1-136.
DR   PDB; 6A5L; EM; 5.60 A; a/e=1-136.
DR   PDB; 6A5O; EM; 9.90 A; a/e=1-136.
DR   PDB; 6A5P; EM; 7.00 A; a/e=1-136.
DR   PDB; 6A5R; EM; 8.70 A; a/e=1-136.
DR   PDB; 6A5T; EM; 6.70 A; a/e=1-136.
DR   PDB; 6A5U; EM; 7.60 A; a/e=1-136.
DR   PDB; 6HGT; X-ray; 2.33 A; E/F/G/H=4-18.
DR   PDB; 6INQ; EM; 6.90 A; a/e=1-136.
DR   PDB; 6IR9; EM; 3.80 A; a/e=1-136.
DR   PDB; 6J4W; EM; 7.90 A; a/e=1-136.
DR   PDB; 6J4X; EM; 4.30 A; a/e=1-136.
DR   PDB; 6J4Y; EM; 4.30 A; a/e=1-136.
DR   PDB; 6J4Z; EM; 4.10 A; a/e=1-136.
DR   PDB; 6J50; EM; 4.70 A; a/e=1-136.
DR   PDB; 6J51; EM; 4.20 A; a/e=1-136.
DR   PDB; 6QXZ; NMR; -; B=2-10.
DR   PDB; 6R0C; EM; 4.20 A; A/E=1-136.
DR   PDB; 6RNY; EM; 3.90 A; A/E=1-136.
DR   PDB; 6U04; X-ray; 2.20 A; A=2-13.
DR   PDBsum; 2L43; -.
DR   PDBsum; 3ASK; -.
DR   PDBsum; 3ASL; -.
DR   PDBsum; 3AV2; -.
DR   PDBsum; 3JVK; -.
DR   PDBsum; 3MUK; -.
DR   PDBsum; 3MUL; -.
DR   PDBsum; 3QL9; -.
DR   PDBsum; 3QLA; -.
DR   PDBsum; 3QLC; -.
DR   PDBsum; 3WTP; -.
DR   PDBsum; 4GNE; -.
DR   PDBsum; 4GNF; -.
DR   PDBsum; 4GNG; -.
DR   PDBsum; 4GU0; -.
DR   PDBsum; 4GUR; -.
DR   PDBsum; 4GUS; -.
DR   PDBsum; 4GY5; -.
DR   PDBsum; 4H9N; -.
DR   PDBsum; 4H9O; -.
DR   PDBsum; 4H9P; -.
DR   PDBsum; 4H9Q; -.
DR   PDBsum; 4H9R; -.
DR   PDBsum; 4H9S; -.
DR   PDBsum; 4HGA; -.
DR   PDBsum; 4L58; -.
DR   PDBsum; 4N4I; -.
DR   PDBsum; 4O62; -.
DR   PDBsum; 4QQ4; -.
DR   PDBsum; 4TMP; -.
DR   PDBsum; 4U7T; -.
DR   PDBsum; 4W5A; -.
DR   PDBsum; 5B32; -.
DR   PDBsum; 5B33; -.
DR   PDBsum; 5BNV; -.
DR   PDBsum; 5BNX; -.
DR   PDBsum; 5DWQ; -.
DR   PDBsum; 5DX0; -.
DR   PDBsum; 5JA4; -.
DR   PDBsum; 5JJY; -.
DR   PDBsum; 5JLB; -.
DR   PDBsum; 5KDM; -.
DR   PDBsum; 5X7X; -.
DR   PDBsum; 6A5L; -.
DR   PDBsum; 6A5O; -.
DR   PDBsum; 6A5P; -.
DR   PDBsum; 6A5R; -.
DR   PDBsum; 6A5T; -.
DR   PDBsum; 6A5U; -.
DR   PDBsum; 6HGT; -.
DR   PDBsum; 6INQ; -.
DR   PDBsum; 6IR9; -.
DR   PDBsum; 6J4W; -.
DR   PDBsum; 6J4X; -.
DR   PDBsum; 6J4Y; -.
DR   PDBsum; 6J4Z; -.
DR   PDBsum; 6J50; -.
DR   PDBsum; 6J51; -.
DR   PDBsum; 6QXZ; -.
DR   PDBsum; 6R0C; -.
DR   PDBsum; 6RNY; -.
DR   PDBsum; 6U04; -.
DR   SMR; P84243; -.
DR   BioGrid; 109272; 144.
DR   BioGrid; 109273; 38.
DR   CORUM; P84243; -.
DR   DIP; DIP-40046N; -.
DR   IntAct; P84243; 68.
DR   MINT; P84243; -.
DR   STRING; 9606.ENSP00000355778; -.
DR   iPTMnet; P84243; -.
DR   PhosphoSitePlus; P84243; -.
DR   SwissPalm; P84243; -.
DR   BioMuta; H3F3A; -.
DR   DMDM; 55977062; -.
DR   EPD; P84243; -.
DR   jPOST; P84243; -.
DR   MassIVE; P84243; -.
DR   MaxQB; P84243; -.
DR   PaxDb; P84243; -.
DR   PeptideAtlas; P84243; -.
DR   PRIDE; P84243; -.
DR   ProteomicsDB; 57757; -.
DR   TopDownProteomics; P84243; -.
DR   DNASU; 3020; -.
DR   DNASU; 3021; -.
DR   Ensembl; ENST00000254810; ENSP00000254810; ENSG00000132475.
DR   Ensembl; ENST00000366815; ENSP00000355780; ENSG00000163041.
DR   Ensembl; ENST00000366816; ENSP00000355781; ENSG00000163041.
DR   Ensembl; ENST00000366813; ENSP00000355778; ENSG00000163041.
DR   Ensembl; ENST00000586607; ENSP00000466020; ENSG00000132475.
DR   Ensembl; ENST00000587560; ENSP00000468714; ENSG00000132475.
DR   Ensembl; ENST00000589599; ENSP00000465813; ENSG00000132475.
DR   Ensembl; ENST00000655399; ENSP00000499800; ENSG00000163041.
DR   Ensembl; ENST00000661429; ENSP00000499385; ENSG00000163041.
DR   Ensembl; ENST00000666609; ENSP00000499275; ENSG00000163041.
DR   GeneID; 3020; -.
DR   GeneID; 3021; -.
DR   KEGG; hsa:3020; -.
DR   KEGG; hsa:3021; -.
DR   UCSC; uc001hpw.4; human.
DR   CTD; 3020; -.
DR   CTD; 3021; -.
DR   DisGeNET; 3020; -.
DR   DisGeNET; 3021; -.
DR   GeneCards; H3-3A; -.
DR   GeneCards; H3-3B; -.
DR   HGNC; HGNC:4764; H3-3A.
DR   HGNC; HGNC:4765; H3-3B.
DR   HPA; CAB011481; -.
DR   HPA; CAB037166; -.
DR   HPA; CAB037178; -.
DR   HPA; CAB037187; -.
DR   HPA; CAB037221; -.
DR   HPA; HPA042570; -.
DR   MalaCards; H3-3A; -.
DR   MIM; 137800; phenotype.
DR   MIM; 601058; gene.
DR   MIM; 601128; gene.
DR   neXtProt; NX_P84243; -.
DR   OpenTargets; ENSG00000132475; -.
DR   OpenTargets; ENSG00000163041; -.
DR   PharmGKB; PA29140; -.
DR   eggNOG; KOG1745; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00950000182954; -.
DR   HOGENOM; CLU_078295_4_0_1; -.
DR   InParanoid; P84243; -.
DR   KO; K11253; -.
DR   OMA; CTMARTK; -.
DR   OrthoDB; 1564596at2759; -.
DR   PhylomeDB; P84243; -.
DR   TreeFam; TF314241; -.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SIGNOR; P84243; -.
DR   ChiTaRS; H3F3A; human.
DR   ChiTaRS; H3F3B; human.
DR   EvolutionaryTrace; P84243; -.
DR   GeneWiki; H3F3A; -.
DR   Pharos; P84243; Tbio.
DR   PRO; PR:P84243; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P84243; protein.
DR   Bgee; ENSG00000132475; Expressed in secondary oocyte and 237 other tissues.
DR   ExpressionAtlas; P84243; baseline and differential.
DR   Genevisible; P84243; HS.
DR   GO; GO:0001740; C:Barr body; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0000228; C:nuclear chromosome; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0008283; P:cell population proliferation; IEA:Ensembl.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0000183; P:chromatin silencing at rDNA; TAS:Reactome.
DR   GO; GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0042692; P:muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:1902340; P:negative regulation of chromosome condensation; IEA:Ensembl.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006997; P:nucleus organization; IEA:Ensembl.
DR   GO; GO:0048477; P:oogenesis; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0031508; P:pericentric heterochromatin assembly; IEA:Ensembl.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB.
DR   GO; GO:0090230; P:regulation of centromere complex assembly; IEA:Ensembl.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0007338; P:single fertilization; IEA:Ensembl.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   GO; GO:0032200; P:telomere organization; TAS:BHF-UCL.
DR   GO; GO:0031509; P:telomeric heterochromatin assembly; IEA:Ensembl.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   PANTHER; PTHR11426; PTHR11426; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00322; HISTONE_H3_1; 1.
DR   PROSITE; PS00959; HISTONE_H3_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Chromosome; Citrullination;
KW   Direct protein sequencing; Disease mutation; DNA-binding; Hydroxylation;
KW   Methylation; Nucleosome core; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..136
FT                   /note="Histone H3.3"
FT                   /id="PRO_0000221247"
FT   SITE            32
FT                   /note="Interaction with ZMYND11"
FT                   /evidence="ECO:0000269|PubMed:24590075"
FT   MOD_RES         3
FT                   /note="Asymmetric dimethylarginine; by PRMT6; alternate"
FT                   /evidence="ECO:0000269|PubMed:17898714,
FT                   ECO:0000269|PubMed:18077460, ECO:0000269|PubMed:18079182"
FT   MOD_RES         3
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:16567635"
FT   MOD_RES         4
FT                   /note="Phosphothreonine; by HASPIN"
FT                   /evidence="ECO:0000269|PubMed:15681610,
FT                   ECO:0000269|PubMed:16185088"
FT   MOD_RES         5
FT                   /note="Allysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27735137"
FT   MOD_RES         5
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         5
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         5
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         5
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708"
FT   MOD_RES         5
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         5
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         7
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:20228790"
FT   MOD_RES         9
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15345777,
FT                   ECO:0000269|PubMed:16567635"
FT   MOD_RES         9
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84244"
FT   MOD_RES         10
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:11242053,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:7309716"
FT   MOD_RES         10
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:11242053,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:7309716"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16457588,
FT                   ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:17194708"
FT   MOD_RES         10
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         10
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         10
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:11242053,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:16457588, ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:7309716"
FT   MOD_RES         11
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000269|PubMed:28190768,
FT                   ECO:0000269|PubMed:29480802"
FT   MOD_RES         11
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC, RPS6KA3,
FT                   RPS6KA4 and RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:10464286,
FT                   ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:12560483,
FT                   ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:15851689,
FT                   ECO:0000269|PubMed:16185088"
FT   MOD_RES         12
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:12560483,
FT                   ECO:0000269|PubMed:18066052"
FT   MOD_RES         15
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         15
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         15
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:16497732,
FT                   ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716"
FT   MOD_RES         15
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         15
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         18
FT                   /note="Asymmetric dimethylarginine; by CARM1; alternate"
FT                   /evidence="ECO:0000269|PubMed:15345777,
FT                   ECO:0000269|PubMed:15471871, ECO:0000269|PubMed:16497732"
FT   MOD_RES         18
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15345777,
FT                   ECO:0000269|PubMed:16497732, ECO:0000269|PubMed:16567635"
FT   MOD_RES         19
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         19
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         19
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         19
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         19
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         19
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         19
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         24
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716"
FT   MOD_RES         24
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         24
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         24
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708"
FT   MOD_RES         27
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000269|PubMed:16567635"
FT   MOD_RES         28
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:7309716"
FT   MOD_RES         28
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315,
FT                   ECO:0000269|PubMed:16185088, ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:7309716"
FT   MOD_RES         28
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         28
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         28
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708"
FT   MOD_RES         28
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         28
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         28
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:7309716"
FT   MOD_RES         29
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000269|PubMed:28190768,
FT                   ECO:0000269|PubMed:29480802"
FT   MOD_RES         29
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC and
FT                   RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:10464286,
FT                   ECO:0000269|PubMed:11856369, ECO:0000269|PubMed:15681610,
FT                   ECO:0000269|PubMed:15684425, ECO:0000269|PubMed:15851689,
FT                   ECO:0000269|PubMed:16185088"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:15851689,
FT                   ECO:0000269|PubMed:16185088"
FT   MOD_RES         37
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:7309716"
FT   MOD_RES         37
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:7309716"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         37
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17189264,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         37
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16185088,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:7309716"
FT   MOD_RES         38
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         42
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:19783980"
FT   MOD_RES         57
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:22387026"
FT   MOD_RES         57
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         57
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         57
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708"
FT   MOD_RES         57
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         57
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         57
FT                   /note="N6-methyllysine; by EHMT2; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708,
FT                   ECO:0000269|PubMed:22387026"
FT   MOD_RES         57
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20850016"
FT   MOD_RES         65
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         65
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         80
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84244"
FT   MOD_RES         80
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15525939,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708"
FT   MOD_RES         80
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         80
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17194708"
FT   MOD_RES         80
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         80
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15525939,
FT                   ECO:0000269|PubMed:16267050, ECO:0000269|PubMed:17194708"
FT   MOD_RES         80
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435,
FT                   ECO:0000269|PubMed:29211711"
FT   MOD_RES         81
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20850016"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71DI3"
FT   MOD_RES         116
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19520870"
FT   MOD_RES         116
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         123
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         123
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19520870,
FT                   ECO:0000269|PubMed:23415232"
FT   MOD_RES         123
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         123
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:16267050,
FT                   ECO:0000269|PubMed:17194708"
FT   MOD_RES         123
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435,
FT                   ECO:0000269|PubMed:27436229"
FT   VARIANT         28
FT                   /note="K -> M (in GLM; glioblastoma multiforme samples and
FT                   diffuse intrinsic pontine glioma; somatic mutation; more
FT                   prevalent in pediatric than adult malignancies; results in
FT                   reduced allosteric activation of PRC2 causing a global
FT                   decrease of H3K27me3 levels; has no effect on H3K4me3 or
FT                   H3K36me3 levels; dbSNP:rs1057519903)"
FT                   /evidence="ECO:0000269|PubMed:22286061,
FT                   ECO:0000269|PubMed:22286216, ECO:0000269|PubMed:23539183"
FT                   /id="VAR_079021"
FT   VARIANT         35
FT                   /note="G -> R (in GLM; glioblastoma multiforme samples;
FT                   somatic mutation; also found in osteosarcoma samples;
FT                   results in global decrease of H3K36me2 and H3K36me3 levels;
FT                   has no effect on H3K27me3 levels; dbSNP:rs1553260624)"
FT                   /evidence="ECO:0000269|PubMed:22286061,
FT                   ECO:0000269|PubMed:23539183"
FT                   /id="VAR_079022"
FT   VARIANT         35
FT                   /note="G -> V (in GLM; glioblastoma multiforme samples;
FT                   somatic mutation; affects regulation of gene expression and
FT                   results in up-regulation of MYCN; results in global
FT                   decrease of H3K36me2 and H3K36me3 levels; has no effect on
FT                   H3K27me3 levels)"
FT                   /evidence="ECO:0000269|PubMed:22286061,
FT                   ECO:0000269|PubMed:23539183, ECO:0000269|PubMed:23539269"
FT                   /id="VAR_079023"
FT   VARIANT         35
FT                   /note="G -> W (probable disease-associated mutation found
FT                   in giant cell tumors of bone; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:24162739"
FT                   /id="VAR_079024"
FT   VARIANT         37
FT                   /note="K -> M (probable disease-associated mutation found
FT                   in chondroblastoma and clear cell chondrosarcoma; somatic
FT                   mutation; also found in a subset of human papillomavirus-
FT                   negative head and neck squamous cell carcinomas; results in
FT                   global decrease of H3K36me2 and H3K36me3 levels and
FT                   increased H3K27me3 levels)"
FT                   /evidence="ECO:0000269|PubMed:24162739,
FT                   ECO:0000269|PubMed:27174990, ECO:0000269|PubMed:28067913"
FT                   /id="VAR_079025"
FT   MUTAGEN         43
FT                   /note="R->K: Reduced binding of histone H1 to histone H3.3-
FT                   containing nucleosomes."
FT                   /evidence="ECO:0000269|PubMed:27016736"
FT   CONFLICT        9
FT                   /note="R -> L (in Ref. 7; AAH81561)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..6
FT                   /evidence="ECO:0000244|PDB:3QL9"
FT   HELIX           8..10
FT                   /evidence="ECO:0000244|PDB:4GY5"
FT   STRAND          16..18
FT                   /evidence="ECO:0000244|PDB:5DX0"
FT   STRAND          35..37
FT                   /evidence="ECO:0000244|PDB:5JLB"
FT   STRAND          45..47
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   HELIX           49..59
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   HELIX           65..79
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   STRAND          80..82
FT                   /evidence="ECO:0000244|PDB:5X7X"
FT   STRAND          84..86
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   HELIX           87..110
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   STRAND          118..120
FT                   /evidence="ECO:0000244|PDB:5X7X"
FT   HELIX           122..132
FT                   /evidence="ECO:0000244|PDB:4H9N"
SQ   SEQUENCE   136 AA;  15328 MW;  5158ED279E6F9E1C CRC64;
     MARTKQTARK STGGKAPRKQ LATKAARKSA PSTGGVKKPH RYRPGTVALR EIRRYQKSTE
     LLIRKLPFQR LVREIAQDFK TDLRFQSAAI GALQEASEAY LVGLFEDTNL CAIHAKRVTI
     MPKDIQLARR IRGERA
//
ID   H3C_HUMAN               Reviewed;         135 AA.
AC   Q6NXT2; E9P281;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   26-FEB-2020, entry version 146.
DE   RecName: Full=Histone H3.3C;
DE   AltName: Full=Histone H3.5;
GN   Name=H3F3C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Seminiferous tubule;
RX   PubMed=21274551; DOI=10.1007/s00412-011-0310-4;
RA   Schenk R., Jenke A., Zilbauer M., Wirth S., Postberg J.;
RT   "H3.5 is a novel hominid-specific histone H3 variant that is specifically
RT   expressed in the seminiferous tubules of human testes.";
RL   Chromosoma 120:275-285(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION AT SER-57 AND THR-80.
RX   PubMed=20850016; DOI=10.1016/j.cell.2010.08.020;
RA   Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S., Butter F.,
RA   Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G., Mann M.;
RT   "Quantitative interaction proteomics and genome-wide profiling of
RT   epigenetic histone marks and their readers.";
RL   Cell 142:967-980(2010).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling. Hominid-specific H3.5/H3F3C
CC       preferentially colocalizes with euchromatin, and it is associated with
CC       actively transcribed genes. {ECO:0000269|PubMed:21274551}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- INTERACTION:
CC       P49321-2:NASP; NbExp=7; IntAct=EBI-2868501, EBI-7038920;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in the seminiferous tubules
CC       of testis. {ECO:0000269|PubMed:21274551}.
CC   -!- PTM: Acetylation is generally linked to gene activation. Acetylation on
CC       Lys-10 (H3K9ac) impairs methylation at Arg-9 (H3R8me2s). Acetylation on
CC       Lys-19 (H3K18ac) and Lys-24 (H3K24ac) favors methylation at Arg-18
CC       (H3R17me). Acetylation at Lys-122 (H3K122ac) by EP300/p300 plays a
CC       central role in chromatin structure: localizes at the surface of the
CC       histone octamer and stimulates transcription, possibly by promoting
CC       nucleosome instability (By similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Citrullination at Arg-9 (H3R8ci) and/or Arg-18 (H3R17ci) by PADI4
CC       impairs methylation and represses transcription.
CC       {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Asymmetric dimethylation at Arg-18 (H3R17me2a) by CARM1 is linked
CC       to gene activation. Symmetric dimethylation at Arg-9 (H3R8me2s) by
CC       PRMT5 is linked to gene repression. Asymmetric dimethylation at Arg-3
CC       (H3R2me2a) by PRMT6 is linked to gene repression and is mutually
CC       exclusive with H3 Lys-5 methylation (H3K4me2 and H3K4me3). H3R2me2a is
CC       present at the 3' of genes regardless of their transcription state and
CC       is enriched on inactive promoters, while it is absent on active
CC       promoters (By similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Methylation at Lys-5 (H3K4me) is linked to gene activation.
CC       Methylation at Lys-5 (H3K4me) facilitates subsequent acetylation of H3
CC       and H4. Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me) are linked
CC       to gene repression. Methylation at Lys-10 (H3K9me) is a specific target
CC       for HP1 proteins (CBX1, CBX3 and CBX5) and prevents subsequent
CC       phosphorylation at Ser-11 (H3S10ph) and acetylation of H3 and H4.
CC       Methylation at Lys-5 (H3K4me) requires preliminary monoubiquitination
CC       of H2B at 'Lys-120'. Methylation at Lys-10 (H3K9me) and Lys-28
CC       (H3K27me) are enriched in inactive X chromosome chromatin.
CC       Monomethylation at Lys-56 (H3K56me1) by EHMT2/G9A in G1 phase promotes
CC       interaction with PCNA and is required for DNA replication (By
CC       similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Phosphorylated at Thr-4 (H3T3ph) by HASPIN during prophase and
CC       dephosphorylated during anaphase. Phosphorylation at Ser-11 (H3S10ph)
CC       by AURKB is crucial for chromosome condensation and cell-cycle
CC       progression during mitosis and meiosis. In addition phosphorylation at
CC       Ser-11 (H3S10ph) by RPS6KA4 and RPS6KA5 is important during interphase
CC       because it enables the transcription of genes following external
CC       stimulation, like mitogens, stress, growth factors or UV irradiation
CC       and result in the activation of genes, such as c-fos and c-jun.
CC       Phosphorylation at Ser-11 (H3S10ph), which is linked to gene
CC       activation, prevents methylation at Lys-10 (H3K9me) but facilitates
CC       acetylation of H3 and H4. Phosphorylation at Ser-11 (H3S10ph) by AURKB
CC       mediates the dissociation of HP1 proteins (CBX1, CBX3 and CBX5) from
CC       heterochromatin. Phosphorylation at Ser-11 (H3S10ph) is also an
CC       essential regulatory mechanism for neoplastic cell transformation.
CC       Phosphorylated at Ser-29 (H3S28ph) by MAP3K20 isoform 1, RPS6KA5 or
CC       AURKB during mitosis or upon ultraviolet B irradiation. Phosphorylation
CC       at Thr-7 (H3T6ph) by PRKCB is a specific tag for epigenetic
CC       transcriptional activation that prevents demethylation of Lys-5
CC       (H3K4me) by LSD1/KDM1A. At centromeres, specifically phosphorylated at
CC       Thr-12 (H3T11ph) from prophase to early anaphase, by DAPK3 and PKN1.
CC       Phosphorylation at Thr-12 (H3T11ph) by PKN1 is a specific tag for
CC       epigenetic transcriptional activation that promotes demethylation of
CC       Lys-10 (H3K9me) by KDM4C/JMJD2C. Phosphorylation at Tyr-41 (H3Y41ph) by
CC       JAK2 promotes exclusion of CBX5 (HP1 alpha) from chromatin (By
CC       similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Lysine deamination at Lys-5 (H3K4all) to form allysine is mediated
CC       by LOXL2. Allysine formation by LOXL2 only takes place on H3K4me3 and
CC       results in gene repression (By similarity).
CC       {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes with
CC       histone acetylation. It is present during late spermatogenesis.
CC       {ECO:0000250|UniProtKB:P68433}.
CC   -!- PTM: Succinylated. Desuccinylation at Lys-122 (H3K122succ) by SIRT7 in
CC       response to DNA damage promotes chromatin condensation and double-
CC       strand breaks (DSBs) repair. {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Serine ADP-ribosylation constitutes the primary form of ADP-
CC       ribosylation of proteins in response to DNA damage. Serine ADP-
CC       ribosylation at Ser-11 (H3S10ADPr) is mutually exclusive with
CC       phosphorylation at Ser-11 (H3S10ph) and impairs acetylation at Lys-10
CC       (H3K9ac). {ECO:0000250|UniProtKB:P68431}.
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HQ873957; ADW85800.1; -; mRNA.
DR   EMBL; AC023050; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC066906; AAH66906.1; -; mRNA.
DR   CCDS; CCDS31769.1; -.
DR   RefSeq; NP_001013721.2; NM_001013699.2.
DR   PDB; 2PUY; X-ray; 1.43 A; E=2-11.
DR   PDB; 3KV4; X-ray; 2.19 A; B=2-25.
DR   PDB; 4Z5T; X-ray; 2.80 A; A/E=1-135.
DR   PDB; 5BWN; X-ray; 1.94 A; B=6-14.
DR   PDB; 5BWO; X-ray; 2.38 A; B=6-14.
DR   PDB; 5F6K; X-ray; 2.41 A; M=2-10.
DR   PDB; 5I3L; X-ray; 1.85 A; C=2-21.
DR   PDBsum; 2PUY; -.
DR   PDBsum; 3KV4; -.
DR   PDBsum; 4Z5T; -.
DR   PDBsum; 5BWN; -.
DR   PDBsum; 5BWO; -.
DR   PDBsum; 5F6K; -.
DR   PDBsum; 5I3L; -.
DR   SMR; Q6NXT2; -.
DR   BioGrid; 136289; 30.
DR   IntAct; Q6NXT2; 19.
DR   MINT; Q6NXT2; -.
DR   STRING; 9606.ENSP00000339835; -.
DR   iPTMnet; Q6NXT2; -.
DR   PhosphoSitePlus; Q6NXT2; -.
DR   SwissPalm; Q6NXT2; -.
DR   BioMuta; H3F3C; -.
DR   DMDM; 116248097; -.
DR   EPD; Q6NXT2; -.
DR   jPOST; Q6NXT2; -.
DR   MassIVE; Q6NXT2; -.
DR   MaxQB; Q6NXT2; -.
DR   PaxDb; Q6NXT2; -.
DR   PeptideAtlas; Q6NXT2; -.
DR   PRIDE; Q6NXT2; -.
DR   ProteomicsDB; 66771; -.
DR   TopDownProteomics; Q6NXT2; -.
DR   Ensembl; ENST00000340398; ENSP00000339835; ENSG00000188375.
DR   GeneID; 440093; -.
DR   KEGG; hsa:440093; -.
DR   UCSC; uc001rkr.3; human.
DR   CTD; 440093; -.
DR   GeneCards; H3-5; -.
DR   HGNC; HGNC:33164; H3F3C.
DR   HPA; HPA042570; -.
DR   MIM; 616134; gene.
DR   neXtProt; NX_Q6NXT2; -.
DR   OpenTargets; ENSG00000188375; -.
DR   PharmGKB; PA165512903; -.
DR   eggNOG; KOG1745; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00950000182954; -.
DR   HOGENOM; CLU_078295_4_0_1; -.
DR   InParanoid; Q6NXT2; -.
DR   KO; K11253; -.
DR   OMA; QEASEPY; -.
DR   OrthoDB; 1564596at2759; -.
DR   PhylomeDB; Q6NXT2; -.
DR   TreeFam; TF314241; -.
DR   ChiTaRS; H3F3C; human.
DR   EvolutionaryTrace; Q6NXT2; -.
DR   GenomeRNAi; 440093; -.
DR   Pharos; Q6NXT2; Tbio.
DR   PRO; PR:Q6NXT2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q6NXT2; protein.
DR   Bgee; ENSG00000188375; Expressed in testis and 48 other tissues.
DR   Genevisible; Q6NXT2; HS.
DR   GO; GO:0005719; C:nuclear euchromatin; IDA:UniProtKB.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   PANTHER; PTHR11426; PTHR11426; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00322; HISTONE_H3_1; 1.
DR   PROSITE; PS00959; HISTONE_H3_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Chromosome; Citrullination;
KW   DNA-binding; Hydroxylation; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..135
FT                   /note="Histone H3.3C"
FT                   /id="PRO_0000253960"
FT   MOD_RES         3
FT                   /note="Asymmetric dimethylarginine; by PRMT6; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         3
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         4
FT                   /note="Phosphothreonine; by HASPIN"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="Allysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         5
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         7
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         9
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         9
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         10
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         10
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         10
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         11
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         11
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC, RPS6KA3,
FT                   RPS6KA4 and RPS6KA5"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         12
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         15
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         15
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         15
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         15
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         15
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         18
FT                   /note="Asymmetric dimethylarginine; by CARM1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         18
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         19
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         19
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         19
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         19
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         24
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         24
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         24
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         24
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         27
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         28
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         28
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         28
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         28
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         29
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         29
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC and
FT                   RPS6KA5"
FT                   /evidence="ECO:0000250|UniProtKB:P68432"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         37
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         41
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         56
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         56
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         56
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         56
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         56
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         56
FT                   /note="N6-methyllysine; by EHMT2; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         56
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20850016"
FT   MOD_RES         64
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         64
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         80
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20850016"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         107
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71DI3"
FT   MOD_RES         115
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         115
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         122
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         122
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         122
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         122
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         122
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   VARIANT         39
FT                   /note="H -> R (in dbSNP:rs3759295)"
FT                   /id="VAR_068164"
FT   CONFLICT        88
FT                   /note="A -> V (in Ref. 1; ADW85800 and 3; AAH66906)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..7
FT                   /evidence="ECO:0000244|PDB:2PUY"
FT   HELIX           45..56
FT                   /evidence="ECO:0000244|PDB:4Z5T"
FT   HELIX           64..78
FT                   /evidence="ECO:0000244|PDB:4Z5T"
FT   HELIX           86..113
FT                   /evidence="ECO:0000244|PDB:4Z5T"
FT   STRAND          117..119
FT                   /evidence="ECO:0000244|PDB:4Z5T"
FT   HELIX           121..130
FT                   /evidence="ECO:0000244|PDB:4Z5T"
SQ   SEQUENCE   135 AA;  15214 MW;  F2941F8A9BC61BB5 CRC64;
     MARTKQTARK STGGKAPRKQ LATKAARKST PSTCGVKPHR YRPGTVALRE IRRYQKSTEL
     LIRKLPFQRL VREIAQDFNT DLRFQSAAVG ALQEASEAYL VGLLEDTNLC AIHAKRVTIM
     PKDIQLARRI RGERA
//
ID   H4G_HUMAN               Reviewed;          98 AA.
AC   Q99525;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   26-FEB-2020, entry version 148.
DE   RecName: Full=Histone H4-like protein type G;
GN   Name=HIST1H4G; Synonyms=H4/L, H4FL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9119399; DOI=10.1006/geno.1996.4592;
RA   Albig W., Kioschis P., Poustka A., Meergans K., Doenecke D.;
RT   "Human histone gene organization: nonregular arrangement within a large
RT   cluster.";
RL   Genomics 40:314-322(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q6RW13:AGTRAP; NbExp=3; IntAct=EBI-10294329, EBI-741181;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the histone H4 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z80788; CAB02550.1; -; Genomic_DNA.
DR   EMBL; AY128660; AAN01445.1; -; Genomic_DNA.
DR   EMBL; AL031777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471087; EAW55550.1; -; Genomic_DNA.
DR   EMBL; BC126276; AAI26277.1; -; mRNA.
DR   EMBL; BC126278; AAI26279.1; -; mRNA.
DR   CCDS; CCDS4599.1; -.
DR   RefSeq; NP_003538.1; NM_003547.2.
DR   SMR; Q99525; -.
DR   BioGrid; 113965; 4.
DR   IntAct; Q99525; 9.
DR   STRING; 9606.ENSP00000477870; -.
DR   iPTMnet; Q99525; -.
DR   PhosphoSitePlus; Q99525; -.
DR   BioMuta; HIST1H4G; -.
DR   DMDM; 74752149; -.
DR   jPOST; Q99525; -.
DR   MassIVE; Q99525; -.
DR   PaxDb; Q99525; -.
DR   PeptideAtlas; Q99525; -.
DR   PRIDE; Q99525; -.
DR   ProteomicsDB; 78310; -.
DR   DNASU; 8369; -.
DR   Ensembl; ENST00000611444; ENSP00000477870; ENSG00000275663.
DR   GeneID; 8369; -.
DR   KEGG; hsa:8369; -.
DR   UCSC; uc003nhf.4; human.
DR   CTD; 8369; -.
DR   DisGeNET; 8369; -.
DR   GeneCards; H4C7; -.
DR   HGNC; HGNC:4792; HIST1H4G.
DR   HPA; HPA042201; -.
DR   MIM; 602832; gene.
DR   neXtProt; NX_Q99525; -.
DR   OpenTargets; ENSG00000275663; -.
DR   PharmGKB; PA29167; -.
DR   eggNOG; KOG3467; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00980000198478; -.
DR   HOGENOM; CLU_109117_2_3_1; -.
DR   InParanoid; Q99525; -.
DR   KO; K11254; -.
DR   OMA; LENVIWY; -.
DR   OrthoDB; 1594208at2759; -.
DR   PhylomeDB; Q99525; -.
DR   GeneWiki; HIST1H4G; -.
DR   GenomeRNAi; 8369; -.
DR   Pharos; Q99525; Tdark.
DR   PRO; PR:Q99525; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q99525; protein.
DR   Bgee; ENSG00000275663; Expressed in muscle tissue and 18 other tissues.
DR   Genevisible; Q99525; HS.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR001951; Histone_H4.
DR   PRINTS; PR00623; HISTONEH4.
DR   SMART; SM00417; H4; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   1: Evidence at protein level;
KW   Chromosome; DNA-binding; Nucleosome core; Nucleus; Reference proteome.
FT   CHAIN           1..98
FT                   /note="Histone H4-like protein type G"
FT                   /id="PRO_0000324392"
FT   DNA_BIND        17..21
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   98 AA;  11009 MW;  B76078AC96AE4DEB CRC64;
     MSVRGKAGKG LGKGGAKCHR KVLSDNIQGI TKCTIRRLAR HGGVKRILGL IYEETRRVFK
     VFLENVIWYA VTNTEHAKRK TVTAMAVVYV LKRQGRTL
//
ID   H4_HUMAN                Reviewed;         103 AA.
AC   P62805; A2VCL0; P02304; P02305; Q6DRA9; Q6FGB8; Q6NWP7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   26-FEB-2020, entry version 198.
DE   RecName: Full=Histone H4;
GN   Name=H4C1; Synonyms=H4/A, H4FA, HIST1H4A;
GN   and
GN   Name=H4C2; Synonyms=H4/I, H4FI, HIST1H4B;
GN   and
GN   Name=H4C3; Synonyms=H4/G, H4FG, HIST1H4C;
GN   and
GN   Name=H4C4; Synonyms=H4/B, H4FB, HIST1H4D;
GN   and
GN   Name=H4C5; Synonyms=H4/J, H4FJ, HIST1H4E;
GN   and
GN   Name=H4C6; Synonyms=H4/C, H4FC, HIST1H4F;
GN   and
GN   Name=H4C8; Synonyms=H4/H, H4FH, HIST1H4H;
GN   and
GN   Name=H4C9; Synonyms=H4/M, H4FM, HIST1H4I;
GN   and
GN   Name=H4C11; Synonyms=H4/E, H4FE, HIST1H4J;
GN   and
GN   Name=H4C12; Synonyms=H4/D, H4FD, HIST1H4K;
GN   and
GN   Name=H4C13; Synonyms=H4/K, H4FK, HIST1H4L;
GN   and
GN   Name=H4C14; Synonyms=H4/N, H4F2, H4FN, HIST2H4, HIST2H4A;
GN   and
GN   Name=H4C15; Synonyms=H4/O, H4FO, HIST2H4B;
GN   and
GN   Name=H4-16; Synonyms=HIST4H4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6314274; DOI=10.1093/nar/11.20.7069;
RA   Sierra F., Stein G., Stein J.;
RT   "Structure and in vitro transcription of a human H4 histone gene.";
RL   Nucleic Acids Res. 11:7069-7086(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3035717; DOI=10.1126/science.3035717;
RA   Pauli U., Chrysogelos S., Stein G., Stein J., Nick H.;
RT   "Protein-DNA interactions in vivo upstream of a cell cycle-regulated human
RT   H4 histone gene.";
RL   Science 236:1308-1311(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-f;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7626218; DOI=10.1089/dna.1995.14.591;
RA   Drabent B., Kardalinou E., Bode C., Doenecke D.;
RT   "Association of histone H4 genes with the mammalian testis-specific H1t
RT   histone gene.";
RL   DNA Cell Biol. 14:591-597(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9031620; DOI=10.1016/s0378-1119(96)00582-3;
RA   Albig W., Meergans T., Doenecke D.;
RT   "Characterization of the H1.5 gene completes the set of human H1 subtype
RT   genes.";
RL   Gene 184:141-148(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9119399; DOI=10.1006/geno.1996.4592;
RA   Albig W., Kioschis P., Poustka A., Meergans K., Doenecke D.;
RT   "Human histone gene organization: nonregular arrangement within a large
RT   cluster.";
RL   Genomics 40:314-322(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H4C1; H4C2; H4C3; H4C4; H4C5; H4C6;
RP   H4C8; H4C9; H4C11; H4C12; H4C13; H4C14 AND H4-16).
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8988030;
RA   Akasaka T., Miura I., Takahashi N., Akasaka H., Yonetani N., Ohno H.,
RA   Fukuhara S., Okuma M.;
RT   "A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma
RT   results in replacement of the 5' regulatory region of BCL6 with a novel H4
RT   histone gene.";
RL   Cancer Res. 57:7-12(1997).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15527963; DOI=10.1016/j.gene.2004.07.036;
RA   Braastad C.D., Hovhannisyan H., van Wijnen A.J., Stein J.L., Stein G.S.;
RT   "Functional characterization of a human histone gene cluster duplication.";
RL   Gene 342:35-40(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (H4C6; H4C8 AND H4C14).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (H4C1; H4C2; H4C3; H4C4;
RP   H4C5; H4C6; H4C8; H4C9; H4C11; H4C12 AND H4C13).
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum, Eye, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   PROTEIN SEQUENCE OF 25-36; 47-56; 61-78 AND 81-93, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [16]
RP   ACETYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=7664735; DOI=10.1002/j.1460-2075.1995.tb00066.x;
RA   O'Neill L.P., Turner B.M.;
RT   "Histone H4 acetylation distinguishes coding regions of the human genome
RT   from heterochromatin in a differentiation-dependent but transcription-
RT   independent manner.";
RL   EMBO J. 14:3946-3957(1995).
RN   [17]
RP   DNA-BINDING REGION.
RX   PubMed=3340182; DOI=10.1038/331365a0;
RA   Ebralidse K.K., Grachev S.A., Mirzabekov A.D.;
RT   "A highly basic histone H4 domain bound to the sharply bent region of
RT   nucleosomal DNA.";
RL   Nature 331:365-367(1988).
RN   [18]
RP   ACETYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=2474456; DOI=10.1016/0014-5793(89)80947-0;
RA   Turner B.M., O'Neill L.P., Allan I.M.;
RT   "Histone H4 acetylation in human cells. Frequency of acetylation at
RT   different sites defined by immunolabeling with site-specific antibodies.";
RL   FEBS Lett. 253:141-145(1989).
RN   [19]
RP   METHYLATION AT ARG-4.
RX   PubMed=11448779; DOI=10.1016/s0960-9822(01)00294-9;
RA   Strahl B.D., Briggs S.D., Brame C.J., Caldwell J.A., Koh S.S., Ma H.,
RA   Cook R.G., Shabanowitz J., Hunt D.F., Stallcup M.R., Allis C.D.;
RT   "Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by
RT   the nuclear receptor coactivator PRMT1.";
RL   Curr. Biol. 11:996-1000(2001).
RN   [20]
RP   METHYLATION AT ARG-4.
RX   PubMed=11387442; DOI=10.1126/science.1060781;
RA   Wang H., Huang Z.-Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D.,
RA   Briggs S.D., Allis C.D., Wong J., Tempst P., Zhang Y.;
RT   "Methylation of histone H4 at arginine 3 facilitating transcriptional
RT   activation by nuclear hormone receptor.";
RL   Science 293:853-857(2001).
RN   [21]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL TRANSLOCATION
RP   WITH BCL6.
RX   PubMed=12414651;
RA   Kurata M., Maesako Y., Ueda C., Nishikori M., Akasaka T., Uchiyama T.,
RA   Ohno H.;
RT   "Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's
RT   lymphoma and construction of the histone H4/BCL6 fusion gene, leading to
RT   altered expression of Bcl-6.";
RL   Cancer Res. 62:6224-6230(2002).
RN   [22]
RP   METHYLATION AT LYS-21.
RX   PubMed=12086618; DOI=10.1016/s1097-2765(02)00548-8;
RA   Nishioka K., Rice J.C., Sarma K., Erdjument-Bromage H., Werner J., Wang Y.,
RA   Chuikov S., Valenzuela P., Tempst P., Steward R., Lis J.T., Allis C.D.,
RA   Reinberg D.;
RT   "PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20
RT   of histone H4 and is associated with silent chromatin.";
RL   Mol. Cell 9:1201-1213(2002).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [24]
RP   SUMOYLATION.
RX   PubMed=14578449; DOI=10.1073/pnas.1735528100;
RA   Shiio Y., Eisenman R.N.;
RT   "Histone sumoylation is associated with transcriptional repression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13225-13230(2003).
RN   [25]
RP   CITRULLINATION AT ARG-4, AND METHYLATION AT ARG-4.
RX   PubMed=15345777; DOI=10.1126/science.1101400;
RA   Wang Y., Wysocka J., Sayegh J., Lee Y.-H., Perlin J.R., Leonelli L.,
RA   Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S.,
RA   Stallcup M.R., Allis C.D., Coonrod S.A.;
RT   "Human PAD4 regulates histone arginine methylation levels via
RT   demethylimination.";
RL   Science 306:279-283(2004).
RN   [26]
RP   METHYLATION AT LYS-21.
RX   PubMed=15964846; DOI=10.1074/jbc.m501691200;
RA   Yin Y., Liu C., Tsai S.N., Zhou B., Ngai S.M., Zhu G.;
RT   "SET8 recognizes the sequence RHRK20VLRDN within the N terminus of histone
RT   H4 and mono-methylates lysine 20.";
RL   J. Biol. Chem. 280:30025-30031(2005).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-52, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [29]
RP   UBIQUITINATION.
RX   PubMed=16678110; DOI=10.1016/j.molcel.2006.03.035;
RA   Wang H., Zhai L., Xu J., Joo H.-Y., Jackson S., Erdjument-Bromage H.,
RA   Tempst P., Xiong Y., Zhang Y.;
RT   "Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase
RT   facilitates cellular response to DNA damage.";
RL   Mol. Cell 22:383-394(2006).
RN   [30]
RP   CITRULLINATION AT ARG-4.
RX   PubMed=16567635; DOI=10.1073/pnas.0509639103;
RA   Arita K., Shimizu T., Hashimoto H., Hidaka Y., Yamada M., Sato M.;
RT   "Structural basis for histone N-terminal recognition by human
RT   peptidylarginine deiminase 4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5291-5296(2006).
RN   [31]
RP   ACETYLATION AT SER-2; LYS-13 AND LYS-17, PHOSPHORYLATION AT SER-2, AND
RP   METHYLATION AT LYS-21.
RX   PubMed=17967882; DOI=10.1128/mcb.01517-07;
RA   Pesavento J.J., Yang H., Kelleher N.L., Mizzen C.A.;
RT   "Certain and progressive methylation of histone H4 at lysine 20 during the
RT   cell cycle.";
RL   Mol. Cell. Biol. 28:468-486(2008).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [33]
RP   ACETYLATION AT LYS-92, AND UBIQUITINATION AT LYS-92.
RX   PubMed=19818714; DOI=10.1016/j.molcel.2009.08.019;
RA   Yan Q., Dutt S., Xu R., Graves K., Juszczynski P., Manis J.P., Shipp M.A.;
RT   "BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates
RT   the DNA damage response.";
RL   Mol. Cell 36:110-120(2009).
RN   [34]
RP   PROPIONYLATION AT LYS-9; LYS-17; LYS-32; LYS-45; LYS-78; LYS-80 AND LYS-92,
RP   AND BUTYRYLATION AT LYS-9; LYS-17; LYS-32; LYS-45; LYS-78; LYS-80 AND
RP   LYS-92.
RX   PubMed=17267393; DOI=10.1074/mcp.m700021-mcp200;
RA   Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R.,
RA   Peng J., Gu W., Zhao Y.;
RT   "Lysine propionylation and butyrylation are novel post-translational
RT   modifications in histones.";
RL   Mol. Cell. Proteomics 6:812-819(2007).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-9; LYS-13; LYS-17 AND
RP   LYS-32, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND TYR-52, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [39]
RP   CROTONYLATION AT LYS-6; LYS-9 AND LYS-13.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [40]
RP   PHOSPHORYLATION AT SER-48.
RX   PubMed=21724829; DOI=10.1101/gad.2055511;
RA   Kang B., Pu M., Hu G., Wen W., Dong Z., Zhao K., Stillman B., Zhang Z.;
RT   "Phosphorylation of H4 Ser 47 promotes HIRA-mediated nucleosome assembly.";
RL   Genes Dev. 25:1359-1364(2011).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [42]
RP   SUCCINYLATION AT LYS-13; LYS-32; LYS-78 AND LYS-92.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [44]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND TYR-89, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [45]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-9; LYS-13; LYS-17; LYS-32; LYS-45;
RP   LYS-60; LYS-78; LYS-80 AND LYS-92.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [46]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-13, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [47]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [48]
RP   BUTYRYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [49]
RP   HYDROXYBUTYRYLATION AT LYS-9; LYS-13; LYS-32; LYS-78 AND LYS-92.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [50]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-21; LYS-32; LYS-60; LYS-80 AND
RP   LYS-92, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [51]
RP   GLUTARYLATION AT LYS-6; LYS-13; LYS-32; LYS-60 LYS-78; LYS-80 AND LYS-92.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=15951514; DOI=10.1093/nar/gki663;
RA   Tsunaka Y., Kajimura N., Tate S., Morikawa K.;
RT   "Alteration of the nucleosomal DNA path in the crystal structure of a human
RT   nucleosome core particle.";
RL   Nucleic Acids Res. 33:3424-3434(2005).
RN   [53] {ECO:0000244|PDB:5AY8}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH H2A; H2B AND H3.Y.
RX   PubMed=27016736; DOI=10.1093/nar/gkw202;
RA   Kujirai T., Horikoshi N., Sato K., Maehara K., Machida S., Osakabe A.,
RA   Kimura H., Ohkawa Y., Kurumizaka H.;
RT   "Structure and function of human histone H3.Y nucleosome.";
RL   Nucleic Acids Res. 44:6127-6141(2016).
RN   [54]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-64.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- INTERACTION:
CC       P35609:ACTN2; NbExp=3; IntAct=EBI-302023, EBI-77797;
CC       Q9Y294:ASF1A; NbExp=20; IntAct=EBI-302023, EBI-749553;
CC       Q12830:BPTF; NbExp=3; IntAct=EBI-302023, EBI-1560273;
CC       Q12830-4:BPTF; NbExp=16; IntAct=EBI-302023, EBI-4288838;
CC       P25440:BRD2; NbExp=5; IntAct=EBI-302023, EBI-2874802;
CC       O60885-1:BRD4; NbExp=10; IntAct=EBI-302023, EBI-9345088;
CC       P55201:BRPF1; NbExp=8; IntAct=EBI-302023, EBI-2837428;
CC       P45973:CBX5; NbExp=2; IntAct=EBI-302023, EBI-78219;
CC       P49450:CENPA; NbExp=6; IntAct=EBI-302023, EBI-1751979;
CC       P49450-1:CENPA; NbExp=2; IntAct=EBI-302023, EBI-15826012;
CC       Q9NQ92:COPRS; NbExp=3; IntAct=EBI-302023, EBI-1642558;
CC       Q92793:CREBBP; NbExp=6; IntAct=EBI-302023, EBI-81215;
CC       P45481:Crebbp (xeno); NbExp=2; IntAct=EBI-302023, EBI-296306;
CC       P16104:H2AFX; NbExp=4; IntAct=EBI-302023, EBI-494830;
CC       P84243:H3F3B; NbExp=12; IntAct=EBI-302023, EBI-120658;
CC       O14929:HAT1; NbExp=7; IntAct=EBI-302023, EBI-2339359;
CC       Q13547:HDAC1; NbExp=3; IntAct=EBI-302023, EBI-301834;
CC       P04908:HIST1H2AE; NbExp=11; IntAct=EBI-302023, EBI-358971;
CC       P68431:HIST1H3F; NbExp=7; IntAct=EBI-302023, EBI-79722;
CC       Q71DI3:HIST2H3D; NbExp=4; IntAct=EBI-302023, EBI-750650;
CC       Q16695:HIST3H3; NbExp=3; IntAct=EBI-302023, EBI-358900;
CC       Q9H9V9:JMJD4; NbExp=3; IntAct=EBI-302023, EBI-2866290;
CC       O75164:KDM4A; NbExp=7; IntAct=EBI-302023, EBI-936709;
CC       Q9NQR1:KMT5A; NbExp=5; IntAct=EBI-302023, EBI-1268946;
CC       Q9Y468:L3MBTL1; NbExp=4; IntAct=EBI-302023, EBI-1265089;
CC       Q05BQ5:MBTD1; NbExp=3; IntAct=EBI-302023, EBI-5666902;
CC       P49736:MCM2; NbExp=9; IntAct=EBI-302023, EBI-374819;
CC       P25205:MCM3; NbExp=2; IntAct=EBI-302023, EBI-355153;
CC       P33992:MCM5; NbExp=2; IntAct=EBI-302023, EBI-359410;
CC       Q86UY6-1:NAA40; NbExp=3; IntAct=EBI-302023, EBI-16140302;
CC       Q9BVI0:PHF20; NbExp=3; IntAct=EBI-302023, EBI-2560802;
CC       A8MW92:PHF20L1; NbExp=2; IntAct=EBI-302023, EBI-2560834;
CC       Q99873:PRMT1; NbExp=2; IntAct=EBI-302023, EBI-78738;
CC       O14744:PRMT5; NbExp=6; IntAct=EBI-302023, EBI-351098;
CC       Q582G4:PRMT7 (xeno); NbExp=4; IntAct=EBI-302023, EBI-16101095;
CC       P62826:RAN; NbExp=2; IntAct=EBI-302023, EBI-286642;
CC       Q16576:RBBP7; NbExp=9; IntAct=EBI-302023, EBI-352227;
CC       Q14684-1:RRP1B; NbExp=3; IntAct=EBI-302023, EBI-5280110;
CC       P38890:SET5 (xeno); NbExp=2; IntAct=EBI-302023, EBI-24263;
CC       Q9VK33:Sfmbt (xeno); NbExp=10; IntAct=EBI-302023, EBI-117801;
CC       Q8IUQ4:SIAH1; NbExp=3; IntAct=EBI-302023, EBI-747107;
CC       O60264:SMARCA5; NbExp=2; IntAct=EBI-302023, EBI-352588;
CC       Q04724:TLE1; NbExp=6; IntAct=EBI-302023, EBI-711424;
CC       Q12888:TP53BP1; NbExp=14; IntAct=EBI-302023, EBI-396540;
CC       Q12888-1:TP53BP1; NbExp=3; IntAct=EBI-302023, EBI-8022649;
CC       P63104:YWHAZ; NbExp=3; IntAct=EBI-302023, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Acetylation at Lys-6 (H4K5ac), Lys-9 (H4K8ac), Lys-13 (H4K12ac)
CC       and Lys-17 (H4K16ac) occurs in coding regions of the genome but not in
CC       heterochromatin. {ECO:0000269|PubMed:17967882,
CC       ECO:0000269|PubMed:2474456, ECO:0000269|PubMed:7664735}.
CC   -!- PTM: Citrullination at Arg-4 (H4R3ci) by PADI4 impairs methylation.
CC       {ECO:0000269|PubMed:11387442, ECO:0000269|PubMed:11448779,
CC       ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:16567635}.
CC   -!- PTM: Monomethylation and asymmetric dimethylation at Arg-4 (H4R3me1 and
CC       H4R3me2a, respectively) by PRMT1 favors acetylation at Lys-9 (H4K8ac)
CC       and Lys-13 (H4K12ac). Demethylation is performed by JMJD6. Symmetric
CC       dimethylation on Arg-4 (H4R3me2s) by the PRDM1/PRMT5 complex may play a
CC       crucial role in the germ-cell lineage. {ECO:0000269|PubMed:11387442,
CC       ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:15345777}.
CC   -!- PTM: Monomethylated, dimethylated or trimethylated at Lys-21 (H4K20me1,
CC       H4K20me2, H4K20me3) (PubMed:12086618, PubMed:15964846,
CC       PubMed:17967882). Monomethylation is performed by SET8
CC       (PubMed:15964846). Dimethylation and trimethylation is performed by
CC       KMT5B and KMT5C and induces gene silencing (By similarity).
CC       {ECO:0000250|UniProtKB:P62806, ECO:0000269|PubMed:12086618,
CC       ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882}.
CC   -!- PTM: Phosphorylated by PAK2 at Ser-48 (H4S47ph). This phosphorylation
CC       increases the association of H3.3-H4 with the histone chaperone HIRA,
CC       thus promoting nucleosome assembly of H3.3-H4 and inhibiting nucleosome
CC       assembly of H3.1-H4. {ECO:0000269|PubMed:17967882,
CC       ECO:0000269|PubMed:21724829}.
CC   -!- PTM: Ubiquitinated by the CUL4-DDB-RBX1 complex in response to
CC       ultraviolet irradiation. This may weaken the interaction between
CC       histones and DNA and facilitate DNA accessibility to repair proteins.
CC       Monoubiquitinated at Lys-92 of histone H4 (H4K91ub1) in response to DNA
CC       damage. The exact role of H4K91ub1 in DNA damage response is still
CC       unclear but it may function as a licensing signal for additional
CC       histone H4 post-translational modifications such as H4 Lys-21
CC       methylation (H4K20me). {ECO:0000269|PubMed:12086618,
CC       ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:16678110,
CC       ECO:0000269|PubMed:17967882, ECO:0000269|PubMed:19818714}.
CC   -!- PTM: Sumoylated, which is associated with transcriptional repression.
CC       {ECO:0000269|PubMed:14578449}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes with
CC       histone acetylation. {ECO:0000250|UniProtKB:P62806}.
CC   -!- PTM: Glutarylation at Lys-92 (H4K91glu) destabilizes nucleosomes by
CC       promoting dissociation of the H2A-H2B dimers from nucleosomes.
CC       {ECO:0000269|PubMed:31542297}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving HISTONE H4 is a cause
CC       of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation
CC       t(3;6)(q27;p21), with BCL6. {ECO:0000269|PubMed:12414651}.
CC   -!- SIMILARITY: Belongs to the histone H4 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI28106.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00038; CAA24918.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M16707; AAA52652.1; -; Genomic_DNA.
DR   EMBL; M60749; AAA63188.1; -; Genomic_DNA.
DR   EMBL; X60481; CAA43011.1; -; Genomic_DNA.
DR   EMBL; X60482; CAA43012.1; -; Genomic_DNA.
DR   EMBL; X60483; CAA43013.1; -; Genomic_DNA.
DR   EMBL; X60484; CAA43014.1; -; Genomic_DNA.
DR   EMBL; X60486; CAA43016.1; -; Genomic_DNA.
DR   EMBL; X60487; CAA43017.1; -; Genomic_DNA.
DR   EMBL; X67081; CAA47464.1; -; Genomic_DNA.
DR   EMBL; Z80787; CAB02549.1; -; Genomic_DNA.
DR   EMBL; X83548; CAA58538.1; -; Genomic_DNA.
DR   EMBL; AF525682; AAM83108.1; -; Genomic_DNA.
DR   EMBL; AY128653; AAN01438.1; -; Genomic_DNA.
DR   EMBL; AY128654; AAN01439.1; -; Genomic_DNA.
DR   EMBL; AY128655; AAN01440.1; -; Genomic_DNA.
DR   EMBL; AY128656; AAN01441.1; -; Genomic_DNA.
DR   EMBL; AY128657; AAN01442.1; -; Genomic_DNA.
DR   EMBL; AY128658; AAN01443.1; -; Genomic_DNA.
DR   EMBL; AY128659; AAN01444.1; -; Genomic_DNA.
DR   EMBL; AY128661; AAN01446.1; -; Genomic_DNA.
DR   EMBL; AY128662; AAN01447.1; -; Genomic_DNA.
DR   EMBL; AY128663; AAN01448.1; -; Genomic_DNA.
DR   EMBL; AY128664; AAN01449.1; -; Genomic_DNA.
DR   EMBL; AY128665; AAN01450.1; -; Genomic_DNA.
DR   EMBL; AB000905; BAA19208.1; -; Genomic_DNA.
DR   EMBL; AY648850; AAT68253.1; -; Genomic_DNA.
DR   EMBL; CR542169; CAG46966.1; -; mRNA.
DR   EMBL; CR542172; CAG46969.1; -; mRNA.
DR   EMBL; CR542180; CAG46977.1; -; mRNA.
DR   EMBL; CR542187; CAG46984.1; -; mRNA.
DR   EMBL; CR542189; CAG46986.1; -; mRNA.
DR   EMBL; AL021807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL021917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353759; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591493; CAI12560.1; -; Genomic_DNA.
DR   EMBL; AL591493; CAI12567.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55509.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55510.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55538.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55549.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55555.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96325.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03086.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03111.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03112.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03121.1; -; Genomic_DNA.
DR   EMBL; BC017361; AAH17361.1; -; mRNA.
DR   EMBL; BC054014; AAH54014.1; -; mRNA.
DR   EMBL; BC066248; AAH66248.1; -; mRNA.
DR   EMBL; BC066249; AAH66249.1; -; mRNA.
DR   EMBL; BC066250; AAH66250.1; -; mRNA.
DR   EMBL; BC067495; AAH67495.1; -; mRNA.
DR   EMBL; BC067496; AAH67496.1; -; mRNA.
DR   EMBL; BC067497; AAH67497.1; -; mRNA.
DR   EMBL; BC069288; AAH69288.1; -; mRNA.
DR   EMBL; BC069392; AAH69392.1; -; mRNA.
DR   EMBL; BC069467; AAH69467.1; -; mRNA.
DR   EMBL; BC069654; AAH69654.1; -; mRNA.
DR   EMBL; BC093763; AAH93763.1; -; mRNA.
DR   EMBL; BC093765; AAH93765.1; -; mRNA.
DR   EMBL; BC093969; AAH93969.1; -; mRNA.
DR   EMBL; BC111093; AAI11094.1; -; mRNA.
DR   EMBL; BC111434; AAI11435.1; -; mRNA.
DR   EMBL; BC112193; AAI12194.1; -; mRNA.
DR   EMBL; BC120939; AAI20940.1; -; mRNA.
DR   EMBL; BC128104; AAI28105.1; -; mRNA.
DR   EMBL; BC128105; AAI28106.1; ALT_FRAME; mRNA.
DR   EMBL; BC130558; AAI30559.1; -; mRNA.
DR   EMBL; BC130560; AAI30561.1; -; mRNA.
DR   EMBL; BC143045; AAI43046.1; -; mRNA.
DR   CCDS; CCDS30847.1; -.
DR   CCDS; CCDS30851.1; -.
DR   CCDS; CCDS4571.1; -.
DR   CCDS; CCDS4572.1; -.
DR   CCDS; CCDS4583.1; -.
DR   CCDS; CCDS4589.1; -.
DR   CCDS; CCDS4593.1; -.
DR   CCDS; CCDS4598.1; -.
DR   CCDS; CCDS4604.1; -.
DR   CCDS; CCDS4620.1; -.
DR   CCDS; CCDS4630.1; -.
DR   CCDS; CCDS4631.1; -.
DR   CCDS; CCDS4637.1; -.
DR   CCDS; CCDS8665.1; -.
DR   PIR; D40335; HSHU4.
DR   RefSeq; NP_001029249.1; NM_001034077.4.
DR   RefSeq; NP_003486.1; NM_003495.2.
DR   RefSeq; NP_003529.1; NM_003538.3.
DR   RefSeq; NP_003530.1; NM_003539.3.
DR   RefSeq; NP_003531.1; NM_003540.3.
DR   RefSeq; NP_003532.1; NM_003541.2.
DR   RefSeq; NP_003533.1; NM_003542.3.
DR   RefSeq; NP_003534.1; NM_003543.3.
DR   RefSeq; NP_003535.1; NM_003544.2.
DR   RefSeq; NP_003536.1; NM_003545.3.
DR   RefSeq; NP_003537.1; NM_003546.2.
DR   RefSeq; NP_003539.1; NM_003548.2.
DR   RefSeq; NP_068803.1; NM_021968.3.
DR   RefSeq; NP_778224.1; NM_175054.2.
DR   PDB; 1ZKK; X-ray; 1.45 A; E/F/G/H=16-25.
DR   PDB; 2BQZ; X-ray; 1.50 A; B/F=18-26.
DR   PDB; 2CV5; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 2IG0; X-ray; 1.70 A; B=17-26.
DR   PDB; 2KWN; NMR; -; B=10-24.
DR   PDB; 2KWO; NMR; -; B=2-21.
DR   PDB; 2LVM; NMR; -; B=15-28.
DR   PDB; 2QQS; X-ray; 2.82 A; C/D=17-26.
DR   PDB; 2RJE; X-ray; 1.86 A; P/Q=16-26.
DR   PDB; 2RNY; NMR; -; B=14-28.
DR   PDB; 2RS9; NMR; -; A=2-11.
DR   PDB; 3A6N; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AFA; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 3AN2; X-ray; 3.60 A; B/F=1-103.
DR   PDB; 3AV1; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 3AV2; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 3AYW; X-ray; 2.90 A; B/F=1-103.
DR   PDB; 3AZE; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3AZF; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZG; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 3AZH; X-ray; 3.49 A; B/F=1-103.
DR   PDB; 3AZI; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZJ; X-ray; 2.89 A; B/F=1-103.
DR   PDB; 3AZK; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3AZL; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZM; X-ray; 2.89 A; B/F=1-103.
DR   PDB; 3AZN; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3CFS; X-ray; 2.40 A; E=28-42.
DR   PDB; 3CFV; X-ray; 2.60 A; E/F=25-42.
DR   PDB; 3F9W; X-ray; 1.60 A; E/F/G/H=16-25.
DR   PDB; 3F9X; X-ray; 1.25 A; E/F/G/H=16-25.
DR   PDB; 3F9Y; X-ray; 1.50 A; E/F=16-25.
DR   PDB; 3F9Z; X-ray; 1.60 A; E/F/G/H=16-25.
DR   PDB; 3IJ1; X-ray; 2.10 A; B=16-26.
DR   PDB; 3JPX; X-ray; 2.05 A; B=14-28.
DR   PDB; 3NQJ; X-ray; 2.10 A; B=21-103.
DR   PDB; 3NQU; X-ray; 2.50 A; B=1-103.
DR   PDB; 3O36; X-ray; 1.70 A; D/E=15-20.
DR   PDB; 3QBY; X-ray; 1.95 A; H=16-26.
DR   PDB; 3QZS; X-ray; 1.80 A; C/D=13-22.
DR   PDB; 3QZT; X-ray; 1.50 A; B=13-22.
DR   PDB; 3QZV; X-ray; 2.00 A; C=8-18.
DR   PDB; 3R45; X-ray; 2.60 A; B=1-103.
DR   PDB; 3UVW; X-ray; 1.37 A; B=2-12.
DR   PDB; 3UVX; X-ray; 1.91 A; B=12-22.
DR   PDB; 3UVY; X-ray; 2.02 A; B=16-26.
DR   PDB; 3UW9; X-ray; 2.30 A; E/F=8-18.
DR   PDB; 3W96; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3W97; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3W98; X-ray; 3.42 A; B/F=1-103.
DR   PDB; 3W99; X-ray; 3.00 A; B/F=17-103.
DR   PDB; 3WA9; X-ray; 3.07 A; B/F=1-103.
DR   PDB; 3WAA; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3WKJ; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 3WTP; X-ray; 2.67 A; B/F=1-103.
DR   PDB; 3X1S; X-ray; 2.81 A; B/F=2-103.
DR   PDB; 3X1T; X-ray; 2.81 A; B/F=2-103.
DR   PDB; 3X1U; X-ray; 3.25 A; B/F=2-103.
DR   PDB; 3X1V; X-ray; 2.92 A; B/F=2-103.
DR   PDB; 4GQB; X-ray; 2.06 A; C=2-22.
DR   PDB; 4H9N; X-ray; 1.95 A; B=2-103.
DR   PDB; 4H9O; X-ray; 2.05 A; B=2-103.
DR   PDB; 4H9P; X-ray; 2.20 A; B=2-103.
DR   PDB; 4H9Q; X-ray; 1.95 A; B=2-103.
DR   PDB; 4H9R; X-ray; 2.20 A; B=2-103.
DR   PDB; 4H9S; X-ray; 2.60 A; C/D=21-103.
DR   PDB; 4HGA; X-ray; 2.80 A; C=1-103.
DR   PDB; 4M38; X-ray; 2.20 A; E/F=2-22.
DR   PDB; 4N3W; X-ray; 1.90 A; C=14-28.
DR   PDB; 4N4F; X-ray; 1.83 A; C=6-26.
DR   PDB; 4QUT; X-ray; 1.70 A; B=10-16.
DR   PDB; 4QUU; X-ray; 1.80 A; B=4-16.
DR   PDB; 4QYD; X-ray; 1.94 A; B=5-18.
DR   PDB; 4U9W; X-ray; 2.49 A; E/F/G/H=2-6.
DR   PDB; 4YM5; X-ray; 4.00 A; B/F=1-103.
DR   PDB; 4YM6; X-ray; 3.51 A; B/F=1-103.
DR   PDB; 4YY6; X-ray; 1.45 A; Z=2-12.
DR   PDB; 4YYD; X-ray; 1.52 A; Z=2-12.
DR   PDB; 4YYG; X-ray; 2.10 A; B=2-12.
DR   PDB; 4YYH; X-ray; 1.74 A; Y/Z=2-12.
DR   PDB; 4YYI; X-ray; 1.50 A; C/F=2-12.
DR   PDB; 4YYJ; X-ray; 1.85 A; C/F=2-12.
DR   PDB; 4YYK; X-ray; 1.79 A; C/F=2-12.
DR   PDB; 4YYM; X-ray; 1.50 A; Z=2-12.
DR   PDB; 4YYN; X-ray; 1.85 A; Z=2-12.
DR   PDB; 4Z2M; X-ray; 2.98 A; H/J=1-103.
DR   PDB; 4Z5T; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 5AV5; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AV6; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AV8; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AV9; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AVB; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AVC; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AY8; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 5B0Y; X-ray; 2.56 A; B/F=1-103.
DR   PDB; 5B0Z; X-ray; 1.99 A; B/F=1-103.
DR   PDB; 5B24; X-ray; 3.60 A; B/F=1-103.
DR   PDB; 5B2I; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 5B2J; X-ray; 2.60 A; B/F=1-103.
DR   PDB; 5B31; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5B32; X-ray; 2.35 A; B/F=1-103.
DR   PDB; 5B33; X-ray; 2.92 A; B/F=1-103.
DR   PDB; 5B40; X-ray; 3.33 A; B/F=1-103.
DR   PDB; 5BNV; X-ray; 2.79 A; B/E=2-103.
DR   PDB; 5BNX; X-ray; 2.31 A; B=2-103.
DR   PDB; 5BO0; X-ray; 2.91 A; B=2-103.
DR   PDB; 5C3I; X-ray; 3.50 A; C/G/K/O/S/W=1-103.
DR   PDB; 5CPI; X-ray; 2.90 A; B/F=1-103.
DR   PDB; 5CPJ; X-ray; 3.15 A; B/F=1-103.
DR   PDB; 5CPK; X-ray; 2.63 A; B/F=1-103.
DR   PDB; 5FA5; X-ray; 2.34 A; C=2-21.
DR   PDB; 5FFW; X-ray; 1.50 A; C=2-11.
DR   PDB; 5FWE; X-ray; 2.05 A; C/D=2-16.
DR   PDB; 5GSE; X-ray; 3.14 A; B/F/L/P=1-103.
DR   PDB; 5GSU; X-ray; 3.10 A; B/F=2-103.
DR   PDB; 5GT0; X-ray; 2.82 A; B/F=2-103.
DR   PDB; 5GT3; X-ray; 2.91 A; B/F=2-103.
DR   PDB; 5GTC; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 5GXQ; X-ray; 2.85 A; B/F=1-103.
DR   PDB; 5JA4; X-ray; 2.42 A; B=2-103.
DR   PDB; 5JRG; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 5KDM; X-ray; 3.50 A; B=2-103.
DR   PDB; 5TEG; X-ray; 1.30 A; D/E=17-24.
DR   PDB; 5X7X; X-ray; 2.18 A; B/F=1-103.
DR   PDB; 5XF3; X-ray; 2.60 A; B/F=1-103.
DR   PDB; 5XF4; X-ray; 2.87 A; B/F=1-103.
DR   PDB; 5XF5; X-ray; 2.82 A; B/F=1-103.
DR   PDB; 5Y0C; X-ray; 2.09 A; B/F=1-103.
DR   PDB; 5Y0D; X-ray; 1.99 A; B/F=1-103.
DR   PDB; 5YE3; X-ray; 1.70 A; C=2-13.
DR   PDB; 5YE4; X-ray; 1.80 A; E/F=2-13.
DR   PDB; 5Z23; X-ray; 2.73 A; B/F=1-103.
DR   PDB; 5Z30; X-ray; 2.45 A; B/F=1-103.
DR   PDB; 5ZBX; X-ray; 2.58 A; B/F=1-103.
DR   PDB; 5ZGC; X-ray; 2.90 A; G/H/I/J/K/L=12-22.
DR   PDB; 6A5L; EM; 5.60 A; b/f=1-103.
DR   PDB; 6A5O; EM; 9.90 A; b/f=1-103.
DR   PDB; 6A5P; EM; 7.00 A; b/f=1-103.
DR   PDB; 6A5R; EM; 8.70 A; b/f=1-103.
DR   PDB; 6A5T; EM; 6.70 A; b/f=1-103.
DR   PDB; 6A5U; EM; 7.60 A; b/f=1-103.
DR   PDB; 6ACP; X-ray; 2.30 A; B=89-95.
DR   PDB; 6BUZ; EM; 3.92 A; B/F=1-103.
DR   PDB; 6C0W; EM; 4.00 A; B/F=1-102.
DR   PDB; 6E0C; EM; 2.63 A; B/F=1-103.
DR   PDB; 6E0P; EM; 2.60 A; B/F=1-103.
DR   PDB; 6FML; EM; 4.34 A; N/R=2-103.
DR   PDB; 6HKT; X-ray; 9.70 A; B/F/L/P/V/Z/b/f/l/p/v/z=1-103.
DR   PDB; 6HTS; EM; 4.80 A; J/N=1-103.
DR   PDB; 6INQ; EM; 6.90 A; b/f=1-103.
DR   PDB; 6IR9; EM; 3.80 A; b/f=1-103.
DR   PDB; 6J4W; EM; 7.90 A; b/f=1-103.
DR   PDB; 6J4X; EM; 4.30 A; b/f=1-103.
DR   PDB; 6J4Y; EM; 4.30 A; b/f=1-103.
DR   PDB; 6J4Z; EM; 4.10 A; b/f=1-103.
DR   PDB; 6J50; EM; 4.70 A; b/f=1-103.
DR   PDB; 6J51; EM; 4.20 A; b/f=1-103.
DR   PDB; 6JR0; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 6JR1; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 6MLC; X-ray; 1.80 A; E/F=2-21.
DR   PDB; 6MUO; EM; 3.60 A; B/F=9-102.
DR   PDB; 6MUP; EM; 3.50 A; B/F=9-102.
DR   PDB; 6O1D; EM; 3.40 A; B/F=1-103.
DR   PDB; 6R0C; EM; 4.20 A; B/F=1-103.
DR   PDB; 6R8Y; EM; 4.30 A; B/F=1-103.
DR   PDB; 6R8Z; EM; 3.90 A; B/F=1-103.
DR   PDB; 6R90; EM; 4.50 A; B/F=1-103.
DR   PDB; 6R91; EM; 4.10 A; B/F=1-103.
DR   PDB; 6R92; EM; 4.80 A; B/F=1-103.
DR   PDB; 6R93; EM; 4.00 A; B/F=1-103.
DR   PDB; 6R94; EM; 3.50 A; B/F=1-103.
DR   PDB; 6RNY; EM; 3.90 A; B/F=1-103.
DR   PDB; 6SE0; EM; 3.80 A; B/F=1-103.
DR   PDB; 6SE6; EM; 3.50 A; B/F=1-103.
DR   PDB; 6SEE; EM; 4.20 A; B/F=1-103.
DR   PDB; 6SEF; EM; 3.70 A; B/F=1-103.
DR   PDB; 6SEG; EM; 3.10 A; B/F=1-103.
DR   PDB; 6UHD; X-ray; 1.60 A; C/D=2-21.
DR   PDBsum; 1ZKK; -.
DR   PDBsum; 2BQZ; -.
DR   PDBsum; 2CV5; -.
DR   PDBsum; 2IG0; -.
DR   PDBsum; 2KWN; -.
DR   PDBsum; 2KWO; -.
DR   PDBsum; 2LVM; -.
DR   PDBsum; 2QQS; -.
DR   PDBsum; 2RJE; -.
DR   PDBsum; 2RNY; -.
DR   PDBsum; 2RS9; -.
DR   PDBsum; 3A6N; -.
DR   PDBsum; 3AFA; -.
DR   PDBsum; 3AN2; -.
DR   PDBsum; 3AV1; -.
DR   PDBsum; 3AV2; -.
DR   PDBsum; 3AYW; -.
DR   PDBsum; 3AZE; -.
DR   PDBsum; 3AZF; -.
DR   PDBsum; 3AZG; -.
DR   PDBsum; 3AZH; -.
DR   PDBsum; 3AZI; -.
DR   PDBsum; 3AZJ; -.
DR   PDBsum; 3AZK; -.
DR   PDBsum; 3AZL; -.
DR   PDBsum; 3AZM; -.
DR   PDBsum; 3AZN; -.
DR   PDBsum; 3CFS; -.
DR   PDBsum; 3CFV; -.
DR   PDBsum; 3F9W; -.
DR   PDBsum; 3F9X; -.
DR   PDBsum; 3F9Y; -.
DR   PDBsum; 3F9Z; -.
DR   PDBsum; 3IJ1; -.
DR   PDBsum; 3JPX; -.
DR   PDBsum; 3NQJ; -.
DR   PDBsum; 3NQU; -.
DR   PDBsum; 3O36; -.
DR   PDBsum; 3QBY; -.
DR   PDBsum; 3QZS; -.
DR   PDBsum; 3QZT; -.
DR   PDBsum; 3QZV; -.
DR   PDBsum; 3R45; -.
DR   PDBsum; 3UVW; -.
DR   PDBsum; 3UVX; -.
DR   PDBsum; 3UVY; -.
DR   PDBsum; 3UW9; -.
DR   PDBsum; 3W96; -.
DR   PDBsum; 3W97; -.
DR   PDBsum; 3W98; -.
DR   PDBsum; 3W99; -.
DR   PDBsum; 3WA9; -.
DR   PDBsum; 3WAA; -.
DR   PDBsum; 3WKJ; -.
DR   PDBsum; 3WTP; -.
DR   PDBsum; 3X1S; -.
DR   PDBsum; 3X1T; -.
DR   PDBsum; 3X1U; -.
DR   PDBsum; 3X1V; -.
DR   PDBsum; 4GQB; -.
DR   PDBsum; 4H9N; -.
DR   PDBsum; 4H9O; -.
DR   PDBsum; 4H9P; -.
DR   PDBsum; 4H9Q; -.
DR   PDBsum; 4H9R; -.
DR   PDBsum; 4H9S; -.
DR   PDBsum; 4HGA; -.
DR   PDBsum; 4M38; -.
DR   PDBsum; 4N3W; -.
DR   PDBsum; 4N4F; -.
DR   PDBsum; 4QUT; -.
DR   PDBsum; 4QUU; -.
DR   PDBsum; 4QYD; -.
DR   PDBsum; 4U9W; -.
DR   PDBsum; 4YM5; -.
DR   PDBsum; 4YM6; -.
DR   PDBsum; 4YY6; -.
DR   PDBsum; 4YYD; -.
DR   PDBsum; 4YYG; -.
DR   PDBsum; 4YYH; -.
DR   PDBsum; 4YYI; -.
DR   PDBsum; 4YYJ; -.
DR   PDBsum; 4YYK; -.
DR   PDBsum; 4YYM; -.
DR   PDBsum; 4YYN; -.
DR   PDBsum; 4Z2M; -.
DR   PDBsum; 4Z5T; -.
DR   PDBsum; 5AV5; -.
DR   PDBsum; 5AV6; -.
DR   PDBsum; 5AV8; -.
DR   PDBsum; 5AV9; -.
DR   PDBsum; 5AVB; -.
DR   PDBsum; 5AVC; -.
DR   PDBsum; 5AY8; -.
DR   PDBsum; 5B0Y; -.
DR   PDBsum; 5B0Z; -.
DR   PDBsum; 5B24; -.
DR   PDBsum; 5B2I; -.
DR   PDBsum; 5B2J; -.
DR   PDBsum; 5B31; -.
DR   PDBsum; 5B32; -.
DR   PDBsum; 5B33; -.
DR   PDBsum; 5B40; -.
DR   PDBsum; 5BNV; -.
DR   PDBsum; 5BNX; -.
DR   PDBsum; 5BO0; -.
DR   PDBsum; 5C3I; -.
DR   PDBsum; 5CPI; -.
DR   PDBsum; 5CPJ; -.
DR   PDBsum; 5CPK; -.
DR   PDBsum; 5FA5; -.
DR   PDBsum; 5FFW; -.
DR   PDBsum; 5FWE; -.
DR   PDBsum; 5GSE; -.
DR   PDBsum; 5GSU; -.
DR   PDBsum; 5GT0; -.
DR   PDBsum; 5GT3; -.
DR   PDBsum; 5GTC; -.
DR   PDBsum; 5GXQ; -.
DR   PDBsum; 5JA4; -.
DR   PDBsum; 5JRG; -.
DR   PDBsum; 5KDM; -.
DR   PDBsum; 5TEG; -.
DR   PDBsum; 5X7X; -.
DR   PDBsum; 5XF3; -.
DR   PDBsum; 5XF4; -.
DR   PDBsum; 5XF5; -.
DR   PDBsum; 5Y0C; -.
DR   PDBsum; 5Y0D; -.
DR   PDBsum; 5YE3; -.
DR   PDBsum; 5YE4; -.
DR   PDBsum; 5Z23; -.
DR   PDBsum; 5Z30; -.
DR   PDBsum; 5ZBX; -.
DR   PDBsum; 5ZGC; -.
DR   PDBsum; 6A5L; -.
DR   PDBsum; 6A5O; -.
DR   PDBsum; 6A5P; -.
DR   PDBsum; 6A5R; -.
DR   PDBsum; 6A5T; -.
DR   PDBsum; 6A5U; -.
DR   PDBsum; 6ACP; -.
DR   PDBsum; 6BUZ; -.
DR   PDBsum; 6C0W; -.
DR   PDBsum; 6E0C; -.
DR   PDBsum; 6E0P; -.
DR   PDBsum; 6FML; -.
DR   PDBsum; 6HKT; -.
DR   PDBsum; 6HTS; -.
DR   PDBsum; 6INQ; -.
DR   PDBsum; 6IR9; -.
DR   PDBsum; 6J4W; -.
DR   PDBsum; 6J4X; -.
DR   PDBsum; 6J4Y; -.
DR   PDBsum; 6J4Z; -.
DR   PDBsum; 6J50; -.
DR   PDBsum; 6J51; -.
DR   PDBsum; 6JR0; -.
DR   PDBsum; 6JR1; -.
DR   PDBsum; 6MLC; -.
DR   PDBsum; 6MUO; -.
DR   PDBsum; 6MUP; -.
DR   PDBsum; 6O1D; -.
DR   PDBsum; 6R0C; -.
DR   PDBsum; 6R8Y; -.
DR   PDBsum; 6R8Z; -.
DR   PDBsum; 6R90; -.
DR   PDBsum; 6R91; -.
DR   PDBsum; 6R92; -.
DR   PDBsum; 6R93; -.
DR   PDBsum; 6R94; -.
DR   PDBsum; 6RNY; -.
DR   PDBsum; 6SE0; -.
DR   PDBsum; 6SE6; -.
DR   PDBsum; 6SEE; -.
DR   PDBsum; 6SEF; -.
DR   PDBsum; 6SEG; -.
DR   PDBsum; 6UHD; -.
DR   SMR; P62805; -.
DR   BioGrid; 113899; 33.
DR   BioGrid; 113955; 471.
DR   BioGrid; 113956; 22.
DR   BioGrid; 113957; 35.
DR   BioGrid; 113958; 22.
DR   BioGrid; 113959; 25.
DR   BioGrid; 113960; 22.
DR   BioGrid; 113961; 29.
DR   BioGrid; 113962; 22.
DR   BioGrid; 113963; 27.
DR   BioGrid; 113964; 23.
DR   BioGrid; 113966; 56.
DR   BioGrid; 125732; 103.
DR   BioGrid; 299853; 31.
DR   CORUM; P62805; -.
DR   DIP; DIP-33079N; -.
DR   IntAct; P62805; 207.
DR   MINT; P62805; -.
DR   STRING; 9606.ENSP00000484789; -.
DR   BindingDB; P62805; -.
DR   ChEMBL; CHEMBL5876; -.
DR   iPTMnet; P62805; -.
DR   PhosphoSitePlus; P62805; -.
DR   SwissPalm; P62805; -.
DR   BioMuta; HIST4H4; -.
DR   DMDM; 51317339; -.
DR   SWISS-2DPAGE; P62805; -.
DR   CPTAC; CPTAC-1055; -.
DR   CPTAC; CPTAC-1056; -.
DR   EPD; P62805; -.
DR   jPOST; P62805; -.
DR   MassIVE; P62805; -.
DR   MaxQB; P62805; -.
DR   PaxDb; P62805; -.
DR   PeptideAtlas; P62805; -.
DR   PRIDE; P62805; -.
DR   ProteomicsDB; 57424; -.
DR   TopDownProteomics; P62805; -.
DR   DNASU; 8294; -.
DR   DNASU; 8360; -.
DR   DNASU; 8362; -.
DR   DNASU; 8363; -.
DR   DNASU; 8364; -.
DR   DNASU; 8365; -.
DR   DNASU; 8366; -.
DR   DNASU; 8367; -.
DR   DNASU; 8368; -.
DR   DNASU; 8370; -.
DR   Ensembl; ENST00000244537; ENSP00000244537; ENSG00000274618.
DR   Ensembl; ENST00000355057; ENSP00000347168; ENSG00000197238.
DR   Ensembl; ENST00000358064; ENSP00000350767; ENSG00000197837.
DR   Ensembl; ENST00000377727; ENSP00000366956; ENSG00000158406.
DR   Ensembl; ENST00000377745; ENSP00000366974; ENSG00000278705.
DR   Ensembl; ENST00000377803; ENSP00000367034; ENSG00000197061.
DR   Ensembl; ENST00000539745; ENSP00000443017; ENSG00000197837.
DR   Ensembl; ENST00000578186; ENSP00000462667; ENSG00000270882.
DR   Ensembl; ENST00000579512; ENSP00000462355; ENSG00000270276.
DR   Ensembl; ENST00000611927; ENSP00000479794; ENSG00000273542.
DR   Ensembl; ENST00000612061; ENSP00000482412; ENSG00000270276.
DR   Ensembl; ENST00000613412; ENSP00000481343; ENSG00000270882.
DR   Ensembl; ENST00000614247; ENSP00000479461; ENSG00000277157.
DR   Ensembl; ENST00000614272; ENSP00000478519; ENSG00000270882.
DR   Ensembl; ENST00000615164; ENSP00000484789; ENSG00000276966.
DR   Ensembl; ENST00000615353; ENSP00000481486; ENSG00000276180.
DR   Ensembl; ENST00000617569; ENSP00000479106; ENSG00000278637.
DR   Ensembl; ENST00000618193; ENSP00000478786; ENSG00000270882.
DR   Ensembl; ENST00000618305; ENSP00000480960; ENSG00000275126.
DR   Ensembl; ENST00000621520; ENSP00000481507; ENSG00000270276.
DR   Ensembl; ENST00000634560; ENSP00000489319; ENSG00000158406.
DR   Ensembl; ENST00000634956; ENSP00000489567; ENSG00000158406.
DR   Ensembl; ENST00000635491; ENSP00000489236; ENSG00000158406.
DR   GeneID; 121504; -.
DR   GeneID; 554313; -.
DR   GeneID; 8294; -.
DR   GeneID; 8359; -.
DR   GeneID; 8360; -.
DR   GeneID; 8361; -.
DR   GeneID; 8362; -.
DR   GeneID; 8363; -.
DR   GeneID; 8364; -.
DR   GeneID; 8365; -.
DR   GeneID; 8366; -.
DR   GeneID; 8367; -.
DR   GeneID; 8368; -.
DR   GeneID; 8370; -.
DR   KEGG; hsa:121504; -.
DR   KEGG; hsa:554313; -.
DR   KEGG; hsa:8294; -.
DR   KEGG; hsa:8359; -.
DR   KEGG; hsa:8360; -.
DR   KEGG; hsa:8361; -.
DR   KEGG; hsa:8362; -.
DR   KEGG; hsa:8363; -.
DR   KEGG; hsa:8364; -.
DR   KEGG; hsa:8365; -.
DR   KEGG; hsa:8366; -.
DR   KEGG; hsa:8367; -.
DR   KEGG; hsa:8368; -.
DR   KEGG; hsa:8370; -.
DR   UCSC; uc001ess.4; human.
DR   CTD; 121504; -.
DR   CTD; 554313; -.
DR   CTD; 8294; -.
DR   CTD; 8359; -.
DR   CTD; 8360; -.
DR   CTD; 8361; -.
DR   CTD; 8362; -.
DR   CTD; 8363; -.
DR   CTD; 8364; -.
DR   CTD; 8365; -.
DR   CTD; 8366; -.
DR   CTD; 8367; -.
DR   CTD; 8368; -.
DR   CTD; 8370; -.
DR   DisGeNET; 121504; -.
DR   DisGeNET; 554313; -.
DR   DisGeNET; 8294; -.
DR   DisGeNET; 8359; -.
DR   DisGeNET; 8360; -.
DR   DisGeNET; 8361; -.
DR   DisGeNET; 8362; -.
DR   DisGeNET; 8363; -.
DR   DisGeNET; 8364; -.
DR   DisGeNET; 8365; -.
DR   DisGeNET; 8366; -.
DR   DisGeNET; 8367; -.
DR   DisGeNET; 8368; -.
DR   DisGeNET; 8370; -.
DR   GeneCards; H4-16; -.
DR   GeneCards; H4C1; -.
DR   GeneCards; H4C11; -.
DR   GeneCards; H4C12; -.
DR   GeneCards; H4C13; -.
DR   GeneCards; H4C14; -.
DR   GeneCards; H4C15; -.
DR   GeneCards; H4C2; -.
DR   GeneCards; H4C3; -.
DR   GeneCards; H4C4; -.
DR   GeneCards; H4C5; -.
DR   GeneCards; H4C6; -.
DR   GeneCards; H4C8; -.
DR   GeneCards; H4C9; -.
DR   HGNC; HGNC:20510; H4-16.
DR   HGNC; HGNC:4781; H4C1.
DR   HGNC; HGNC:4785; H4C11.
DR   HGNC; HGNC:4784; H4C12.
DR   HGNC; HGNC:4791; H4C13.
DR   HGNC; HGNC:4794; H4C14.
DR   HGNC; HGNC:29607; H4C15.
DR   HGNC; HGNC:4789; H4C2.
DR   HGNC; HGNC:4787; H4C3.
DR   HGNC; HGNC:4782; H4C4.
DR   HGNC; HGNC:4790; H4C5.
DR   HGNC; HGNC:4783; H4C6.
DR   HGNC; HGNC:4788; H4C8.
DR   HGNC; HGNC:4793; H4C9.
DR   HPA; CAB011503; -.
DR   HPA; CAB021887; -.
DR   HPA; CAB037279; -.
DR   HPA; HPA042201; -.
DR   MIM; 142750; gene.
DR   MIM; 602822; gene.
DR   MIM; 602823; gene.
DR   MIM; 602824; gene.
DR   MIM; 602825; gene.
DR   MIM; 602826; gene.
DR   MIM; 602827; gene.
DR   MIM; 602828; gene.
DR   MIM; 602829; gene.
DR   MIM; 602830; gene.
DR   MIM; 602831; gene.
DR   MIM; 602833; gene.
DR   MIM; 615069; gene.
DR   neXtProt; NX_P62805; -.
DR   OpenTargets; ENSG00000158406; -.
DR   OpenTargets; ENSG00000197061; -.
DR   OpenTargets; ENSG00000197238; -.
DR   OpenTargets; ENSG00000197837; -.
DR   OpenTargets; ENSG00000270276; -.
DR   OpenTargets; ENSG00000270882; -.
DR   OpenTargets; ENSG00000273542; -.
DR   OpenTargets; ENSG00000274618; -.
DR   OpenTargets; ENSG00000275126; -.
DR   OpenTargets; ENSG00000276180; -.
DR   OpenTargets; ENSG00000276966; -.
DR   OpenTargets; ENSG00000277157; -.
DR   OpenTargets; ENSG00000278637; -.
DR   OpenTargets; ENSG00000278705; -.
DR   PharmGKB; PA29169; -.
DR   eggNOG; KOG3467; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00980000198478; -.
DR   GeneTree; ENSGT00980000198564; -.
DR   HOGENOM; CLU_109117_2_3_1; -.
DR   InParanoid; P62805; -.
DR   KO; K11254; -.
DR   OMA; QKEHING; -.
DR   OrthoDB; 1536672at2759; -.
DR   PhylomeDB; P62805; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-3214842; HDMs demethylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   SIGNOR; P62805; -.
DR   ChiTaRS; HIST1H4A; human.
DR   ChiTaRS; HIST1H4C; human.
DR   ChiTaRS; HIST1H4E; human.
DR   ChiTaRS; HIST1H4F; human.
DR   ChiTaRS; HIST1H4H; human.
DR   ChiTaRS; HIST1H4J; human.
DR   ChiTaRS; HIST1H4K; human.
DR   ChiTaRS; HIST2H4B; human.
DR   EvolutionaryTrace; P62805; -.
DR   GeneWiki; HIST1H4A; -.
DR   GeneWiki; HIST1H4B; -.
DR   GeneWiki; HIST1H4C; -.
DR   GeneWiki; HIST1H4D; -.
DR   GeneWiki; HIST1H4E; -.
DR   GeneWiki; HIST1H4F; -.
DR   GeneWiki; HIST1H4H; -.
DR   GeneWiki; HIST1H4I; -.
DR   GeneWiki; HIST1H4J; -.
DR   GeneWiki; HIST1H4K; -.
DR   GeneWiki; HIST1H4L; -.
DR   GeneWiki; HIST2H4A; -.
DR   GeneWiki; HIST4H4; -.
DR   Pharos; P62805; Tbio.
DR   PRO; PR:P62805; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P62805; protein.
DR   Bgee; ENSG00000158406; Expressed in stomach and 162 other tissues.
DR   ExpressionAtlas; P62805; baseline and differential.
DR   Genevisible; P62805; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0000228; C:nuclear chromosome; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0034080; P:CENP-A containing nucleosome assembly; TAS:Reactome.
DR   GO; GO:0000183; P:chromatin silencing at rDNA; TAS:Reactome.
DR   GO; GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0045653; P:negative regulation of megakaryocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0016233; P:telomere capping; TAS:Reactome.
DR   GO; GO:0032200; P:telomere organization; TAS:BHF-UCL.
DR   CDD; cd00076; H4; 1.
DR   DisProt; DP02034; -.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR035425; CENP-T/H4_C.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR001951; Histone_H4.
DR   InterPro; IPR019809; Histone_H4_CS.
DR   InterPro; IPR004823; TAF_TATA-bd.
DR   Pfam; PF15511; CENP-T_C; 1.
DR   PRINTS; PR00623; HISTONEH4.
DR   SMART; SM00417; H4; 1.
DR   SMART; SM00803; TAF; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00047; HISTONE_H4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosomal rearrangement; Chromosome;
KW   Citrullination; Direct protein sequencing; DNA-binding; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:17967882"
FT   CHAIN           2..103
FT                   /note="Histone H4"
FT                   /id="PRO_0000158320"
FT   DNA_BIND        17..21
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:17967882"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17967882"
FT   MOD_RES         4
FT                   /note="Asymmetric dimethylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000269|PubMed:11387442,
FT                   ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:15345777"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15345777,
FT                   ECO:0000269|PubMed:16567635"
FT   MOD_RES         4
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000269|PubMed:11387442,
FT                   ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:15345777"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5 and PRMT7;
FT                   alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:2474456, ECO:0000269|PubMed:7664735"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         6
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         9
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         9
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         9
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:2474456, ECO:0000269|PubMed:7664735"
FT   MOD_RES         9
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393,
FT                   ECO:0000269|PubMed:27105113"
FT   MOD_RES         9
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         9
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:17967882, ECO:0000269|PubMed:2474456,
FT                   ECO:0000269|PubMed:7664735"
FT   MOD_RES         13
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         13
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         17
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:17967882, ECO:0000269|PubMed:2474456,
FT                   ECO:0000269|PubMed:7664735"
FT   MOD_RES         17
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393,
FT                   ECO:0000269|PubMed:27105113"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         17
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         21
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:12086618,
FT                   ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882"
FT   MOD_RES         21
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:12086618,
FT                   ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882"
FT   MOD_RES         21
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:12086618,
FT                   ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882"
FT   MOD_RES         32
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         32
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         32
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         32
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         32
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         32
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         32
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         45
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         45
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         45
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         48
FT                   /note="Phosphoserine; by PAK2"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569,
FT                   ECO:0000269|PubMed:21724829"
FT   MOD_RES         52
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:15592455,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         60
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         60
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         78
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         78
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         78
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         78
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         78
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         78
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         80
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         80
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         80
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         80
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         81
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         89
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         92
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         92
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         92
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19818714"
FT   MOD_RES         92
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         92
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         92
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         92
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CROSSLNK        13
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        32
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        60
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        80
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:19818714"
FT   VARIANT         64
FT                   /note="E -> Q (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs747622981)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036206"
FT   CONFLICT        71
FT                   /note="V -> A (in Ref. 14; AAH67496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        77
FT                   /note="A -> P (in Ref. 11; CAG46986)"
FT                   /evidence="ECO:0000305"
FT   TURN            7..10
FT                   /evidence="ECO:0000244|PDB:4YYM"
FT   STRAND          16..18
FT                   /evidence="ECO:0000244|PDB:6MLC"
FT   STRAND          21..23
FT                   /evidence="ECO:0000244|PDB:3F9X"
FT   STRAND          28..30
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   HELIX           32..41
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   STRAND          45..47
FT                   /evidence="ECO:0000244|PDB:6E0P"
FT   HELIX           49..76
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   STRAND          80..82
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   HELIX           84..91
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   STRAND          94..96
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   TURN            97..102
FT                   /evidence="ECO:0000244|PDB:4H9N"
SQ   SEQUENCE   103 AA;  11367 MW;  A9E5DFD3F8B97598 CRC64;
     MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL IYEETRGVLK
     VFLENVIRDA VTYTEHAKRK TVTAMDVVYA LKRQGRTLYG FGG
//
ID   HILS1_HUMAN             Reviewed;         231 AA.
AC   P60008;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2003, sequence version 1.
DT   26-FEB-2020, entry version 111.
DE   RecName: Full=Spermatid-specific linker histone H1-like protein;
GN   Name=HILS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Testis;
RX   PubMed=12920187; DOI=10.1073/pnas.1837812100;
RA   Yan W., Ma L., Burns K.H., Matzuk M.M.;
RT   "HILS1 is a spermatid-specific linker histone H1-like protein implicated in
RT   chromatin remodeling during mammalian spermiogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10546-10551(2003).
CC   -!- FUNCTION: DNA-binding protein that may be implicated in chromatin
CC       remodeling and/or transcriptional regulation during spermiogenesis, the
CC       process of spermatid maturation into spermatozoa.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00837}.
CC       Chromosome {ECO:0000255|PROSITE-ProRule:PRU00837}.
CC   -!- TISSUE SPECIFICITY: Expressed exclusively in the testis.
CC   -!- SIMILARITY: Belongs to the histone H1/H5 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00837}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY286318; AAQ23050.1; -; mRNA.
DR   IntAct; P60008; 1.
DR   iPTMnet; P60008; -.
DR   PhosphoSitePlus; P60008; -.
DR   BioMuta; HGNC:30616; -.
DR   DMDM; 38372285; -.
DR   MassIVE; P60008; -.
DR   PRIDE; P60008; -.
DR   ProteomicsDB; 57179; -.
DR   HGNC; HGNC:30616; HILS1.
DR   MIM; 608101; gene.
DR   neXtProt; NX_P60008; -.
DR   InParanoid; P60008; -.
DR   PhylomeDB; P60008; -.
DR   Pharos; P60008; Tbio.
DR   PRO; PR:P60008; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; P60008; protein.
DR   GO; GO:0001673; C:male germ cell nucleus; IDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005719; C:nuclear euchromatin; IBA:GO_Central.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0003676; F:nucleic acid binding; IDA:UniProtKB.
DR   GO; GO:0031492; F:nucleosomal DNA binding; IBA:GO_Central.
DR   GO; GO:0006338; P:chromatin remodeling; NAS:UniProtKB.
DR   GO; GO:0006342; P:chromatin silencing; IDA:UniProtKB.
DR   GO; GO:0030261; P:chromosome condensation; IDA:UniProtKB.
DR   GO; GO:0007281; P:germ cell development; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0031936; P:negative regulation of chromatin silencing; IBA:GO_Central.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; IBA:GO_Central.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0016584; P:nucleosome positioning; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; IDA:UniProtKB.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00538; Linker_histone; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS51504; H15; 1.
PE   1: Evidence at protein level;
KW   Chromatin regulator; Chromosome; Developmental protein; Differentiation;
KW   DNA-binding; Nucleus; Phosphoprotein; Reference proteome; Spermatogenesis;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..231
FT                   /note="Spermatid-specific linker histone H1-like protein"
FT                   /id="PRO_0000196014"
FT   DOMAIN          113..177
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   MOD_RES         135
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZZW6"
SQ   SEQUENCE   231 AA;  25632 MW;  DF3612D213CB406F CRC64;
     MLHASTIWHL RSTPPRRKQW GHCDPHRILV ASEVTTEITS PTPAPRAQVC GGQPWVTVLD
     PLSGHTGREA ERHFATVSIS AVELKYCHGW RPAGQRVPSK TATGQRTCAK PCQKPSTSKV
     ILRAVADKGT CKYVSLATLK KAVSTTGYDM ARNAYHFKRV LKGLVDKGSA GSFTLGKKQA
     SKSKLKVKRQ RQQRWRSGQR PFGQHRSLLG SKQGHKRLIK GVRRVAKCHC N
//
